data_1uhm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uhm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CZ ' ' CG ' ' A' ' 89' ' ' TYR . 34.0 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.24 0.543 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -52.72 -46.35 67.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.1 mm-40 -56.95 -46.2 82.27 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.175 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.473 ' HB3' HG12 ' A' ' 73' ' ' ILE . 96.6 mt -52.33 -32.07 36.33 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.932 -1.105 . . . . 0.0 108.987 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.614 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 5.8 mt -82.2 -55.94 6.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.553 0.692 . . . . 0.0 109.362 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.606 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.8 mt -59.12 -51.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 6.0 mt-10 -62.95 -39.92 96.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.57 -45.1 96.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.537 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 6.9 mt -64.45 -36.61 84.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -1.046 . . . . 0.0 109.175 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m -72.88 -30.07 63.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.0 108.909 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.426 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.73 -19.75 23.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.556 -0.715 . . . . 0.0 110.041 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 9.4 mt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.093 -1.004 . . . . 0.0 109.581 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.521 ' CB ' HD11 ' A' ' 58' ' ' LEU . 33.7 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 9.5 p -125.09 172.61 9.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.608 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.9 ttp180 -44.82 -48.56 29.02 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.78 -0.575 . . . . 0.0 111.151 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.4 Cg_endo -67.48 -42.37 7.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.234 1.123 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.32 -28.13 51.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.7 mm? -86.72 -51.19 6.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.803 . . . . 0.0 109.519 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 29.4 mttp -54.61 -42.04 70.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -52.39 -49.74 63.82 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.111 0.958 . . . . 0.0 108.646 177.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -59.76 -45.33 92.58 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 77' ' ' TYR . 28.8 mt -65.18 -32.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.467 -0.771 . . . . 0.0 111.159 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.69 -41.48 10.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.85 -1.156 . . . . 0.0 111.178 -179.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 11.9 mt-10 -95.88 -65.25 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 33.2 m-20 -56.43 -19.88 17.1 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.653 -1.279 . . . . 0.0 108.102 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.06 177.33 1.99 Allowed Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 177.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 50.0 Cg_endo -68.46 176.77 5.33 Favored 'Trans proline' 0 C--N 1.281 -3.006 0 O-C-N 123.997 1.525 . . . . 0.0 114.261 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.591 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.3 tt -50.72 -15.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.846 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.6 p -45.42 -29.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.606 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.94 -35.94 6.21 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.591 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -82.43 45.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -1.012 . . . . 0.0 109.972 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.78 -127.01 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 43.5 t -150.68 -78.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.86 -1.15 . . . . 0.0 110.844 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' PHE . 55.8 t-20 -52.4 -34.55 48.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.128 -0.982 . . . . 0.0 110.868 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.606 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 1.2 t80 -48.51 -38.76 21.07 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.731 -1.23 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.527 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -46.8 -32.93 4.01 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.678 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 tp -75.93 -32.86 59.77 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 47' ' ' TYR . 5.7 m-85 -69.73 -46.72 65.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 51' ' ' ILE . 32.8 t80 -58.09 -41.02 82.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.132 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.9 m-20 -56.82 -55.11 38.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.966 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -38.88 66.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.285 -0.885 . . . . 0.0 108.889 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -63.02 -41.32 99.51 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.614 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 11.4 mm -63.42 -58.8 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 36.2 mttp -56.06 -41.44 75.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -49.23 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -69.45 -48.13 46.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 40.2 t -63.9 -43.44 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -1.031 . . . . 0.0 110.57 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.3 tp10 -61.92 -34.56 76.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.66 11.77 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.39 78.65 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 7.1 t0 -85.54 -68.42 0.73 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -1.155 . . . . 0.0 109.969 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -105.22 169.73 8.28 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.541 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -110.9 126.85 55.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.523 ' OE1' ' CA ' ' A' ' 113' ' ' VAL . 1.3 mm100 -138.51 109.72 8.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.763 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.3 Cg_endo . . . . . 0 C--N 1.305 -1.723 0 O-C-N 124.021 1.537 . . . . 0.0 109.891 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.06 121.66 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -1.165 . . . . 0.0 109.926 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.6 p -81.27 126.19 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -125.23 128.76 48.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.83 . . . . 0.0 109.781 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.474 ' N ' HD23 ' A' ' 55' ' ' LEU . 11.6 tp . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.103 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 96.5 m-85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.26 0.553 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.539 ' HD2' ' CD1' ' A' ' 52' ' ' ILE 0.25 2.7 tmm_? -49.14 -44.61 42.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 13.7 mt-10 -57.74 -45.58 85.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.091 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 98.7 mt -52.99 -32.56 47.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.062 -1.023 . . . . 0.0 108.883 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.61 ' CG2' ' CD2' ' A' ' 103' ' ' PHE . 5.3 mt -78.93 -56.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.563 0.697 . . . . 0.0 109.314 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 103' ' ' PHE . 23.5 mt -59.0 -53.08 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 1.9 mm-40 -61.07 -39.66 90.71 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.99 -46.83 93.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -63.89 -38.78 92.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -1.055 . . . . 0.0 109.077 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -69.75 -28.2 65.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.64 -22.47 21.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.0 109.724 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.543 HD12 ' CB ' ' A' ' 64' ' ' SER . 12.8 mt . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.326 -0.859 . . . . 0.0 109.219 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.543 ' CB ' HD12 ' A' ' 58' ' ' LEU . 20.9 m . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -128.59 174.06 9.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 111.549 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.624 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -47.57 -47.51 60.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.792 -0.568 . . . . 0.0 111.318 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -66.96 -42.21 8.69 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.286 1.15 . . . . 0.0 110.47 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.52 -27.24 56.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.669 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.542 ' N ' HD21 ' A' ' 69' ' ' LEU . 4.5 mm? -92.08 -47.42 7.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 109.597 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 19.1 mttp -55.88 -40.21 72.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 108.517 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.495 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 5.3 ttpt -54.54 -52.7 61.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t80 -58.52 -43.54 89.22 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.581 HD13 ' CD1' ' A' ' 90' ' ' PHE . 54.8 mt -63.35 -33.1 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 0.0 111.104 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.557 ' N ' ' HA3' ' A' ' 81' ' ' GLY . 6.5 pttt -91.62 -41.55 10.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.007 -1.058 . . . . 0.0 111.418 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.525 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.5 mt-10 -95.42 -65.44 0.98 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.042 . . . . 0.0 109.897 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.549 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.9 m-20 -56.82 -21.1 26.45 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.077 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.533 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -125.25 176.54 2.35 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -66.05 175.44 4.73 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 O-C-N 123.976 1.514 . . . . 0.0 114.119 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.615 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 17.8 mm -52.42 -12.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.937 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.3 p -45.97 -31.14 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.601 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.31 -38.25 7.29 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -82.32 42.29 0.74 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.621 -0.929 . . . . 0.0 110.078 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.04 -133.76 0.29 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' PHE . 20.7 m -143.9 -92.18 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.912 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.2 t30 -40.18 -28.14 0.05 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.142 -0.974 . . . . 0.0 110.965 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -48.32 -42.11 30.26 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.537 179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.54 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.4 t0 -47.42 -30.66 3.48 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.767 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.5 tp -76.81 -28.15 55.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.464 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 49.1 m-85 -77.05 -46.98 21.85 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.207 -0.933 . . . . 0.0 108.892 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 70.7 t80 -56.9 -43.03 80.93 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-20 -55.5 -57.0 13.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.185 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.87 -40.17 69.43 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.028 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -62.0 -45.57 93.04 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.485 -0.76 . . . . 0.0 109.016 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 16.7 mm -60.01 -58.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -0.807 . . . . 0.0 109.015 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.76 -38.2 74.99 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.758 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 5.2 tptt -66.03 -50.97 62.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.848 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -63.63 -51.48 53.73 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 103' ' ' PHE . 93.1 t -60.81 -39.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.978 . . . . 0.0 110.054 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 34.4 tp10 -63.19 -33.48 75.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.186 -0.947 . . . . 0.0 109.863 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.93 17.39 3.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.384 -0.822 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.6 73.4 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -87.57 -69.2 0.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.329 -1.101 . . . . 0.0 110.103 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.66 169.32 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -108.59 125.54 51.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -138.74 97.87 8.92 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.987 . . . . 0.0 110.63 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.5 Cg_endo . . . . . 0 C--N 1.305 -1.762 0 O-C-N 123.905 1.476 . . . . 0.0 109.896 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -102.37 160.16 14.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.972 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.9 p -121.19 117.58 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.862 -1.149 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -114.25 128.63 56.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.532 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 56.8 tp . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 61.9 m-85 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -69.7 -45.62 67.85 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 53' ' ' GLU . 39.4 mt-10 -58.47 -42.25 87.06 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.294 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 47' ' ' TYR . 77.8 mt -54.26 -34.17 60.16 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.869 -1.145 . . . . 0.0 108.701 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG12 ' CE2' ' A' ' 90' ' ' PHE . 57.7 mt -79.35 -55.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.636 -0.665 . . . . 0.0 109.27 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.8 mt -59.24 -54.49 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.5 mt-10 -62.2 -41.58 98.5 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.9 -43.71 96.54 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.55 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 7.1 mt -62.35 -36.54 82.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -1.021 . . . . 0.0 109.041 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -72.2 -28.42 63.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.355 -0.84 . . . . 0.0 109.051 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 72' ' ' PHE . . . -90.26 -18.13 26.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.59 -0.694 . . . . 0.0 109.632 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD13 ' CB ' ' A' ' 64' ' ' SER . 14.4 mt . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.239 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.546 ' CB ' HD13 ' A' ' 58' ' ' LEU . 13.8 m . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 p -127.81 176.58 7.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.4 tpp85 -46.28 -47.6 45.62 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.5 Cg_endo -67.99 -42.51 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.274 1.144 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 64' ' ' SER . . . -58.06 -36.52 72.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 113' ' ' VAL . 4.5 mm? -78.36 -49.52 13.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.815 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.7 mtpt -52.09 -39.63 60.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.457 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 7.6 ttpt -50.94 -51.7 49.71 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.53 -48.41 81.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.616 HD11 ' CD2' ' A' ' 90' ' ' PHE . 11.8 mt -61.62 -33.49 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.596 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.531 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -91.28 -41.65 10.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.151 -0.968 . . . . 0.0 111.575 -179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 38.5 mt-10 -92.3 -65.81 0.97 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.963 -1.086 . . . . 0.0 110.106 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 18.0 m-20 -59.09 -22.02 60.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.865 -1.147 . . . . 0.0 108.214 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.533 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -123.8 176.87 1.97 Allowed Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.58 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -65.07 172.74 6.9 Favored 'Trans proline' 0 C--N 1.282 -2.941 0 O-C-N 124.071 1.564 . . . . 0.0 113.527 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -52.9 -12.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.495 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.589 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 8.5 p -45.64 -29.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.541 ' CA ' HG22 ' A' ' 73' ' ' ILE . . . -89.13 -36.72 7.49 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 16.1 t -65.57 -8.63 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.543 -0.975 . . . . 0.0 110.432 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.79 -160.69 0.5 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 111.108 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.5 t -127.21 -67.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.264 -0.897 . . . . 0.0 110.682 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 84' ' ' SER . 16.0 t-20 -40.73 -41.27 1.5 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.215 -0.928 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -48.12 -40.91 25.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.541 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 7.6 t70 -46.72 -32.18 3.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -71.99 -33.82 68.41 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.636 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 21.6 m-85 -75.09 -43.01 55.46 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.402 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CD2' HD11 ' A' ' 73' ' ' ILE . 43.7 t80 -57.46 -39.02 75.43 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -62.88 -54.88 31.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.508 -0.745 . . . . 0.0 109.487 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.69 -38.86 49.39 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.844 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.542 ' CB ' HD12 ' A' ' 51' ' ' ILE . . . -66.16 -47.61 73.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.546 HG13 ' CE1' ' A' ' 90' ' ' PHE . 14.5 mm -56.26 -61.03 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.076 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -56.68 -40.31 75.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.635 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -61.6 -47.33 85.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.47 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.44 -52.22 10.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.48 HG22 HG21 ' A' ' 94' ' ' ILE . 57.9 t -59.17 -36.72 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.355 -1.085 . . . . 0.0 110.419 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 4.0 tp10 -61.66 -37.33 83.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.199 -0.938 . . . . 0.0 110.06 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.54 17.36 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 109.931 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.52 25.31 74.96 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.481 ' OD2' ' HA2' ' A' ' 97' ' ' GLY . 25.1 m-20 -82.78 -67.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.136 -1.214 . . . . 0.0 109.893 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -102.91 168.23 9.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.977 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 34.3 mm-40 -105.9 125.71 51.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -0.845 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.524 ' NE2' HG23 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -141.09 102.37 6.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.118 -0.989 . . . . 0.0 111.103 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.304 -1.766 0 O-C-N 123.632 1.333 . . . . 0.0 109.648 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -103.57 160.65 14.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -1.109 . . . . 0.0 109.672 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.536 HG13 ' CD2' ' A' ' 69' ' ' LEU . 1.8 p -122.61 117.33 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.87 -1.144 . . . . 0.0 110.718 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 14.1 mtpt -115.43 129.27 56.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 109.762 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 10.2 tp . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.199 -0.938 . . . . 0.0 110.906 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 42.9 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.305 0.574 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.92 -45.7 91.26 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.33 -46.17 83.54 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.246 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.584 HD13 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 mt -50.41 -33.35 20.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.884 -1.135 . . . . 0.0 108.451 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.595 HG12 ' CE2' ' A' ' 90' ' ' PHE . 48.9 mt -80.77 -56.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.449 0.642 . . . . 0.0 109.384 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.617 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 74.2 mt -57.65 -53.41 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.7 mt-10 -59.24 -40.29 85.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.3 -46.49 86.43 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 9.1 mt -67.56 -39.89 84.93 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.54 -0.976 . . . . 0.0 108.657 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.4 m -66.19 -28.35 68.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -87.43 -29.21 21.62 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.542 ' CD1' ' HB3' ' A' ' 64' ' ' SER . 10.4 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.843 . . . . 0.0 108.997 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.542 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 1.1 m . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.199 0.523 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 7.1 p -134.64 175.99 9.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.164 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.27 -47.03 68.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.589 -0.694 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 41.0 Cg_endo -69.34 -42.81 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.231 1.122 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -30.44 66.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.975 . . . . 0.0 109.791 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 69' ' ' LEU . 4.5 mm? -86.7 -49.91 7.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.588 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 73' ' ' ILE . 5.5 mtpt -56.33 -39.64 73.14 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.452 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.67 -49.97 45.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 3.1 t80 -63.0 -47.52 82.79 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.614 HD13 ' CD2' ' A' ' 90' ' ' PHE . 14.9 mt -61.04 -31.85 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.446 -0.783 . . . . 0.0 111.114 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.25 -43.04 10.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.0 -1.062 . . . . 0.0 111.643 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 26.7 mt-10 -94.0 -65.36 0.99 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.968 -1.082 . . . . 0.0 109.911 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 9.7 m-20 -59.08 -17.42 25.87 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 108.383 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.2 m-85 -129.29 176.47 2.78 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 43.3 Cg_endo -65.27 173.35 6.34 Favored 'Trans proline' 0 C--N 1.28 -3.031 0 O-C-N 123.942 1.496 . . . . 0.0 114.082 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 33.6 mt -50.48 -16.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.452 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.589 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.2 p -44.51 -29.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . -91.31 -33.07 8.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.572 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 12.4 t -51.17 -55.7 16.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.621 -0.929 . . . . 0.0 110.743 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.67 -171.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.523 -0.736 . . . . 0.0 111.241 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -119.99 -54.63 2.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 110.429 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.477 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.4 t-20 -42.07 -41.35 2.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -49.03 -41.39 34.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.979 -1.075 . . . . 0.0 108.209 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.513 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 33.3 t0 -45.69 -31.41 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -70.33 -40.62 74.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.436 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 71.5 m-85 -68.32 -42.75 78.91 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.614 ' CD2' HD13 ' A' ' 73' ' ' ILE . 32.3 t80 -59.42 -32.6 70.33 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.3 m-80 -66.95 -53.59 30.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.53 -0.731 . . . . 0.0 109.427 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.62 -40.19 65.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.113 -0.992 . . . . 0.0 108.797 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . . . -66.46 -36.17 82.11 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.562 ' HA ' HD13 ' A' ' 51' ' ' ILE . 6.5 mm -65.19 -60.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.37 -38.12 73.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 8.4 tptm -63.08 -50.02 72.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.362 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.93 -52.72 31.21 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 105' ' ' GLN . 59.8 t -59.37 -33.77 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.492 -1.005 . . . . 0.0 109.902 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 1.2 tp10 -60.73 -40.33 92.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.287 -0.883 . . . . 0.0 109.616 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.56 15.77 3.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 109.891 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.16 24.99 76.47 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 3.4 m-20 -81.15 -67.41 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.213 -1.169 . . . . 0.0 109.86 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.712 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -106.78 162.23 13.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.251 -0.906 . . . . 0.0 109.725 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 11.9 mm-40 -101.19 125.57 47.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.672 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.489 ' OE1' HG21 ' A' ' 94' ' ' ILE . 1.1 mm-40 -133.99 98.17 14.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 111.283 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--N 1.304 -1.78 0 O-C-N 123.933 1.491 . . . . 0.0 109.342 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -112.52 160.05 18.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -1.051 . . . . 0.0 109.856 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.487 HG13 ' CD2' ' A' ' 69' ' ' LEU . 1.4 p -121.57 113.23 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.082 . . . . 0.0 109.752 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -109.85 129.85 55.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.979 . . . . 0.0 110.133 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.508 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 19.8 tp . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 60.8 m-85 . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 52' ' ' ILE . 17.2 ttm180 -59.24 -45.76 90.31 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 53' ' ' GLU . 59.1 mt-10 -59.08 -43.77 91.82 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' A' ' 73' ' ' ILE . 96.2 mt -53.42 -32.53 50.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.654 -1.279 . . . . 0.0 108.713 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.627 HG12 ' CE1' ' A' ' 90' ' ' PHE . 22.7 mt -81.23 -56.42 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.679 0.752 . . . . 0.0 109.107 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.612 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 57.4 mt -59.11 -53.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.991 0.901 . . . . 0.0 108.68 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -61.6 -39.33 90.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.596 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.59 -49.14 79.76 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.2 mt -58.52 -36.35 73.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.444 -1.033 . . . . 0.0 109.61 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -74.29 -30.13 61.95 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.771 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.94 -10.62 41.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.666 -0.646 . . . . 0.0 110.069 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD13 ' CB ' ' A' ' 64' ' ' SER . 12.5 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 109.773 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.577 ' CB ' HD13 ' A' ' 58' ' ' LEU . 27.3 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.15 0.5 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 53.7 p -130.63 173.5 10.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 111.145 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 12.0 ttp180 -52.42 -45.68 95.13 Favored Pre-proline 0 C--N 1.296 -1.725 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.7 -42.97 4.16 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.299 1.157 . . . . 0.0 110.788 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.18 -22.57 17.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.075 -1.016 . . . . 0.0 109.615 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 3.7 mm? -91.05 -48.4 6.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.356 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 27.9 mttt -56.34 -42.07 77.11 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 1.7 ttpt -51.24 -49.81 60.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.879 0.847 . . . . 0.0 108.815 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.596 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.05 -47.4 86.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 90' ' ' PHE . 15.5 mt -63.41 -31.29 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.969 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HB2' ' N ' ' A' ' 82' ' ' SER . 45.1 pttt -91.6 -41.04 10.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.877 -1.139 . . . . 0.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.534 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.6 mt-10 -96.03 -65.7 0.95 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.055 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.491 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 50.7 m-20 -56.62 -19.92 18.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.622 -1.299 . . . . 0.0 107.992 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CB ' ' HD2' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -126.44 177.97 1.74 Allowed Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.143 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.77 176.19 5.45 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.949 1.5 . . . . 0.0 114.108 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.587 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -51.99 -15.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.857 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.605 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -44.28 -30.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.572 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.27 -36.45 6.6 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.587 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.2 m -73.06 -1.21 16.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -1.075 . . . . 0.0 110.323 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -81.27 -151.35 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 110.619 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.78 -74.59 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.855 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 35.4 t-20 -41.12 -35.64 0.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.322 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.605 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.7 t80 -51.5 -42.05 61.4 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.078 -1.049 . . . . 0.0 108.553 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 26.1 m-20 -45.61 -27.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -80.83 -34.49 33.84 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.031 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 20.8 m-85 -71.94 -41.1 68.2 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.05 -1.032 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.627 ' CE1' HG12 ' A' ' 51' ' ' ILE . 71.0 t80 -59.84 -43.27 94.69 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.484 -0.76 . . . . 0.0 108.956 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 59.5 m-20 -56.98 -56.83 16.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.51 -0.744 . . . . 0.0 109.462 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.99 -39.84 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.075 -1.016 . . . . 0.0 108.985 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.537 ' CB ' HD13 ' A' ' 51' ' ' ILE . . . -64.44 -45.5 87.21 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.465 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 12.8 mm -60.15 -60.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.42 -38.16 73.91 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.893 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -66.61 -48.68 68.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 0.0 110.155 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -65.11 -52.52 40.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 105' ' ' GLN . 37.8 t -61.56 -41.29 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.549 -0.971 . . . . 0.0 110.457 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 6.6 tp10 -61.25 -35.34 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.224 -0.923 . . . . 0.0 110.016 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . . . -83.7 14.04 4.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.972 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.09 24.23 76.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.4 m-20 -85.84 -69.28 0.67 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -1.23 . . . . 0.0 109.754 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -115.5 125.73 53.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.52 ' NE2' ' CG2' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -134.91 98.18 13.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.664 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 123.873 1.459 . . . . 0.0 110.076 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -99.92 160.17 14.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -1.069 . . . . 0.0 109.933 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 69' ' ' LEU . 3.2 p -122.22 127.1 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 110.352 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -126.45 129.56 48.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.543 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 8.7 tp . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 63.0 m-85 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.95 -45.53 82.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 53.2 mm-40 -57.85 -19.32 28.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.877 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 29.6 mt -86.34 -31.75 21.37 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.7 -1.25 . . . . 0.0 108.961 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 8.2 mt -78.14 -56.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.595 -0.691 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.578 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 24.9 mt -52.74 -49.99 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 78.0 mt-10 -64.95 -41.5 95.43 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.912 0.863 . . . . 0.0 108.786 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -55.95 -44.83 87.71 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 8.9 mt -67.77 -44.15 78.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -1.047 . . . . 0.0 109.355 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -67.64 -26.29 66.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.208 -0.932 . . . . 0.0 108.848 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.57 -25.85 20.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.663 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 64' ' ' SER . 8.3 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.23 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 58' ' ' LEU . 65.4 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.135 0.493 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 5.1 p -120.97 173.04 7.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.091 -1.006 . . . . 0.0 110.97 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.603 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -43.73 -48.71 20.29 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.878 -0.513 . . . . 0.0 111.38 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.6 Cg_endo -67.55 -42.87 6.4 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.263 1.138 . . . . 0.0 110.436 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.95 -28.93 59.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.473 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' N ' HD21 ' A' ' 69' ' ' LEU . 3.7 mm? -83.3 -51.68 7.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 109.504 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 2.3 mtpt -50.06 -38.54 38.63 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.643 -1.223 . . . . 0.0 107.747 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -49.81 -55.96 12.17 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.74 -45.5 89.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 ' CD1' ' A' ' 90' ' ' PHE . 22.2 mt -62.39 -34.19 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.477 -0.765 . . . . 0.0 111.022 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.541 ' N ' ' HA3' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -91.27 -41.81 10.74 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.037 -1.04 . . . . 0.0 111.595 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 20.8 mt-10 -94.61 -65.02 1.01 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.549 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.2 m-20 -57.94 -20.56 38.59 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HB3' ' HD2' ' A' ' 78' ' ' PRO . 1.6 m-85 -126.15 177.11 2.09 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 44.3 Cg_endo -65.09 174.86 4.38 Favored 'Trans proline' 0 C--N 1.283 -2.869 0 O-C-N 123.838 1.441 . . . . 0.0 114.03 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pt -52.97 -12.46 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.031 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.4 p -46.34 -28.95 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.589 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -36.93 7.88 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 107.179 -2.368 . . . . 0.0 107.179 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 48.3 t -57.22 -38.68 74.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.883 . . . . 0.0 110.289 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -52.08 -169.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.526 -0.733 . . . . 0.0 111.033 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 85' ' ' ASN . 4.8 p -124.62 -65.8 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 110.339 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 61.4 t30 -42.65 -36.0 1.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -0.911 . . . . 0.0 109.988 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.589 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -50.92 -42.03 59.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.202 -0.999 . . . . 0.0 108.388 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 46.9 t0 -45.52 -27.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -80.46 -34.45 35.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.594 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 m-85 -70.76 -43.61 68.44 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.606 ' CD1' HD13 ' A' ' 73' ' ' ILE . 71.5 t80 -55.13 -40.54 70.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-80 -59.22 -55.77 30.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.554 -0.717 . . . . 0.0 109.717 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.52 -38.35 53.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.718 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -69.49 -40.63 76.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 9.9 mm -63.42 -60.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 2.8 mttp -57.13 -37.81 72.57 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 12.5 tptm -63.96 -49.09 73.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.84 . . . . 0.0 109.468 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.93 -53.96 20.42 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 61.9 t -56.49 -34.02 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -1.067 . . . . 0.0 109.826 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 24.5 tp10 -68.66 -35.03 76.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.53 11.29 5.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 110.043 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.18 21.57 78.85 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -88.98 -65.44 1.02 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 110.468 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -99.05 166.94 11.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.765 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 114' ' ' LYS . 52.7 mm-40 -114.12 124.0 51.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.526 ' OE1' ' CG2' ' A' ' 94' ' ' ILE . 1.2 mt-30 -135.41 114.48 11.43 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 111.222 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 50.9 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 O-C-N 123.883 1.465 . . . . 0.0 109.141 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.36 159.49 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.4 p -114.4 101.6 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -101.86 129.39 48.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 178.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.501 ' N ' HD21 ' A' ' 55' ' ' LEU . 13.3 tp . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.235 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 55.1 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.033 0.444 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HA ' ' HB1' ' A' ' 93' ' ' ALA 0.25 3.2 ttp180 -49.74 -44.6 48.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 53.3 mm-40 -57.67 -45.37 85.68 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.823 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 35.6 mt -52.21 -31.22 30.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.816 -1.177 . . . . 0.0 108.596 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG12 ' CE1' ' A' ' 90' ' ' PHE . 4.4 mt -80.09 -56.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.566 0.698 . . . . 0.0 109.308 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.634 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.5 mt -61.41 -54.48 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.1 mt-10 -58.77 -38.63 78.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.68 -49.62 75.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -59.97 -39.15 84.66 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.585 -0.95 . . . . 0.0 108.58 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -70.31 -24.44 63.02 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 53' ' ' GLU . . . -86.04 -31.21 22.1 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' CD1' ' HB3' ' A' ' 64' ' ' SER . 25.5 mt . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.564 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.345 0.593 . . . . 0.0 110.263 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 p -134.63 170.67 15.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.599 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 18.5 ttp180 -49.24 -49.25 71.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.1 Cg_endo -67.45 -42.4 7.34 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.301 1.158 . . . . 0.0 110.627 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' HB3' ' OG ' ' A' ' 65' ' ' SER . . . -54.12 -31.1 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 109.464 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.0 mm? -82.84 -51.19 7.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.443 -0.785 . . . . 0.0 109.537 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 4.6 mttt -50.36 -41.23 51.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 5.3 tmmm? -49.14 -55.85 11.03 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.594 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.97 -46.14 88.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.585 HD12 ' CD1' ' A' ' 90' ' ' PHE . 17.5 mt -65.53 -31.72 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.924 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 82' ' ' SER . 46.0 pttt -91.81 -40.77 11.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.966 -1.084 . . . . 0.0 111.624 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 14.9 mt-10 -95.97 -65.31 0.98 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.905 -1.122 . . . . 0.0 109.89 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 18.6 m-20 -56.31 -21.6 25.19 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.666 -1.272 . . . . 0.0 107.845 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.519 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.57 175.7 2.49 Favored Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.558 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 49.5 Cg_endo -69.84 178.31 4.75 Favored 'Trans proline' 0 C--N 1.28 -3.033 0 O-C-N 123.903 1.475 . . . . 0.0 113.885 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.598 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -51.0 -15.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.034 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.633 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.06 -30.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.77 -34.64 6.79 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -83.1 23.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -1.064 . . . . 0.0 110.362 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -104.83 -139.07 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.473 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -140.55 -77.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.893 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' SER . 50.4 t30 -42.05 -36.29 1.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.6 t80 -49.22 -40.53 34.08 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.361 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.1 m-20 -46.62 -29.66 1.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.15 -33.79 50.13 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.01 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.67 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 12.7 m-85 -72.21 -44.83 62.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.152 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CE1' HG12 ' A' ' 51' ' ' ILE . 83.8 t80 -56.55 -39.9 74.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.486 -0.759 . . . . 0.0 109.184 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -60.63 -55.39 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.464 -0.773 . . . . 0.0 109.279 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -50.87 -36.63 38.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 108.852 178.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -71.29 -39.43 71.51 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.212 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 5.7 mm -64.16 -59.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 108.976 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.53 -41.02 80.08 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -61.87 -42.89 99.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.964 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -74.43 -52.01 7.89 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 48.0 t -61.71 -40.11 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.123 . . . . 0.0 110.346 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 9.2 tp10 -59.87 -36.85 77.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.72 13.44 4.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.49 78.04 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD2' ' HA2' ' A' ' 97' ' ' GLY . 11.5 m-20 -82.66 -68.28 0.72 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.732 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.72 157.69 17.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.542 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -96.73 123.89 40.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.54 ' NE2' ' HB ' ' A' ' 113' ' ' VAL . 6.0 mm-40 -134.98 106.09 10.47 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 110.701 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 109.978 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.13 126.53 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -1.064 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 2.1 p -83.49 104.52 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -101.29 125.86 47.97 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.039 -1.038 . . . . 0.0 109.301 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.414 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 73.5 m-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.365 0.602 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 51' ' ' ILE . 5.0 ttp85 -54.93 -47.58 74.24 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.0 mm-40 -57.16 -43.67 82.74 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.227 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 HD12 ' CE1' ' A' ' 86' ' ' PHE . 21.1 mt -53.21 -33.21 51.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.84 -1.162 . . . . 0.0 108.635 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.564 HG12 ' CE2' ' A' ' 90' ' ' PHE . 48.1 mt -79.84 -56.31 7.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.57 0.7 . . . . 0.0 109.169 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.597 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.3 mt -57.42 -52.13 60.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.3 mt-10 -64.57 -40.72 96.05 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -56.87 -44.04 92.34 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 6.2 mt -65.71 -38.76 90.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -1.072 . . . . 0.0 109.428 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -67.7 -31.19 70.98 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.286 -0.884 . . . . 0.0 108.906 178.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.94 -24.43 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.631 -0.668 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD23 ' CB ' ' A' ' 64' ' ' SER . 10.2 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.534 ' CB ' HD23 ' A' ' 58' ' ' LEU . 19.5 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.111 0.482 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.527 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 11.9 p -134.75 174.4 10.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.0 111.009 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.599 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -51.11 -47.23 88.06 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.661 -0.649 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.6 Cg_endo -69.97 -41.91 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.263 1.139 . . . . 0.0 110.396 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.13 65.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD1' HD11 ' A' ' 58' ' ' LEU . 4.4 mm? -75.98 -47.11 26.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 74' ' ' LYS . 93.6 mttt -54.59 -46.61 73.8 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 70' ' ' LYS . 9.4 ttpt -42.01 -56.76 2.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 2.2 t80 -57.59 -42.89 84.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 86' ' ' PHE . 32.5 mt -66.02 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 111.476 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.48 -42.51 10.24 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.747 -1.22 . . . . 0.0 111.087 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -95.4 -65.04 1.0 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.061 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.4 m-20 -56.93 -19.64 19.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.877 -1.14 . . . . 0.0 107.969 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.3 m-85 -126.89 175.04 3.59 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.553 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.62 176.55 4.9 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 O-C-N 123.941 1.495 . . . . 0.0 113.841 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.623 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 8.2 mt -52.55 -12.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.96 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.5 p -46.55 -29.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.14 -37.35 7.2 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 4.1 t -72.0 -2.89 19.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.563 -0.963 . . . . 0.0 110.263 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -78.27 -153.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.429 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 86' ' ' PHE . 28.2 m -133.19 -78.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.763 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 43.5 t-20 -40.72 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -0.922 . . . . 0.0 110.331 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 90' ' ' PHE . 1.6 t80 -56.32 -44.98 80.46 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.086 -1.009 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 6.3 p-10 -45.42 -26.89 0.61 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.8 tp -82.28 -30.11 30.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.585 -0.697 . . . . 0.0 109.964 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.599 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.5 m-85 -76.45 -42.11 45.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 47.3 t80 -58.29 -42.47 86.68 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -59.04 -57.67 12.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.305 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -52.21 -38.54 58.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.683 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 51' ' ' ILE . . . -66.23 -41.4 90.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.563 HG13 ' CE1' ' A' ' 90' ' ' PHE . 9.7 mm -62.39 -60.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.752 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -57.29 -37.62 72.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -65.09 -49.84 68.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.44 -0.787 . . . . 0.0 109.775 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -64.51 -51.41 52.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 74.4 t -61.56 -40.97 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -1.023 . . . . 0.0 109.813 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 11.9 tp10 -58.52 -34.28 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 109.691 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.11 15.58 5.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.745 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 23.96 76.95 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.6 m-20 -85.1 -68.05 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -1.22 . . . . 0.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.28 159.51 17.35 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.905 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -100.13 143.45 30.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.519 ' NE2' ' CG2' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -149.82 98.08 3.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.968 . . . . 0.0 111.014 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 45.1 Cg_endo . . . . . 0 C--N 1.305 -1.725 0 O-C-N 123.726 1.382 . . . . 0.0 109.439 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.097 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.509 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -100.95 160.62 14.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -1.003 . . . . 0.0 109.907 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.494 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.4 p -114.43 121.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.948 -1.095 . . . . 0.0 110.262 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -122.2 125.77 46.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 22.0 tp . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.363 -0.835 . . . . 0.0 110.032 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 97.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.178 0.513 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 10.5 ttm180 -53.71 -46.12 70.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 16.3 mt-10 -57.06 -44.72 83.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.14 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 19.0 mt -51.6 -32.63 29.49 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.789 -1.194 . . . . 0.0 108.304 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -81.54 -55.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.602 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.2 mt -56.57 -52.27 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.1 mt-10 -62.48 -40.96 98.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.32 -45.64 95.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 6.5 mt -64.46 -41.25 96.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -1.002 . . . . 0.0 109.551 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -68.01 -28.79 67.72 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 108.832 178.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.55 -20.84 22.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.658 -0.651 . . . . 0.0 109.822 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 69' ' ' LEU . 10.4 mt . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.487 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.529 ' CB ' HD11 ' A' ' 58' ' ' LEU . 47.9 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.5 p -125.69 176.25 7.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.617 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -46.53 -47.62 48.5 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 110.98 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -67.46 -42.26 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.634 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 64' ' ' SER . . . -55.93 -33.71 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.6 mm? -81.08 -51.33 8.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.448 -0.782 . . . . 0.0 109.61 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.515 ' NZ ' ' HB3' ' A' ' 87' ' ' ASP . 2.7 mtpt -53.8 -41.54 67.4 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 3.9 tmmm? -47.55 -53.74 13.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.998 0.904 . . . . 0.0 108.733 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.0 t80 -59.88 -49.66 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' A' ' 90' ' ' PHE . 19.9 mt -63.88 -31.53 53.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.395 -0.815 . . . . 0.0 110.669 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.618 ' HG3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -92.4 -34.97 13.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.085 . . . . 0.0 111.897 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.618 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 39.6 mt-10 -98.35 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.701 -1.249 . . . . 0.0 109.461 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 13.4 m-20 -57.01 -18.97 15.81 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -127.57 174.1 4.68 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.539 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.1 Cg_endo -65.8 175.84 4.16 Favored 'Trans proline' 0 C--N 1.281 -2.978 0 O-C-N 124.096 1.577 . . . . 0.0 114.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.574 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 4.0 mt -51.97 -13.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.504 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.59 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.5 p -45.83 -29.84 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -86.54 -38.95 7.94 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.574 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 50.0 m -62.51 -29.05 70.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.695 -0.885 . . . . 0.0 110.435 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.2 -162.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.435 -0.79 . . . . 0.0 111.409 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -127.11 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.665 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -39.53 -38.91 0.64 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 0.0 110.406 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.602 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -47.12 -39.06 12.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 3.7 p-10 -48.13 -35.03 10.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.5 tp -69.0 -30.9 69.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.21 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 20.2 m-30 -76.84 -45.45 28.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.602 ' CE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -61.25 -35.17 76.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 65.3 m-20 -63.75 -56.78 12.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.711 . . . . 0.0 109.364 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.12 -37.19 33.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.668 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . . . -67.3 -40.09 86.01 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.218 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 13.3 mm -63.15 -59.84 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 1.8 mtpt -57.67 -40.36 79.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tppt? -61.41 -47.27 86.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.547 -0.721 . . . . 0.0 109.766 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -68.89 -51.82 27.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 103' ' ' PHE . 48.2 t -61.23 -40.7 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -1.064 . . . . 0.0 110.188 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 10.3 tp10 -60.2 -35.49 75.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 110.033 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HB1' ' CG ' ' A' ' 102' ' ' ASP . . . -85.58 16.18 4.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -0.818 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.39 25.5 74.72 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.7 m-20 -86.19 -68.37 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 110.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -105.73 179.4 4.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.06 131.08 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.47 ' HG3' HG23 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.32 101.66 6.16 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.061 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--N 1.306 -1.676 0 O-C-N 123.946 1.498 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -113.47 127.14 55.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -1.134 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.464 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.1 p -81.13 128.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 132.54 53.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 18.5 tp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 42.6 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.14 0.495 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.413 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -50.57 -44.53 56.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' GLU . 4.6 mm-40 -57.53 -43.94 84.75 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.393 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 46.2 mt -53.03 -31.2 39.97 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.682 -1.261 . . . . 0.0 107.856 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 4.6 mt -81.95 -55.57 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.58 0.705 . . . . 0.0 109.178 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 59.8 mt -59.27 -55.31 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -58.65 -38.87 79.05 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.43 -48.62 84.01 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.542 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.0 mt -59.2 -36.43 75.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -1.083 . . . . 0.0 109.388 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -37.69 87.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.255 -0.903 . . . . 0.0 108.854 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.11 -18.75 24.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.562 -0.712 . . . . 0.0 109.82 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.542 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 11.1 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 109.041 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 58' ' ' LEU . 74.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.5 p -107.19 178.89 4.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.042 . . . . 0.0 111.094 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.618 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -46.67 -47.14 50.73 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.716 -0.615 . . . . 0.0 110.799 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.71 -43.44 5.42 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.113 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.27 -35.15 59.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 108.862 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 3.8 mm? -79.3 -46.17 18.25 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HE2' ' CD2' ' A' ' 86' ' ' PHE . 5.8 mtpt -54.59 -40.93 69.31 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.3 ttpt -46.84 -49.72 19.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -65.99 -49.57 67.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.594 HD12 ' CD1' ' A' ' 90' ' ' PHE . 14.0 mt -62.08 -30.35 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.56 ' HB2' ' CA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.06 -42.61 10.4 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.072 -1.018 . . . . 0.0 112.153 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.521 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 10.9 mt-10 -95.82 -65.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 109.849 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 7.3 m-20 -57.82 -18.96 25.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.814 -1.179 . . . . 0.0 107.902 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 3.0 m-85 -127.82 175.39 3.45 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.563 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.1 Cg_endo -66.18 174.55 5.86 Favored 'Trans proline' 0 C--N 1.282 -2.93 0 O-C-N 123.894 1.47 . . . . 0.0 114.118 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.585 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.02 -16.18 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.781 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.4 p -44.18 -31.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.46 -35.24 6.64 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.329 -2.308 . . . . 0.0 107.329 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.585 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -84.73 26.32 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.549 -0.971 . . . . 0.0 110.525 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -107.49 -133.66 0.33 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' PHE . 14.7 t -143.53 -83.05 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 0.0 110.831 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 13.1 t-20 -40.91 -28.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.209 -0.932 . . . . 0.0 110.79 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.9 t80 -52.02 -42.2 62.84 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.461 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.1 t0 -45.55 -30.14 1.38 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.9 tp -76.17 -36.49 58.69 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.921 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 7.7 m-85 -71.07 -44.04 66.55 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.103 -0.998 . . . . 0.0 108.379 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CD1' HD12 ' A' ' 73' ' ' ILE . 73.6 t80 -57.84 -38.52 75.8 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 25.8 m-20 -60.86 -56.13 24.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.559 -0.713 . . . . 0.0 109.449 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.36 -39.0 63.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 109.023 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.539 ' HB3' ' CB ' ' A' ' 47' ' ' TYR . . . -68.03 -38.74 82.88 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.024 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 8.1 mm -64.19 -59.74 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.372 -0.83 . . . . 0.0 109.021 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -59.03 -38.62 79.73 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.341 -0.849 . . . . 0.0 108.853 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.1 tptm -64.46 -47.84 77.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.08 -50.22 53.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.499 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 99.5 t -62.35 -45.52 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.367 -1.078 . . . . 0.0 109.737 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 35.9 tp10 -56.77 -33.69 66.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.518 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . . . -83.82 12.88 5.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.856 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.0 23.65 77.9 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 25.2 m-20 -87.34 -67.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.139 -1.213 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.721 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.17 159.98 16.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.932 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 21.0 mm-40 -97.27 134.62 40.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' CG2' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -142.51 98.3 5.94 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 111.415 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--N 1.303 -1.851 0 O-C-N 123.948 1.499 . . . . 0.0 109.581 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -105.36 159.5 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.153 . . . . 0.0 110.047 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.48 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.2 p -121.7 115.02 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.981 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 4.6 mmtt -108.9 143.97 37.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.087 -1.008 . . . . 0.0 109.765 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 14.5 tp . . . . . 0 C--N 1.296 -1.722 0 O-C-N 121.507 -0.745 . . . . 0.0 110.362 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 65.4 m-85 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.161 0.505 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 13.5 ttp180 -52.1 -47.16 65.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' GLU . 24.6 mm-40 -57.16 -44.29 83.32 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 74.4 mt -52.21 -32.25 35.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.633 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 90' ' ' PHE . 12.7 mt -81.7 -56.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 68.7 mt -58.11 -52.29 60.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.9 mt-10 -62.38 -41.22 98.47 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -55.79 -40.7 81.26 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 8.5 mt -67.41 -37.04 82.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.457 -1.025 . . . . 0.0 109.559 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -29.5 62.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 108.922 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.8 -22.93 20.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.586 -0.696 . . . . 0.0 110.058 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.557 ' CB ' HD13 ' A' ' 58' ' ' LEU . 30.9 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 16.7 p -133.37 178.32 7.0 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.131 -0.98 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -46.81 -46.42 51.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.716 -0.615 . . . . 0.0 111.235 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.14 -42.64 5.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.268 1.141 . . . . 0.0 110.665 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' SER . . . -57.32 -24.75 57.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 4.0 mm? -92.97 -48.59 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.1 mtpt -58.41 -41.29 84.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -47.97 -51.84 22.12 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.985 0.898 . . . . 0.0 108.806 178.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 2.9 t80 -62.22 -48.98 77.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 77' ' ' TYR . 46.3 mt -65.17 -29.91 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.552 ' HB2' ' N ' ' A' ' 82' ' ' SER . 8.5 ptpt -92.02 -42.43 9.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.766 -1.209 . . . . 0.0 111.52 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.538 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 8.6 mt-10 -95.57 -64.8 1.02 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 6.0 m-20 -55.75 -22.01 21.83 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.828 -1.17 . . . . 0.0 107.953 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.79 178.02 1.6 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 177.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 46.1 Cg_endo -68.79 175.62 7.05 Favored 'Trans proline' 0 C--N 1.281 -3.011 0 O-C-N 123.88 1.463 . . . . 0.0 114.231 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.6 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.2 mp -49.71 -15.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.864 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.5 -31.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.35 -37.78 6.51 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -85.21 46.6 1.3 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.79 -0.83 . . . . 0.0 109.455 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.84 178.76 6.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 0.0 110.943 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 85' ' ' ASN . 65.8 m -104.75 156.3 18.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.455 -0.778 . . . . 0.0 109.786 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' SER . 5.7 t-20 76.79 -40.54 0.37 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.427 -0.796 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -48.65 -42.08 33.31 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.657 -1.277 . . . . 0.0 108.192 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.2 p30 -47.23 -36.41 8.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.8 tp -63.46 -34.35 77.58 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.253 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.595 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 79.8 m-85 -76.13 -47.88 22.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' HG12 ' A' ' 51' ' ' ILE . 37.9 t80 -61.2 -36.03 78.77 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 75.0 m-20 -62.51 -56.71 15.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.13 -39.18 42.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.165 -0.96 . . . . 0.0 108.499 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.484 ' C ' ' CD1' ' A' ' 51' ' ' ILE . . . -63.34 -40.85 98.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 13.2 mm -64.19 -59.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 20.6 mtpt -55.41 -37.99 68.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.8 tppt? -65.4 -51.32 61.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -67.94 -47.35 60.73 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.445 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 98.8 t -63.08 -42.17 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -1.021 . . . . 0.0 110.459 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 5.8 tp10 -61.62 -34.54 75.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.29 15.67 3.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 25.51 74.46 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 3.8 t0 -84.93 -67.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -1.153 . . . . 0.0 110.097 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.18 159.82 16.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.173 -0.954 . . . . 0.0 109.727 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.35 128.46 44.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.168 -0.958 . . . . 0.0 109.206 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.497 ' HG3' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.41 109.67 6.26 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.119 -0.988 . . . . 0.0 111.137 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.004 1.528 . . . . 0.0 109.536 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -96.51 137.62 35.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.128 . . . . 0.0 109.998 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.3 p -94.31 106.03 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.042 -1.036 . . . . 0.0 110.755 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.29 128.94 45.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.745 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.542 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 26.2 tp . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.957 . . . . 0.0 109.705 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.605 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 71.3 m-85 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 1.9 ttm180 -57.42 -46.17 83.83 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.3 mt-10 -55.95 -45.27 78.91 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 75.7 mt -51.77 -35.3 43.22 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.74 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG12 ' CE1' ' A' ' 90' ' ' PHE . 17.3 mt -79.35 -56.25 7.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.516 0.674 . . . . 0.0 109.374 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.7 mt -56.81 -51.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.8 mm-40 -60.83 -43.46 98.22 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -52.82 -41.85 58.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.3 mt -72.12 -40.34 68.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.649 -0.912 . . . . 0.0 108.678 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 m -67.08 -23.2 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.13 -23.95 21.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' A' ' 64' ' ' SER . 12.0 mt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.525 ' CB ' HD13 ' A' ' 58' ' ' LEU . 63.0 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 17.8 p -88.67 -179.06 5.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.091 -1.006 . . . . 0.0 111.257 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -51.03 -44.75 87.65 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.701 -0.624 . . . . 0.0 110.774 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.5 Cg_endo -68.68 -43.07 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.314 1.165 . . . . 0.0 109.818 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.98 -30.48 10.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.464 -0.895 . . . . 0.0 108.735 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.9 mm? -87.17 -50.85 6.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 88.9 mttt -53.92 -39.23 65.67 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.9 ttpp -51.56 -50.38 60.19 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.555 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.08 -47.95 82.4 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.585 HD11 ' CD1' ' A' ' 90' ' ' PHE . 17.0 mt -61.42 -33.27 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 110.663 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HB2' ' N ' ' A' ' 82' ' ' SER . 43.6 pttt -91.52 -40.26 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 37.8 mt-10 -93.99 -66.11 0.94 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.897 -1.127 . . . . 0.0 110.218 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 25.4 m-20 -58.74 -21.49 55.41 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.68 -1.262 . . . . 0.0 108.077 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.46 175.0 2.86 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.2 Cg_endo -65.24 174.09 5.44 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 O-C-N 124.179 1.62 . . . . 0.0 113.839 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.634 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 6.3 mt -52.46 -12.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.812 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -45.96 -29.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.27 -36.45 7.06 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.339 -2.305 . . . . 0.0 107.339 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.634 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.8 t -73.44 -0.25 14.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.604 -0.939 . . . . 0.0 110.295 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -79.21 -149.34 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.209 -0.932 . . . . 0.0 110.827 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 85' ' ' ASN . 2.7 p -133.72 -79.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -41.64 -35.09 0.69 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.279 -0.888 . . . . 0.0 110.572 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.603 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.3 t80 -48.8 -40.95 31.01 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.902 -1.123 . . . . 0.0 108.339 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 92.5 m-20 -47.11 -26.23 1.05 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 5.7 tp -82.74 -33.75 27.39 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.883 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.605 ' HB3' ' CG ' ' A' ' 47' ' ' TYR . 30.1 m-85 -71.15 -45.69 63.01 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.301 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.586 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 81.0 t80 -52.92 -31.95 42.81 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 19.5 m-20 -67.59 -52.29 40.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.538 -0.726 . . . . 0.0 109.433 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.23 -40.38 67.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 108.992 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . . . -65.81 -37.28 85.84 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.948 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 9.6 mm -64.08 -59.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 108.865 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.43 -40.95 79.51 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -61.44 -45.33 94.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.781 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.63 -51.26 12.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 92.5 t -61.86 -38.61 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.6 tp10 -58.49 -39.19 79.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . . . -83.15 13.26 4.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.529 -0.732 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.15 23.5 77.51 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 -83.11 -67.96 0.75 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.0 166.16 11.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 56.8 mm-40 -109.55 136.65 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.553 ' HG3' ' CG2' ' A' ' 94' ' ' ILE . 6.0 mm-40 -146.28 107.16 4.16 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.034 -1.041 . . . . 0.0 111.435 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.6 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 123.89 1.469 . . . . 0.0 109.0 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.97 138.25 54.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.159 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 2.1 p -82.17 117.57 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 111.041 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -111.12 132.9 53.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 17.7 tp . . . . . 0 C--N 1.298 -1.658 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.586 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 92.1 m-85 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 52' ' ' ILE 0.25 7.0 ttp180 -51.43 -44.15 62.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 5.0 mt-10 -56.76 -46.77 81.22 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.2 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 14.9 mt -52.07 -34.78 45.22 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.482 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 3.3 mt -75.85 -56.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 109.393 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.625 HG12 ' CE1' ' A' ' 103' ' ' PHE . 25.3 mt -59.65 -54.07 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.907 0.86 . . . . 0.0 108.738 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 8.0 mt-10 -60.33 -35.68 76.2 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.775 0.798 . . . . 0.0 108.905 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -64.49 -49.71 63.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.567 ' CD2' ' HB2' ' A' ' 115' ' ' LEU . 7.1 mt -59.65 -42.0 91.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -1.085 . . . . 0.0 109.303 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -66.1 -31.48 72.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.268 -0.895 . . . . 0.0 109.085 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.653 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.92 -15.35 29.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.543 HD12 ' CB ' ' A' ' 64' ' ' SER . 12.3 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.543 ' CB ' HD12 ' A' ' 58' ' ' LEU . 16.4 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.062 0.458 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 8.2 p -135.02 174.76 10.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.129 -0.982 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 ttp180 -45.34 -47.74 34.55 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.692 -0.63 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.2 Cg_endo -66.45 -42.81 9.08 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.14 1.074 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 64' ' ' SER . . . -59.89 -34.33 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.651 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 58' ' ' LEU . 4.2 mm? -80.92 -51.59 8.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -49.38 -38.23 27.81 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.303 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.494 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.81 -53.86 35.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 1.8 t80 -60.78 -46.17 91.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.596 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 8.3 mt -64.15 -31.44 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.235 -0.915 . . . . 0.0 110.635 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HB2' ' N ' ' A' ' 82' ' ' SER . 1.1 ptpt -92.1 -38.78 11.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.932 -1.105 . . . . 0.0 110.888 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 16.5 mt-10 -95.36 -64.88 1.02 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.807 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 89.1 m-20 -58.64 -17.94 26.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CE2' ' CZ ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -128.0 176.7 2.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.561 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 45.0 Cg_endo -67.16 175.68 5.46 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 O-C-N 124.021 1.537 . . . . 0.0 113.764 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.618 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 11.6 mt -52.39 -12.7 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.004 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.9 p -46.34 -30.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.593 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.05 -36.77 8.13 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 107.184 -2.366 . . . . 0.0 107.184 176.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.618 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.1 t -74.44 1.82 10.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.653 -0.91 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -84.79 -150.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.165 -0.959 . . . . 0.0 110.914 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' ASN . 31.0 t -134.18 -80.8 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.246 -0.909 . . . . 0.0 110.759 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' SER . 45.5 t-20 -39.19 -34.48 0.18 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.23 -0.919 . . . . 0.0 110.417 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -48.69 -40.29 27.64 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.437 178.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 50.5 t0 -48.11 -30.68 4.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.862 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.32 -28.69 59.76 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.193 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.586 ' HB3' ' CG ' ' A' ' 47' ' ' TYR . 12.4 m-85 -76.18 -46.14 29.9 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.9 t80 -57.72 -38.31 75.05 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 26.0 m-20 -60.04 -55.29 35.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.514 -0.741 . . . . 0.0 109.331 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.13 -41.39 75.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.345 -0.847 . . . . 0.0 109.201 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . . . -64.32 -40.12 95.26 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.09 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 6.7 mm -60.93 -59.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 108.677 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -57.32 -41.41 79.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.3 tppp? -59.43 -47.8 84.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.614 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -69.5 -52.94 18.88 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 59.1 t -60.64 -39.6 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.524 -0.986 . . . . 0.0 110.376 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.1 tp10 -64.44 -34.13 77.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.787 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.515 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . . . -82.44 11.79 5.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.912 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 22.73 78.75 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -85.9 -67.65 0.79 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.231 -1.158 . . . . 0.0 110.14 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -100.87 178.67 4.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 109.663 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -120.2 126.5 50.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.01 128.0 17.41 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.993 . . . . 0.0 110.514 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 51.8 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.776 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.541 ' O ' ' CD ' ' A' ' 106' ' ' PRO . . . -121.39 153.1 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -1.074 . . . . 0.0 109.913 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.465 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.1 p -120.07 115.02 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.679 -1.263 . . . . 0.0 110.458 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -108.27 124.81 50.88 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.567 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 2.6 tm? . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.378 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.694 ' CE2' ' CG ' ' A' ' 89' ' ' TYR . 42.6 m-85 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.038 0.447 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.425 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -50.96 -45.64 60.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.07 -45.05 83.59 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.177 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 94.8 mt -52.29 -31.97 35.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.82 -1.175 . . . . 0.0 108.448 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 90' ' ' PHE . 4.7 mt -82.16 -54.69 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.582 HG12 ' CE1' ' A' ' 103' ' ' PHE . 64.0 mt -58.42 -52.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 11.4 mt-10 -62.36 -38.62 90.25 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.768 0.794 . . . . 0.0 109.052 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -62.66 -45.94 94.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 6.8 mt -59.74 -37.2 78.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -1.101 . . . . 0.0 109.629 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -74.27 -28.31 61.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.028 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.83 -11.12 40.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.607 -0.683 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 110.111 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.556 ' CB ' HD12 ' A' ' 58' ' ' LEU . 72.2 m . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 37.1 p -134.84 173.53 11.6 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.447 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -49.83 -45.8 80.26 Favored Pre-proline 0 C--N 1.299 -1.597 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.956 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.3 Cg_endo -70.41 -42.77 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.354 1.186 . . . . 0.0 110.281 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.42 -24.44 30.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.751 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.1 mm? -90.89 -51.1 5.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.75 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 89.8 mttt -59.31 -36.96 76.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.55 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.537 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 3.4 ttpt -55.88 -51.08 68.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.83 -46.7 87.06 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 18.6 mt -63.05 -33.97 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.587 -0.696 . . . . 0.0 111.169 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 82' ' ' SER . 17.1 ptmt -91.43 -42.14 10.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.85 -1.157 . . . . 0.0 111.435 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.51 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 15.6 mt-10 -94.43 -65.06 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 109.875 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 24.2 m-20 -56.7 -23.82 44.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.807 -1.183 . . . . 0.0 108.094 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.546 ' CB ' ' HD2' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -122.76 178.19 1.38 Allowed Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.564 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 45.3 Cg_endo -65.67 176.66 3.36 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 O-C-N 123.996 1.524 . . . . 0.0 114.414 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.582 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.21 -12.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.72 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.5 p -45.81 -29.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.588 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.94 -35.78 7.53 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.582 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 40.7 t -57.23 -40.46 77.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.571 -0.958 . . . . 0.0 110.317 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.33 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.738 . . . . 0.0 110.838 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 12.4 t -122.75 -64.38 1.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 110.472 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 7.1 m120 -43.98 -37.2 2.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.588 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 1.1 t80 -48.38 -42.27 31.32 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.155 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -44.75 -29.69 0.82 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.9 tp -78.33 -35.08 48.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.231 0.539 . . . . 0.0 109.667 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.694 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 6.2 m-85 -69.15 -46.3 67.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.13 -0.981 . . . . 0.0 108.666 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' HG12 ' A' ' 51' ' ' ILE . 54.1 t80 -57.58 -36.19 71.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 16.7 m-20 -60.23 -55.13 37.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.075 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -55.43 -39.78 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 108.875 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . . . -64.62 -40.63 95.82 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.594 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 9.7 mm -63.07 -57.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 3.3 mtmm -60.12 -35.54 75.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -67.87 -53.4 26.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.48 -0.763 . . . . 0.0 109.651 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -61.65 -46.7 93.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 79.2 t -65.42 -46.2 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 7.9 tp10 -58.92 -33.47 70.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 109.874 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.28 13.49 4.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.32 24.19 76.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 4.2 t0 -87.06 -67.25 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.224 -1.162 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.46 159.97 16.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.024 . . . . 0.0 110.1 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -97.54 128.76 44.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 109.754 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.54 ' OE1' ' CA ' ' A' ' 113' ' ' VAL . 0.8 OUTLIER -144.05 98.82 5.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.962 . . . . 0.0 111.234 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.3 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 124.186 1.624 . . . . 0.0 108.965 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.556 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -81.65 125.72 30.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -1.202 . . . . 0.0 109.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.3 p -92.18 133.76 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.862 -1.149 . . . . 0.0 110.962 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -126.82 124.18 39.06 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.352 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 55' ' ' LEU . 1.4 tp . . . . . 0 C--N 1.298 -1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 71.2 m-85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.079 0.466 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 3.2 ttm180 -55.64 -44.15 76.88 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 mm-40 -58.57 -43.24 89.35 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.199 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' CE1' ' A' ' 86' ' ' PHE . 36.4 mt -51.74 -32.22 29.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.588 -1.32 . . . . 0.0 107.636 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 90' ' ' PHE . 10.1 mt -82.34 -53.95 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.8 mt -58.72 -54.55 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.3 mt-10 -59.33 -38.89 81.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -57.83 -48.02 84.9 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.9 mt -66.86 -49.03 66.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.65 -0.912 . . . . 0.0 108.756 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -60.35 -24.86 65.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.49 -22.63 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 64' ' ' SER . 11.7 mt . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 109.259 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.528 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 10.3 m . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.2 p -99.71 172.05 7.51 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.041 -1.037 . . . . 0.0 111.202 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -45.96 -48.07 41.52 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.823 -0.548 . . . . 0.0 110.801 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.8 Cg_endo -67.32 -42.7 7.1 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.214 1.113 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.62 -28.36 20.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.279 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' HG11 ' A' ' 113' ' ' VAL . 4.6 mm? -86.7 -48.84 7.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.573 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -52.02 -43.32 63.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 6.2 ttpt -47.19 -53.52 12.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.57 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.61 -46.92 85.99 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.579 HD11 ' CD1' ' A' ' 90' ' ' PHE . 13.9 mt -63.54 -33.91 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.823 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.543 ' N ' ' HA3' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -91.65 -40.29 11.38 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.977 -1.077 . . . . 0.0 111.458 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.51 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 11.4 mt-10 -95.59 -65.42 0.98 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.055 -1.028 . . . . 0.0 109.729 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.484 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.3 m-20 -56.5 -21.52 26.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.076 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CB ' ' HD2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -125.7 177.74 1.78 Allowed Pre-proline 0 C--N 1.309 -1.158 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 45.2 Cg_endo -67.99 177.14 4.57 Favored 'Trans proline' 0 C--N 1.282 -2.939 0 O-C-N 123.925 1.487 . . . . 0.0 113.755 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 13.0 mt -52.72 -12.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.812 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.602 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.2 p -45.97 -30.38 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.46 -37.15 6.66 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 106.591 -2.603 . . . . 0.0 106.591 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -83.33 37.01 0.54 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.752 -0.852 . . . . 0.0 110.078 178.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.88 -137.27 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.988 . . . . 0.0 110.493 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' PHE . 16.5 p -139.13 -88.73 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.005 . . . . 0.0 111.106 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' OD1' ' CZ ' ' A' ' 89' ' ' TYR . 6.0 t-20 -35.62 -30.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.695 . . . . 0.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 2.1 t80 -54.19 -44.07 71.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.939 -1.1 . . . . 0.0 108.684 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.4 m-20 -46.96 -26.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.781 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.1 tp -80.94 -29.13 35.52 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.786 -0.765 . . . . 0.0 109.724 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.603 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 22.5 m-85 -77.33 -44.51 29.28 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.153 -0.967 . . . . 0.0 108.732 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.593 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.1 t80 -60.25 -46.37 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.359 -0.838 . . . . 0.0 108.822 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 3.5 m-80 -55.04 -57.5 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.27 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.58 -42.27 70.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.502 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -63.09 -40.49 97.8 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.54 ' CD1' HG23 ' A' ' 51' ' ' ILE . 8.5 mm -61.06 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.477 -0.765 . . . . 0.0 108.993 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -56.53 -37.95 71.17 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.588 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 23.9 tptp -65.51 -51.37 60.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.541 -0.724 . . . . 0.0 109.491 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.82 -49.93 64.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 54.1 t -50.71 -23.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -1.037 . . . . 0.0 109.372 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -93.33 -49.2 6.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.56 5.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 0.0 109.926 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -69.15 -9.21 60.0 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 m-20 66.79 37.14 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.861 -0.788 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.59 ' CE2' ' HA3' ' A' ' 97' ' ' GLY . 3.9 m-30 -87.08 146.63 26.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 109.821 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 23.8 mm-40 -97.44 124.73 41.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 108.892 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -144.63 98.48 4.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 110.897 -179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.4 Cg_endo . . . . . 0 C--N 1.306 -1.669 0 O-C-N 123.653 1.344 . . . . 0.0 109.7 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -117.71 160.36 21.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 109.603 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.508 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.3 p -110.66 124.23 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.629 -1.294 . . . . 0.0 110.32 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.69 132.63 53.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.918 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 55' ' ' LEU . 12.2 tp . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 29.8 m-85 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 4.1 ttt180 -61.14 -45.47 94.53 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 53' ' ' GLU . 55.1 mt-10 -58.38 -43.97 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD13 ' CE1' ' A' ' 86' ' ' PHE . 46.6 mt -51.38 -34.09 32.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.688 -1.257 . . . . 0.0 108.311 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 90' ' ' PHE . 30.2 mt -79.83 -55.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.435 HD13 ' HD3' ' A' ' 48' ' ' ARG . 60.2 mt -58.63 -53.98 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -61.17 -40.28 93.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.89 -47.74 84.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 115' ' ' LEU . 8.2 mt -67.05 -49.87 63.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.937 . . . . 0.0 108.521 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -55.45 -24.39 30.56 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 53' ' ' GLU . . . -90.78 -27.27 19.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.49 ' CD1' ' OG ' ' A' ' 64' ' ' SER . 13.2 mt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.196 -0.94 . . . . 0.0 108.728 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.49 ' OG ' ' CD1' ' A' ' 58' ' ' LEU . 68.1 m . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 20.5 p -131.26 174.51 9.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 111.237 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 tpp180 -48.07 -46.31 65.01 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.872 -0.517 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.7 Cg_endo -70.4 -43.15 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.229 1.12 . . . . 0.0 110.59 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -55.19 -31.9 61.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 69' ' ' LEU . 3.6 mm? -78.45 -53.86 6.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.119 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OD1' ' A' ' 87' ' ' ASP . 77.0 mttt -50.01 -36.41 28.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.65 -50.94 59.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.574 ' CZ ' ' CE2' ' A' ' 77' ' ' TYR . 3.7 t80 -63.46 -45.93 88.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.586 HD11 ' CD1' ' A' ' 90' ' ' PHE . 14.0 mt -63.77 -32.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.418 -0.801 . . . . 0.0 110.757 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.55 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 35.2 pttt -91.2 -41.38 11.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.095 -1.003 . . . . 0.0 111.494 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.55 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 34.2 mt-10 -93.83 -65.14 1.01 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.945 -1.097 . . . . 0.0 109.668 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.9 m-20 -59.94 -15.68 23.92 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.857 -1.152 . . . . 0.0 108.632 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.574 ' CE2' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -130.88 176.93 2.5 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.553 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.2 Cg_endo -65.74 173.63 6.57 Favored 'Trans proline' 0 C--N 1.283 -2.904 0 O-C-N 123.968 1.509 . . . . 0.0 113.594 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 3.1 mt -52.75 -12.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.882 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p -45.63 -30.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.28 -37.32 6.7 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.62 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -80.95 45.5 0.83 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.66 -0.906 . . . . 0.0 110.367 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.06 -138.18 0.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 1.9 t -141.46 -77.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.986 -1.071 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 20.1 t-20 -41.95 -36.93 1.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -1.0 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 2.0 t80 -51.35 -42.01 61.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.838 -1.163 . . . . 0.0 108.62 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.502 ' OD1' ' NZ ' ' A' ' 70' ' ' LYS . 6.2 t0 -46.17 -27.31 0.95 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.18 -33.28 33.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.841 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.594 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.3 m-85 -71.92 -43.34 65.46 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.205 -0.934 . . . . 0.0 108.949 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.588 ' CE1' HG12 ' A' ' 51' ' ' ILE . 68.6 t80 -58.46 -38.82 78.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.405 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 13.2 m-80 -61.53 -55.4 31.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.666 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.14 -39.2 42.54 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.396 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.5 ' C ' ' CD1' ' A' ' 51' ' ' ILE . . . -69.11 -38.61 79.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 51' ' ' ILE . 10.1 mm -62.58 -60.55 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -39.17 73.81 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.291 -0.881 . . . . 0.0 108.644 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 16.8 tptt -66.78 -51.23 58.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.58 -49.56 68.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 62.0 t -51.17 -25.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.472 -1.017 . . . . 0.0 109.369 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -90.5 -49.45 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.592 -0.693 . . . . 0.0 110.543 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.83 -32.58 5.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -67.56 -9.93 56.57 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.6 t0 69.3 37.37 2.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.642 -0.916 . . . . 0.0 110.992 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.6 m-30 -89.18 144.75 25.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.137 . . . . 0.0 109.398 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 23.9 mm-40 -97.43 126.66 42.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.14 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.519 ' NE2' ' HB ' ' A' ' 113' ' ' VAL . 6.7 mm-40 -143.55 124.33 7.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.517 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--N 1.307 -1.652 0 O-C-N 123.805 1.424 . . . . 0.0 109.552 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -120.21 146.99 45.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -1.096 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 1.5 p -116.88 117.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.77 -1.207 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 23.5 mtpt -112.95 128.0 56.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.508 ' N ' HD23 ' A' ' 55' ' ' LEU . 16.6 tp . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.278 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 75.0 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.288 0.566 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -52.76 -45.57 67.13 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -57.86 -45.48 86.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.347 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 74.7 mt -51.44 -32.38 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.799 -1.188 . . . . 0.0 108.392 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' A' ' 90' ' ' PHE . 50.8 mt -82.72 -55.12 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.631 HG12 ' CE1' ' A' ' 103' ' ' PHE . 56.1 mt -57.49 -53.59 42.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.5 mt-10 -60.14 -39.95 88.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.03 -44.17 96.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 7.2 mt -64.35 -39.13 93.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.5 -1.0 . . . . 0.0 109.553 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -71.65 -27.82 63.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 108.64 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.78 -19.72 23.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.619 -0.676 . . . . 0.0 109.77 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' CB ' ' A' ' 64' ' ' SER . 9.9 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.326 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.564 ' CB ' HD13 ' A' ' 58' ' ' LEU . 9.0 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -133.69 171.06 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.923 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.3 ttp85 -46.14 -47.77 43.82 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.74 -43.23 5.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.258 1.136 . . . . 0.0 110.861 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 64' ' ' SER . . . -55.52 -20.63 13.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 3.8 mm? -93.17 -45.22 7.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.16 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -57.44 -44.15 84.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 2.4 ttpt -47.2 -49.7 22.33 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.5 t80 -64.71 -49.04 72.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.56 -0.712 . . . . 0.0 109.283 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 90' ' ' PHE . 15.9 mt -60.82 -31.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 111.013 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.26 -41.83 10.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.079 -1.013 . . . . 0.0 111.732 -178.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 22.3 mt-10 -95.73 -65.55 0.97 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.926 -1.109 . . . . 0.0 110.055 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 97.5 m-20 -56.87 -22.01 33.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.827 -1.171 . . . . 0.0 107.916 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.3 m-85 -123.84 175.85 2.59 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.557 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.9 Cg_endo -66.69 175.56 5.17 Favored 'Trans proline' 0 C--N 1.28 -3.041 0 O-C-N 124.016 1.535 . . . . 0.0 114.069 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.61 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.57 -14.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.021 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.619 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 4.0 p -45.58 -30.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.16 -35.27 7.14 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -84.19 21.69 1.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.741 -0.858 . . . . 0.0 110.244 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -101.86 -140.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 0.0 110.571 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 1.3 p -135.86 -87.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.937 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.4 m120 -39.86 -26.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 0.0 111.092 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 2.0 t80 -51.46 -42.83 61.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.829 -1.169 . . . . 0.0 108.55 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.531 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 2.0 m-20 -46.52 -29.79 1.94 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.86 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -77.19 -32.25 55.93 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.93 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 17.4 m-85 -75.53 -43.29 49.59 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.952 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 67.0 t80 -60.97 -43.95 98.05 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.671 -0.811 . . . . 0.0 108.963 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.8 m-20 -56.48 -58.39 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.778 . . . . 0.0 109.23 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.56 -38.36 63.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 108.928 178.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 47' ' ' TYR . . . -69.88 -35.04 74.35 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.298 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.579 ' CG1' ' CE2' ' A' ' 90' ' ' PHE . 7.1 mm -67.53 -59.68 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.96 -38.22 75.6 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.5 tppt? -60.91 -47.67 85.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.99 -51.4 34.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 105' ' ' GLN . 70.4 t -63.01 -42.43 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.456 -1.026 . . . . 0.0 110.262 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 21.9 tp10 -61.4 -35.35 77.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.153 -0.967 . . . . 0.0 109.815 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 96' ' ' LYS . . . -81.46 11.44 4.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.82 23.59 77.78 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 1.1 t0 -85.35 -65.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -1.136 . . . . 0.0 110.167 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -99.81 -169.87 1.81 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.208 -0.932 . . . . 0.0 109.742 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' LYS . 34.9 mm-40 -129.66 125.09 35.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.7 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.529 ' OE1' ' CG2' ' A' ' 94' ' ' ILE . 5.8 mt-30 -138.26 130.6 16.12 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 110.379 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 123.89 1.468 . . . . 0.0 109.507 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -119.18 160.36 22.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -1.136 . . . . 0.0 109.79 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.502 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -128.24 122.14 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.785 -1.197 . . . . 0.0 111.052 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' GLU . 33.1 mtpt -116.35 124.38 49.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.838 . . . . 0.0 109.486 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 3.1 tm? . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.596 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 76.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 52' ' ' ILE . 18.6 ttp180 -51.89 -44.11 63.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' GLU . 9.2 mt-10 -57.95 -43.92 86.68 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 31.1 mt -52.82 -31.95 41.57 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.551 -1.343 . . . . 0.0 107.859 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 2.9 mt -82.77 -55.27 7.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.569 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 69.9 mt -58.03 -53.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.5 mt-10 -61.39 -40.09 93.09 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -57.21 -47.55 86.87 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.8 mt -65.61 -39.58 91.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.691 -0.888 . . . . 0.0 109.157 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 m -68.67 -29.27 67.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.196 -0.94 . . . . 0.0 108.609 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.64 -19.71 23.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.611 -0.681 . . . . 0.0 109.868 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.412 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.549 ' CB ' HD12 ' A' ' 58' ' ' LEU . 5.6 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 12.0 p -135.6 172.78 12.52 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.192 -0.943 . . . . 0.0 111.243 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.612 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -48.71 -48.43 69.7 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.737 -0.602 . . . . 0.0 110.972 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -67.64 -42.47 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.301 1.158 . . . . 0.0 110.358 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.75 50.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.752 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.54 ' CD2' HD12 ' A' ' 58' ' ' LEU . 4.5 mm? -91.17 -48.71 6.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.544 ' O ' ' CD ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -55.19 -47.67 74.91 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 9.0 ttpt -42.51 -53.68 4.23 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.548 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.72 -42.26 99.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.871 -0.518 . . . . 0.0 109.668 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.609 HD11 ' CD1' ' A' ' 90' ' ' PHE . 24.4 mt -64.38 -33.26 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.164 -0.96 . . . . 0.0 111.526 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -88.14 -44.6 10.79 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.836 -1.165 . . . . 0.0 111.252 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -96.8 -64.98 1.0 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 110.333 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 30.0 m-20 -53.81 -22.44 9.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.716 -1.24 . . . . 0.0 107.704 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -125.32 174.99 3.37 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.539 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 51.5 Cg_endo -70.88 179.43 4.31 Favored 'Trans proline' 0 C--N 1.279 -3.085 0 O-C-N 123.923 1.486 . . . . 0.0 114.38 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -50.68 -15.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.073 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.601 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 2.6 p -44.89 -31.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.61 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.73 -42.15 5.48 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -85.98 44.68 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.683 -0.892 . . . . 0.0 109.618 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -116.56 -103.46 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -170.16 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.846 -1.158 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -45.63 -22.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.734 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.61 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 1.7 t80 -51.36 -44.49 62.11 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.878 -1.139 . . . . 0.0 108.607 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -45.98 -27.23 0.86 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.55 -30.65 33.03 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.829 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.596 ' HB3' ' CG ' ' A' ' 47' ' ' TYR . 18.5 m-85 -76.03 -43.56 43.43 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.66 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CD1' HD11 ' A' ' 73' ' ' ILE . 76.4 t80 -56.47 -41.53 76.72 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.9 m-20 -57.35 -58.95 6.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -54.75 -40.42 69.33 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.511 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . . . -63.6 -44.8 92.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.563 -0.711 . . . . 0.0 109.159 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 8.1 mm -62.21 -58.19 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.4 -37.18 72.31 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -66.0 -52.43 49.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.64 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -61.99 -48.04 86.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 94' ' ' ILE . 43.7 t -64.27 -44.55 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.464 -1.021 . . . . 0.0 109.989 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.9 tp10 -61.29 -36.13 79.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 96' ' ' LYS . . . -77.34 4.81 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.45 19.57 77.97 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 6.5 m-20 -85.06 -66.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -1.204 . . . . 0.0 110.138 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.9 174.35 5.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 23.2 mm-40 -117.69 133.83 55.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.28 -0.887 . . . . 0.0 109.757 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.477 ' OE1' ' HB ' ' A' ' 113' ' ' VAL . 1.3 mm100 -140.67 100.13 6.78 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.98 . . . . 0.0 111.174 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--N 1.304 -1.773 0 O-C-N 123.968 1.509 . . . . 0.0 109.398 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.96 124.81 42.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 110.731 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.477 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 2.4 p -80.11 119.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 8.7 mtpt -113.29 125.65 54.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 63.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.306 0.574 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD2' ' CA ' ' A' ' 97' ' ' GLY 0.25 0.0 OUTLIER -53.04 -44.7 67.58 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.553 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 15.6 mt-10 -56.91 -46.73 81.76 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.202 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 51.6 mt -49.72 -32.81 14.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.865 -1.147 . . . . 0.0 107.992 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG12 ' CE2' ' A' ' 90' ' ' PHE . 8.2 mt -78.88 -56.14 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.387 0.613 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.598 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 mt -58.0 -51.0 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.47 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -63.43 -38.55 91.58 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.599 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.16 -44.68 96.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 5.2 mt -65.03 -36.82 85.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.6 -0.941 . . . . 0.0 108.999 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -65.45 -30.66 71.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -91.38 -19.05 23.32 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.313 0.578 . . . . 0.0 109.769 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 54' ' ' GLY . 10.1 mt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.159 -0.963 . . . . 0.0 109.219 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.505 ' CB ' HD13 ' A' ' 58' ' ' LEU . 8.5 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 75.8 p -129.25 176.79 7.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.177 -0.952 . . . . 0.0 111.206 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -59.56 -43.83 96.53 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.824 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.449 1.236 . . . . 0.0 110.137 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB1' ' OG ' ' A' ' 65' ' ' SER . . . -55.01 -30.3 59.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.369 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 69' ' ' LEU . 3.6 mm? -78.03 -53.44 7.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 109.161 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HA ' ' CD1' ' A' ' 73' ' ' ILE . 56.1 mttt -48.34 -34.42 10.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.977 -1.077 . . . . 0.0 108.308 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.6 ttpt -56.37 -51.9 66.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -60.39 -45.09 94.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.581 HD13 ' CD2' ' A' ' 90' ' ' PHE . 15.9 mt -61.67 -32.09 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -0.779 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.532 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 5.7 ptmm? -91.23 -41.48 10.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.065 -1.022 . . . . 0.0 111.571 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.532 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 30.5 mt-10 -92.12 -66.3 0.94 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.924 -1.11 . . . . 0.0 109.76 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 1.2 m120 -56.28 -27.04 53.97 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.985 -1.072 . . . . 0.0 108.278 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.545 ' HB3' ' HD2' ' A' ' 78' ' ' PRO . 1.2 m-85 -120.48 177.87 1.32 Allowed Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.562 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.4 Cg_endo -64.62 173.37 5.6 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.097 1.577 . . . . 0.0 113.783 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.573 ' CA ' ' HB2' ' A' ' 82' ' ' SER . 5.8 pt -52.88 -12.93 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.914 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.579 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 9.0 p -46.63 -28.55 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -35.46 8.77 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.573 ' HB2' ' CA ' ' A' ' 79' ' ' ILE . 14.3 m -51.16 -52.46 43.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.676 -0.896 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -49.95 -173.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.575 0.703 . . . . 0.0 111.222 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ASP . 46.8 t -117.2 -63.62 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 110.546 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 39.9 t30 -38.64 -38.8 0.43 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.348 -0.845 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.586 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -51.15 -41.37 60.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.894 -1.129 . . . . 0.0 108.428 178.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -45.69 -31.16 1.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -71.62 -39.5 70.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.727 -0.608 . . . . 0.0 109.733 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.589 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 19.8 m-85 -67.37 -42.47 83.38 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.653 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.591 ' CE2' HG12 ' A' ' 51' ' ' ILE . 11.1 t80 -64.67 -41.5 96.04 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.871 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.1 m-20 -55.3 -52.03 64.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.836 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.26 -41.87 76.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.139 -0.976 . . . . 0.0 108.914 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.535 ' HB1' ' CB ' ' A' ' 47' ' ' TYR . . . -58.88 -39.07 80.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.4 -0.813 . . . . 0.0 109.144 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 18.1 mm -59.66 -56.45 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 108.977 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -39.69 93.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 29.1 tptt -63.03 -49.44 74.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.374 -0.829 . . . . 0.0 109.46 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -65.75 -50.36 54.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 19.6 t -49.6 -23.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.067 -1.255 . . . . 0.0 108.904 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 3.2 tp10 -87.17 -49.78 7.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.715 . . . . 0.0 110.178 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.78 -33.74 4.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -68.25 -11.33 61.38 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 97' ' ' GLY . 9.2 m-20 65.1 32.13 10.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.796 -0.826 . . . . 0.0 111.215 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.598 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 3.6 m-30 -77.5 146.57 36.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 109.22 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 58.1 mm-40 -97.38 123.39 41.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 108.609 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -140.89 99.04 6.8 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 111.076 -178.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 44.1 Cg_endo . . . . . 0 C--N 1.305 -1.731 0 O-C-N 123.593 1.312 . . . . 0.0 109.508 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -115.12 159.74 20.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.1 p -111.34 142.34 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.946 -1.096 . . . . 0.0 110.781 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 6.3 mttm -136.93 130.03 31.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.479 -0.763 . . . . 0.0 109.684 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 24.5 tp . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.077 -1.014 . . . . 0.0 110.352 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 57.0 m-85 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.398 0.618 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HA ' HD11 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -57.14 -43.75 82.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.112 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.9 mt-10 -59.7 -45.36 92.36 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.385 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -50.68 -31.51 16.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.78 -1.2 . . . . 0.0 108.089 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.595 HG12 ' CE1' ' A' ' 90' ' ' PHE . 41.7 mt -84.0 -55.09 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 63.5 mt -56.14 -50.55 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -54.42 -45.06 76.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 7.5 mt -63.21 -39.5 94.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.662 -0.905 . . . . 0.0 109.013 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -67.21 -30.92 70.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.98 -13.37 33.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.717 -0.614 . . . . 0.0 109.704 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 64' ' ' SER . 9.3 mt . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.156 -0.965 . . . . 0.0 109.011 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.549 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 67.1 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 4.8 p -113.44 171.49 7.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.099 -1.001 . . . . 0.0 111.064 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -41.17 -50.26 8.25 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.87 -0.519 . . . . 0.0 111.059 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -66.86 -44.02 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.365 1.192 . . . . 0.0 110.495 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.06 -26.34 10.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 109.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 2.8 mm? -86.87 -45.19 11.08 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -49.48 -42.42 43.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -50.26 -51.99 40.06 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.084 0.945 . . . . 0.0 109.013 178.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.594 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -59.37 -47.33 85.84 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' CD1' ' A' ' 90' ' ' PHE . 41.8 mt -64.33 -32.74 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 111.332 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 82' ' ' SER . 14.4 ptmt -91.22 -42.2 10.55 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.033 -1.042 . . . . 0.0 111.379 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 9.6 mt-10 -94.95 -64.92 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.923 -1.111 . . . . 0.0 110.009 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.1 m-20 -56.53 -23.44 39.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.71 -1.244 . . . . 0.0 108.003 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.562 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -122.45 177.54 1.57 Allowed Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.551 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 47.9 Cg_endo -66.27 175.47 4.9 Favored 'Trans proline' 0 C--N 1.283 -2.896 0 O-C-N 124.037 1.546 . . . . 0.0 114.429 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pp -52.54 -13.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.607 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p -45.92 -30.39 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.77 -37.2 6.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -85.17 36.87 0.65 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.647 -0.914 . . . . 0.0 110.32 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.92 -110.62 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.019 -1.05 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 86' ' ' PHE . 4.4 m -166.11 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.877 -1.139 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' SER . 57.4 t-20 -39.86 -27.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.289 -0.882 . . . . 0.0 110.663 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.6 t80 -54.35 -42.07 69.83 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.953 -1.092 . . . . 0.0 108.847 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.543 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 3.9 p-10 -47.79 -28.02 2.33 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.175 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tp -78.6 -32.48 47.58 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.96 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.666 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 29.1 m-85 -74.28 -41.13 61.73 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.715 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.625 ' CD1' HD11 ' A' ' 73' ' ' ILE . 67.0 t80 -63.36 -48.11 79.3 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.383 -0.823 . . . . 0.0 108.791 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.6 m-80 -52.12 -57.26 10.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.166 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.05 -39.01 65.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.059 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . . . -68.46 -37.99 80.69 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.351 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 51' ' ' ILE . 12.9 mm -62.84 -61.11 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 25.1 mttt -57.35 -39.88 76.89 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -59.73 -43.11 94.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.462 -0.774 . . . . 0.0 109.746 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -70.9 -51.97 16.68 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 48.4 t -64.83 -42.07 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -1.124 . . . . 0.0 110.325 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 17.2 tp10 -60.18 -38.09 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.172 -0.955 . . . . 0.0 109.72 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.39 8.37 6.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.455 -0.778 . . . . 0.0 110.292 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.73 22.02 75.65 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 5.3 t0 -82.89 -66.94 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -1.148 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.21 177.0 4.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.739 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 16.7 mm-40 -111.01 126.14 54.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.45 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.508 ' HG3' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.5 98.32 9.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 110.985 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 O-C-N 123.684 1.36 . . . . 0.0 109.909 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.47 161.65 16.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.174 . . . . 0.0 109.741 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.471 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 2.1 p -126.64 100.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.016 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 28.8 mttp -99.81 126.52 45.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 25.0 tp . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.222 0.534 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 130.63 43.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -0.913 . . . . 0.0 110.304 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER -160.96 40.56 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 111.005 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.292 22.9 t 52.11 105.64 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.668 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -72.29 149.66 44.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.072 -1.018 . . . . 0.0 110.178 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 9.8 p -131.82 162.54 30.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 110.352 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CZ ' ' CG ' ' A' ' 89' ' ' TYR . 34.0 m-85 -59.44 -39.09 82.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.591 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -52.72 -46.35 67.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.1 mm-40 -56.95 -46.2 82.27 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.175 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 ' HB3' HG12 ' A' ' 73' ' ' ILE . 96.6 mt -52.33 -32.07 36.33 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.932 -1.105 . . . . 0.0 108.987 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.614 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 5.8 mt -82.2 -55.94 6.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.553 0.692 . . . . 0.0 109.362 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.606 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.8 mt -59.12 -51.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 6.0 mt-10 -62.95 -39.92 96.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.57 -45.1 96.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.537 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 6.9 mt -64.45 -36.61 84.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -1.046 . . . . 0.0 109.175 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m -72.88 -30.07 63.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.0 108.909 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.73 -19.75 23.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.556 -0.715 . . . . 0.0 110.041 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 9.4 mt -57.51 -40.76 79.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.093 -1.004 . . . . 0.0 109.581 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 2.0 mtpp 63.13 29.31 16.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.61 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -116.73 141.47 48.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.43 -24.8 13.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.39 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -75.35 -18.59 59.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.64 165.07 12.89 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.521 ' CB ' HD11 ' A' ' 58' ' ' LEU . 33.7 m -130.95 175.46 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.949 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 9.5 p -125.09 172.61 9.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.608 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.9 ttp180 -44.82 -48.56 29.02 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.78 -0.575 . . . . 0.0 111.151 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.4 Cg_endo -67.48 -42.37 7.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.234 1.123 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.32 -28.13 51.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.7 mm? -86.72 -51.19 6.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.803 . . . . 0.0 109.519 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 29.4 mttp -54.61 -42.04 70.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -52.39 -49.74 63.82 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.111 0.958 . . . . 0.0 108.646 177.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -59.76 -45.33 92.58 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 77' ' ' TYR . 28.8 mt -65.18 -32.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.467 -0.771 . . . . 0.0 111.159 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.69 -41.48 10.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.85 -1.156 . . . . 0.0 111.178 -179.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 11.9 mt-10 -95.88 -65.25 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 33.2 m-20 -56.43 -19.88 17.1 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.653 -1.279 . . . . 0.0 108.102 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.544 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.06 177.33 1.99 Allowed Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 177.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 50.0 Cg_endo -68.46 176.77 5.33 Favored 'Trans proline' 0 C--N 1.281 -3.006 0 O-C-N 123.997 1.525 . . . . 0.0 114.261 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.591 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.3 tt -50.72 -15.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.846 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.6 p -45.42 -29.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.606 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.94 -35.94 6.21 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.591 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -82.43 45.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -1.012 . . . . 0.0 109.972 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.78 -127.01 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 43.5 t -150.68 -78.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.86 -1.15 . . . . 0.0 110.844 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' PHE . 55.8 t-20 -52.4 -34.55 48.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.128 -0.982 . . . . 0.0 110.868 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.606 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 1.2 t80 -48.51 -38.76 21.07 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.731 -1.23 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.527 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -46.8 -32.93 4.01 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.678 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 tp -75.93 -32.86 59.77 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 47' ' ' TYR . 5.7 m-85 -69.73 -46.72 65.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 51' ' ' ILE . 32.8 t80 -58.09 -41.02 82.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.132 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.9 m-20 -56.82 -55.11 38.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.966 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -38.88 66.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.285 -0.885 . . . . 0.0 108.889 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 51' ' ' ILE . . . -63.02 -41.32 99.51 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.614 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 11.4 mm -63.42 -58.8 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 36.2 mttp -56.06 -41.44 75.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -49.23 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -69.45 -48.13 46.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 40.2 t -63.9 -43.44 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -1.031 . . . . 0.0 110.57 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.3 tp10 -61.92 -34.56 76.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.66 11.77 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 74.78 21.39 78.65 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 7.1 t0 -85.54 -68.42 0.73 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -1.155 . . . . 0.0 109.969 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -105.22 169.73 8.28 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.541 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -110.9 126.85 55.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.523 ' OE1' ' CA ' ' A' ' 113' ' ' VAL . 1.3 mm100 -138.51 109.72 8.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.763 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.487 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 51.3 Cg_endo -80.53 -157.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.021 1.537 . . . . 0.0 109.891 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 2.4 mptp? -136.96 -82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 110.22 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.66 -146.65 30.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.86 4.86 5.73 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.261 1.663 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.85 -103.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 O-C-N 121.872 -0.518 . . . . 0.0 109.935 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.52 128.85 1.0 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.06 121.66 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -1.165 . . . . 0.0 109.926 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.6 p -81.27 126.19 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -125.23 128.76 48.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.83 . . . . 0.0 109.781 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 11.6 tp -74.59 117.37 16.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.103 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 115' ' ' LEU . . . 169.98 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.435 ' O ' ' OXT' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -62.05 150.6 37.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.16 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' OXT' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.298 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.233 0.54 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.99 86.44 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.13 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 44' ' ' SER . 1.5 t 56.75 -156.93 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.857 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.3 31.2 t -174.39 179.35 1.82 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.922 -175.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -77.37 117.26 18.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 42.7 p -131.54 177.5 7.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.637 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 96.5 m-85 -62.9 -33.05 74.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.393 -0.817 . . . . 0.0 110.195 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.539 ' HD2' ' CD1' ' A' ' 52' ' ' ILE 0.25 2.7 tmm_? -49.14 -44.61 42.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 13.7 mt-10 -57.74 -45.58 85.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.091 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 98.7 mt -52.99 -32.56 47.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.062 -1.023 . . . . 0.0 108.883 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.61 ' CG2' ' CD2' ' A' ' 103' ' ' PHE . 5.3 mt -78.93 -56.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.563 0.697 . . . . 0.0 109.314 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 103' ' ' PHE . 23.5 mt -59.0 -53.08 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 1.9 mm-40 -61.07 -39.66 90.71 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.99 -46.83 93.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -63.89 -38.78 92.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -1.055 . . . . 0.0 109.077 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -69.75 -28.2 65.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.64 -22.47 21.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.0 109.724 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.543 HD12 ' CB ' ' A' ' 64' ' ' SER . 12.8 mt -55.66 -36.43 67.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.326 -0.859 . . . . 0.0 109.219 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 7.2 mtpp 62.52 30.53 17.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.355 0.598 . . . . 0.0 110.177 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HG3' ' C ' ' A' ' 59' ' ' LYS . 29.6 mt-10 -141.0 119.76 12.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 109.883 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -87.48 -19.09 28.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.375 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -60.79 -27.68 68.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.94 165.07 11.42 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.543 ' CB ' HD12 ' A' ' 58' ' ' LEU . 20.9 m -144.84 -179.83 6.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.546 -0.973 . . . . 0.0 109.787 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -128.59 174.06 9.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 111.549 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.624 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -47.57 -47.51 60.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.792 -0.568 . . . . 0.0 111.318 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -66.96 -42.21 8.69 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.286 1.15 . . . . 0.0 110.47 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.52 -27.24 56.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.669 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.542 ' N ' HD21 ' A' ' 69' ' ' LEU . 4.5 mm? -92.08 -47.42 7.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 109.597 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 19.1 mttp -55.88 -40.21 72.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 108.517 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.495 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 5.3 ttpt -54.54 -52.7 61.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t80 -58.52 -43.54 89.22 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.581 HD13 ' CD1' ' A' ' 90' ' ' PHE . 54.8 mt -63.35 -33.1 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 0.0 111.104 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' N ' ' HA3' ' A' ' 81' ' ' GLY . 6.5 pttt -91.62 -41.55 10.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.007 -1.058 . . . . 0.0 111.418 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.525 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.5 mt-10 -95.42 -65.44 0.98 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.042 . . . . 0.0 109.897 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.549 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.9 m-20 -56.82 -21.1 26.45 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.077 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.533 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -125.25 176.54 2.35 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -66.05 175.44 4.73 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 O-C-N 123.976 1.514 . . . . 0.0 114.119 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.615 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 17.8 mm -52.42 -12.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.937 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.3 p -45.97 -31.14 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.601 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.31 -38.25 7.29 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -82.32 42.29 0.74 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.621 -0.929 . . . . 0.0 110.078 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.04 -133.76 0.29 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' PHE . 20.7 m -143.9 -92.18 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.912 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.2 t30 -40.18 -28.14 0.05 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.142 -0.974 . . . . 0.0 110.965 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.637 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -48.32 -42.11 30.26 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.537 179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.54 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.4 t0 -47.42 -30.66 3.48 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.767 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.5 tp -76.81 -28.15 55.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.464 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 49.1 m-85 -77.05 -46.98 21.85 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.207 -0.933 . . . . 0.0 108.892 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 70.7 t80 -56.9 -43.03 80.93 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-20 -55.5 -57.0 13.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.185 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.87 -40.17 69.43 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.028 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -62.0 -45.57 93.04 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.485 -0.76 . . . . 0.0 109.016 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 16.7 mm -60.01 -58.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -0.807 . . . . 0.0 109.015 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.76 -38.2 74.99 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.758 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 5.2 tptt -66.03 -50.97 62.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.848 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -63.63 -51.48 53.73 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 103' ' ' PHE . 93.1 t -60.81 -39.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.978 . . . . 0.0 110.054 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 34.4 tp10 -63.19 -33.48 75.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.186 -0.947 . . . . 0.0 109.863 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.93 17.39 3.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.384 -0.822 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.6 73.4 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -87.57 -69.2 0.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.329 -1.101 . . . . 0.0 110.103 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.66 169.32 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -108.59 125.54 51.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -138.74 97.87 8.92 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.987 . . . . 0.0 110.63 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.5 Cg_endo -78.33 -163.97 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.905 1.476 . . . . 0.0 109.896 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -118.56 -67.69 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.949 . . . . 0.0 110.101 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.47 -150.56 16.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.92 4.75 5.85 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.146 1.603 . . . . 0.0 111.268 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.57 -91.0 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.848 -0.533 . . . . 0.0 110.153 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.86 112.35 0.32 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -102.37 160.16 14.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.972 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.9 p -121.19 117.58 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.862 -1.149 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -114.25 128.63 56.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.532 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 56.8 tp -82.99 128.19 34.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.86 88.57 2.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 110.086 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -110.34 118.04 35.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.224 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.284 0.564 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.29 59.99 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.1 OUTLIER -94.93 43.99 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.299 23.3 t 50.77 178.07 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.908 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -104.5 114.5 28.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.116 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.488 ' OG ' ' CG ' ' A' ' 49' ' ' GLU . 13.8 p -98.98 137.25 37.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 61.9 m-85 -48.07 -25.86 1.6 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.23 -0.919 . . . . 0.0 109.082 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -69.7 -45.62 67.85 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 53' ' ' GLU . 39.4 mt-10 -58.47 -42.25 87.06 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.294 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 47' ' ' TYR . 77.8 mt -54.26 -34.17 60.16 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.869 -1.145 . . . . 0.0 108.701 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG12 ' CE2' ' A' ' 90' ' ' PHE . 57.7 mt -79.35 -55.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.636 -0.665 . . . . 0.0 109.27 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.8 mt -59.24 -54.49 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.5 mt-10 -62.2 -41.58 98.5 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.9 -43.71 96.54 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.55 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 7.1 mt -62.35 -36.54 82.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -1.021 . . . . 0.0 109.041 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -72.2 -28.42 63.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.355 -0.84 . . . . 0.0 109.051 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.26 -18.13 26.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.59 -0.694 . . . . 0.0 109.632 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD13 ' CB ' ' A' ' 64' ' ' SER . 14.4 mt -61.67 -42.05 98.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.239 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 57.52 31.78 20.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.599 -0.688 . . . . 0.0 110.395 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -93.87 -43.05 8.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 109.881 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER 73.26 -4.0 2.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 111.144 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -117.53 -26.26 6.69 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.031 -1.043 . . . . 0.0 109.951 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.08 168.65 11.41 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.546 ' CB ' HD13 ' A' ' 58' ' ' LEU . 13.8 m -149.94 177.03 10.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 p -127.81 176.58 7.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.4 tpp85 -46.28 -47.6 45.62 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.5 Cg_endo -67.99 -42.51 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.274 1.144 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 64' ' ' SER . . . -58.06 -36.52 72.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 113' ' ' VAL . 4.5 mm? -78.36 -49.52 13.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.815 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.7 mtpt -52.09 -39.63 60.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.457 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 7.6 ttpt -50.94 -51.7 49.71 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.53 -48.41 81.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.616 HD11 ' CD2' ' A' ' 90' ' ' PHE . 11.8 mt -61.62 -33.49 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.596 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.531 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -91.28 -41.65 10.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.151 -0.968 . . . . 0.0 111.575 -179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 38.5 mt-10 -92.3 -65.81 0.97 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.963 -1.086 . . . . 0.0 110.106 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 18.0 m-20 -59.09 -22.02 60.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.865 -1.147 . . . . 0.0 108.214 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.533 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -123.8 176.87 1.97 Allowed Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.58 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -65.07 172.74 6.9 Favored 'Trans proline' 0 C--N 1.282 -2.941 0 O-C-N 124.071 1.564 . . . . 0.0 113.527 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -52.9 -12.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.495 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.589 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 8.5 p -45.64 -29.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' CA ' HG22 ' A' ' 73' ' ' ILE . . . -89.13 -36.72 7.49 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 16.1 t -65.57 -8.63 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.543 -0.975 . . . . 0.0 110.432 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.79 -160.69 0.5 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 111.108 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.5 t -127.21 -67.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.264 -0.897 . . . . 0.0 110.682 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 84' ' ' SER . 16.0 t-20 -40.73 -41.27 1.5 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.215 -0.928 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.589 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -48.12 -40.91 25.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.541 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 7.6 t70 -46.72 -32.18 3.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -71.99 -33.82 68.41 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.636 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 21.6 m-85 -75.09 -43.01 55.46 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.402 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CD2' HD11 ' A' ' 73' ' ' ILE . 43.7 t80 -57.46 -39.02 75.43 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -62.88 -54.88 31.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.508 -0.745 . . . . 0.0 109.487 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.69 -38.86 49.39 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.844 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.542 ' CB ' HD12 ' A' ' 51' ' ' ILE . . . -66.16 -47.61 73.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.546 HG13 ' CE1' ' A' ' 90' ' ' PHE . 14.5 mm -56.26 -61.03 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.076 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -56.68 -40.31 75.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.635 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -61.6 -47.33 85.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.47 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.44 -52.22 10.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.48 HG22 HG21 ' A' ' 94' ' ' ILE . 57.9 t -59.17 -36.72 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.355 -1.085 . . . . 0.0 110.419 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 4.0 tp10 -61.66 -37.33 83.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.199 -0.938 . . . . 0.0 110.06 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.54 17.36 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 109.931 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.52 25.31 74.96 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.481 ' OD2' ' HA2' ' A' ' 97' ' ' GLY . 25.1 m-20 -82.78 -67.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.136 -1.214 . . . . 0.0 109.893 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -102.91 168.23 9.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.977 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 34.3 mm-40 -105.9 125.71 51.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -0.845 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.524 ' NE2' HG23 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -141.09 102.37 6.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.118 -0.989 . . . . 0.0 111.103 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -80.85 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.632 1.333 . . . . 0.0 109.648 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -123.02 -61.56 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.086 . . . . 0.0 110.246 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.81 -145.56 3.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.85 4.89 5.7 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.329 1.699 . . . . 0.0 111.407 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.86 -97.86 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.814 -0.554 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.19 116.35 0.37 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -103.57 160.65 14.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -1.109 . . . . 0.0 109.672 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.536 HG13 ' CD2' ' A' ' 69' ' ' LEU . 1.8 p -122.61 117.33 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.87 -1.144 . . . . 0.0 110.718 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 14.1 mtpt -115.43 129.27 56.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 109.762 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 10.2 tp -74.87 96.28 3.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.199 -0.938 . . . . 0.0 110.906 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . 31.91 57.48 0.34 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.809 -0.557 . . . . 0.0 111.236 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 61' ' ' ARG . 22.8 mmtm -85.51 115.83 23.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.6 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.231 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' CD ' ' N ' ' A' ' 41' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.271 0.558 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.88 179.11 4.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.361 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER 42.5 40.03 1.77 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.26 -0.9 . . . . 0.0 110.794 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.302 23.3 t 50.15 -175.95 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.381 -1.328 . . . . 0.0 110.946 175.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -73.69 128.36 35.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.758 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 66.1 p -78.72 164.22 24.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 42.9 m-85 -53.69 -27.3 27.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.92 -45.7 91.26 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.33 -46.17 83.54 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.246 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.584 HD13 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 mt -50.41 -33.35 20.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.884 -1.135 . . . . 0.0 108.451 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.595 HG12 ' CE2' ' A' ' 90' ' ' PHE . 48.9 mt -80.77 -56.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.449 0.642 . . . . 0.0 109.384 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.617 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 74.2 mt -57.65 -53.41 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.7 mt-10 -59.24 -40.29 85.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.3 -46.49 86.43 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 9.1 mt -67.56 -39.89 84.93 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.54 -0.976 . . . . 0.0 108.657 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.4 m -66.19 -28.35 68.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -87.43 -29.21 21.62 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.542 ' CD1' ' HB3' ' A' ' 64' ' ' SER . 10.4 mt -55.79 -21.16 17.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.843 . . . . 0.0 108.997 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.1 mtpt 61.4 57.17 2.43 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.336 0.589 . . . . 0.0 110.389 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 35.9 mm-40 56.19 157.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 167.96 166.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -61.83 -21.59 64.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.02 169.22 31.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.542 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 1.1 m -136.34 160.81 37.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 110.23 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 7.1 p -134.64 175.99 9.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.164 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.27 -47.03 68.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.589 -0.694 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 41.0 Cg_endo -69.34 -42.81 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.231 1.122 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -30.44 66.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.975 . . . . 0.0 109.791 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 69' ' ' LEU . 4.5 mm? -86.7 -49.91 7.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.588 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 73' ' ' ILE . 5.5 mtpt -56.33 -39.64 73.14 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.452 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.67 -49.97 45.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 3.1 t80 -63.0 -47.52 82.79 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.614 HD13 ' CD2' ' A' ' 90' ' ' PHE . 14.9 mt -61.04 -31.85 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.446 -0.783 . . . . 0.0 111.114 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.25 -43.04 10.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.0 -1.062 . . . . 0.0 111.643 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 26.7 mt-10 -94.0 -65.36 0.99 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.968 -1.082 . . . . 0.0 109.911 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 9.7 m-20 -59.08 -17.42 25.87 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 108.383 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.2 m-85 -129.29 176.47 2.78 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 43.3 Cg_endo -65.27 173.35 6.34 Favored 'Trans proline' 0 C--N 1.28 -3.031 0 O-C-N 123.942 1.496 . . . . 0.0 114.082 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 33.6 mt -50.48 -16.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.452 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.589 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.2 p -44.51 -29.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . -91.31 -33.07 8.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.572 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 12.4 t -51.17 -55.7 16.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.621 -0.929 . . . . 0.0 110.743 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.67 -171.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.523 -0.736 . . . . 0.0 111.241 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -119.99 -54.63 2.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 110.429 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.477 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.4 t-20 -42.07 -41.35 2.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 81' ' ' GLY . 0.5 OUTLIER -49.03 -41.39 34.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.979 -1.075 . . . . 0.0 108.209 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.513 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 33.3 t0 -45.69 -31.41 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -70.33 -40.62 74.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.436 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 71.5 m-85 -68.32 -42.75 78.91 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.614 ' CD2' HD13 ' A' ' 73' ' ' ILE . 32.3 t80 -59.42 -32.6 70.33 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.3 m-80 -66.95 -53.59 30.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.53 -0.731 . . . . 0.0 109.427 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.62 -40.19 65.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.113 -0.992 . . . . 0.0 108.797 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . . . -66.46 -36.17 82.11 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.562 ' HA ' HD13 ' A' ' 51' ' ' ILE . 6.5 mm -65.19 -60.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.37 -38.12 73.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 8.4 tptm -63.08 -50.02 72.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.362 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.456 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.93 -52.72 31.21 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 105' ' ' GLN . 59.8 t -59.37 -33.77 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.492 -1.005 . . . . 0.0 109.902 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 1.2 tp10 -60.73 -40.33 92.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.287 -0.883 . . . . 0.0 109.616 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.56 15.77 3.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 109.891 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.16 24.99 76.47 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 3.4 m-20 -81.15 -67.41 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.213 -1.169 . . . . 0.0 109.86 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.712 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -106.78 162.23 13.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.251 -0.906 . . . . 0.0 109.725 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 11.9 mm-40 -101.19 125.57 47.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.672 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.489 ' OE1' HG21 ' A' ' 94' ' ' ILE . 1.1 mm-40 -133.99 98.17 14.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 111.283 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.1 Cg_endo -78.9 172.69 14.61 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.933 1.491 . . . . 0.0 109.342 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 108' ' ' GLY . 11.2 mmtt -104.02 -55.39 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 109.89 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.07 -151.29 0.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.89 4.74 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.281 1.674 . . . . 0.0 111.371 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.66 -107.25 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.186 0 O-C-N 121.751 -0.593 . . . . 0.0 110.063 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.93 117.51 0.48 Allowed Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -112.52 160.05 18.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -1.051 . . . . 0.0 109.856 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.487 HG13 ' CD2' ' A' ' 69' ' ' LEU . 1.4 p -121.57 113.23 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.082 . . . . 0.0 109.752 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -109.85 129.85 55.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.979 . . . . 0.0 110.133 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.508 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 19.8 tp -76.61 116.77 17.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.03 108.07 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -73.14 144.97 46.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.274 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.294 0.569 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.78 135.4 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 44' ' ' SER . 54.4 p -125.47 31.98 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.771 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.305 15.9 t 50.14 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 118.184 -1.406 . . . . 0.0 110.777 175.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.94 156.35 20.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 4.8 p -116.13 135.69 53.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 0.0 110.061 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 60.8 m-85 -47.85 -30.71 4.3 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.042 -1.036 . . . . 0.0 108.812 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 52' ' ' ILE . 17.2 ttm180 -59.24 -45.76 90.31 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 53' ' ' GLU . 59.1 mt-10 -59.08 -43.77 91.82 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' A' ' 73' ' ' ILE . 96.2 mt -53.42 -32.53 50.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.654 -1.279 . . . . 0.0 108.713 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.627 HG12 ' CE1' ' A' ' 90' ' ' PHE . 22.7 mt -81.23 -56.42 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.679 0.752 . . . . 0.0 109.107 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.612 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 57.4 mt -59.11 -53.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.991 0.901 . . . . 0.0 108.68 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -61.6 -39.33 90.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.596 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.59 -49.14 79.76 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.2 mt -58.52 -36.35 73.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.444 -1.033 . . . . 0.0 109.61 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -74.29 -30.13 61.95 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.771 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.94 -10.62 41.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.666 -0.646 . . . . 0.0 110.069 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD13 ' CB ' ' A' ' 64' ' ' SER . 12.5 mt -64.58 -53.49 46.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 109.773 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 56.67 16.83 2.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.88 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.47 -152.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.848 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -150.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.068 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -75.05 -0.74 19.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.475 -0.766 . . . . 0.0 110.754 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . -162.8 168.94 37.86 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.071 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.577 ' CB ' HD13 ' A' ' 58' ' ' LEU . 27.3 m -137.81 -172.88 3.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -1.061 . . . . 0.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 53.7 p -130.63 173.5 10.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 111.145 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 12.0 ttp180 -52.42 -45.68 95.13 Favored Pre-proline 0 C--N 1.296 -1.725 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.7 -42.97 4.16 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.299 1.157 . . . . 0.0 110.788 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.18 -22.57 17.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.075 -1.016 . . . . 0.0 109.615 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 3.7 mm? -91.05 -48.4 6.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.356 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 27.9 mttt -56.34 -42.07 77.11 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 1.7 ttpt -51.24 -49.81 60.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.879 0.847 . . . . 0.0 108.815 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.596 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.05 -47.4 86.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.61 HD11 ' CD1' ' A' ' 90' ' ' PHE . 15.5 mt -63.41 -31.29 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.969 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HB2' ' N ' ' A' ' 82' ' ' SER . 45.1 pttt -91.6 -41.04 10.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.877 -1.139 . . . . 0.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.6 mt-10 -96.03 -65.7 0.95 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.055 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.491 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 50.7 m-20 -56.62 -19.92 18.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.622 -1.299 . . . . 0.0 107.992 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CB ' ' HD2' ' A' ' 78' ' ' PRO . 0.1 OUTLIER -126.44 177.97 1.74 Allowed Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.143 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.77 176.19 5.45 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.949 1.5 . . . . 0.0 114.108 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.587 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -51.99 -15.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.857 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.605 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -44.28 -30.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.572 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.27 -36.45 6.6 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.587 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.2 m -73.06 -1.21 16.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -1.075 . . . . 0.0 110.323 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -81.27 -151.35 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 110.619 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.78 -74.59 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.855 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 35.4 t-20 -41.12 -35.64 0.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.322 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.605 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.7 t80 -51.5 -42.05 61.4 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.078 -1.049 . . . . 0.0 108.553 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 26.1 m-20 -45.61 -27.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -80.83 -34.49 33.84 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.031 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 20.8 m-85 -71.94 -41.1 68.2 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.05 -1.032 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.627 ' CE1' HG12 ' A' ' 51' ' ' ILE . 71.0 t80 -59.84 -43.27 94.69 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.484 -0.76 . . . . 0.0 108.956 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 59.5 m-20 -56.98 -56.83 16.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.51 -0.744 . . . . 0.0 109.462 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.99 -39.84 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.075 -1.016 . . . . 0.0 108.985 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.537 ' CB ' HD13 ' A' ' 51' ' ' ILE . . . -64.44 -45.5 87.21 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.465 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 12.8 mm -60.15 -60.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.42 -38.16 73.91 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.893 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -66.61 -48.68 68.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 0.0 110.155 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -65.11 -52.52 40.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 105' ' ' GLN . 37.8 t -61.56 -41.29 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.549 -0.971 . . . . 0.0 110.457 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 6.6 tp10 -61.25 -35.34 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.224 -0.923 . . . . 0.0 110.016 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . . . -83.7 14.04 4.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.972 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.09 24.23 76.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.4 m-20 -85.84 -69.28 0.67 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -1.23 . . . . 0.0 109.754 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -115.5 125.73 53.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.52 ' NE2' ' CG2' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -134.91 98.18 13.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.664 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo -78.46 170.18 18.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.873 1.459 . . . . 0.0 110.076 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -98.17 -91.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.87 -150.64 43.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.02 4.73 5.91 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.18 1.621 . . . . 0.0 111.341 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -164.97 -105.18 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.202 0 O-C-N 121.79 -0.569 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.31 109.71 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -99.92 160.17 14.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -1.069 . . . . 0.0 109.933 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 69' ' ' LEU . 3.2 p -122.22 127.1 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 110.352 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 11.9 mtpt -126.45 129.56 48.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.543 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 8.7 tp -82.27 102.36 11.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . 14.83 60.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.078 0.466 . . . . 0.0 112.114 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' LEU . 43.3 mttt -112.06 143.28 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.144 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.206 0.527 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.95 120.13 13.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.9 OUTLIER -98.42 26.37 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.771 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.503 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.299 13.8 t 51.71 174.28 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.304 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.33 114.95 29.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 85.8 p -101.72 143.74 31.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 110.296 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 63.0 m-85 -48.74 -26.69 2.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.02 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.95 -45.53 82.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 53.2 mm-40 -57.85 -19.32 28.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.877 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 29.6 mt -86.34 -31.75 21.37 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.7 -1.25 . . . . 0.0 108.961 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 8.2 mt -78.14 -56.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.595 -0.691 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.578 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 24.9 mt -52.74 -49.99 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 78.0 mt-10 -64.95 -41.5 95.43 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.912 0.863 . . . . 0.0 108.786 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -55.95 -44.83 87.71 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 8.9 mt -67.77 -44.15 78.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -1.047 . . . . 0.0 109.355 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -67.64 -26.29 66.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.208 -0.932 . . . . 0.0 108.848 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.57 -25.85 20.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.663 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 64' ' ' SER . 8.3 mt -54.19 -35.92 62.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.23 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 41.31 37.43 0.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.855 -0.528 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.67 -159.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.922 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -46.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -72.08 -24.73 61.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.26 170.98 12.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 58' ' ' LEU . 65.4 m -134.93 166.53 22.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 0.0 110.15 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.503 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 5.1 p -120.97 173.04 7.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.091 -1.006 . . . . 0.0 110.97 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.603 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -43.73 -48.71 20.29 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.878 -0.513 . . . . 0.0 111.38 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.6 Cg_endo -67.55 -42.87 6.4 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.263 1.138 . . . . 0.0 110.436 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.95 -28.93 59.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.473 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' N ' HD21 ' A' ' 69' ' ' LEU . 3.7 mm? -83.3 -51.68 7.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 109.504 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 2.3 mtpt -50.06 -38.54 38.63 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.643 -1.223 . . . . 0.0 107.747 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -49.81 -55.96 12.17 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.74 -45.5 89.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 ' CD1' ' A' ' 90' ' ' PHE . 22.2 mt -62.39 -34.19 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.477 -0.765 . . . . 0.0 111.022 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.541 ' N ' ' HA3' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -91.27 -41.81 10.74 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.037 -1.04 . . . . 0.0 111.595 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 20.8 mt-10 -94.61 -65.02 1.01 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.549 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.2 m-20 -57.94 -20.56 38.59 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HB3' ' HD2' ' A' ' 78' ' ' PRO . 1.6 m-85 -126.15 177.11 2.09 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 44.3 Cg_endo -65.09 174.86 4.38 Favored 'Trans proline' 0 C--N 1.283 -2.869 0 O-C-N 123.838 1.441 . . . . 0.0 114.03 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pt -52.97 -12.46 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.031 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.4 p -46.34 -28.95 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.589 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -36.93 7.88 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 107.179 -2.368 . . . . 0.0 107.179 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 48.3 t -57.22 -38.68 74.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.883 . . . . 0.0 110.289 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -52.08 -169.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.526 -0.733 . . . . 0.0 111.033 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 85' ' ' ASN . 4.8 p -124.62 -65.8 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 110.339 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 61.4 t30 -42.65 -36.0 1.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -0.911 . . . . 0.0 109.988 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.589 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -50.92 -42.03 59.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.202 -0.999 . . . . 0.0 108.388 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 46.9 t0 -45.52 -27.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -80.46 -34.45 35.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.594 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 m-85 -70.76 -43.61 68.44 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.606 ' CD1' HD13 ' A' ' 73' ' ' ILE . 71.5 t80 -55.13 -40.54 70.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-80 -59.22 -55.77 30.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.554 -0.717 . . . . 0.0 109.717 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.52 -38.35 53.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.718 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -69.49 -40.63 76.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 9.9 mm -63.42 -60.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 2.8 mttp -57.13 -37.81 72.57 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 12.5 tptm -63.96 -49.09 73.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.84 . . . . 0.0 109.468 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.93 -53.96 20.42 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 61.9 t -56.49 -34.02 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -1.067 . . . . 0.0 109.826 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 24.5 tp10 -68.66 -35.03 76.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.53 11.29 5.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 110.043 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.18 21.57 78.85 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -88.98 -65.44 1.02 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 110.468 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -99.05 166.94 11.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.765 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 114' ' ' LYS . 52.7 mm-40 -114.12 124.0 51.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' OE1' ' CG2' ' A' ' 94' ' ' ILE . 1.2 mt-30 -135.41 114.48 11.43 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 111.222 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.54 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 50.9 Cg_endo -89.94 -155.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.883 1.465 . . . . 0.0 109.141 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.54 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -135.9 -85.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.955 -1.091 . . . . 0.0 110.568 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.51 -151.61 1.44 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.94 5.24 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.107 1.583 . . . . 0.0 111.389 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -179.3 101.45 0.03 OUTLIER 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.367 0.603 . . . . 0.0 109.695 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.33 113.17 5.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.36 159.49 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.4 p -114.4 101.6 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -101.86 129.39 48.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 178.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.501 ' N ' HD21 ' A' ' 55' ' ' LEU . 13.3 tp -67.78 148.75 50.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.235 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 102' ' ' ASP . . . -67.71 66.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 117' ' ' LYS . 16.6 pttt -72.81 127.21 31.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 4.0 mttp . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.198 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.174 0.511 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.18 99.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.016 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 44' ' ' SER . 1.1 p 63.52 -160.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.561 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.295 30.4 t -174.29 95.06 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.073 -175.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 123.71 26.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 109.979 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p -121.42 178.82 4.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.159 -0.963 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 55.1 m-85 -66.85 -39.05 87.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 110.037 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HA ' ' HB1' ' A' ' 93' ' ' ALA 0.25 3.2 ttp180 -49.74 -44.6 48.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 53.3 mm-40 -57.67 -45.37 85.68 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.823 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 35.6 mt -52.21 -31.22 30.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.816 -1.177 . . . . 0.0 108.596 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG12 ' CE1' ' A' ' 90' ' ' PHE . 4.4 mt -80.09 -56.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.566 0.698 . . . . 0.0 109.308 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.634 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.5 mt -61.41 -54.48 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.1 mt-10 -58.77 -38.63 78.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.68 -49.62 75.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -59.97 -39.15 84.66 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.585 -0.95 . . . . 0.0 108.58 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -70.31 -24.44 63.02 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -86.04 -31.21 22.1 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' CD1' ' HB3' ' A' ' 64' ' ' SER . 25.5 mt -51.47 -36.23 43.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.9 mtpm? 59.3 32.45 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.317 0.579 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 45.4 mt-10 -123.62 -44.97 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER 65.88 7.42 4.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -0.841 . . . . 0.0 110.306 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -96.02 -39.2 9.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 172.88 161.78 23.86 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.564 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -151.83 165.2 35.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.492 -1.005 . . . . 0.0 110.263 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 4.7 p -134.63 170.67 15.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 18.5 ttp180 -49.24 -49.25 71.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.1 Cg_endo -67.45 -42.4 7.34 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.301 1.158 . . . . 0.0 110.627 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' HB3' ' OG ' ' A' ' 65' ' ' SER . . . -54.12 -31.1 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 109.464 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.0 mm? -82.84 -51.19 7.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.443 -0.785 . . . . 0.0 109.537 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 4.6 mttt -50.36 -41.23 51.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 5.3 tmmm? -49.14 -55.85 11.03 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.594 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.97 -46.14 88.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.585 HD12 ' CD1' ' A' ' 90' ' ' PHE . 17.5 mt -65.53 -31.72 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.924 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 82' ' ' SER . 46.0 pttt -91.81 -40.77 11.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.966 -1.084 . . . . 0.0 111.624 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 14.9 mt-10 -95.97 -65.31 0.98 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.905 -1.122 . . . . 0.0 109.89 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 18.6 m-20 -56.31 -21.6 25.19 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.666 -1.272 . . . . 0.0 107.845 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.519 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.57 175.7 2.49 Favored Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.558 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 49.5 Cg_endo -69.84 178.31 4.75 Favored 'Trans proline' 0 C--N 1.28 -3.033 0 O-C-N 123.903 1.475 . . . . 0.0 113.885 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.598 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -51.0 -15.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.034 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.633 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.06 -30.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.77 -34.64 6.79 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -83.1 23.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -1.064 . . . . 0.0 110.362 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -104.83 -139.07 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.473 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -140.55 -77.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.893 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' SER . 50.4 t30 -42.05 -36.29 1.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.6 t80 -49.22 -40.53 34.08 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.361 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.1 m-20 -46.62 -29.66 1.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.15 -33.79 50.13 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.01 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.67 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 12.7 m-85 -72.21 -44.83 62.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.152 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CE1' HG12 ' A' ' 51' ' ' ILE . 83.8 t80 -56.55 -39.9 74.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.486 -0.759 . . . . 0.0 109.184 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -60.63 -55.39 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.464 -0.773 . . . . 0.0 109.279 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -50.87 -36.63 38.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 108.852 178.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -71.29 -39.43 71.51 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.212 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 5.7 mm -64.16 -59.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 108.976 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.53 -41.02 80.08 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -61.87 -42.89 99.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.964 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.471 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -74.43 -52.01 7.89 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 48.0 t -61.71 -40.11 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.123 . . . . 0.0 110.346 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 9.2 tp10 -59.87 -36.85 77.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.72 13.44 4.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.49 78.04 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD2' ' HA2' ' A' ' 97' ' ' GLY . 11.5 m-20 -82.66 -68.28 0.72 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.732 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.72 157.69 17.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.542 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' CG ' ' HA ' ' A' ' 117' ' ' LYS . 6.1 mm-40 -96.73 123.89 40.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.54 ' NE2' ' HB ' ' A' ' 113' ' ' VAL . 6.0 mm-40 -134.98 106.09 10.47 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 110.701 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.531 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 49.4 Cg_endo -79.51 -160.19 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 109.978 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -134.04 -86.84 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.073 -1.017 . . . . 0.0 110.418 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.73 -162.05 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.23 5.22 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.102 1.58 . . . . 0.0 111.285 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.04 96.05 0.5 Allowed 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.255 0.55 . . . . 0.0 110.063 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.45 135.68 22.52 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.13 126.53 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -1.064 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 2.1 p -83.49 104.52 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 5.4 mttp -101.29 125.86 47.97 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.039 -1.038 . . . . 0.0 109.301 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 0.4 OUTLIER -67.64 151.17 47.73 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.414 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 115' ' ' LEU . . . 72.25 164.81 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.53 ' HA ' ' CG ' ' A' ' 104' ' ' GLU . 14.1 ttpt -115.22 137.78 51.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 30.3 mttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.377 0.608 . . . . 0.0 110.634 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' GLU . . . 59.97 63.36 1.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.505 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 44' ' ' SER . 74.9 m -138.3 -172.45 3.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 0.0 110.589 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.302 41.1 t -174.63 162.65 3.4 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.97 -175.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.57 115.66 27.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.424 ' OG ' ' HG2' ' A' ' 49' ' ' GLU . 78.5 p -80.29 -178.93 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.382 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 73.5 m-85 -58.84 -40.55 84.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 109.928 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 51' ' ' ILE . 5.0 ttp85 -54.93 -47.58 74.24 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.0 mm-40 -57.16 -43.67 82.74 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.227 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 HD12 ' CE1' ' A' ' 86' ' ' PHE . 21.1 mt -53.21 -33.21 51.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.84 -1.162 . . . . 0.0 108.635 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.564 HG12 ' CE2' ' A' ' 90' ' ' PHE . 48.1 mt -79.84 -56.31 7.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.57 0.7 . . . . 0.0 109.169 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.597 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.3 mt -57.42 -52.13 60.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.3 mt-10 -64.57 -40.72 96.05 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -56.87 -44.04 92.34 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 6.2 mt -65.71 -38.76 90.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -1.072 . . . . 0.0 109.428 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -67.7 -31.19 70.98 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.286 -0.884 . . . . 0.0 108.906 178.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -90.94 -24.43 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.631 -0.668 . . . . 0.0 110.029 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD23 ' CB ' ' A' ' 64' ' ' SER . 10.2 mt -52.49 -30.38 29.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 37.88 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.365 0.602 . . . . 0.0 110.717 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -94.77 -35.65 12.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 110.075 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 1.2 tpt180 71.32 -54.16 0.67 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.839 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 63' ' ' GLY . 3.0 ptpt -63.62 -18.26 63.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.071 -1.018 . . . . 0.0 110.703 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' N ' ' HG3' ' A' ' 62' ' ' LYS . . . 125.5 172.04 13.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.534 ' CB ' HD23 ' A' ' 58' ' ' LEU . 19.5 m -147.62 -172.2 3.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 109.951 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.527 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 11.9 p -134.75 174.4 10.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.0 111.009 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -51.11 -47.23 88.06 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.661 -0.649 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.6 Cg_endo -69.97 -41.91 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.263 1.139 . . . . 0.0 110.396 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.13 65.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' CD1' HD11 ' A' ' 58' ' ' LEU . 4.4 mm? -75.98 -47.11 26.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 74' ' ' LYS . 93.6 mttt -54.59 -46.61 73.8 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 70' ' ' LYS . 9.4 ttpt -42.01 -56.76 2.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 2.2 t80 -57.59 -42.89 84.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 86' ' ' PHE . 32.5 mt -66.02 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 111.476 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.48 -42.51 10.24 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.747 -1.22 . . . . 0.0 111.087 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -95.4 -65.04 1.0 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.061 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.4 m-20 -56.93 -19.64 19.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.877 -1.14 . . . . 0.0 107.969 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.3 m-85 -126.89 175.04 3.59 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.553 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.62 176.55 4.9 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 O-C-N 123.941 1.495 . . . . 0.0 113.841 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.623 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 8.2 mt -52.55 -12.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.96 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.5 p -46.55 -29.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.14 -37.35 7.2 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 4.1 t -72.0 -2.89 19.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.563 -0.963 . . . . 0.0 110.263 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -78.27 -153.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.429 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 86' ' ' PHE . 28.2 m -133.19 -78.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.763 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 43.5 t-20 -40.72 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -0.922 . . . . 0.0 110.331 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 90' ' ' PHE . 1.6 t80 -56.32 -44.98 80.46 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.086 -1.009 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 6.3 p-10 -45.42 -26.89 0.61 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.8 tp -82.28 -30.11 30.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.585 -0.697 . . . . 0.0 109.964 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.599 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.5 m-85 -76.45 -42.11 45.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 47.3 t80 -58.29 -42.47 86.68 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -59.04 -57.67 12.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.305 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -52.21 -38.54 58.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.683 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 51' ' ' ILE . . . -66.23 -41.4 90.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.563 HG13 ' CE1' ' A' ' 90' ' ' PHE . 9.7 mm -62.39 -60.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.752 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -57.29 -37.62 72.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -65.09 -49.84 68.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.44 -0.787 . . . . 0.0 109.775 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -64.51 -51.41 52.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 74.4 t -61.56 -40.97 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -1.023 . . . . 0.0 109.813 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 11.9 tp10 -58.52 -34.28 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 109.691 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.11 15.58 5.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.745 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 23.96 76.95 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.6 m-20 -85.1 -68.05 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -1.22 . . . . 0.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.28 159.51 17.35 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.905 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 117' ' ' LYS . 24.9 mm-40 -100.13 143.45 30.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.519 ' NE2' ' CG2' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -149.82 98.08 3.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.968 . . . . 0.0 111.014 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 45.1 Cg_endo -74.97 -167.18 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.726 1.382 . . . . 0.0 109.439 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 70.4 mmtt -130.92 -110.36 0.26 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.996 -1.065 . . . . 0.0 110.227 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.31 -154.31 45.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.94 5.16 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.137 1.598 . . . . 0.0 111.388 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -173.23 97.89 0.12 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.284 0.564 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.53 119.51 12.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.509 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -100.95 160.62 14.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -1.003 . . . . 0.0 109.907 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.494 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.4 p -114.43 121.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.948 -1.095 . . . . 0.0 110.262 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -122.2 125.77 46.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 22.0 tp -70.61 132.8 46.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.363 -0.835 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 115' ' ' LEU . . . 71.64 156.41 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -112.88 143.97 43.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.002 . . . . 0.0 110.321 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.204 0.526 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.68 55.02 1.65 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.429 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -154.36 172.35 17.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.833 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.316 48.4 t -175.56 176.91 1.85 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.804 -175.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 3.3 mtmp? -70.68 124.51 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.1 p -123.96 170.75 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.776 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 97.1 m-85 -63.22 -23.64 67.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.706 . . . . 0.0 110.184 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 10.5 ttm180 -53.71 -46.12 70.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 16.3 mt-10 -57.06 -44.72 83.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.14 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 19.0 mt -51.6 -32.63 29.49 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.789 -1.194 . . . . 0.0 108.304 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 90' ' ' PHE . 11.0 mt -81.54 -55.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.602 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.2 mt -56.57 -52.27 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.1 mt-10 -62.48 -40.96 98.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.32 -45.64 95.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 6.5 mt -64.46 -41.25 96.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -1.002 . . . . 0.0 109.551 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -68.01 -28.79 67.72 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 108.832 178.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.55 -20.84 22.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.658 -0.651 . . . . 0.0 109.822 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.53 HD11 ' CD2' ' A' ' 69' ' ' LEU . 10.4 mt -57.44 -39.32 76.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.487 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.7 mtpt 61.79 22.33 12.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.607 -0.683 . . . . 0.0 110.194 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -120.43 112.31 18.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -77.97 -17.63 56.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -13.2 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.972 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 111.33 169.57 18.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.529 ' CB ' HD11 ' A' ' 58' ' ' LEU . 47.9 m -141.66 172.69 12.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -1.102 . . . . 0.0 109.944 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.5 p -125.69 176.25 7.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.617 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -46.53 -47.62 48.5 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 110.98 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -67.46 -42.26 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.634 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 64' ' ' SER . . . -55.93 -33.71 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.6 mm? -81.08 -51.33 8.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.448 -0.782 . . . . 0.0 109.61 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.515 ' NZ ' ' HB3' ' A' ' 87' ' ' ASP . 2.7 mtpt -53.8 -41.54 67.4 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 3.9 tmmm? -47.55 -53.74 13.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.998 0.904 . . . . 0.0 108.733 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.578 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.0 t80 -59.88 -49.66 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.599 HD13 ' CD1' ' A' ' 90' ' ' PHE . 19.9 mt -63.88 -31.53 53.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.395 -0.815 . . . . 0.0 110.669 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.618 ' HG3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -92.4 -34.97 13.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.085 . . . . 0.0 111.897 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.618 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 39.6 mt-10 -98.35 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.701 -1.249 . . . . 0.0 109.461 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 13.4 m-20 -57.01 -18.97 15.81 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.532 ' CB ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -127.57 174.1 4.68 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.539 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.1 Cg_endo -65.8 175.84 4.16 Favored 'Trans proline' 0 C--N 1.281 -2.978 0 O-C-N 124.096 1.577 . . . . 0.0 114.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.574 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 4.0 mt -51.97 -13.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.504 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.59 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.5 p -45.83 -29.84 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -86.54 -38.95 7.94 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.574 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 50.0 m -62.51 -29.05 70.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.695 -0.885 . . . . 0.0 110.435 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.2 -162.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.435 -0.79 . . . . 0.0 111.409 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -127.11 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.665 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -39.53 -38.91 0.64 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 0.0 110.406 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.602 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -47.12 -39.06 12.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 3.7 p-10 -48.13 -35.03 10.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.5 tp -69.0 -30.9 69.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.21 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 20.2 m-30 -76.84 -45.45 28.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.602 ' CE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -61.25 -35.17 76.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 65.3 m-20 -63.75 -56.78 12.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.711 . . . . 0.0 109.364 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.12 -37.19 33.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.668 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . . . -67.3 -40.09 86.01 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.218 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 13.3 mm -63.15 -59.84 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 1.8 mtpt -57.67 -40.36 79.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tppt? -61.41 -47.27 86.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.547 -0.721 . . . . 0.0 109.766 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -68.89 -51.82 27.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 103' ' ' PHE . 48.2 t -61.23 -40.7 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -1.064 . . . . 0.0 110.188 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 10.3 tp10 -60.2 -35.49 75.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 110.033 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HB1' ' CG ' ' A' ' 102' ' ' ASP . . . -85.58 16.18 4.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -0.818 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.39 25.5 74.72 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 14.7 m-20 -86.19 -68.37 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 110.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -105.73 179.4 4.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.06 131.08 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.47 ' HG3' HG23 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.32 101.66 6.16 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.061 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.1 Cg_endo -83.78 177.57 6.09 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.946 1.498 . . . . 0.0 109.764 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 33.4 mmtm -114.07 -110.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.051 -1.031 . . . . 0.0 110.073 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.17 -157.43 52.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.58 4.94 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.006 1.53 . . . . 0.0 111.351 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -176.4 99.24 0.06 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.315 0.579 . . . . 0.0 110.153 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.09 126.97 12.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -113.47 127.14 55.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -1.134 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.464 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.1 p -81.13 128.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.423 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -124.91 132.54 53.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 18.5 tp -82.75 113.95 20.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.15 112.51 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.412 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 121.09 25.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.121 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.1 tttt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.202 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.566 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 1.3 mm-40 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.246 0.546 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 41' ' ' GLU . . . 62.97 144.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.025 . . . . 0.0 109.645 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -65.75 -168.44 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.626 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.304 37.9 t -174.65 60.4 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.704 -1.199 . . . . 0.0 110.748 -175.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 148.73 29.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 5.1 p -117.29 -179.58 3.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.867 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 42.6 m-85 -64.73 -32.69 74.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.93 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.413 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -50.57 -44.53 56.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' GLU . 4.6 mm-40 -57.53 -43.94 84.75 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.393 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 46.2 mt -53.03 -31.2 39.97 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.682 -1.261 . . . . 0.0 107.856 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 4.6 mt -81.95 -55.57 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.58 0.705 . . . . 0.0 109.178 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 59.8 mt -59.27 -55.31 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -58.65 -38.87 79.05 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.43 -48.62 84.01 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.542 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.0 mt -59.2 -36.43 75.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -1.083 . . . . 0.0 109.388 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -37.69 87.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.255 -0.903 . . . . 0.0 108.854 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -91.11 -18.75 24.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.562 -0.712 . . . . 0.0 109.82 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.542 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 11.1 mt -49.58 -31.77 11.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 109.041 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.3 ptmt 24.22 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.292 0.568 . . . . 0.0 111.564 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 58' ' ' LEU . 2.1 mt-10 -100.54 -115.34 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 172.82 -49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.639 -1.288 . . . . 0.0 110.843 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.72 -22.19 37.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 110.805 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' N ' ' HG3' ' A' ' 62' ' ' LYS . . . 138.57 169.14 11.49 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.516 -1.326 . . . . 0.0 109.977 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 58' ' ' LEU . 74.4 m -139.73 148.84 42.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -1.054 . . . . 0.0 109.5 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.5 p -107.19 178.89 4.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.042 . . . . 0.0 111.094 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.618 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -46.67 -47.14 50.73 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.716 -0.615 . . . . 0.0 110.799 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.71 -43.44 5.42 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.113 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.27 -35.15 59.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 108.862 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 3.8 mm? -79.3 -46.17 18.25 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.59 ' HE2' ' CD2' ' A' ' 86' ' ' PHE . 5.8 mtpt -54.59 -40.93 69.31 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.3 ttpt -46.84 -49.72 19.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -65.99 -49.57 67.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.594 HD12 ' CD1' ' A' ' 90' ' ' PHE . 14.0 mt -62.08 -30.35 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.56 ' HB2' ' CA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.06 -42.61 10.4 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.072 -1.018 . . . . 0.0 112.153 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.521 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 10.9 mt-10 -95.82 -65.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 109.849 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 7.3 m-20 -57.82 -18.96 25.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.814 -1.179 . . . . 0.0 107.902 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.559 ' CE1' ' CE1' ' A' ' 72' ' ' PHE . 3.0 m-85 -127.82 175.39 3.45 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.563 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.1 Cg_endo -66.18 174.55 5.86 Favored 'Trans proline' 0 C--N 1.282 -2.93 0 O-C-N 123.894 1.47 . . . . 0.0 114.118 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.585 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.02 -16.18 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.781 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.4 p -44.18 -31.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.46 -35.24 6.64 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.329 -2.308 . . . . 0.0 107.329 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.585 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -84.73 26.32 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.549 -0.971 . . . . 0.0 110.525 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -107.49 -133.66 0.33 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' PHE . 14.7 t -143.53 -83.05 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 0.0 110.831 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 13.1 t-20 -40.91 -28.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.209 -0.932 . . . . 0.0 110.79 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.626 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.9 t80 -52.02 -42.2 62.84 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.461 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.1 t0 -45.55 -30.14 1.38 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.9 tp -76.17 -36.49 58.69 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.921 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 7.7 m-85 -71.07 -44.04 66.55 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.103 -0.998 . . . . 0.0 108.379 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CD1' HD12 ' A' ' 73' ' ' ILE . 73.6 t80 -57.84 -38.52 75.8 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 25.8 m-20 -60.86 -56.13 24.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.559 -0.713 . . . . 0.0 109.449 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.36 -39.0 63.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 109.023 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.539 ' HB3' ' CB ' ' A' ' 47' ' ' TYR . . . -68.03 -38.74 82.88 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.024 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 8.1 mm -64.19 -59.74 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.372 -0.83 . . . . 0.0 109.021 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -59.03 -38.62 79.73 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.341 -0.849 . . . . 0.0 108.853 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.1 tptm -64.46 -47.84 77.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.08 -50.22 53.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.499 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 99.5 t -62.35 -45.52 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.367 -1.078 . . . . 0.0 109.737 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 35.9 tp10 -56.77 -33.69 66.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.518 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . . . -83.82 12.88 5.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.856 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.0 23.65 77.9 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 25.2 m-20 -87.34 -67.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.139 -1.213 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.721 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.17 159.98 16.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.932 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 21.0 mm-40 -97.27 134.62 40.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' CG2' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -142.51 98.3 5.94 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 111.415 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo -75.95 -157.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.948 1.499 . . . . 0.0 109.581 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -127.32 -53.45 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.973 -1.079 . . . . 0.0 110.133 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.52 -151.27 0.48 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.95 4.79 5.82 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.242 1.654 . . . . 0.0 111.289 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.31 -94.22 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.878 -0.514 . . . . 0.0 110.122 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 113.84 0.29 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -105.36 159.5 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.153 . . . . 0.0 110.047 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.48 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.2 p -121.7 115.02 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.981 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 4.6 mmtt -108.9 143.97 37.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.087 -1.008 . . . . 0.0 109.765 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 117' ' ' LYS . 14.5 tp -89.28 134.04 34.22 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.507 -0.745 . . . . 0.0 110.362 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . -42.34 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -84.96 132.02 34.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 110.211 -179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' C ' ' HE3' ' A' ' 117' ' ' LYS . 1.6 mttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.212 0.53 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' SER . . . -42.05 130.33 3.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 44' ' ' SER . 4.8 p -56.32 -165.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.3 34.5 t -174.69 68.09 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.925 -175.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HE2' ' OH ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -72.5 134.27 45.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.357 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 78.3 p -115.43 174.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 110.223 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 65.4 m-85 -62.17 -39.52 92.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 109.845 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 13.5 ttp180 -52.1 -47.16 65.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' GLU . 24.6 mm-40 -57.16 -44.29 83.32 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 74.4 mt -52.21 -32.25 35.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.633 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 90' ' ' PHE . 12.7 mt -81.7 -56.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 68.7 mt -58.11 -52.29 60.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.9 mt-10 -62.38 -41.22 98.47 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -55.79 -40.7 81.26 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 8.5 mt -67.41 -37.04 82.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.457 -1.025 . . . . 0.0 109.559 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -29.5 62.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 108.922 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.8 -22.93 20.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.586 -0.696 . . . . 0.0 110.058 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt -53.12 -40.48 64.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 36.9 43.57 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.622 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HG3' HD23 ' A' ' 58' ' ' LEU . 2.4 mt-10 -85.11 -83.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.69 -62.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 111.043 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -122.03 -40.94 2.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 111.408 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.18 172.9 32.79 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.232 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.557 ' CB ' HD13 ' A' ' 58' ' ' LEU . 30.9 m -138.25 -179.08 5.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.971 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 16.7 p -133.37 178.32 7.0 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.131 -0.98 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -46.81 -46.42 51.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.716 -0.615 . . . . 0.0 111.235 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.14 -42.64 5.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.268 1.141 . . . . 0.0 110.665 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' SER . . . -57.32 -24.75 57.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 4.0 mm? -92.97 -48.59 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.1 mtpt -58.41 -41.29 84.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -47.97 -51.84 22.12 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.985 0.898 . . . . 0.0 108.806 178.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 2.9 t80 -62.22 -48.98 77.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 77' ' ' TYR . 46.3 mt -65.17 -29.91 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.552 ' HB2' ' N ' ' A' ' 82' ' ' SER . 8.5 ptpt -92.02 -42.43 9.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.766 -1.209 . . . . 0.0 111.52 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.538 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 8.6 mt-10 -95.57 -64.8 1.02 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 6.0 m-20 -55.75 -22.01 21.83 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.828 -1.17 . . . . 0.0 107.953 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.79 178.02 1.6 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 177.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 46.1 Cg_endo -68.79 175.62 7.05 Favored 'Trans proline' 0 C--N 1.281 -3.011 0 O-C-N 123.88 1.463 . . . . 0.0 114.231 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.6 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.2 mp -49.71 -15.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.864 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.5 -31.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.35 -37.78 6.51 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -85.21 46.6 1.3 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.79 -0.83 . . . . 0.0 109.455 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.84 178.76 6.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 0.0 110.943 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 85' ' ' ASN . 65.8 m -104.75 156.3 18.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.455 -0.778 . . . . 0.0 109.786 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' SER . 5.7 t-20 76.79 -40.54 0.37 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.427 -0.796 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.627 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -48.65 -42.08 33.31 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.657 -1.277 . . . . 0.0 108.192 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.2 p30 -47.23 -36.41 8.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.8 tp -63.46 -34.35 77.58 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.253 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.595 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 79.8 m-85 -76.13 -47.88 22.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' HG12 ' A' ' 51' ' ' ILE . 37.9 t80 -61.2 -36.03 78.77 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 75.0 m-20 -62.51 -56.71 15.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.13 -39.18 42.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.165 -0.96 . . . . 0.0 108.499 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.484 ' C ' ' CD1' ' A' ' 51' ' ' ILE . . . -63.34 -40.85 98.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 13.2 mm -64.19 -59.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 20.6 mtpt -55.41 -37.99 68.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.8 tppt? -65.4 -51.32 61.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -67.94 -47.35 60.73 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.445 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 98.8 t -63.08 -42.17 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -1.021 . . . . 0.0 110.459 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 5.8 tp10 -61.62 -34.54 75.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.29 15.67 3.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 25.51 74.46 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 3.8 t0 -84.93 -67.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -1.153 . . . . 0.0 110.097 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.18 159.82 16.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.173 -0.954 . . . . 0.0 109.727 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -97.35 128.46 44.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.168 -0.958 . . . . 0.0 109.206 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.497 ' HG3' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.41 109.67 6.26 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.119 -0.988 . . . . 0.0 111.137 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 50.5 Cg_endo -86.87 -158.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.004 1.528 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 1.3 mptp? -135.77 -83.87 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.996 -1.065 . . . . 0.0 110.238 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 44.01 -151.53 0.56 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.463 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 48.9 Cg_endo -77.83 4.86 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.279 1.673 . . . . 0.0 111.409 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 109' ' ' PRO . . . -179.86 97.36 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.235 0.541 . . . . 0.0 110.137 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.68 120.14 16.02 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -96.51 137.62 35.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.128 . . . . 0.0 109.998 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.483 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.3 p -94.31 106.03 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.042 -1.036 . . . . 0.0 110.755 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.29 128.94 45.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.745 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 117' ' ' LYS . 26.2 tp -76.46 116.73 17.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.957 . . . . 0.0 109.705 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . -13.57 78.34 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.308 0.575 . . . . 0.0 112.405 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -115.89 127.43 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.402 -0.812 . . . . 0.0 110.074 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.217 0.532 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.3 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 110.493 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 44' ' ' SER . 5.0 p -134.78 178.85 6.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.307 43.5 t -174.86 132.29 0.33 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.356 -175.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -69.75 161.05 30.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 109.526 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.455 ' OG ' ' HG3' ' A' ' 49' ' ' GLU . 21.3 p -121.65 139.86 53.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.001 -1.062 . . . . 0.0 110.187 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.605 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 71.3 m-85 -50.47 -22.8 2.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.231 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 1.9 ttm180 -57.42 -46.17 83.83 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.3 mt-10 -55.95 -45.27 78.91 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 75.7 mt -51.77 -35.3 43.22 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.74 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG12 ' CE1' ' A' ' 90' ' ' PHE . 17.3 mt -79.35 -56.25 7.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.516 0.674 . . . . 0.0 109.374 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.7 mt -56.81 -51.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.8 mm-40 -60.83 -43.46 98.22 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -52.82 -41.85 58.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.3 mt -72.12 -40.34 68.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.649 -0.912 . . . . 0.0 108.678 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 m -67.08 -23.2 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.13 -23.95 21.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 12.0 mt -57.56 -30.14 64.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.681 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER 68.95 70.86 0.27 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.323 0.582 . . . . 0.0 111.078 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.78 76.59 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.721 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -113.54 154.28 27.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -5.78 21.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.04 167.1 16.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.525 ' CB ' HD13 ' A' ' 58' ' ' LEU . 63.0 m -158.79 135.12 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.523 -0.987 . . . . 0.0 109.365 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 17.8 p -88.67 -179.06 5.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.091 -1.006 . . . . 0.0 111.257 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -51.03 -44.75 87.65 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.701 -0.624 . . . . 0.0 110.774 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.5 Cg_endo -68.68 -43.07 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.314 1.165 . . . . 0.0 109.818 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.98 -30.48 10.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.464 -0.895 . . . . 0.0 108.735 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 3.9 mm? -87.17 -50.85 6.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 88.9 mttt -53.92 -39.23 65.67 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.9 ttpp -51.56 -50.38 60.19 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.555 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.08 -47.95 82.4 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.585 HD11 ' CD1' ' A' ' 90' ' ' PHE . 17.0 mt -61.42 -33.27 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 110.663 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HB2' ' N ' ' A' ' 82' ' ' SER . 43.6 pttt -91.52 -40.26 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 37.8 mt-10 -93.99 -66.11 0.94 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.897 -1.127 . . . . 0.0 110.218 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 25.4 m-20 -58.74 -21.49 55.41 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.68 -1.262 . . . . 0.0 108.077 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.549 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.46 175.0 2.86 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.2 Cg_endo -65.24 174.09 5.44 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 O-C-N 124.179 1.62 . . . . 0.0 113.839 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.634 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 6.3 mt -52.46 -12.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.812 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -45.96 -29.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.27 -36.45 7.06 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.339 -2.305 . . . . 0.0 107.339 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.634 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.8 t -73.44 -0.25 14.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.604 -0.939 . . . . 0.0 110.295 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -79.21 -149.34 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.209 -0.932 . . . . 0.0 110.827 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 85' ' ' ASN . 2.7 p -133.72 -79.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -41.64 -35.09 0.69 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.279 -0.888 . . . . 0.0 110.572 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.603 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.3 t80 -48.8 -40.95 31.01 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.902 -1.123 . . . . 0.0 108.339 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 92.5 m-20 -47.11 -26.23 1.05 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 5.7 tp -82.74 -33.75 27.39 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.883 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.605 ' HB3' ' CG ' ' A' ' 47' ' ' TYR . 30.1 m-85 -71.15 -45.69 63.01 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.301 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.586 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 81.0 t80 -52.92 -31.95 42.81 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 19.5 m-20 -67.59 -52.29 40.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.538 -0.726 . . . . 0.0 109.433 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.23 -40.38 67.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 108.992 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . . . -65.81 -37.28 85.84 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.948 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 9.6 mm -64.08 -59.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 108.865 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.43 -40.95 79.51 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -61.44 -45.33 94.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.781 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.63 -51.26 12.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 92.5 t -61.86 -38.61 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.6 tp10 -58.49 -39.19 79.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . . . -83.15 13.26 4.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.529 -0.732 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.15 23.5 77.51 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 -83.11 -67.96 0.75 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.0 166.16 11.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 56.8 mm-40 -109.55 136.65 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.553 ' HG3' ' CG2' ' A' ' 94' ' ' ILE . 6.0 mm-40 -146.28 107.16 4.16 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.034 -1.041 . . . . 0.0 111.435 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.532 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 51.6 Cg_endo -77.97 -166.37 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.89 1.469 . . . . 0.0 109.0 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 1.9 mptp? -133.45 -86.32 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.021 -1.049 . . . . 0.0 110.8 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 45.64 -155.96 0.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 47.9 Cg_endo -77.55 4.39 6.02 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.958 1.504 . . . . 0.0 111.139 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 109' ' ' PRO . . . -179.52 99.6 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.289 0.566 . . . . 0.0 110.053 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.71 149.14 23.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.97 138.25 54.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.159 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 2.1 p -82.17 117.57 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 111.041 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -111.12 132.9 53.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 117' ' ' LYS . 17.7 tp -73.56 141.51 46.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.63 84.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.398 -0.814 . . . . 0.0 110.087 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -99.62 145.14 27.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 110.371 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.25 152.94 38.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.254 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 44' ' ' SER . 35.3 t -104.66 48.94 0.82 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.345 -0.847 . . . . 0.0 110.827 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.296 28.8 t 50.83 -176.0 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.101 175.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -85.01 155.33 21.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 p -131.82 152.4 51.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.242 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 92.1 m-85 -53.76 -22.26 8.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.323 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 52' ' ' ILE 0.25 7.0 ttp180 -51.43 -44.15 62.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 5.0 mt-10 -56.76 -46.77 81.22 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.2 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 14.9 mt -52.07 -34.78 45.22 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.482 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 3.3 mt -75.85 -56.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 109.393 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.625 HG12 ' CE1' ' A' ' 103' ' ' PHE . 25.3 mt -59.65 -54.07 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.907 0.86 . . . . 0.0 108.738 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 8.0 mt-10 -60.33 -35.68 76.2 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.775 0.798 . . . . 0.0 108.905 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -64.49 -49.71 63.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.567 ' CD2' ' HB2' ' A' ' 115' ' ' LEU . 7.1 mt -59.65 -42.0 91.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -1.085 . . . . 0.0 109.303 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -66.1 -31.48 72.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.268 -0.895 . . . . 0.0 109.085 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.653 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.92 -15.35 29.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.543 HD12 ' CB ' ' A' ' 64' ' ' SER . 12.3 mt -59.73 -42.47 93.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 70.99 14.57 6.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.846 -0.533 . . . . 0.0 110.392 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.67 159.47 15.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.17 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.12 -8.86 8.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -100.92 -25.58 14.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.47 168.66 11.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.543 ' CB ' HD12 ' A' ' 58' ' ' LEU . 16.4 m -142.99 -177.28 5.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -1.076 . . . . 0.0 109.834 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 8.2 p -135.02 174.76 10.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.129 -0.982 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 ttp180 -45.34 -47.74 34.55 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.692 -0.63 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.2 Cg_endo -66.45 -42.81 9.08 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.14 1.074 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 64' ' ' SER . . . -59.89 -34.33 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.651 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 58' ' ' LEU . 4.2 mm? -80.92 -51.59 8.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -49.38 -38.23 27.81 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.303 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.494 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.81 -53.86 35.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 1.8 t80 -60.78 -46.17 91.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.596 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 8.3 mt -64.15 -31.44 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.235 -0.915 . . . . 0.0 110.635 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HB2' ' N ' ' A' ' 82' ' ' SER . 1.1 ptpt -92.1 -38.78 11.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.932 -1.105 . . . . 0.0 110.888 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 16.5 mt-10 -95.36 -64.88 1.02 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.807 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 89.1 m-20 -58.64 -17.94 26.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CE2' ' CZ ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -128.0 176.7 2.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.561 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 45.0 Cg_endo -67.16 175.68 5.46 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 O-C-N 124.021 1.537 . . . . 0.0 113.764 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.618 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 11.6 mt -52.39 -12.7 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.004 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.9 p -46.34 -30.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.05 -36.77 8.13 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 107.184 -2.366 . . . . 0.0 107.184 176.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.618 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.1 t -74.44 1.82 10.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.653 -0.91 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -84.79 -150.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.165 -0.959 . . . . 0.0 110.914 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' ASN . 31.0 t -134.18 -80.8 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.246 -0.909 . . . . 0.0 110.759 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' SER . 45.5 t-20 -39.19 -34.48 0.18 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.23 -0.919 . . . . 0.0 110.417 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -48.69 -40.29 27.64 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.437 178.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 50.5 t0 -48.11 -30.68 4.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.862 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.32 -28.69 59.76 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.193 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.586 ' HB3' ' CG ' ' A' ' 47' ' ' TYR . 12.4 m-85 -76.18 -46.14 29.9 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.9 t80 -57.72 -38.31 75.05 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 26.0 m-20 -60.04 -55.29 35.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.514 -0.741 . . . . 0.0 109.331 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.13 -41.39 75.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.345 -0.847 . . . . 0.0 109.201 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 51' ' ' ILE . . . -64.32 -40.12 95.26 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.09 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 6.7 mm -60.93 -59.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 108.677 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -57.32 -41.41 79.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.3 tppp? -59.43 -47.8 84.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.614 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -69.5 -52.94 18.88 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 59.1 t -60.64 -39.6 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.524 -0.986 . . . . 0.0 110.376 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.1 tp10 -64.44 -34.13 77.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.787 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.515 ' CB ' ' OD1' ' A' ' 102' ' ' ASP . . . -82.44 11.79 5.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.912 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 22.73 78.75 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -85.9 -67.65 0.79 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.231 -1.158 . . . . 0.0 110.14 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -100.87 178.67 4.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 109.663 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -120.2 126.5 50.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.01 128.0 17.41 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.993 . . . . 0.0 110.514 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 51.8 Cg_endo -86.2 -156.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.776 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 106' ' ' PRO . 9.9 mmtm -161.26 110.23 1.58 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.273 -0.892 . . . . 0.0 109.147 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.15 -149.52 6.55 Favored Glycine 0 C--N 1.286 -2.233 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.27 4.78 5.58 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.256 1.661 . . . . 0.0 111.325 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.0 78.5 0.59 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.316 0.579 . . . . 0.0 109.966 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.05 128.48 47.74 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' O ' ' CD ' ' A' ' 106' ' ' PRO . . . -121.39 153.1 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -1.074 . . . . 0.0 109.913 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.465 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.1 p -120.07 115.02 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.679 -1.263 . . . . 0.0 110.458 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -108.27 124.81 50.88 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.567 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 2.6 tm? -73.62 137.6 44.32 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.378 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.508 ' N ' HD12 ' A' ' 115' ' ' LEU . . . -176.3 98.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 110.299 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -95.0 109.47 21.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.13 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 pttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.261 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 31.8 tt0 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 124.29 21.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 0.0 110.178 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.84 49.73 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.298 28.0 t 50.8 -174.66 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.007 175.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -64.32 130.55 44.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.475 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 58.7 p -131.53 -179.27 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.414 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.694 ' CE2' ' CG ' ' A' ' 89' ' ' TYR . 42.6 m-85 -66.76 -36.56 82.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.425 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -50.96 -45.64 60.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.07 -45.05 83.59 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.177 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 94.8 mt -52.29 -31.97 35.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.82 -1.175 . . . . 0.0 108.448 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 90' ' ' PHE . 4.7 mt -82.16 -54.69 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.582 HG12 ' CE1' ' A' ' 103' ' ' PHE . 64.0 mt -58.42 -52.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 11.4 mt-10 -62.36 -38.62 90.25 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.768 0.794 . . . . 0.0 109.052 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -62.66 -45.94 94.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 6.8 mt -59.74 -37.2 78.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -1.101 . . . . 0.0 109.629 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -74.27 -28.31 61.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.028 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.83 -11.12 40.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.607 -0.683 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt -68.14 -53.37 25.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 110.111 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 66.87 39.17 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.025 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -92.78 -167.39 1.73 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.44 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -127.18 -58.97 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.682 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -81.2 -40.38 23.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.18 168.38 31.11 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.556 ' CB ' HD12 ' A' ' 58' ' ' LEU . 72.2 m -114.96 -177.72 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -1.048 . . . . 0.0 109.562 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 37.1 p -134.84 173.53 11.6 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.447 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.605 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -49.83 -45.8 80.26 Favored Pre-proline 0 C--N 1.299 -1.597 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.956 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.3 Cg_endo -70.41 -42.77 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.354 1.186 . . . . 0.0 110.281 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.42 -24.44 30.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.751 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.1 mm? -90.89 -51.1 5.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.75 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 87' ' ' ASP . 89.8 mttt -59.31 -36.96 76.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.55 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.537 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 3.4 ttpt -55.88 -51.08 68.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.83 -46.7 87.06 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.574 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 18.6 mt -63.05 -33.97 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.587 -0.696 . . . . 0.0 111.169 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB2' ' N ' ' A' ' 82' ' ' SER . 17.1 ptmt -91.43 -42.14 10.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.85 -1.157 . . . . 0.0 111.435 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 15.6 mt-10 -94.43 -65.06 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 109.875 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 24.2 m-20 -56.7 -23.82 44.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.807 -1.183 . . . . 0.0 108.094 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.546 ' CB ' ' HD2' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -122.76 178.19 1.38 Allowed Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.564 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 45.3 Cg_endo -65.67 176.66 3.36 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 O-C-N 123.996 1.524 . . . . 0.0 114.414 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.582 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.21 -12.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.72 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.5 p -45.81 -29.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.588 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.94 -35.78 7.53 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.582 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 40.7 t -57.23 -40.46 77.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.571 -0.958 . . . . 0.0 110.317 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.33 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.738 . . . . 0.0 110.838 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 12.4 t -122.75 -64.38 1.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 110.472 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 7.1 m120 -43.98 -37.2 2.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.588 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 1.1 t80 -48.38 -42.27 31.32 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.155 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -44.75 -29.69 0.82 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.9 tp -78.33 -35.08 48.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.231 0.539 . . . . 0.0 109.667 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.694 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 6.2 m-85 -69.15 -46.3 67.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.13 -0.981 . . . . 0.0 108.666 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' HG12 ' A' ' 51' ' ' ILE . 54.1 t80 -57.58 -36.19 71.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 16.7 m-20 -60.23 -55.13 37.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.075 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -55.43 -39.78 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 108.875 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . . . -64.62 -40.63 95.82 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.594 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 9.7 mm -63.07 -57.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 3.3 mtmm -60.12 -35.54 75.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -67.87 -53.4 26.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.48 -0.763 . . . . 0.0 109.651 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -61.65 -46.7 93.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 79.2 t -65.42 -46.2 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 7.9 tp10 -58.92 -33.47 70.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 109.874 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.28 13.49 4.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.32 24.19 76.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 4.2 t0 -87.06 -67.25 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.224 -1.162 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.46 159.97 16.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.024 . . . . 0.0 110.1 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.531 ' CG ' ' HA ' ' A' ' 117' ' ' LYS . 6.9 mm-40 -97.54 128.76 44.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 109.754 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.54 ' OE1' ' CA ' ' A' ' 113' ' ' VAL . 0.8 OUTLIER -144.05 98.82 5.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.962 . . . . 0.0 111.234 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.3 Cg_endo -76.26 -148.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.186 1.624 . . . . 0.0 108.965 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -149.07 105.79 3.56 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.627 -1.296 . . . . 0.0 109.348 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.09 -146.52 6.15 Favored Glycine 0 C--N 1.283 -2.382 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.26 4.88 6.2 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.348 1.709 . . . . 0.0 111.345 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 111' ' ' GLY . . . -170.86 21.92 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.822 -0.549 . . . . 0.0 111.118 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 110' ' ' ALA . . . 36.87 91.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -81.65 125.72 30.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -1.202 . . . . 0.0 109.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.3 p -92.18 133.76 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.862 -1.149 . . . . 0.0 110.962 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -126.82 124.18 39.06 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.352 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 116' ' ' ALA . 1.4 tp -67.43 151.03 48.12 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.546 ' N ' ' HG ' ' A' ' 115' ' ' LEU . . . 74.07 157.06 0.18 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.057 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.531 ' HA ' ' CG ' ' A' ' 104' ' ' GLU . 5.5 ptpp? -115.01 143.96 44.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.348 0.594 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.94 70.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 44' ' ' SER . 4.1 t -119.84 41.1 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.958 . . . . 0.0 110.772 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.3 23.1 t 50.59 -178.96 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.057 175.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -89.67 159.96 16.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 6.0 p -130.58 178.23 6.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.105 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 71.2 m-85 -62.46 -30.06 70.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 3.2 ttm180 -55.64 -44.15 76.88 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 mm-40 -58.57 -43.24 89.35 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.199 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD12 ' CE1' ' A' ' 86' ' ' PHE . 36.4 mt -51.74 -32.22 29.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.588 -1.32 . . . . 0.0 107.636 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 90' ' ' PHE . 10.1 mt -82.34 -53.95 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.8 mt -58.72 -54.55 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.3 mt-10 -59.33 -38.89 81.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -57.83 -48.02 84.9 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.9 mt -66.86 -49.03 66.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.65 -0.912 . . . . 0.0 108.756 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -60.35 -24.86 65.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.49 -22.63 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 64' ' ' SER . 11.7 mt -60.5 -26.64 66.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 109.259 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 3.1 mtpt 70.37 70.16 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.253 0.549 . . . . 0.0 110.751 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 1.1 tp10 61.69 -118.6 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 72.23 149.2 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.969 -1.082 . . . . 0.0 110.329 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -13.67 50.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 110.585 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.25 169.48 18.4 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.528 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 10.3 m -141.98 155.13 45.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -1.045 . . . . 0.0 109.686 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.2 p -99.71 172.05 7.51 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.041 -1.037 . . . . 0.0 111.202 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -45.96 -48.07 41.52 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.823 -0.548 . . . . 0.0 110.801 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.8 Cg_endo -67.32 -42.7 7.1 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.214 1.113 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.62 -28.36 20.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.279 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' HG11 ' A' ' 113' ' ' VAL . 4.6 mm? -86.7 -48.84 7.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.573 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -52.02 -43.32 63.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 6.2 ttpt -47.19 -53.52 12.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.57 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.61 -46.92 85.99 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.579 HD11 ' CD1' ' A' ' 90' ' ' PHE . 13.9 mt -63.54 -33.91 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.823 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.543 ' N ' ' HA3' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -91.65 -40.29 11.38 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.977 -1.077 . . . . 0.0 111.458 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 11.4 mt-10 -95.59 -65.42 0.98 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.055 -1.028 . . . . 0.0 109.729 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.484 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.3 m-20 -56.5 -21.52 26.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.076 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.528 ' CB ' ' HD2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -125.7 177.74 1.78 Allowed Pre-proline 0 C--N 1.309 -1.158 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 45.2 Cg_endo -67.99 177.14 4.57 Favored 'Trans proline' 0 C--N 1.282 -2.939 0 O-C-N 123.925 1.487 . . . . 0.0 113.755 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 13.0 mt -52.72 -12.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.812 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.602 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.2 p -45.97 -30.38 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.46 -37.15 6.66 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 106.591 -2.603 . . . . 0.0 106.591 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -83.33 37.01 0.54 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.752 -0.852 . . . . 0.0 110.078 178.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.88 -137.27 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.988 . . . . 0.0 110.493 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' PHE . 16.5 p -139.13 -88.73 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.005 . . . . 0.0 111.106 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' OD1' ' CZ ' ' A' ' 89' ' ' TYR . 6.0 t-20 -35.62 -30.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.695 . . . . 0.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 2.1 t80 -54.19 -44.07 71.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.939 -1.1 . . . . 0.0 108.684 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.4 m-20 -46.96 -26.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.781 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.1 tp -80.94 -29.13 35.52 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.786 -0.765 . . . . 0.0 109.724 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.603 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 22.5 m-85 -77.33 -44.51 29.28 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.153 -0.967 . . . . 0.0 108.732 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.593 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.1 t80 -60.25 -46.37 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.359 -0.838 . . . . 0.0 108.822 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 3.5 m-80 -55.04 -57.5 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.27 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.58 -42.27 70.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.502 ' CB ' HD11 ' A' ' 51' ' ' ILE . . . -63.09 -40.49 97.8 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.54 ' CD1' HG23 ' A' ' 51' ' ' ILE . 8.5 mm -61.06 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.477 -0.765 . . . . 0.0 108.993 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -56.53 -37.95 71.17 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.588 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 23.9 tptp -65.51 -51.37 60.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.541 -0.724 . . . . 0.0 109.491 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.82 -49.93 64.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 54.1 t -50.71 -23.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -1.037 . . . . 0.0 109.372 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -93.33 -49.2 6.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.56 5.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 0.0 109.926 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -69.15 -9.21 60.0 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 m-20 66.79 37.14 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.861 -0.788 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.59 ' CE2' ' HA3' ' A' ' 97' ' ' GLY . 3.9 m-30 -87.08 146.63 26.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 109.821 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 23.8 mm-40 -97.44 124.73 41.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 108.892 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -144.63 98.48 4.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 110.897 -179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.4 Cg_endo -78.12 178.58 7.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.653 1.344 . . . . 0.0 109.7 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 5.0 mptp? -118.19 -92.51 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 110.282 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.67 -156.59 7.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.73 5.3 5.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.142 1.601 . . . . 0.0 111.572 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -170.75 100.5 0.23 Allowed 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.389 0.614 . . . . 0.0 110.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 133.26 12.11 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -117.71 160.36 21.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 109.603 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.508 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.3 p -110.66 124.23 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.629 -1.294 . . . . 0.0 110.32 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.69 132.63 53.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.918 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 55' ' ' LEU . 12.2 tp -76.06 98.3 4.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.654 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 115' ' ' LEU . . . 63.71 160.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 109.728 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -109.4 111.13 22.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.096 -1.003 . . . . 0.0 110.299 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.272 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.21 0.529 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.93 57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.12 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 44' ' ' SER . 6.3 t 56.3 -165.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.31 -0.869 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.302 33.1 t -174.3 86.69 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.941 -175.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -90.7 126.86 36.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 17.9 p -118.2 149.82 40.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.036 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 29.8 m-85 -54.9 -33.51 62.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 0.0 109.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HA ' ' HB2' ' A' ' 93' ' ' ALA . 4.1 ttt180 -61.14 -45.47 94.53 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 53' ' ' GLU . 55.1 mt-10 -58.38 -43.97 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD13 ' CE1' ' A' ' 86' ' ' PHE . 46.6 mt -51.38 -34.09 32.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.688 -1.257 . . . . 0.0 108.311 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 90' ' ' PHE . 30.2 mt -79.83 -55.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.435 HD13 ' HD3' ' A' ' 48' ' ' ARG . 60.2 mt -58.63 -53.98 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -61.17 -40.28 93.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.89 -47.74 84.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 115' ' ' LEU . 8.2 mt -67.05 -49.87 63.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.937 . . . . 0.0 108.521 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 m -55.45 -24.39 30.56 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.78 -27.27 19.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 13.2 mt -52.39 -22.75 4.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -0.94 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 63.71 30.99 14.63 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.131 0.491 . . . . 0.0 110.913 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 61' ' ' ARG . 2.8 mt-10 57.33 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.516 -0.74 . . . . 0.0 110.972 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 176.26 -121.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 0.0 109.457 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 62' ' ' LYS . 1.7 ttmm -116.7 12.1 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 109.738 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.3 165.73 14.76 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.49 ' OG ' ' CD1' ' A' ' 58' ' ' LEU . 68.1 m -138.27 176.98 8.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -1.06 . . . . 0.0 109.649 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 20.5 p -131.26 174.51 9.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 111.237 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.613 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 tpp180 -48.07 -46.31 65.01 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.872 -0.517 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.7 Cg_endo -70.4 -43.15 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.229 1.12 . . . . 0.0 110.59 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -55.19 -31.9 61.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 69' ' ' LEU . 3.6 mm? -78.45 -53.86 6.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.119 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OD1' ' A' ' 87' ' ' ASP . 77.0 mttt -50.01 -36.41 28.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.65 -50.94 59.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.574 ' CZ ' ' CE2' ' A' ' 77' ' ' TYR . 3.7 t80 -63.46 -45.93 88.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.586 HD11 ' CD1' ' A' ' 90' ' ' PHE . 14.0 mt -63.77 -32.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.418 -0.801 . . . . 0.0 110.757 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.55 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 35.2 pttt -91.2 -41.38 11.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.095 -1.003 . . . . 0.0 111.494 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.55 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 34.2 mt-10 -93.83 -65.14 1.01 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.945 -1.097 . . . . 0.0 109.668 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.9 m-20 -59.94 -15.68 23.92 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.857 -1.152 . . . . 0.0 108.632 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.574 ' CE2' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -130.88 176.93 2.5 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.553 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.2 Cg_endo -65.74 173.63 6.57 Favored 'Trans proline' 0 C--N 1.283 -2.904 0 O-C-N 123.968 1.509 . . . . 0.0 113.594 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 3.1 mt -52.75 -12.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.882 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p -45.63 -30.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.28 -37.32 6.7 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.62 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -80.95 45.5 0.83 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.66 -0.906 . . . . 0.0 110.367 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.06 -138.18 0.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 1.9 t -141.46 -77.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.986 -1.071 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 20.1 t-20 -41.95 -36.93 1.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -1.0 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.612 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 2.0 t80 -51.35 -42.01 61.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.838 -1.163 . . . . 0.0 108.62 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.502 ' OD1' ' NZ ' ' A' ' 70' ' ' LYS . 6.2 t0 -46.17 -27.31 0.95 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.18 -33.28 33.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.841 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.594 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.3 m-85 -71.92 -43.34 65.46 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.205 -0.934 . . . . 0.0 108.949 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.588 ' CE1' HG12 ' A' ' 51' ' ' ILE . 68.6 t80 -58.46 -38.82 78.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.405 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 13.2 m-80 -61.53 -55.4 31.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.666 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.14 -39.2 42.54 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.396 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.5 ' C ' ' CD1' ' A' ' 51' ' ' ILE . . . -69.11 -38.61 79.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 51' ' ' ILE . 10.1 mm -62.58 -60.55 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -39.17 73.81 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.291 -0.881 . . . . 0.0 108.644 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 16.8 tptt -66.78 -51.23 58.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.58 -49.56 68.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 62.0 t -51.17 -25.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.472 -1.017 . . . . 0.0 109.369 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -90.5 -49.45 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.592 -0.693 . . . . 0.0 110.543 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.83 -32.58 5.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -67.56 -9.93 56.57 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.6 t0 69.3 37.37 2.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.642 -0.916 . . . . 0.0 110.992 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.6 m-30 -89.18 144.75 25.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.137 . . . . 0.0 109.398 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 23.9 mm-40 -97.43 126.66 42.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.14 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.519 ' NE2' ' HB ' ' A' ' 113' ' ' VAL . 6.7 mm-40 -143.55 124.33 7.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.517 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 49.3 Cg_endo -85.23 -164.84 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.805 1.424 . . . . 0.0 109.552 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -137.56 -3.7 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 111.516 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 107' ' ' LYS . . . -52.52 -167.09 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.46 4.94 4.54 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.887 1.467 . . . . 0.0 111.617 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' GLY . . . -131.97 64.68 1.59 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.408 0.623 . . . . 0.0 109.675 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 110' ' ' ALA . . . -43.61 113.61 0.75 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -120.21 146.99 45.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -1.096 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 1.5 p -116.88 117.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.77 -1.207 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 23.5 mtpt -112.95 128.0 56.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.508 ' N ' HD23 ' A' ' 55' ' ' LEU . 16.6 tp -68.35 101.81 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.278 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 115' ' ' LEU . . . 39.74 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 110.602 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -68.35 95.75 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.96 . . . . 0.0 110.078 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 tttt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.222 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.214 0.531 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 43' ' ' SER . . . -163.4 170.08 18.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 110.197 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -58.14 -157.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.808 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.295 30.2 t -173.71 54.29 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.941 -175.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -103.2 149.15 24.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.833 . . . . 0.0 109.963 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -120.84 171.73 8.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 110.492 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 75.0 m-85 -57.84 -24.42 57.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.06 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -52.76 -45.57 67.13 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -57.86 -45.48 86.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.347 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 74.7 mt -51.44 -32.38 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.799 -1.188 . . . . 0.0 108.392 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' A' ' 90' ' ' PHE . 50.8 mt -82.72 -55.12 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.631 HG12 ' CE1' ' A' ' 103' ' ' PHE . 56.1 mt -57.49 -53.59 42.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.5 mt-10 -60.14 -39.95 88.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.03 -44.17 96.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 7.2 mt -64.35 -39.13 93.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.5 -1.0 . . . . 0.0 109.553 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -71.65 -27.82 63.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 108.64 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.78 -19.72 23.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.619 -0.676 . . . . 0.0 109.77 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD13 ' CB ' ' A' ' 64' ' ' SER . 9.9 mt -57.92 -40.78 81.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.326 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.4 mtpp 63.57 67.25 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.733 -0.605 . . . . 0.0 110.398 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 11.6 mt-10 -148.84 -44.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.953 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER 68.77 2.31 3.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 111.137 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.49 -19.76 12.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.997 -1.064 . . . . 0.0 109.977 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' HA2' ' CG ' ' A' ' 114' ' ' LYS . . . 133.22 163.91 10.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.564 ' CB ' HD13 ' A' ' 58' ' ' LEU . 9.0 m -148.99 -170.13 3.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.698 -0.884 . . . . 0.0 109.687 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -133.69 171.06 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.923 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.3 ttp85 -46.14 -47.77 43.82 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.74 -43.23 5.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.258 1.136 . . . . 0.0 110.861 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 64' ' ' SER . . . -55.52 -20.63 13.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 3.8 mm? -93.17 -45.22 7.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.16 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -57.44 -44.15 84.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 2.4 ttpt -47.2 -49.7 22.33 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.5 t80 -64.71 -49.04 72.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.56 -0.712 . . . . 0.0 109.283 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 90' ' ' PHE . 15.9 mt -60.82 -31.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 111.013 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.26 -41.83 10.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.079 -1.013 . . . . 0.0 111.732 -178.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 22.3 mt-10 -95.73 -65.55 0.97 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.926 -1.109 . . . . 0.0 110.055 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.486 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 97.5 m-20 -56.87 -22.01 33.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.827 -1.171 . . . . 0.0 107.916 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.3 m-85 -123.84 175.85 2.59 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.557 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.9 Cg_endo -66.69 175.56 5.17 Favored 'Trans proline' 0 C--N 1.28 -3.041 0 O-C-N 124.016 1.535 . . . . 0.0 114.069 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.61 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.57 -14.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.021 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.619 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 4.0 p -45.58 -30.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.16 -35.27 7.14 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -84.19 21.69 1.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.741 -0.858 . . . . 0.0 110.244 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -101.86 -140.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 0.0 110.571 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 1.3 p -135.86 -87.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.937 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.4 m120 -39.86 -26.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 0.0 111.092 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.619 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 2.0 t80 -51.46 -42.83 61.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.829 -1.169 . . . . 0.0 108.55 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.531 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 2.0 m-20 -46.52 -29.79 1.94 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.86 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -77.19 -32.25 55.93 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.93 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 17.4 m-85 -75.53 -43.29 49.59 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.952 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 67.0 t80 -60.97 -43.95 98.05 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.671 -0.811 . . . . 0.0 108.963 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.8 m-20 -56.48 -58.39 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.778 . . . . 0.0 109.23 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.56 -38.36 63.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 108.928 178.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 47' ' ' TYR . . . -69.88 -35.04 74.35 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.298 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.579 ' CG1' ' CE2' ' A' ' 90' ' ' PHE . 7.1 mm -67.53 -59.68 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.96 -38.22 75.6 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.5 tppt? -60.91 -47.67 85.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.99 -51.4 34.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 105' ' ' GLN . 70.4 t -63.01 -42.43 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.456 -1.026 . . . . 0.0 110.262 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 21.9 tp10 -61.4 -35.35 77.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.153 -0.967 . . . . 0.0 109.815 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 96' ' ' LYS . . . -81.46 11.44 4.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.82 23.59 77.78 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 1.1 t0 -85.35 -65.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -1.136 . . . . 0.0 110.167 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -99.81 -169.87 1.81 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.208 -0.932 . . . . 0.0 109.742 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' LYS . 34.9 mm-40 -129.66 125.09 35.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.7 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.529 ' OE1' ' CG2' ' A' ' 94' ' ' ILE . 5.8 mt-30 -138.26 130.6 16.12 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 110.379 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -82.96 -160.8 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.89 1.468 . . . . 0.0 109.507 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 106' ' ' PRO . 1.2 mmtt -158.41 109.92 2.2 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.217 -0.927 . . . . 0.0 109.199 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.17 7.45 Favored Glycine 0 C--N 1.284 -2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.52 5.04 5.46 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.326 1.698 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.09 87.05 1.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 121.321 0.581 . . . . 0.0 110.189 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.44 121.38 8.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -119.18 160.36 22.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -1.136 . . . . 0.0 109.79 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.502 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -128.24 122.14 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.785 -1.197 . . . . 0.0 111.052 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.504 ' CG ' ' HA2' ' A' ' 63' ' ' GLY . 33.1 mtpt -116.35 124.38 49.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.838 . . . . 0.0 109.486 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 3.1 tm? -76.19 110.09 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 115' ' ' LEU . . . 166.82 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 110.504 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -115.1 123.52 49.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.404 -0.81 . . . . 0.0 109.805 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.289 -179.825 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 32.0 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 41' ' ' GLU . . . 56.63 172.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.3 p -131.38 36.91 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.742 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.287 22.3 t 53.33 167.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.198 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.61 99.46 6.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 110.122 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 33.2 p -132.9 148.06 52.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.134 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.596 ' CG ' ' HB3' ' A' ' 89' ' ' TYR . 76.8 m-85 -52.84 -26.61 15.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 109.193 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 52' ' ' ILE . 18.6 ttp180 -51.89 -44.11 63.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' GLU . 9.2 mt-10 -57.95 -43.92 86.68 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 31.1 mt -52.82 -31.95 41.57 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.551 -1.343 . . . . 0.0 107.859 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 94' ' ' ILE . 2.9 mt -82.77 -55.27 7.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.569 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 69.9 mt -58.03 -53.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.5 mt-10 -61.39 -40.09 93.09 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.548 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -57.21 -47.55 86.87 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.55 ' HA ' ' CD1' ' A' ' 58' ' ' LEU . 7.8 mt -65.61 -39.58 91.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.691 -0.888 . . . . 0.0 109.157 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 m -68.67 -29.27 67.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.196 -0.94 . . . . 0.0 108.609 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.64 -19.71 23.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.611 -0.681 . . . . 0.0 109.868 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 55' ' ' LEU . 10.2 mt -58.71 -35.44 72.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.412 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 66.72 44.16 2.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.799 -0.563 . . . . 0.0 110.305 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' CG ' ' C ' ' A' ' 59' ' ' LYS . 33.8 mt-10 -154.36 153.21 31.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -114.58 -19.49 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.148 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 1.2 ptpp? -63.94 -18.42 64.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' CA ' ' HG2' ' A' ' 114' ' ' LYS . . . 117.52 167.23 14.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.549 ' CB ' HD12 ' A' ' 58' ' ' LEU . 5.6 m -139.09 -169.3 2.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.718 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 12.0 p -135.6 172.78 12.52 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.192 -0.943 . . . . 0.0 111.243 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.612 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -48.71 -48.43 69.7 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.737 -0.602 . . . . 0.0 110.972 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -67.64 -42.47 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.301 1.158 . . . . 0.0 110.358 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.75 50.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.752 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.54 ' CD2' HD12 ' A' ' 58' ' ' LEU . 4.5 mm? -91.17 -48.71 6.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' O ' ' CD ' ' A' ' 74' ' ' LYS . 0.1 OUTLIER -55.19 -47.67 74.91 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 9.0 ttpt -42.51 -53.68 4.23 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.548 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.72 -42.26 99.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.871 -0.518 . . . . 0.0 109.668 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.609 HD11 ' CD1' ' A' ' 90' ' ' PHE . 24.4 mt -64.38 -33.26 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.164 -0.96 . . . . 0.0 111.526 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.544 ' CD ' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -88.14 -44.6 10.79 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.836 -1.165 . . . . 0.0 111.252 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -96.8 -64.98 1.0 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 110.333 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.51 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 30.0 m-20 -53.81 -22.44 9.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.716 -1.24 . . . . 0.0 107.704 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.542 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -125.32 174.99 3.37 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.539 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 51.5 Cg_endo -70.88 179.43 4.31 Favored 'Trans proline' 0 C--N 1.279 -3.085 0 O-C-N 123.923 1.486 . . . . 0.0 114.38 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -50.68 -15.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.073 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.601 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 2.6 p -44.89 -31.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.61 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.73 -42.15 5.48 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -85.98 44.68 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.683 -0.892 . . . . 0.0 109.618 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -116.56 -103.46 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -170.16 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.846 -1.158 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -45.63 -22.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.734 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.61 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 1.7 t80 -51.36 -44.49 62.11 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.878 -1.139 . . . . 0.0 108.607 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -45.98 -27.23 0.86 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.55 -30.65 33.03 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.829 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.596 ' HB3' ' CG ' ' A' ' 47' ' ' TYR . 18.5 m-85 -76.03 -43.56 43.43 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.66 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CD1' HD11 ' A' ' 73' ' ' ILE . 76.4 t80 -56.47 -41.53 76.72 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.9 m-20 -57.35 -58.95 6.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -54.75 -40.42 69.33 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.511 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . . . -63.6 -44.8 92.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.563 -0.711 . . . . 0.0 109.159 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.6 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 8.1 mm -62.21 -58.19 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.4 -37.18 72.31 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -66.0 -52.43 49.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.64 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -61.99 -48.04 86.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 94' ' ' ILE . 43.7 t -64.27 -44.55 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.464 -1.021 . . . . 0.0 109.989 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.9 tp10 -61.29 -36.13 79.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 96' ' ' LYS . . . -77.34 4.81 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.122 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.45 19.57 77.97 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 6.5 m-20 -85.06 -66.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -1.204 . . . . 0.0 110.138 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.9 174.35 5.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 23.2 mm-40 -117.69 133.83 55.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.28 -0.887 . . . . 0.0 109.757 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.477 ' OE1' ' HB ' ' A' ' 113' ' ' VAL . 1.3 mm100 -140.67 100.13 6.78 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.98 . . . . 0.0 111.174 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.5 Cg_endo -84.05 -158.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.968 1.509 . . . . 0.0 109.398 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 47.9 mmtm -144.42 -94.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.48 -149.96 31.29 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.75 5.11 5.49 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.234 1.65 . . . . 0.0 111.498 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -176.73 100.47 0.06 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.3 0.571 . . . . 0.0 110.028 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.78 132.37 19.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.96 124.81 42.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 110.731 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.477 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 2.4 p -80.11 119.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.514 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 8.7 mtpt -113.29 125.65 54.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -81.51 141.22 34.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.443 ' N ' ' HG ' ' A' ' 115' ' ' LEU . . . -138.09 -160.36 1.05 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.356 -0.84 . . . . 0.0 109.806 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 123.35 12.33 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.18 -179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.228 0.537 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 156.27 29.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.942 . . . . 0.0 110.25 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.5 OUTLIER -83.0 -166.89 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.217 -0.927 . . . . 0.0 110.583 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.299 33.6 t -174.13 103.15 0.11 Allowed 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.068 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -83.43 126.02 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.904 . . . . 0.0 110.031 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 87.7 p -118.07 162.8 17.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 63.7 m-85 -57.19 -27.96 62.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD2' ' CA ' ' A' ' 97' ' ' GLY 0.25 0.0 OUTLIER -53.04 -44.7 67.58 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.553 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 15.6 mt-10 -56.91 -46.73 81.76 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.202 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 51.6 mt -49.72 -32.81 14.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.865 -1.147 . . . . 0.0 107.992 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG12 ' CE2' ' A' ' 90' ' ' PHE . 8.2 mt -78.88 -56.14 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.387 0.613 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.598 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 mt -58.0 -51.0 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.47 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -63.43 -38.55 91.58 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.599 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.16 -44.68 96.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 5.2 mt -65.03 -36.82 85.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.6 -0.941 . . . . 0.0 108.999 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -65.45 -30.66 71.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -91.38 -19.05 23.32 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.313 0.578 . . . . 0.0 109.769 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 10.1 mt -57.11 -18.3 14.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.159 -0.963 . . . . 0.0 109.219 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 1.6 mmmt 81.71 15.87 0.49 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.191 0.519 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 60.15 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.041 -1.037 . . . . 0.0 110.463 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 1.0 OUTLIER 179.89 -153.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.929 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 114' ' ' LYS . 2.8 ttpm? -79.14 4.82 13.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.952 . . . . 0.0 109.859 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.73 168.88 13.48 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.505 ' CB ' HD13 ' A' ' 58' ' ' LEU . 8.5 m -131.84 -168.82 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -1.047 . . . . 0.0 109.903 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 75.8 p -129.25 176.79 7.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.177 -0.952 . . . . 0.0 111.206 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -59.56 -43.83 96.53 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.824 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.449 1.236 . . . . 0.0 110.137 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.469 ' HB1' ' OG ' ' A' ' 65' ' ' SER . . . -55.01 -30.3 59.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.369 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 69' ' ' LEU . 3.6 mm? -78.03 -53.44 7.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 109.161 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HA ' ' CD1' ' A' ' 73' ' ' ILE . 56.1 mttt -48.34 -34.42 10.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.977 -1.077 . . . . 0.0 108.308 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.6 ttpt -56.37 -51.9 66.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -60.39 -45.09 94.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.581 HD13 ' CD2' ' A' ' 90' ' ' PHE . 15.9 mt -61.67 -32.09 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -0.779 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.532 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 5.7 ptmm? -91.23 -41.48 10.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.065 -1.022 . . . . 0.0 111.571 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.532 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 30.5 mt-10 -92.12 -66.3 0.94 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.924 -1.11 . . . . 0.0 109.76 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 1.2 m120 -56.28 -27.04 53.97 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.985 -1.072 . . . . 0.0 108.278 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.545 ' HB3' ' HD2' ' A' ' 78' ' ' PRO . 1.2 m-85 -120.48 177.87 1.32 Allowed Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.562 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.4 Cg_endo -64.62 173.37 5.6 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.097 1.577 . . . . 0.0 113.783 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.573 ' CA ' ' HB2' ' A' ' 82' ' ' SER . 5.8 pt -52.88 -12.93 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.914 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.579 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 9.0 p -46.63 -28.55 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.586 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -35.46 8.77 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.573 ' HB2' ' CA ' ' A' ' 79' ' ' ILE . 14.3 m -51.16 -52.46 43.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.676 -0.896 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -49.95 -173.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.575 0.703 . . . . 0.0 111.222 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ASP . 46.8 t -117.2 -63.62 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 110.546 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 39.9 t30 -38.64 -38.8 0.43 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.348 -0.845 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.586 ' CE2' ' HA2' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -51.15 -41.37 60.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.894 -1.129 . . . . 0.0 108.428 178.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -45.69 -31.16 1.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -71.62 -39.5 70.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.727 -0.608 . . . . 0.0 109.733 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.589 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 19.8 m-85 -67.37 -42.47 83.38 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.653 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.591 ' CE2' HG12 ' A' ' 51' ' ' ILE . 11.1 t80 -64.67 -41.5 96.04 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.871 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.1 m-20 -55.3 -52.03 64.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.836 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.26 -41.87 76.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.139 -0.976 . . . . 0.0 108.914 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.535 ' HB1' ' CB ' ' A' ' 47' ' ' TYR . . . -58.88 -39.07 80.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.4 -0.813 . . . . 0.0 109.144 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 18.1 mm -59.66 -56.45 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 108.977 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -39.69 93.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 29.1 tptt -63.03 -49.44 74.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.374 -0.829 . . . . 0.0 109.46 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -65.75 -50.36 54.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 19.6 t -49.6 -23.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.067 -1.255 . . . . 0.0 108.904 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 3.2 tp10 -87.17 -49.78 7.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.715 . . . . 0.0 110.178 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.78 -33.74 4.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -68.25 -11.33 61.38 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 97' ' ' GLY . 9.2 m-20 65.1 32.13 10.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.796 -0.826 . . . . 0.0 111.215 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.598 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 3.6 m-30 -77.5 146.57 36.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 109.22 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 58.1 mm-40 -97.38 123.39 41.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 108.609 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -140.89 99.04 6.8 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 111.076 -178.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 44.1 Cg_endo -73.58 -158.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.593 1.312 . . . . 0.0 109.508 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 106' ' ' PRO . 14.9 mmtm -140.83 -110.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 -157.21 51.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.01 6.05 4.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.159 1.61 . . . . 0.0 111.56 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.64 97.52 0.67 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.413 0.625 . . . . 0.0 109.621 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.62 125.88 17.6 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -115.12 159.74 20.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.1 p -111.34 142.34 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.946 -1.096 . . . . 0.0 110.781 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 6.3 mttm -136.93 130.03 31.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.479 -0.763 . . . . 0.0 109.684 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 24.5 tp -80.97 93.81 6.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.077 -1.014 . . . . 0.0 110.352 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 115' ' ' LEU . . . 56.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.407 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -54.68 138.95 40.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tttp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.106 -179.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.335 0.588 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.66 103.76 3.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.205 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 44' ' ' SER . 17.9 m -79.28 -158.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.727 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.301 30.4 t -174.52 80.9 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.841 -175.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -66.95 155.67 37.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 30.4 p -125.93 153.78 43.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 57.0 m-85 -54.93 -24.49 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HA ' HD11 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -57.14 -43.75 82.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.112 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.9 mt-10 -59.7 -45.36 92.36 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.385 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.4 mt -50.68 -31.51 16.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.78 -1.2 . . . . 0.0 108.089 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.595 HG12 ' CE1' ' A' ' 90' ' ' PHE . 41.7 mt -84.0 -55.09 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 63.5 mt -56.14 -50.55 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.594 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -54.42 -45.06 76.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.54 ' CD1' ' HB2' ' A' ' 115' ' ' LEU . 7.5 mt -63.21 -39.5 94.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.662 -0.905 . . . . 0.0 109.013 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -67.21 -30.92 70.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -90.98 -13.37 33.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.717 -0.614 . . . . 0.0 109.704 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 64' ' ' SER . 9.3 mt -56.03 -46.14 78.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.156 -0.965 . . . . 0.0 109.011 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 53.13 21.79 2.3 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.371 0.605 . . . . 0.0 110.304 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.11 -161.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.848 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -143.48 3.61 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 0.0 111.076 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 -8.91 20.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.873 -1.142 . . . . 0.0 110.553 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 64' ' ' SER . . . 107.81 -29.64 10.08 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.218 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 63' ' ' GLY . 67.1 m 65.37 159.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.015 -0.697 . . . . 0.0 109.425 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 4.8 p -113.44 171.49 7.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.099 -1.001 . . . . 0.0 111.064 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -41.17 -50.26 8.25 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.87 -0.519 . . . . 0.0 111.059 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -66.86 -44.02 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.365 1.192 . . . . 0.0 110.495 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.06 -26.34 10.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 109.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 2.8 mm? -86.87 -45.19 11.08 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -49.48 -42.42 43.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -50.26 -51.99 40.06 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.084 0.945 . . . . 0.0 109.013 178.067 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.594 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -59.37 -47.33 85.84 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.625 HD11 ' CD1' ' A' ' 90' ' ' PHE . 41.8 mt -64.33 -32.74 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 111.332 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HB2' ' N ' ' A' ' 82' ' ' SER . 14.4 ptmt -91.22 -42.2 10.55 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.033 -1.042 . . . . 0.0 111.379 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 9.6 mt-10 -94.95 -64.92 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.923 -1.111 . . . . 0.0 110.009 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.1 m-20 -56.53 -23.44 39.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.71 -1.244 . . . . 0.0 108.003 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.562 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -122.45 177.54 1.57 Allowed Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.551 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 47.9 Cg_endo -66.27 175.47 4.9 Favored 'Trans proline' 0 C--N 1.283 -2.896 0 O-C-N 124.037 1.546 . . . . 0.0 114.429 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pp -52.54 -13.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.607 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p -45.92 -30.39 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.77 -37.2 6.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -85.17 36.87 0.65 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.647 -0.914 . . . . 0.0 110.32 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.92 -110.62 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.019 -1.05 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 86' ' ' PHE . 4.4 m -166.11 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.877 -1.139 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' SER . 57.4 t-20 -39.86 -27.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.289 -0.882 . . . . 0.0 110.663 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 80' ' ' VAL . 1.6 t80 -54.35 -42.07 69.83 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.953 -1.092 . . . . 0.0 108.847 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.543 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 3.9 p-10 -47.79 -28.02 2.33 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.175 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tp -78.6 -32.48 47.58 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.96 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.666 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 29.1 m-85 -74.28 -41.13 61.73 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.715 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.625 ' CD1' HD11 ' A' ' 73' ' ' ILE . 67.0 t80 -63.36 -48.11 79.3 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.383 -0.823 . . . . 0.0 108.791 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.6 m-80 -52.12 -57.26 10.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.166 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.05 -39.01 65.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.059 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 47' ' ' TYR . . . -68.46 -37.99 80.69 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.351 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 51' ' ' ILE . 12.9 mm -62.84 -61.11 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 25.1 mttt -57.35 -39.88 76.89 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -59.73 -43.11 94.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.462 -0.774 . . . . 0.0 109.746 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -70.9 -51.97 16.68 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 105' ' ' GLN . 48.4 t -64.83 -42.07 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -1.124 . . . . 0.0 110.325 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 17.2 tp10 -60.18 -38.09 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.172 -0.955 . . . . 0.0 109.72 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.39 8.37 6.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.455 -0.778 . . . . 0.0 110.292 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.73 22.02 75.65 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 5.3 t0 -82.89 -66.94 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -1.148 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.21 177.0 4.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.739 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 16.7 mm-40 -111.01 126.14 54.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.45 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.508 ' HG3' ' CG2' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.5 98.32 9.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 110.985 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -78.01 -174.9 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.684 1.36 . . . . 0.0 109.909 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -113.17 -81.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.081 -1.012 . . . . 0.0 110.071 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.45 -145.89 46.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.04 4.8 5.85 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.302 1.685 . . . . 0.0 111.265 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -168.53 -103.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.097 0 O-C-N 121.866 -0.522 . . . . 0.0 110.293 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.48 107.1 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.47 161.65 16.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.174 . . . . 0.0 109.741 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 63' ' ' GLY . 2.1 p -126.64 100.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.016 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 28.8 mttp -99.81 126.52 45.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 25.0 tp -78.44 103.63 8.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 115' ' ' LEU . . . 165.53 177.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.289 -0.882 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.1 139.05 50.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 110.3 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.118 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' A' ' 50' ' ' LEU . 34.0 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.24 0.543 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -52.72 -46.35 67.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.1 mm-40 -56.95 -46.2 82.27 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.175 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.741 HD22 HG23 ' A' ' 73' ' ' ILE . 96.6 mt -52.33 -32.07 36.33 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.932 -1.105 . . . . 0.0 108.987 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.8 mt -82.2 -55.94 6.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.553 0.692 . . . . 0.0 109.362 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.606 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.8 mt -59.12 -51.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 6.0 mt-10 -62.95 -39.92 96.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.618 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.57 -45.1 96.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.996 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.9 mt -64.45 -36.61 84.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -1.046 . . . . 0.0 109.175 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m -72.88 -30.07 63.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.0 108.909 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.426 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.73 -19.75 23.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.556 -0.715 . . . . 0.0 110.041 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.4 mt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.093 -1.004 . . . . 0.0 109.581 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD22 ' A' ' 58' ' ' LEU . 33.7 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.539 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 9.5 p -125.09 172.61 9.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.628 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.9 ttp180 -44.82 -48.56 29.02 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.78 -0.575 . . . . 0.0 111.151 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.4 Cg_endo -67.48 -42.37 7.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.234 1.123 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.32 -28.13 51.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -86.72 -51.19 6.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.803 . . . . 0.0 109.519 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 mttp -54.61 -42.04 70.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -52.39 -49.74 63.82 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.111 0.958 . . . . 0.0 108.646 177.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.618 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -59.76 -45.33 92.58 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.934 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 28.8 mt -65.18 -32.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.467 -0.771 . . . . 0.0 111.159 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.69 -41.48 10.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.85 -1.156 . . . . 0.0 111.178 -179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 11.9 mt-10 -95.88 -65.25 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 33.2 m-20 -56.43 -19.88 17.1 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.653 -1.279 . . . . 0.0 108.102 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.637 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.06 177.33 1.99 Allowed Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 177.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.55 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 50.0 Cg_endo -68.46 176.77 5.33 Favored 'Trans proline' 0 C--N 1.281 -3.006 0 O-C-N 123.997 1.525 . . . . 0.0 114.261 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.3 tt -50.72 -15.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.846 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.6 p -45.42 -29.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.94 -35.94 6.21 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -82.43 45.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -1.012 . . . . 0.0 109.972 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.78 -127.01 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 43.5 t -150.68 -78.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.86 -1.15 . . . . 0.0 110.844 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' PHE . 55.8 t-20 -52.4 -34.55 48.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.128 -0.982 . . . . 0.0 110.868 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.2 t80 -48.51 -38.76 21.07 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.731 -1.23 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -46.8 -32.93 4.01 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.678 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 tp -75.93 -32.86 59.77 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 47' ' ' TYR . 5.7 m-85 -69.73 -46.72 65.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 32.8 t80 -58.09 -41.02 82.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.132 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.9 m-20 -56.82 -55.11 38.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.966 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -54.37 -38.88 66.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.285 -0.885 . . . . 0.0 108.889 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.02 -41.32 99.51 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.4 mm -63.42 -58.8 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 36.2 mttp -56.06 -41.44 75.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -49.23 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -69.45 -48.13 46.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 105' ' ' GLN . 40.2 t -63.9 -43.44 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -1.031 . . . . 0.0 110.57 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.3 tp10 -61.92 -34.56 76.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.66 11.77 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.39 78.65 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 7.1 t0 -85.54 -68.42 0.73 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -1.155 . . . . 0.0 109.969 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.22 169.73 8.28 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.541 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -110.9 126.85 55.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.811 ' HB2' HG11 ' A' ' 98' ' ' VAL . 1.3 mm100 -138.51 109.72 8.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.763 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.3 Cg_endo . . . . . 0 C--N 1.305 -1.723 0 O-C-N 124.021 1.537 . . . . 0.0 109.891 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.06 121.66 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -1.165 . . . . 0.0 109.926 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.6 p -81.27 126.19 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -125.23 128.76 48.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.83 . . . . 0.0 109.781 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.728 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.6 tp . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.103 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 96.5 m-85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.26 0.553 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.775 ' CD ' HD11 ' A' ' 52' ' ' ILE 0.25 2.7 tmm_? -49.14 -44.61 42.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 13.7 mt-10 -57.74 -45.58 85.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.091 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.777 HD22 HG23 ' A' ' 73' ' ' ILE . 98.7 mt -52.99 -32.56 47.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.062 -1.023 . . . . 0.0 108.883 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.3 mt -78.93 -56.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.563 0.697 . . . . 0.0 109.314 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.775 HD11 ' CD ' ' A' ' 48' ' ' ARG . 23.5 mt -59.0 -53.08 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 1.9 mm-40 -61.07 -39.66 90.71 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.99 -46.83 93.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.958 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.1 mt -63.89 -38.78 92.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -1.055 . . . . 0.0 109.077 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -69.75 -28.2 65.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.64 -22.47 21.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.0 109.724 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.977 HD11 HD21 ' A' ' 69' ' ' LEU . 12.8 mt . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.326 -0.859 . . . . 0.0 109.219 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.552 ' OG ' HD22 ' A' ' 58' ' ' LEU . 20.9 m . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -128.59 174.06 9.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 111.549 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.647 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -47.57 -47.51 60.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.792 -0.568 . . . . 0.0 111.318 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -66.96 -42.21 8.69 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.286 1.15 . . . . 0.0 110.47 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.52 -27.24 56.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.669 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.977 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -92.08 -47.42 7.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 109.597 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.786 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.1 mttp -55.88 -40.21 72.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 108.517 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 5.3 ttpt -54.54 -52.7 61.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t80 -58.52 -43.54 89.22 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.938 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 54.8 mt -63.35 -33.1 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 0.0 111.104 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 6.5 pttt -91.62 -41.55 10.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.007 -1.058 . . . . 0.0 111.418 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.55 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.5 mt-10 -95.42 -65.44 0.98 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.042 . . . . 0.0 109.897 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.9 m-20 -56.82 -21.1 26.45 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.077 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -125.25 176.54 2.35 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.6 Cg_endo -66.05 175.44 4.73 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 O-C-N 123.976 1.514 . . . . 0.0 114.119 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.916 HG23 ' HB3' ' A' ' 82' ' ' SER . 17.8 mm -52.42 -12.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.937 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.3 p -45.97 -31.14 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.31 -38.25 7.29 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.916 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -82.32 42.29 0.74 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.621 -0.929 . . . . 0.0 110.078 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.04 -133.76 0.29 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' PHE . 20.7 m -143.9 -92.18 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.912 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.2 t30 -40.18 -28.14 0.05 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.142 -0.974 . . . . 0.0 110.965 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -48.32 -42.11 30.26 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.537 179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.4 t0 -47.42 -30.66 3.48 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.767 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.5 tp -76.81 -28.15 55.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.464 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 49.1 m-85 -77.05 -46.98 21.85 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.207 -0.933 . . . . 0.0 108.892 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.828 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 70.7 t80 -56.9 -43.03 80.93 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-20 -55.5 -57.0 13.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.185 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 6.9 m-20 -54.87 -40.17 69.43 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.028 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -62.0 -45.57 93.04 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.485 -0.76 . . . . 0.0 109.016 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.828 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 16.7 mm -60.01 -58.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -0.807 . . . . 0.0 109.015 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.76 -38.2 74.99 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.758 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 5.2 tptt -66.03 -50.97 62.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.848 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -63.63 -51.48 53.73 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 105' ' ' GLN . 93.1 t -60.81 -39.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.978 . . . . 0.0 110.054 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 34.4 tp10 -63.19 -33.48 75.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.186 -0.947 . . . . 0.0 109.863 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.93 17.39 3.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.384 -0.822 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.6 73.4 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -87.57 -69.2 0.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.329 -1.101 . . . . 0.0 110.103 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -107.66 169.32 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -108.59 125.54 51.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.588 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.74 97.87 8.92 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.987 . . . . 0.0 110.63 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.5 Cg_endo . . . . . 0 C--N 1.305 -1.762 0 O-C-N 123.905 1.476 . . . . 0.0 109.896 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -102.37 160.16 14.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.972 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.487 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.9 p -121.19 117.58 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.862 -1.149 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -114.25 128.63 56.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.715 ' HB2' HD22 ' A' ' 55' ' ' LEU . 56.8 tp . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 61.9 m-85 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -69.7 -45.62 67.85 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' GLU . 39.4 mt-10 -58.47 -42.25 87.06 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.294 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 47' ' ' TYR . 77.8 mt -54.26 -34.17 60.16 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.869 -1.145 . . . . 0.0 108.701 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 94' ' ' ILE . 57.7 mt -79.35 -55.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.636 -0.665 . . . . 0.0 109.27 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.8 mt -59.24 -54.49 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.5 mt-10 -62.2 -41.58 98.5 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.9 -43.71 96.54 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -62.35 -36.54 82.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -1.021 . . . . 0.0 109.041 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -72.2 -28.42 63.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.355 -0.84 . . . . 0.0 109.051 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.13 26.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.59 -0.694 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.019 HD12 ' HA ' ' A' ' 55' ' ' LEU . 14.4 mt . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.239 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.618 ' OG ' HD22 ' A' ' 58' ' ' LEU . 13.8 m . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.588 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.8 p -127.81 176.58 7.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.4 tpp85 -46.28 -47.6 45.62 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.5 Cg_endo -67.99 -42.51 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.274 1.144 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.588 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -58.06 -36.52 72.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -78.36 -49.52 13.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.815 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 73' ' ' ILE . 1.7 mtpt -52.09 -39.63 60.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 7.6 ttpt -50.94 -51.7 49.71 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.53 -48.41 81.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.988 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 11.8 mt -61.62 -33.49 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.596 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.552 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -91.28 -41.65 10.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.151 -0.968 . . . . 0.0 111.575 -179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.552 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 38.5 mt-10 -92.3 -65.81 0.97 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.963 -1.086 . . . . 0.0 110.106 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 18.0 m-20 -59.09 -22.02 60.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.865 -1.147 . . . . 0.0 108.214 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.621 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -123.8 176.87 1.97 Allowed Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.574 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -65.07 172.74 6.9 Favored 'Trans proline' 0 C--N 1.282 -2.941 0 O-C-N 124.071 1.564 . . . . 0.0 113.527 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -52.9 -12.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.495 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG13 HG22 ' A' ' 73' ' ' ILE . 8.5 p -45.64 -29.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.543 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.13 -36.72 7.49 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 16.1 t -65.57 -8.63 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.543 -0.975 . . . . 0.0 110.432 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.79 -160.69 0.5 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 111.108 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.5 t -127.21 -67.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.264 -0.897 . . . . 0.0 110.682 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 16.0 t-20 -40.73 -41.27 1.5 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.215 -0.928 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.988 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.12 -40.91 25.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.6 t70 -46.72 -32.18 3.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -71.99 -33.82 68.41 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.636 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 21.6 m-85 -75.09 -43.01 55.46 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.402 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.614 ' CE2' HG12 ' A' ' 51' ' ' ILE . 43.7 t80 -57.46 -39.02 75.43 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -62.88 -54.88 31.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.508 -0.745 . . . . 0.0 109.487 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.9 m-20 -50.69 -38.86 49.39 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.844 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.651 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.16 -47.61 73.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 51' ' ' ILE . 14.5 mm -56.26 -61.03 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.076 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -56.68 -40.31 75.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.635 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -61.6 -47.33 85.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.47 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.44 -52.22 10.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.752 HG21 ' HG3' ' A' ' 105' ' ' GLN . 57.9 t -59.17 -36.72 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.355 -1.085 . . . . 0.0 110.419 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 4.0 tp10 -61.66 -37.33 83.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.199 -0.938 . . . . 0.0 110.06 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.54 17.36 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 109.931 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.52 25.31 74.96 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.1 m-20 -82.78 -67.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.136 -1.214 . . . . 0.0 109.893 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -102.91 168.23 9.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.977 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 34.3 mm-40 -105.9 125.71 51.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -0.845 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.752 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -141.09 102.37 6.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.118 -0.989 . . . . 0.0 111.103 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.304 -1.766 0 O-C-N 123.632 1.333 . . . . 0.0 109.648 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -103.57 160.65 14.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -1.109 . . . . 0.0 109.672 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.8 p -122.61 117.33 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.87 -1.144 . . . . 0.0 110.718 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 14.1 mtpt -115.43 129.27 56.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 109.762 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.2 tp . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.199 -0.938 . . . . 0.0 110.906 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.667 ' CB ' ' HB2' ' A' ' 93' ' ' ALA . 42.9 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.305 0.574 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.521 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.92 -45.7 91.26 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.33 -46.17 83.54 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.246 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.507 HD13 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 mt -50.41 -33.35 20.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.884 -1.135 . . . . 0.0 108.451 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.9 mt -80.77 -56.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.449 0.642 . . . . 0.0 109.384 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.62 HG12 ' CE1' ' A' ' 103' ' ' PHE . 74.2 mt -57.65 -53.41 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.7 mt-10 -59.24 -40.29 85.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.3 -46.49 86.43 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.791 HD22 ' CB ' ' A' ' 115' ' ' LEU . 9.1 mt -67.56 -39.89 84.93 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.54 -0.976 . . . . 0.0 108.657 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.4 m -66.19 -28.35 68.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -87.43 -29.21 21.62 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 64' ' ' SER . 10.4 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.843 . . . . 0.0 108.997 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.708 ' HB3' HD11 ' A' ' 58' ' ' LEU . 1.1 m . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.199 0.523 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.722 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -134.64 175.99 9.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.164 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.27 -47.03 68.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.589 -0.694 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 41.0 Cg_endo -69.34 -42.81 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.231 1.122 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -57.99 -30.44 66.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.975 . . . . 0.0 109.791 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 65' ' ' SER . 4.5 mm? -86.7 -49.91 7.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.588 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.925 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.5 mtpt -56.33 -39.64 73.14 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.452 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.67 -49.97 45.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 3.1 t80 -63.0 -47.52 82.79 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.974 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 14.9 mt -61.04 -31.85 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.446 -0.783 . . . . 0.0 111.114 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.25 -43.04 10.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.0 -1.062 . . . . 0.0 111.643 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 26.7 mt-10 -94.0 -65.36 0.99 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.968 -1.082 . . . . 0.0 109.911 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 9.7 m-20 -59.08 -17.42 25.87 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 108.383 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.2 m-85 -129.29 176.47 2.78 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 43.3 Cg_endo -65.27 173.35 6.34 Favored 'Trans proline' 0 C--N 1.28 -3.031 0 O-C-N 123.942 1.496 . . . . 0.0 114.082 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 82' ' ' SER . 33.6 mt -50.48 -16.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.452 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.663 HG13 HG22 ' A' ' 73' ' ' ILE . 7.2 p -44.51 -29.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.31 -33.07 8.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB3' HG23 ' A' ' 79' ' ' ILE . 12.4 t -51.17 -55.7 16.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.621 -0.929 . . . . 0.0 110.743 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.67 -171.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.523 -0.736 . . . . 0.0 111.241 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -119.99 -54.63 2.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 110.429 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 51.8 t30 -42.07 -41.35 2.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -49.03 -41.39 34.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.979 -1.075 . . . . 0.0 108.209 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.513 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 33.3 t0 -45.69 -31.41 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -70.33 -40.62 74.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.436 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 71.5 m-85 -68.32 -42.75 78.91 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.618 ' CE2' HG12 ' A' ' 51' ' ' ILE . 32.3 t80 -59.42 -32.6 70.33 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.3 m-80 -66.95 -53.59 30.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.53 -0.731 . . . . 0.0 109.427 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.4 m-20 -53.62 -40.19 65.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.113 -0.992 . . . . 0.0 108.797 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.46 -36.17 82.11 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.694 HG21 ' NE2' ' A' ' 105' ' ' GLN . 6.5 mm -65.19 -60.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.37 -38.12 73.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 8.4 tptm -63.08 -50.02 72.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.362 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.93 -52.72 31.21 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.831 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.8 t -59.37 -33.77 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.492 -1.005 . . . . 0.0 109.902 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 1.2 tp10 -60.73 -40.33 92.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.287 -0.883 . . . . 0.0 109.616 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.56 15.77 3.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 109.891 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.16 24.99 76.47 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 3.4 m-20 -81.15 -67.41 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.213 -1.169 . . . . 0.0 109.86 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.712 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -106.78 162.23 13.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.251 -0.906 . . . . 0.0 109.725 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 11.9 mm-40 -101.19 125.57 47.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.672 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.831 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -133.99 98.17 14.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 111.283 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--N 1.304 -1.78 0 O-C-N 123.933 1.491 . . . . 0.0 109.342 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -112.52 160.05 18.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -1.051 . . . . 0.0 109.856 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 64' ' ' SER . 1.4 p -121.57 113.23 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.082 . . . . 0.0 109.752 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -109.85 129.85 55.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.979 . . . . 0.0 110.133 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.791 ' CB ' HD22 ' A' ' 55' ' ' LEU . 19.8 tp . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 60.8 m-85 . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 52' ' ' ILE . 17.2 ttm180 -59.24 -45.76 90.31 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' GLU . 59.1 mt-10 -59.08 -43.77 91.82 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 73' ' ' ILE . 96.2 mt -53.42 -32.53 50.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.654 -1.279 . . . . 0.0 108.713 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 93' ' ' ALA . 22.7 mt -81.23 -56.42 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.679 0.752 . . . . 0.0 109.107 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 103' ' ' PHE . 57.4 mt -59.11 -53.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.991 0.901 . . . . 0.0 108.68 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -61.6 -39.33 90.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.59 -49.14 79.76 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -58.52 -36.35 73.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.444 -1.033 . . . . 0.0 109.61 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -74.29 -30.13 61.95 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.771 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.94 -10.62 41.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.666 -0.646 . . . . 0.0 110.069 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 69' ' ' LEU . 12.5 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 109.773 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.791 ' OG ' HD13 ' A' ' 58' ' ' LEU . 27.3 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.15 0.5 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HD23 ' A' ' 69' ' ' LEU . 53.7 p -130.63 173.5 10.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 111.145 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.668 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 12.0 ttp180 -52.42 -45.68 95.13 Favored Pre-proline 0 C--N 1.296 -1.725 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.7 -42.97 4.16 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.299 1.157 . . . . 0.0 110.788 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.18 -22.57 17.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.075 -1.016 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -91.05 -48.4 6.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.356 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 73' ' ' ILE . 27.9 mttt -56.34 -42.07 77.11 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 1.7 ttpt -51.24 -49.81 60.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.879 0.847 . . . . 0.0 108.815 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.05 -47.4 86.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.921 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.5 mt -63.41 -31.29 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.969 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 45.1 pttt -91.6 -41.04 10.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.877 -1.139 . . . . 0.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.6 mt-10 -96.03 -65.7 0.95 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.055 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 50.7 m-20 -56.62 -19.92 18.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.622 -1.299 . . . . 0.0 107.992 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.44 177.97 1.74 Allowed Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.143 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 77' ' ' TYR . 47.4 Cg_endo -67.77 176.19 5.45 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.949 1.5 . . . . 0.0 114.108 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -51.99 -15.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.857 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.605 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -44.28 -30.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.27 -36.45 6.6 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.2 m -73.06 -1.21 16.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -1.075 . . . . 0.0 110.323 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -81.27 -151.35 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 110.619 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.78 -74.59 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.855 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 35.4 t-20 -41.12 -35.64 0.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.322 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.5 -42.05 61.4 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.078 -1.049 . . . . 0.0 108.553 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 26.1 m-20 -45.61 -27.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -80.83 -34.49 33.84 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.031 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 20.8 m-85 -71.94 -41.1 68.2 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.05 -1.032 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.0 t80 -59.84 -43.27 94.69 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.484 -0.76 . . . . 0.0 108.956 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 59.5 m-20 -56.98 -56.83 16.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.51 -0.744 . . . . 0.0 109.462 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 m-20 -51.99 -39.84 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.075 -1.016 . . . . 0.0 108.985 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.44 -45.5 87.21 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.465 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 12.8 mm -60.15 -60.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.42 -38.16 73.91 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.893 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -66.61 -48.68 68.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 0.0 110.155 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -65.11 -52.52 40.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.604 HG21 ' HG3' ' A' ' 105' ' ' GLN . 37.8 t -61.56 -41.29 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.549 -0.971 . . . . 0.0 110.457 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 6.6 tp10 -61.25 -35.34 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.224 -0.923 . . . . 0.0 110.016 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.7 14.04 4.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.972 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.09 24.23 76.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.4 m-20 -85.84 -69.28 0.67 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -1.23 . . . . 0.0 109.754 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -115.5 125.73 53.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.673 ' NE2' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -134.91 98.18 13.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.664 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 123.873 1.459 . . . . 0.0 110.076 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -99.92 160.17 14.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -1.069 . . . . 0.0 109.933 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.2 p -122.22 127.1 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 110.352 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -126.45 129.56 48.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.804 ' HB2' HD13 ' A' ' 55' ' ' LEU . 8.7 tp . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.963 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.0 m-85 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.95 -45.53 82.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 53.2 mm-40 -57.85 -19.32 28.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.877 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 47' ' ' TYR . 29.6 mt -86.34 -31.75 21.37 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.7 -1.25 . . . . 0.0 108.961 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.14 -56.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.595 -0.691 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.605 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 24.9 mt -52.74 -49.99 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 78.0 mt-10 -64.95 -41.5 95.43 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.912 0.863 . . . . 0.0 108.786 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -55.95 -44.83 87.71 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.985 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.9 mt -67.77 -44.15 78.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -1.047 . . . . 0.0 109.355 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -67.64 -26.29 66.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.208 -0.932 . . . . 0.0 108.848 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.57 -25.85 20.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.663 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.022 HD22 ' OG ' ' A' ' 64' ' ' SER . 8.3 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.23 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 1.022 ' OG ' HD22 ' A' ' 58' ' ' LEU . 65.4 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.135 0.493 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.519 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 5.1 p -120.97 173.04 7.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.091 -1.006 . . . . 0.0 110.97 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.627 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -43.73 -48.71 20.29 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.878 -0.513 . . . . 0.0 111.38 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.6 Cg_endo -67.55 -42.87 6.4 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.263 1.138 . . . . 0.0 110.436 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.95 -28.93 59.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -83.3 -51.68 7.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 109.504 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.842 ' HA ' HD12 ' A' ' 73' ' ' ILE . 2.3 mtpt -50.06 -38.54 38.63 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.643 -1.223 . . . . 0.0 107.747 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.81 -55.96 12.17 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.629 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.74 -45.5 89.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 22.2 mt -62.39 -34.19 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.477 -0.765 . . . . 0.0 111.022 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.27 -41.81 10.74 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.037 -1.04 . . . . 0.0 111.595 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 20.8 mt-10 -94.61 -65.02 1.01 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.57 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.2 m-20 -57.94 -20.56 38.59 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.645 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.6 m-85 -126.15 177.11 2.09 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.562 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.3 Cg_endo -65.09 174.86 4.38 Favored 'Trans proline' 0 C--N 1.283 -2.869 0 O-C-N 123.838 1.441 . . . . 0.0 114.03 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.613 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pt -52.97 -12.46 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.031 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.4 p -46.34 -28.95 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -36.93 7.88 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 107.179 -2.368 . . . . 0.0 107.179 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.613 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 48.3 t -57.22 -38.68 74.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.883 . . . . 0.0 110.289 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -52.08 -169.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.526 -0.733 . . . . 0.0 111.033 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 85' ' ' ASN . 4.8 p -124.62 -65.8 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 110.339 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 61.4 t30 -42.65 -36.0 1.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -0.911 . . . . 0.0 109.988 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.889 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -50.92 -42.03 59.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.202 -0.999 . . . . 0.0 108.388 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 46.9 t0 -45.52 -27.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -80.46 -34.45 35.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 m-85 -70.76 -43.61 68.44 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.727 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.5 t80 -55.13 -40.54 70.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-80 -59.22 -55.77 30.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.554 -0.717 . . . . 0.0 109.717 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.7 m-20 -51.52 -38.35 53.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.718 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.806 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.49 -40.63 76.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.9 mm -63.42 -60.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 2.8 mttp -57.13 -37.81 72.57 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 12.5 tptm -63.96 -49.09 73.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.84 . . . . 0.0 109.468 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.93 -53.96 20.42 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 103' ' ' PHE . 61.9 t -56.49 -34.02 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -1.067 . . . . 0.0 109.826 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 24.5 tp10 -68.66 -35.03 76.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.53 11.29 5.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 110.043 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.18 21.57 78.85 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.606 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -88.98 -65.44 1.02 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 110.468 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.7 ' HB2' HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -99.05 166.94 11.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.765 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 114' ' ' LYS . 52.7 mm-40 -114.12 124.0 51.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.672 ' HG3' HG21 ' A' ' 98' ' ' VAL . 1.2 mt-30 -135.41 114.48 11.43 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 111.222 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.9 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 O-C-N 123.883 1.465 . . . . 0.0 109.141 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -89.36 159.49 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.654 HG22 HD21 ' A' ' 55' ' ' LEU . 1.4 p -114.4 101.6 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -101.86 129.39 48.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 178.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 55' ' ' LEU . 13.3 tp . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.235 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 55.1 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.033 0.444 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HA ' ' HB1' ' A' ' 93' ' ' ALA 0.25 3.2 ttp180 -49.74 -44.6 48.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 53.3 mm-40 -57.67 -45.37 85.68 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.823 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD12 ' HD1' ' A' ' 47' ' ' TYR . 35.6 mt -52.21 -31.22 30.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.816 -1.177 . . . . 0.0 108.596 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.4 mt -80.09 -56.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.566 0.698 . . . . 0.0 109.308 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.634 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.5 mt -61.41 -54.48 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.1 mt-10 -58.77 -38.63 78.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.68 -49.62 75.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -59.97 -39.15 84.66 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.585 -0.95 . . . . 0.0 108.58 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 56' ' ' THR . 0.7 OUTLIER -70.31 -24.44 63.02 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -86.04 -31.21 22.1 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 64' ' ' SER . 25.5 mt . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.829 ' HB2' HG13 ' A' ' 113' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.345 0.593 . . . . 0.0 110.263 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.737 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.7 p -134.63 170.67 15.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 18.5 ttp180 -49.24 -49.25 71.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.1 Cg_endo -67.45 -42.4 7.34 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.301 1.158 . . . . 0.0 110.627 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -54.12 -31.1 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 109.464 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.0 mm? -82.84 -51.19 7.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.443 -0.785 . . . . 0.0 109.537 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' HD12 ' A' ' 73' ' ' ILE . 4.6 mttt -50.36 -41.23 51.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 5.3 tmmm? -49.14 -55.85 11.03 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.97 -46.14 88.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.929 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 17.5 mt -65.53 -31.72 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.924 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 46.0 pttt -91.81 -40.77 11.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.966 -1.084 . . . . 0.0 111.624 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 14.9 mt-10 -95.97 -65.31 0.98 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.905 -1.122 . . . . 0.0 109.89 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 18.6 m-20 -56.31 -21.6 25.19 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.666 -1.272 . . . . 0.0 107.845 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.616 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.57 175.7 2.49 Favored Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 80' ' ' VAL . 49.5 Cg_endo -69.84 178.31 4.75 Favored 'Trans proline' 0 C--N 1.28 -3.033 0 O-C-N 123.903 1.475 . . . . 0.0 113.885 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.6 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -51.0 -15.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.034 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.633 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.06 -30.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.77 -34.64 6.79 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -83.1 23.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -1.064 . . . . 0.0 110.362 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -104.83 -139.07 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.473 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -140.55 -77.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.893 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' SER . 50.4 t30 -42.05 -36.29 1.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.929 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -49.22 -40.53 34.08 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.361 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.1 m-20 -46.62 -29.66 1.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.15 -33.79 50.13 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.01 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.67 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 12.7 m-85 -72.21 -44.83 62.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.152 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 83.8 t80 -56.55 -39.9 74.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.486 -0.759 . . . . 0.0 109.184 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -60.63 -55.39 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.464 -0.773 . . . . 0.0 109.279 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.3 m-20 -50.87 -36.63 38.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 108.852 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.639 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -71.29 -39.43 71.51 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.212 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.7 mm -64.16 -59.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 108.976 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.53 -41.02 80.08 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -61.87 -42.89 99.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.964 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -74.43 -52.01 7.89 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 105' ' ' GLN . 48.0 t -61.71 -40.11 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.123 . . . . 0.0 110.346 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 9.2 tp10 -59.87 -36.85 77.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.72 13.44 4.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.49 78.04 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.5 m-20 -82.66 -68.28 0.72 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.732 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.72 157.69 17.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.542 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -96.73 123.89 40.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.692 ' HB2' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -134.98 106.09 10.47 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 110.701 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 109.978 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.13 126.53 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -1.064 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 64' ' ' SER . 2.1 p -83.49 104.52 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -101.29 125.86 47.97 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.039 -1.038 . . . . 0.0 109.301 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.665 ' HB2' HD13 ' A' ' 55' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.414 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.63 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 73.5 m-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.365 0.602 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 51' ' ' ILE . 5.0 ttp85 -54.93 -47.58 74.24 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE1' HD12 ' A' ' 52' ' ' ILE . 3.0 mm-40 -57.16 -43.67 82.74 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.227 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 21.1 mt -53.21 -33.21 51.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.84 -1.162 . . . . 0.0 108.635 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.1 mt -79.84 -56.31 7.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.57 0.7 . . . . 0.0 109.169 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 ' OE1' ' A' ' 49' ' ' GLU . 65.3 mt -57.42 -52.13 60.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.3 mt-10 -64.57 -40.72 96.05 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -56.87 -44.04 92.34 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.2 mt -65.71 -38.76 90.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -1.072 . . . . 0.0 109.428 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -67.7 -31.19 70.98 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.286 -0.884 . . . . 0.0 108.906 178.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.94 -24.43 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.631 -0.668 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.032 HD11 HD21 ' A' ' 69' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 1.004 ' OG ' HD22 ' A' ' 58' ' ' LEU . 19.5 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.111 0.482 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.708 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.9 p -134.75 174.4 10.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.0 111.009 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.619 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -51.11 -47.23 88.06 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.661 -0.649 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.6 Cg_endo -69.97 -41.91 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.263 1.139 . . . . 0.0 110.396 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.33 -36.13 65.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' LEU . 4.4 mm? -75.98 -47.11 26.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.9 ' HA ' HD12 ' A' ' 73' ' ' ILE . 93.6 mttt -54.59 -46.61 73.8 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 70' ' ' LYS . 9.4 ttpt -42.01 -56.76 2.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 2.2 t80 -57.59 -42.89 84.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.998 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 32.5 mt -66.02 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 111.476 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.48 -42.51 10.24 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.747 -1.22 . . . . 0.0 111.087 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -95.4 -65.04 1.0 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.061 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.4 m-20 -56.93 -19.64 19.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.877 -1.14 . . . . 0.0 107.969 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.692 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 2.3 m-85 -126.89 175.04 3.59 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.577 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.62 176.55 4.9 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 O-C-N 123.941 1.495 . . . . 0.0 113.841 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 82' ' ' SER . 8.2 mt -52.55 -12.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.96 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.5 p -46.55 -29.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.14 -37.35 7.2 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.875 ' HB3' HG23 ' A' ' 79' ' ' ILE . 4.1 t -72.0 -2.89 19.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.563 -0.963 . . . . 0.0 110.263 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -78.27 -153.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.429 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 86' ' ' PHE . 28.2 m -133.19 -78.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.763 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 43.5 t-20 -40.72 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -0.922 . . . . 0.0 110.331 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.998 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -56.32 -44.98 80.46 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.086 -1.009 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 6.3 p-10 -45.42 -26.89 0.61 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.8 tp -82.28 -30.11 30.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.585 -0.697 . . . . 0.0 109.964 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.5 m-85 -76.45 -42.11 45.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 47.3 t80 -58.29 -42.47 86.68 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -59.04 -57.67 12.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.305 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.9 m-20 -52.21 -38.54 58.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.683 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.23 -41.4 90.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.696 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -62.39 -60.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.752 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -57.29 -37.62 72.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -65.09 -49.84 68.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.44 -0.787 . . . . 0.0 109.775 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -64.51 -51.41 52.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 103' ' ' PHE . 74.4 t -61.56 -40.97 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -1.023 . . . . 0.0 109.813 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 11.9 tp10 -58.52 -34.28 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 109.691 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -86.11 15.58 5.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.745 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 23.96 76.95 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.548 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.6 m-20 -85.1 -68.05 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -1.22 . . . . 0.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -110.28 159.51 17.35 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.905 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -100.13 143.45 30.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.681 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -149.82 98.08 3.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.968 . . . . 0.0 111.014 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 45.1 Cg_endo . . . . . 0 C--N 1.305 -1.725 0 O-C-N 123.726 1.382 . . . . 0.0 109.439 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.097 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -100.95 160.62 14.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -1.003 . . . . 0.0 109.907 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.4 p -114.43 121.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.948 -1.095 . . . . 0.0 110.262 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -122.2 125.77 46.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.743 ' HB2' HD13 ' A' ' 55' ' ' LEU . 22.0 tp . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.363 -0.835 . . . . 0.0 110.032 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 97.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.178 0.513 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 10.5 ttm180 -53.71 -46.12 70.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 16.3 mt-10 -57.06 -44.72 83.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.14 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 19.0 mt -51.6 -32.63 29.49 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.789 -1.194 . . . . 0.0 108.304 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 93' ' ' ALA . 11.0 mt -81.54 -55.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.602 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.2 mt -56.57 -52.27 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.1 mt-10 -62.48 -40.96 98.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.32 -45.64 95.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.966 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.5 mt -64.46 -41.25 96.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -1.002 . . . . 0.0 109.551 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -68.01 -28.79 67.72 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 108.832 178.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.55 -20.84 22.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.658 -0.651 . . . . 0.0 109.822 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.4 mt . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.487 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.604 ' OG ' HD22 ' A' ' 58' ' ' LEU . 47.9 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.5 p -125.69 176.25 7.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -46.53 -47.62 48.5 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 110.98 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -67.46 -42.26 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.634 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.93 -33.71 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -81.08 -51.33 8.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.448 -0.782 . . . . 0.0 109.61 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' NZ ' ' HB3' ' A' ' 87' ' ' ASP . 2.7 mtpt -53.8 -41.54 67.4 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 3.9 tmmm? -47.55 -53.74 13.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.998 0.904 . . . . 0.0 108.733 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.6 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.0 t80 -59.88 -49.66 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.967 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 19.9 mt -63.88 -31.53 53.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.395 -0.815 . . . . 0.0 110.669 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.631 ' HG3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -92.4 -34.97 13.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.085 . . . . 0.0 111.897 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 39.6 mt-10 -98.35 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.701 -1.249 . . . . 0.0 109.461 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.4 m-20 -57.01 -18.97 15.81 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -127.57 174.1 4.68 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.1 Cg_endo -65.8 175.84 4.16 Favored 'Trans proline' 0 C--N 1.281 -2.978 0 O-C-N 124.096 1.577 . . . . 0.0 114.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 82' ' ' SER . 4.0 mt -51.97 -13.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.504 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.59 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.5 p -45.83 -29.84 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -86.54 -38.95 7.94 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.789 ' HB2' HG23 ' A' ' 79' ' ' ILE . 50.0 m -62.51 -29.05 70.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.695 -0.885 . . . . 0.0 110.435 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -59.2 -162.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.435 -0.79 . . . . 0.0 111.409 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -127.11 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.665 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.0 t-20 -39.53 -38.91 0.64 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 0.0 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.967 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -47.12 -39.06 12.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 3.7 p-10 -48.13 -35.03 10.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.5 tp -69.0 -30.9 69.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.21 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 20.2 m-30 -76.84 -45.45 28.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -61.25 -35.17 76.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 65.3 m-20 -63.75 -56.78 12.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.711 . . . . 0.0 109.364 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.2 m-20 -50.12 -37.19 33.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.668 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -67.3 -40.09 86.01 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.218 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.68 HD13 HD13 ' A' ' 51' ' ' ILE . 13.3 mm -63.15 -59.84 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 1.8 mtpt -57.67 -40.36 79.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tppt? -61.41 -47.27 86.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.547 -0.721 . . . . 0.0 109.766 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -68.89 -51.82 27.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 105' ' ' GLN . 48.2 t -61.23 -40.7 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -1.064 . . . . 0.0 110.188 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 10.3 tp10 -60.2 -35.49 75.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 110.033 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.58 16.18 4.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -0.818 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.39 25.5 74.72 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 14.7 m-20 -86.19 -68.37 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 110.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -105.73 179.4 4.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.06 131.08 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.537 ' OE1' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.32 101.66 6.16 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.061 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--N 1.306 -1.676 0 O-C-N 123.946 1.498 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -113.47 127.14 55.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -1.134 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.69 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.1 p -81.13 128.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 132.54 53.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 55' ' ' LEU . 18.5 tp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.14 0.495 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -50.57 -44.53 56.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' GLU . 4.6 mm-40 -57.53 -43.94 84.75 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.393 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' HD1' ' A' ' 47' ' ' TYR . 46.2 mt -53.03 -31.2 39.97 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.682 -1.261 . . . . 0.0 107.856 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.6 mt -81.95 -55.57 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.58 0.705 . . . . 0.0 109.178 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.597 HG12 ' CE1' ' A' ' 103' ' ' PHE . 59.8 mt -59.27 -55.31 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -58.65 -38.87 79.05 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.43 -48.62 84.01 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.835 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.0 mt -59.2 -36.43 75.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -1.083 . . . . 0.0 109.388 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -37.69 87.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.255 -0.903 . . . . 0.0 108.854 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.11 -18.75 24.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.562 -0.712 . . . . 0.0 109.82 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 55' ' ' LEU . 11.1 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 109.041 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.592 ' OG ' HD22 ' A' ' 58' ' ' LEU . 74.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.5 p -107.19 178.89 4.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.042 . . . . 0.0 111.094 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -46.67 -47.14 50.73 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.716 -0.615 . . . . 0.0 110.799 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.71 -43.44 5.42 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.113 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.27 -35.15 59.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 108.862 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -79.3 -46.17 18.25 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.8 mtpt -54.59 -40.93 69.31 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.3 ttpt -46.84 -49.72 19.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -65.99 -49.57 67.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.886 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -62.08 -30.35 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.587 ' HB2' ' CA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.06 -42.61 10.4 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.072 -1.018 . . . . 0.0 112.153 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.545 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 10.9 mt-10 -95.82 -65.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 109.849 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.3 m-20 -57.82 -18.96 25.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.814 -1.179 . . . . 0.0 107.902 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 3.0 m-85 -127.82 175.39 3.45 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.563 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.1 Cg_endo -66.18 174.55 5.86 Favored 'Trans proline' 0 C--N 1.282 -2.93 0 O-C-N 123.894 1.47 . . . . 0.0 114.118 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.648 HD12 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.02 -16.18 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.781 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.4 p -44.18 -31.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.46 -35.24 6.64 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.329 -2.308 . . . . 0.0 107.329 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.648 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -84.73 26.32 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.549 -0.971 . . . . 0.0 110.525 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -107.49 -133.66 0.33 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' PHE . 14.7 t -143.53 -83.05 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 0.0 110.831 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 13.1 t-20 -40.91 -28.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.209 -0.932 . . . . 0.0 110.79 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.886 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.9 t80 -52.02 -42.2 62.84 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.461 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.1 t0 -45.55 -30.14 1.38 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.9 tp -76.17 -36.49 58.69 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.921 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 m-85 -71.07 -44.04 66.55 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.103 -0.998 . . . . 0.0 108.379 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 73' ' ' ILE . 73.6 t80 -57.84 -38.52 75.8 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 25.8 m-20 -60.86 -56.13 24.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.559 -0.713 . . . . 0.0 109.449 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.1 m-20 -53.36 -39.0 63.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 109.023 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.03 -38.74 82.88 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.024 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.669 HG21 ' NE2' ' A' ' 105' ' ' GLN . 8.1 mm -64.19 -59.74 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.372 -0.83 . . . . 0.0 109.021 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -59.03 -38.62 79.73 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.341 -0.849 . . . . 0.0 108.853 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.1 tptm -64.46 -47.84 77.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.08 -50.22 53.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.859 HG21 ' HG3' ' A' ' 105' ' ' GLN . 99.5 t -62.35 -45.52 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.367 -1.078 . . . . 0.0 109.737 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 35.9 tp10 -56.77 -33.69 66.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 1.018 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -83.82 12.88 5.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.856 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.0 23.65 77.9 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 1.018 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.2 m-20 -87.34 -67.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.139 -1.213 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.721 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.17 159.98 16.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.932 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 21.0 mm-40 -97.27 134.62 40.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.859 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -142.51 98.3 5.94 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 111.415 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--N 1.303 -1.851 0 O-C-N 123.948 1.499 . . . . 0.0 109.581 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -105.36 159.5 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.153 . . . . 0.0 110.047 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.2 p -121.7 115.02 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.981 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 4.6 mmtt -108.9 143.97 37.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.087 -1.008 . . . . 0.0 109.765 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.835 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.5 tp . . . . . 0 C--N 1.296 -1.722 0 O-C-N 121.507 -0.745 . . . . 0.0 110.362 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 65.4 m-85 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.161 0.505 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 13.5 ttp180 -52.1 -47.16 65.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' GLU . 24.6 mm-40 -57.16 -44.29 83.32 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 47' ' ' TYR . 74.4 mt -52.21 -32.25 35.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.633 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.764 HD11 ' HB3' ' A' ' 93' ' ' ALA . 12.7 mt -81.7 -56.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.614 HG12 ' CE1' ' A' ' 103' ' ' PHE . 68.7 mt -58.11 -52.29 60.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.9 mt-10 -62.38 -41.22 98.47 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -55.79 -40.7 81.26 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.01 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.5 mt -67.41 -37.04 82.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.457 -1.025 . . . . 0.0 109.559 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -29.5 62.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 108.922 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.8 -22.93 20.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.586 -0.696 . . . . 0.0 110.058 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.01 HD12 ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.816 ' OG ' HD22 ' A' ' 58' ' ' LEU . 30.9 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.571 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 16.7 p -133.37 178.32 7.0 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.131 -0.98 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.629 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -46.81 -46.42 51.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.716 -0.615 . . . . 0.0 111.235 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.14 -42.64 5.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.268 1.141 . . . . 0.0 110.665 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' CD2' ' A' ' 58' ' ' LEU . . . -57.32 -24.75 57.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.949 HD21 HD11 ' A' ' 58' ' ' LEU . 4.0 mm? -92.97 -48.59 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.1 mtpt -58.41 -41.29 84.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -47.97 -51.84 22.12 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.985 0.898 . . . . 0.0 108.806 178.04 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 t80 -62.22 -48.98 77.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.943 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 46.3 mt -65.17 -29.91 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 8.5 ptpt -92.02 -42.43 9.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.766 -1.209 . . . . 0.0 111.52 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 8.6 mt-10 -95.57 -64.8 1.02 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.477 ' CG ' ' HA ' ' A' ' 72' ' ' PHE . 6.0 m-20 -55.75 -22.01 21.83 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.828 -1.17 . . . . 0.0 107.953 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.79 178.02 1.6 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 177.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.584 ' HG2' HG12 ' A' ' 80' ' ' VAL . 46.1 Cg_endo -68.79 175.62 7.05 Favored 'Trans proline' 0 C--N 1.281 -3.011 0 O-C-N 123.88 1.463 . . . . 0.0 114.231 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.605 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.2 mp -49.71 -15.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.864 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.5 -31.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.35 -37.78 6.51 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -85.21 46.6 1.3 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.79 -0.83 . . . . 0.0 109.455 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.84 178.76 6.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 0.0 110.943 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 85' ' ' ASN . 65.8 m -104.75 156.3 18.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.455 -0.778 . . . . 0.0 109.786 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' SER . 5.7 t-20 76.79 -40.54 0.37 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.427 -0.796 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -48.65 -42.08 33.31 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.657 -1.277 . . . . 0.0 108.192 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.2 p30 -47.23 -36.41 8.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.8 tp -63.46 -34.35 77.58 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.253 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 79.8 m-85 -76.13 -47.88 22.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 51' ' ' ILE . 37.9 t80 -61.2 -36.03 78.77 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 75.0 m-20 -62.51 -56.71 15.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 8.1 m-20 -50.13 -39.18 42.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.165 -0.96 . . . . 0.0 108.499 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.764 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.34 -40.85 98.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 51' ' ' ILE . 13.2 mm -64.19 -59.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 20.6 mtpt -55.41 -37.99 68.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.8 tppt? -65.4 -51.32 61.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -67.94 -47.35 60.73 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 105' ' ' GLN . 98.8 t -63.08 -42.17 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -1.021 . . . . 0.0 110.459 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 5.8 tp10 -61.62 -34.54 75.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.29 15.67 3.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 25.51 74.46 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 3.8 t0 -84.93 -67.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -1.153 . . . . 0.0 110.097 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.18 159.82 16.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.173 -0.954 . . . . 0.0 109.727 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 39.9 mm-40 -97.35 128.46 44.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.168 -0.958 . . . . 0.0 109.206 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.741 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -141.41 109.67 6.26 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.119 -0.988 . . . . 0.0 111.137 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.004 1.528 . . . . 0.0 109.536 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -96.51 137.62 35.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.128 . . . . 0.0 109.998 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.3 p -94.31 106.03 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.042 -1.036 . . . . 0.0 110.755 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 0.7 OUTLIER -99.29 128.94 45.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.745 179.095 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.803 ' CB ' HD22 ' A' ' 55' ' ' LEU . 26.2 tp . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.957 . . . . 0.0 109.705 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.712 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 71.3 m-85 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 1.9 ttm180 -57.42 -46.17 83.83 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.3 mt-10 -55.95 -45.27 78.91 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 73' ' ' ILE . 75.7 mt -51.77 -35.3 43.22 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.74 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 103' ' ' PHE . 17.3 mt -79.35 -56.25 7.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.516 0.674 . . . . 0.0 109.374 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.7 mt -56.81 -51.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.8 mm-40 -60.83 -43.46 98.22 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -52.82 -41.85 58.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.3 mt -72.12 -40.34 68.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.649 -0.912 . . . . 0.0 108.678 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 m -67.08 -23.2 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.13 -23.95 21.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 64' ' ' SER . 12.0 mt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 58' ' ' LEU . 63.0 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 17.8 p -88.67 -179.06 5.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.091 -1.006 . . . . 0.0 111.257 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.664 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -51.03 -44.75 87.65 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.701 -0.624 . . . . 0.0 110.774 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.5 Cg_endo -68.68 -43.07 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.314 1.165 . . . . 0.0 109.818 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.98 -30.48 10.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.464 -0.895 . . . . 0.0 108.735 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.545 ' HG ' HG11 ' A' ' 113' ' ' VAL . 3.9 mm? -87.17 -50.85 6.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.775 ' HA ' HD12 ' A' ' 73' ' ' ILE . 88.9 mttt -53.92 -39.23 65.67 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.9 ttpp -51.56 -50.38 60.19 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.571 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.08 -47.95 82.4 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.896 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 17.0 mt -61.42 -33.27 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 110.663 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 43.6 pttt -91.52 -40.26 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 37.8 mt-10 -93.99 -66.11 0.94 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.897 -1.127 . . . . 0.0 110.218 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 25.4 m-20 -58.74 -21.49 55.41 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.68 -1.262 . . . . 0.0 108.077 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.644 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.46 175.0 2.86 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.2 Cg_endo -65.24 174.09 5.44 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 O-C-N 124.179 1.62 . . . . 0.0 113.839 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 6.3 mt -52.46 -12.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.812 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -45.96 -29.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.27 -36.45 7.06 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.339 -2.305 . . . . 0.0 107.339 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.645 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.8 t -73.44 -0.25 14.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.604 -0.939 . . . . 0.0 110.295 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -79.21 -149.34 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.209 -0.932 . . . . 0.0 110.827 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 85' ' ' ASN . 2.7 p -133.72 -79.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 16.3 t-20 -41.64 -35.09 0.69 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.279 -0.888 . . . . 0.0 110.572 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.896 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.3 t80 -48.8 -40.95 31.01 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.902 -1.123 . . . . 0.0 108.339 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 92.5 m-20 -47.11 -26.23 1.05 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 5.7 tp -82.74 -33.75 27.39 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.883 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 30.1 m-85 -71.15 -45.69 63.01 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.301 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 73' ' ' ILE . 81.0 t80 -52.92 -31.95 42.81 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 19.5 m-20 -67.59 -52.29 40.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.538 -0.726 . . . . 0.0 109.433 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -54.23 -40.38 67.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 108.992 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -65.81 -37.28 85.84 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.948 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.701 HG23 ' HG3' ' A' ' 105' ' ' GLN . 9.6 mm -64.08 -59.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 108.865 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.43 -40.95 79.51 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -61.44 -45.33 94.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.781 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.63 -51.26 12.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 103' ' ' PHE . 92.5 t -61.86 -38.61 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.6 tp10 -58.49 -39.19 79.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.15 13.26 4.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.529 -0.732 . . . . 0.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.15 23.5 77.51 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 -83.11 -67.96 0.75 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -109.0 166.16 11.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 56.8 mm-40 -109.55 136.65 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 94' ' ' ILE . 6.0 mm-40 -146.28 107.16 4.16 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.034 -1.041 . . . . 0.0 111.435 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.6 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 123.89 1.469 . . . . 0.0 109.0 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.97 138.25 54.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.159 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.545 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -82.17 117.57 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 111.041 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -111.12 132.9 53.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 55' ' ' LEU . 17.7 tp . . . . . 0 C--N 1.298 -1.658 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.822 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 92.1 m-85 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 52' ' ' ILE 0.25 7.0 ttp180 -51.43 -44.15 62.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 5.0 mt-10 -56.76 -46.77 81.22 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.2 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.672 HD22 HG23 ' A' ' 73' ' ' ILE . 14.9 mt -52.07 -34.78 45.22 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.482 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 94' ' ' ILE . 3.3 mt -75.85 -56.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 109.393 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' CE1' ' A' ' 103' ' ' PHE . 25.3 mt -59.65 -54.07 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.907 0.86 . . . . 0.0 108.738 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 8.0 mt-10 -60.33 -35.68 76.2 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.775 0.798 . . . . 0.0 108.905 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -64.49 -49.71 63.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -59.65 -42.0 91.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -1.085 . . . . 0.0 109.303 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -66.1 -31.48 72.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.268 -0.895 . . . . 0.0 109.085 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.653 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.92 -15.35 29.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 HD21 ' A' ' 69' ' ' LEU . 12.3 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' HD13 ' A' ' 58' ' ' LEU . 16.4 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.062 0.458 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.658 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 8.2 p -135.02 174.76 10.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.129 -0.982 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 ttp180 -45.34 -47.74 34.55 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.692 -0.63 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.2 Cg_endo -66.45 -42.81 9.08 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.14 1.074 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -59.89 -34.33 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.651 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.959 HD21 HD11 ' A' ' 58' ' ' LEU . 4.2 mm? -80.92 -51.59 8.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -49.38 -38.23 27.81 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.303 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.81 -53.86 35.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 1.8 t80 -60.78 -46.17 91.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.722 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 8.3 mt -64.15 -31.44 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.235 -0.915 . . . . 0.0 110.635 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' N ' ' A' ' 82' ' ' SER . 1.1 ptpt -92.1 -38.78 11.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.932 -1.105 . . . . 0.0 110.888 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.558 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 16.5 mt-10 -95.36 -64.88 1.02 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.807 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 11.4 m120 -58.64 -17.94 26.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -128.0 176.7 2.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.0 Cg_endo -67.16 175.68 5.46 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 O-C-N 124.021 1.537 . . . . 0.0 113.764 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 82' ' ' SER . 11.6 mt -52.39 -12.7 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.004 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.9 p -46.34 -30.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.05 -36.77 8.13 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 107.184 -2.366 . . . . 0.0 107.184 176.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB3' HG23 ' A' ' 79' ' ' ILE . 3.1 t -74.44 1.82 10.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.653 -0.91 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -84.79 -150.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.165 -0.959 . . . . 0.0 110.914 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' ASN . 31.0 t -134.18 -80.8 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.246 -0.909 . . . . 0.0 110.759 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' SER . 45.5 t-20 -39.19 -34.48 0.18 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.23 -0.919 . . . . 0.0 110.417 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -48.69 -40.29 27.64 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.437 178.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 50.5 t0 -48.11 -30.68 4.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.862 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.32 -28.69 59.76 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.193 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.609 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 12.4 m-85 -76.18 -46.14 29.9 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.618 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.9 t80 -57.72 -38.31 75.05 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 26.0 m-20 -60.04 -55.29 35.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.514 -0.741 . . . . 0.0 109.331 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.5 m-20 -56.13 -41.39 75.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.345 -0.847 . . . . 0.0 109.201 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.822 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -64.32 -40.12 95.26 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.09 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 51' ' ' ILE . 6.7 mm -60.93 -59.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 108.677 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -57.32 -41.41 79.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.3 tppp? -59.43 -47.8 84.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.614 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -69.5 -52.94 18.88 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.911 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.1 t -60.64 -39.6 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.524 -0.986 . . . . 0.0 110.376 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.1 tp10 -64.44 -34.13 77.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.787 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . . . -82.44 11.79 5.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.912 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 22.73 78.75 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.704 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -85.9 -67.65 0.79 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.231 -1.158 . . . . 0.0 110.14 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -100.87 178.67 4.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 109.663 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -120.2 126.5 50.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.911 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -136.01 128.0 17.41 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.993 . . . . 0.0 110.514 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 51.8 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.776 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.541 ' O ' ' CD ' ' A' ' 106' ' ' PRO . . . -121.39 153.1 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -1.074 . . . . 0.0 109.913 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.458 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.1 p -120.07 115.02 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.679 -1.263 . . . . 0.0 110.458 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -108.27 124.81 50.88 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.848 HD23 HD13 ' A' ' 55' ' ' LEU . 2.6 tm? . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.378 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.038 0.447 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.758 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -50.96 -45.64 60.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.07 -45.05 83.59 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.177 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.724 HD12 ' HD1' ' A' ' 47' ' ' TYR . 94.8 mt -52.29 -31.97 35.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.82 -1.175 . . . . 0.0 108.448 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.7 mt -82.16 -54.69 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.758 HD11 ' HD3' ' A' ' 48' ' ' ARG . 64.0 mt -58.42 -52.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 11.4 mt-10 -62.36 -38.62 90.25 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.768 0.794 . . . . 0.0 109.052 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -62.66 -45.94 94.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.068 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.8 mt -59.74 -37.2 78.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -1.101 . . . . 0.0 109.629 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -74.27 -28.31 61.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.028 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.83 -11.12 40.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.607 -0.683 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.068 HD12 ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 110.111 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.746 ' OG ' HD13 ' A' ' 58' ' ' LEU . 72.2 m . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.677 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 37.1 p -134.84 173.53 11.6 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.447 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.632 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -49.83 -45.8 80.26 Favored Pre-proline 0 C--N 1.299 -1.597 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.956 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.3 Cg_endo -70.41 -42.77 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.354 1.186 . . . . 0.0 110.281 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.42 -24.44 30.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.751 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 58' ' ' LEU . 4.1 mm? -90.89 -51.1 5.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.75 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 73' ' ' ILE . 89.8 mttt -59.31 -36.96 76.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.55 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 3.4 ttpt -55.88 -51.08 68.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.83 -46.7 87.06 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.904 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 18.6 mt -63.05 -33.97 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.587 -0.696 . . . . 0.0 111.169 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 82' ' ' SER . 17.1 ptmt -91.43 -42.14 10.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.85 -1.157 . . . . 0.0 111.435 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 15.6 mt-10 -94.43 -65.06 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 109.875 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 24.2 m-20 -56.7 -23.82 44.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.807 -1.183 . . . . 0.0 108.094 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -122.76 178.19 1.38 Allowed Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.581 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.3 Cg_endo -65.67 176.66 3.36 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 O-C-N 123.996 1.524 . . . . 0.0 114.414 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.21 -12.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.72 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.5 p -45.81 -29.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.94 -35.78 7.53 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HG23 ' A' ' 79' ' ' ILE . 40.7 t -57.23 -40.46 77.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.571 -0.958 . . . . 0.0 110.317 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.33 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.738 . . . . 0.0 110.838 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 12.4 t -122.75 -64.38 1.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 110.472 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 7.1 m120 -43.98 -37.2 2.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.904 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.1 t80 -48.38 -42.27 31.32 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.155 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -44.75 -29.69 0.82 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.9 tp -78.33 -35.08 48.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.231 0.539 . . . . 0.0 109.667 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.694 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 6.2 m-85 -69.15 -46.3 67.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.13 -0.981 . . . . 0.0 108.666 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.822 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 54.1 t80 -57.58 -36.19 71.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 16.7 m-20 -60.23 -55.13 37.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.075 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.7 m-20 -55.43 -39.78 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 108.875 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.666 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.62 -40.63 95.82 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -63.07 -57.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 3.3 mtmm -60.12 -35.54 75.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -67.87 -53.4 26.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.48 -0.763 . . . . 0.0 109.651 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -61.65 -46.7 93.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' A' ' 105' ' ' GLN . 79.2 t -65.42 -46.2 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 7.9 tp10 -58.92 -33.47 70.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 109.874 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.28 13.49 4.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.32 24.19 76.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 4.2 t0 -87.06 -67.25 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.224 -1.162 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.46 159.97 16.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.024 . . . . 0.0 110.1 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -97.54 128.76 44.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 109.754 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.758 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -144.05 98.82 5.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.962 . . . . 0.0 111.234 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.3 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 124.186 1.624 . . . . 0.0 108.965 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.556 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -81.65 125.72 30.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -1.202 . . . . 0.0 109.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.3 p -92.18 133.76 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.862 -1.149 . . . . 0.0 110.962 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -126.82 124.18 39.06 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.352 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.796 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 tp . . . . . 0 C--N 1.298 -1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 71.2 m-85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.079 0.466 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 3.2 ttm180 -55.64 -44.15 76.88 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 mm-40 -58.57 -43.24 89.35 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.199 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.59 HD22 HG23 ' A' ' 73' ' ' ILE . 36.4 mt -51.74 -32.22 29.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.588 -1.32 . . . . 0.0 107.636 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 93' ' ' ALA . 10.1 mt -82.34 -53.95 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.8 mt -58.72 -54.55 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.3 mt-10 -59.33 -38.89 81.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -57.83 -48.02 84.9 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.753 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.9 mt -66.86 -49.03 66.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.65 -0.912 . . . . 0.0 108.756 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -60.35 -24.86 65.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.49 -22.63 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.703 HD11 HD21 ' A' ' 69' ' ' LEU . 11.7 mt . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 109.259 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 10.3 m . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.2 p -99.71 172.05 7.51 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.041 -1.037 . . . . 0.0 111.202 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.63 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -45.96 -48.07 41.52 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.823 -0.548 . . . . 0.0 110.801 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.8 Cg_endo -67.32 -42.7 7.1 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.214 1.113 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.62 -28.36 20.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.279 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.703 HD21 HD11 ' A' ' 58' ' ' LEU . 4.6 mm? -86.7 -48.84 7.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.573 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.902 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -52.02 -43.32 63.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 6.2 ttpt -47.19 -53.52 12.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.61 -46.92 85.99 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.96 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 13.9 mt -63.54 -33.91 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.823 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.65 -40.29 11.38 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.977 -1.077 . . . . 0.0 111.458 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 11.4 mt-10 -95.59 -65.42 0.98 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.055 -1.028 . . . . 0.0 109.729 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.3 m-20 -56.5 -21.52 26.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.076 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.7 177.74 1.78 Allowed Pre-proline 0 C--N 1.309 -1.158 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.559 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.2 Cg_endo -67.99 177.14 4.57 Favored 'Trans proline' 0 C--N 1.282 -2.939 0 O-C-N 123.925 1.487 . . . . 0.0 113.755 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.614 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 13.0 mt -52.72 -12.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.812 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.602 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.2 p -45.97 -30.38 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.46 -37.15 6.66 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 106.591 -2.603 . . . . 0.0 106.591 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -83.33 37.01 0.54 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.752 -0.852 . . . . 0.0 110.078 178.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.88 -137.27 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.988 . . . . 0.0 110.493 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' PHE . 16.5 p -139.13 -88.73 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.005 . . . . 0.0 111.106 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' OD1' ' CZ ' ' A' ' 89' ' ' TYR . 6.0 t-20 -35.62 -30.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.695 . . . . 0.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.96 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 2.1 t80 -54.19 -44.07 71.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.939 -1.1 . . . . 0.0 108.684 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.4 m-20 -46.96 -26.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.781 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.1 tp -80.94 -29.13 35.52 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.786 -0.765 . . . . 0.0 109.724 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.636 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 22.5 m-85 -77.33 -44.51 29.28 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.153 -0.967 . . . . 0.0 108.732 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.602 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.1 t80 -60.25 -46.37 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.359 -0.838 . . . . 0.0 108.822 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 3.5 m-80 -55.04 -57.5 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.27 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 m-20 -54.58 -42.27 70.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.09 -40.49 97.8 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 51' ' ' ILE . 8.5 mm -61.06 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.477 -0.765 . . . . 0.0 108.993 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -56.53 -37.95 71.17 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.588 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 23.9 tptp -65.51 -51.37 60.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.541 -0.724 . . . . 0.0 109.491 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.82 -49.93 64.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 54.1 t -50.71 -23.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -1.037 . . . . 0.0 109.372 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -93.33 -49.2 6.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.56 5.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 0.0 109.926 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -69.15 -9.21 60.0 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 m-20 66.79 37.14 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.861 -0.788 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' A' ' 97' ' ' GLY . 3.9 m-30 -87.08 146.63 26.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 109.821 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 23.8 mm-40 -97.44 124.73 41.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 108.892 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -144.63 98.48 4.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 110.897 -179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.4 Cg_endo . . . . . 0 C--N 1.306 -1.669 0 O-C-N 123.653 1.344 . . . . 0.0 109.7 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -117.71 160.36 21.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 109.603 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.3 p -110.66 124.23 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.629 -1.294 . . . . 0.0 110.32 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.69 132.63 53.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.918 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 55' ' ' LEU . 12.2 tp . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 29.8 m-85 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' A' ' 52' ' ' ILE . 4.1 ttt180 -61.14 -45.47 94.53 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 53' ' ' GLU . 55.1 mt-10 -58.38 -43.97 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 50' ' ' LEU . 46.6 mt -51.38 -34.09 32.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.688 -1.257 . . . . 0.0 108.311 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.66 HG21 ' CD2' ' A' ' 103' ' ' PHE . 30.2 mt -79.83 -55.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' A' ' 48' ' ' ARG . 60.2 mt -58.63 -53.98 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -61.17 -40.28 93.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.89 -47.74 84.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 8.2 mt -67.05 -49.87 63.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.937 . . . . 0.0 108.521 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 2.6 m -55.45 -24.39 30.56 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.78 -27.27 19.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 13.2 mt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.196 -0.94 . . . . 0.0 108.728 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.606 ' OG ' HD13 ' A' ' 58' ' ' LEU . 68.1 m . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.692 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 20.5 p -131.26 174.51 9.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 111.237 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.635 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 tpp180 -48.07 -46.31 65.01 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.872 -0.517 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.7 Cg_endo -70.4 -43.15 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.229 1.12 . . . . 0.0 110.59 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.19 -31.9 61.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 65' ' ' SER . 3.6 mm? -78.45 -53.86 6.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.119 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.829 ' HA ' HD12 ' A' ' 73' ' ' ILE . 77.0 mttt -50.01 -36.41 28.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.65 -50.94 59.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.582 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.7 t80 -63.46 -45.93 88.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.87 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -63.77 -32.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.418 -0.801 . . . . 0.0 110.757 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.572 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 35.2 pttt -91.2 -41.38 11.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.095 -1.003 . . . . 0.0 111.494 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.572 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 34.2 mt-10 -93.83 -65.14 1.01 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.945 -1.097 . . . . 0.0 109.668 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.9 m-20 -59.94 -15.68 23.92 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.857 -1.152 . . . . 0.0 108.632 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.641 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -130.88 176.93 2.5 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.19 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.2 Cg_endo -65.74 173.63 6.57 Favored 'Trans proline' 0 C--N 1.283 -2.904 0 O-C-N 123.968 1.509 . . . . 0.0 113.594 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.621 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 3.1 mt -52.75 -12.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.882 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p -45.63 -30.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.28 -37.32 6.7 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -80.95 45.5 0.83 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.66 -0.906 . . . . 0.0 110.367 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.06 -138.18 0.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 1.9 t -141.46 -77.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.986 -1.071 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 20.1 t-20 -41.95 -36.93 1.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -1.0 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.87 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.35 -42.01 61.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.838 -1.163 . . . . 0.0 108.62 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.2 t0 -46.17 -27.31 0.95 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.18 -33.28 33.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.841 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.3 m-85 -71.92 -43.34 65.46 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.205 -0.934 . . . . 0.0 108.949 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' A' ' 51' ' ' ILE . 68.6 t80 -58.46 -38.82 78.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 13.2 m-80 -61.53 -55.4 31.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.666 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.4 m-20 -50.14 -39.2 42.54 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.396 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.11 -38.61 79.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 98' ' ' VAL . 10.1 mm -62.58 -60.55 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -39.17 73.81 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.291 -0.881 . . . . 0.0 108.644 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 16.8 tptt -66.78 -51.23 58.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.58 -49.56 68.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 94' ' ' ILE . 62.0 t -51.17 -25.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.472 -1.017 . . . . 0.0 109.369 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -90.5 -49.45 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.592 -0.693 . . . . 0.0 110.543 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.83 -32.58 5.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -67.56 -9.93 56.57 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.6 t0 69.3 37.37 2.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.642 -0.916 . . . . 0.0 110.992 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -89.18 144.75 25.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.137 . . . . 0.0 109.398 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 23.9 mm-40 -97.43 126.66 42.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.14 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -143.55 124.33 7.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.842 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--N 1.307 -1.652 0 O-C-N 123.805 1.424 . . . . 0.0 109.552 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.613 ' O ' ' NE2' ' A' ' 105' ' ' GLN . . . -120.21 146.99 45.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -1.096 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.463 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -116.88 117.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.77 -1.207 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 23.5 mtpt -112.95 128.0 56.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 55' ' ' LEU . 16.6 tp . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.278 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 75.0 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.288 0.566 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -52.76 -45.57 67.13 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -57.86 -45.48 86.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.347 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.512 HD12 ' HD1' ' A' ' 47' ' ' TYR . 74.7 mt -51.44 -32.38 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.799 -1.188 . . . . 0.0 108.392 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 94' ' ' ILE . 50.8 mt -82.72 -55.12 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 ' CE1' ' A' ' 103' ' ' PHE . 56.1 mt -57.49 -53.59 42.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.5 mt-10 -60.14 -39.95 88.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.599 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.03 -44.17 96.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.991 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -64.35 -39.13 93.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.5 -1.0 . . . . 0.0 109.553 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -71.65 -27.82 63.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 108.64 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.78 -19.72 23.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.619 -0.676 . . . . 0.0 109.77 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.991 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.9 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.326 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.601 ' OG ' HD22 ' A' ' 58' ' ' LEU . 9.0 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.612 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p -133.69 171.06 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.923 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.3 ttp85 -46.14 -47.77 43.82 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.74 -43.23 5.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.258 1.136 . . . . 0.0 110.861 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.52 -20.63 13.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.941 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -93.17 -45.22 7.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.16 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.44 -44.15 84.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 2.4 ttpt -47.2 -49.7 22.33 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.5 t80 -64.71 -49.04 72.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.56 -0.712 . . . . 0.0 109.283 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 15.9 mt -60.82 -31.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 111.013 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.26 -41.83 10.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.079 -1.013 . . . . 0.0 111.732 -178.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 22.3 mt-10 -95.73 -65.55 0.97 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.926 -1.109 . . . . 0.0 110.055 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 97.5 m-20 -56.87 -22.01 33.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.827 -1.171 . . . . 0.0 107.916 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.3 m-85 -123.84 175.85 2.59 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.58 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.9 Cg_endo -66.69 175.56 5.17 Favored 'Trans proline' 0 C--N 1.28 -3.041 0 O-C-N 124.016 1.535 . . . . 0.0 114.069 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.57 -14.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.021 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.619 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 4.0 p -45.58 -30.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.16 -35.27 7.14 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -84.19 21.69 1.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.741 -0.858 . . . . 0.0 110.244 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -101.86 -140.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 0.0 110.571 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 1.3 p -135.86 -87.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.937 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.4 m120 -39.86 -26.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 0.0 111.092 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.906 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.46 -42.83 61.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.829 -1.169 . . . . 0.0 108.55 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 70' ' ' LYS . 2.0 m-20 -46.52 -29.79 1.94 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.86 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -77.19 -32.25 55.93 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.93 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 17.4 m-85 -75.53 -43.29 49.59 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.952 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.642 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 67.0 t80 -60.97 -43.95 98.05 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.671 -0.811 . . . . 0.0 108.963 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.8 m-20 -56.48 -58.39 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.778 . . . . 0.0 109.23 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.6 m-20 -53.56 -38.36 63.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 108.928 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.88 -35.04 74.35 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.298 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.651 ' HA ' HD13 ' A' ' 51' ' ' ILE . 7.1 mm -67.53 -59.68 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.96 -38.22 75.6 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.5 tppt? -60.91 -47.67 85.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.99 -51.4 34.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 105' ' ' GLN . 70.4 t -63.01 -42.43 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.456 -1.026 . . . . 0.0 110.262 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 21.9 tp10 -61.4 -35.35 77.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.153 -0.967 . . . . 0.0 109.815 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.46 11.44 4.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.82 23.59 77.78 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.518 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 1.1 t0 -85.35 -65.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -1.136 . . . . 0.0 110.167 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -99.81 -169.87 1.81 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.208 -0.932 . . . . 0.0 109.742 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' LYS . 34.9 mm-40 -129.66 125.09 35.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.7 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 98' ' ' VAL . 5.8 mt-30 -138.26 130.6 16.12 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 110.379 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 123.89 1.468 . . . . 0.0 109.507 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.538 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -119.18 160.36 22.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -1.136 . . . . 0.0 109.79 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -128.24 122.14 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.785 -1.197 . . . . 0.0 111.052 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' GLU . 33.1 mtpt -116.35 124.38 49.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.838 . . . . 0.0 109.486 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 55' ' ' LEU . 3.1 tm? . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 76.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 52' ' ' ILE . 18.6 ttp180 -51.89 -44.11 63.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' GLU . 9.2 mt-10 -57.95 -43.92 86.68 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.508 HD22 HG23 ' A' ' 73' ' ' ILE . 31.1 mt -52.82 -31.95 41.57 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.551 -1.343 . . . . 0.0 107.859 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 93' ' ' ALA . 2.9 mt -82.77 -55.27 7.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 ' CE1' ' A' ' 103' ' ' PHE . 69.9 mt -58.03 -53.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.5 mt-10 -61.39 -40.09 93.09 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -57.21 -47.55 86.87 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.8 mt -65.61 -39.58 91.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.691 -0.888 . . . . 0.0 109.157 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 m -68.67 -29.27 67.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.196 -0.94 . . . . 0.0 108.609 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.64 -19.71 23.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.611 -0.681 . . . . 0.0 109.868 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.983 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.412 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.574 ' OG ' HD22 ' A' ' 58' ' ' LEU . 5.6 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 12.0 p -135.6 172.78 12.52 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.192 -0.943 . . . . 0.0 111.243 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -48.71 -48.43 69.7 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.737 -0.602 . . . . 0.0 110.972 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -67.64 -42.47 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.301 1.158 . . . . 0.0 110.358 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.37 -25.75 50.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -91.17 -48.71 6.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.991 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -55.19 -47.67 74.91 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.587 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 9.0 ttpt -42.51 -53.68 4.23 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.57 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.72 -42.26 99.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.871 -0.518 . . . . 0.0 109.668 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 24.4 mt -64.38 -33.26 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.164 -0.96 . . . . 0.0 111.526 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.547 ' HG2' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -88.14 -44.6 10.79 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.836 -1.165 . . . . 0.0 111.252 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -96.8 -64.98 1.0 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 110.333 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 30.0 m-20 -53.81 -22.44 9.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.716 -1.24 . . . . 0.0 107.704 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.64 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -125.32 174.99 3.37 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HG2' HG12 ' A' ' 80' ' ' VAL . 51.5 Cg_endo -70.88 179.43 4.31 Favored 'Trans proline' 0 C--N 1.279 -3.085 0 O-C-N 123.923 1.486 . . . . 0.0 114.38 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.599 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -50.68 -15.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.073 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.601 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 2.6 p -44.89 -31.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.73 -42.15 5.48 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -85.98 44.68 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.683 -0.892 . . . . 0.0 109.618 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -116.56 -103.46 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -170.16 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.846 -1.158 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -45.63 -22.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.734 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 1.012 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.36 -44.49 62.11 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.878 -1.139 . . . . 0.0 108.607 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -45.98 -27.23 0.86 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.55 -30.65 33.03 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.829 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.618 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 18.5 m-85 -76.03 -43.56 43.43 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.66 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.65 ' CE1' HD11 ' A' ' 73' ' ' ILE . 76.4 t80 -56.47 -41.53 76.72 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.9 m-20 -57.35 -58.95 6.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 m-20 -54.75 -40.42 69.33 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.511 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.6 -44.8 92.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.563 -0.711 . . . . 0.0 109.159 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 98' ' ' VAL . 8.1 mm -62.21 -58.19 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.4 -37.18 72.31 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -66.0 -52.43 49.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.64 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -61.99 -48.04 86.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' ILE . 43.7 t -64.27 -44.55 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.464 -1.021 . . . . 0.0 109.989 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.9 tp10 -61.29 -36.13 79.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.34 4.81 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.122 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.45 19.57 77.97 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 6.5 m-20 -85.06 -66.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -1.204 . . . . 0.0 110.138 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.9 174.35 5.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 23.2 mm-40 -117.69 133.83 55.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.28 -0.887 . . . . 0.0 109.757 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.62 ' NE2' HG21 ' A' ' 94' ' ' ILE . 1.3 mm100 -140.67 100.13 6.78 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.98 . . . . 0.0 111.174 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--N 1.304 -1.773 0 O-C-N 123.968 1.509 . . . . 0.0 109.398 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.96 124.81 42.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 110.731 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 2.4 p -80.11 119.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 8.7 mtpt -113.29 125.65 54.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.826 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.722 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.306 0.574 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HD2' ' CA ' ' A' ' 97' ' ' GLY 0.25 0.0 OUTLIER -53.04 -44.7 67.58 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.553 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 15.6 mt-10 -56.91 -46.73 81.76 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.202 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 47' ' ' TYR . 51.6 mt -49.72 -32.81 14.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.865 -1.147 . . . . 0.0 107.992 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.88 -56.14 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.387 0.613 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 mt -58.0 -51.0 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.47 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -63.43 -38.55 91.58 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.625 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.16 -44.68 96.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 115' ' ' LEU . 5.2 mt -65.03 -36.82 85.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.6 -0.941 . . . . 0.0 108.999 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.418 ' HG1' ' H ' ' A' ' 56' ' ' THR . 1.1 m -65.45 -30.66 71.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -91.38 -19.05 23.32 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.313 0.578 . . . . 0.0 109.769 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.836 HD11 HD21 ' A' ' 69' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.159 -0.963 . . . . 0.0 109.219 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.708 ' OG ' HD13 ' A' ' 58' ' ' LEU . 8.5 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 75.8 p -129.25 176.79 7.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.177 -0.952 . . . . 0.0 111.206 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -59.56 -43.83 96.53 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.824 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.449 1.236 . . . . 0.0 110.137 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.01 -30.3 59.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.369 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -78.03 -53.44 7.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 109.161 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.901 ' HA ' HD12 ' A' ' 73' ' ' ILE . 56.1 mttt -48.34 -34.42 10.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.977 -1.077 . . . . 0.0 108.308 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.6 ttpt -56.37 -51.9 66.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.625 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -60.39 -45.09 94.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.979 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.9 mt -61.67 -32.09 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -0.779 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.556 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 5.7 ptmm? -91.23 -41.48 10.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.065 -1.022 . . . . 0.0 111.571 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 30.5 mt-10 -92.12 -66.3 0.94 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.924 -1.11 . . . . 0.0 109.76 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.619 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 1.2 m120 -56.28 -27.04 53.97 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.985 -1.072 . . . . 0.0 108.278 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -120.48 177.87 1.32 Allowed Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.56 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.4 Cg_endo -64.62 173.37 5.6 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.097 1.577 . . . . 0.0 113.783 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.571 ' CA ' ' HB2' ' A' ' 82' ' ' SER . 5.8 pt -52.88 -12.93 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.914 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 73' ' ' ILE . 9.0 p -46.63 -28.55 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -35.46 8.77 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.571 ' HB2' ' CA ' ' A' ' 79' ' ' ILE . 14.3 m -51.16 -52.46 43.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.676 -0.896 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -49.95 -173.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.575 0.703 . . . . 0.0 111.222 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ASP . 46.8 t -117.2 -63.62 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 110.546 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 39.9 t30 -38.64 -38.8 0.43 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.348 -0.845 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -51.15 -41.37 60.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.894 -1.129 . . . . 0.0 108.428 178.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -45.69 -31.16 1.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -71.62 -39.5 70.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.727 -0.608 . . . . 0.0 109.733 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.616 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 19.8 m-85 -67.37 -42.47 83.38 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.653 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 51' ' ' ILE . 11.1 t80 -64.67 -41.5 96.04 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.871 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.1 m-20 -55.3 -52.03 64.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.836 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 m-20 -56.26 -41.87 76.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.139 -0.976 . . . . 0.0 108.914 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.793 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -58.88 -39.07 80.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.4 -0.813 . . . . 0.0 109.144 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HD13 ' A' ' 51' ' ' ILE . 18.1 mm -59.66 -56.45 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 108.977 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -39.69 93.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 29.1 tptt -63.03 -49.44 74.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.374 -0.829 . . . . 0.0 109.46 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -65.75 -50.36 54.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 19.6 t -49.6 -23.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.067 -1.255 . . . . 0.0 108.904 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 3.2 tp10 -87.17 -49.78 7.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.715 . . . . 0.0 110.178 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.78 -33.74 4.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -68.25 -11.33 61.38 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 97' ' ' GLY . 9.2 m-20 65.1 32.13 10.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.796 -0.826 . . . . 0.0 111.215 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 3.6 m-30 -77.5 146.57 36.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 109.22 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 58.1 mm-40 -97.38 123.39 41.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 108.609 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -140.89 99.04 6.8 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 111.076 -178.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 44.1 Cg_endo . . . . . 0 C--N 1.305 -1.731 0 O-C-N 123.593 1.312 . . . . 0.0 109.508 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -115.12 159.74 20.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.1 p -111.34 142.34 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.946 -1.096 . . . . 0.0 110.781 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 6.3 mttm -136.93 130.03 31.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.479 -0.763 . . . . 0.0 109.684 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' LEU . 24.5 tp . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.077 -1.014 . . . . 0.0 110.352 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 57.0 m-85 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.398 0.618 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -57.14 -43.75 82.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.112 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.9 mt-10 -59.7 -45.36 92.36 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.385 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 47' ' ' TYR . 52.4 mt -50.68 -31.51 16.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.78 -1.2 . . . . 0.0 108.089 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 93' ' ' ALA . 41.7 mt -84.0 -55.09 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 63.5 mt -56.14 -50.55 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -54.42 -45.06 76.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 115' ' ' LEU . 7.5 mt -63.21 -39.5 94.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.662 -0.905 . . . . 0.0 109.013 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -67.21 -30.92 70.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.98 -13.37 33.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.717 -0.614 . . . . 0.0 109.704 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 55' ' ' LEU . 9.3 mt . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.156 -0.965 . . . . 0.0 109.011 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 58' ' ' LEU . 67.1 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 4.8 p -113.44 171.49 7.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.099 -1.001 . . . . 0.0 111.064 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.625 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -41.17 -50.26 8.25 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.87 -0.519 . . . . 0.0 111.059 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -66.86 -44.02 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.365 1.192 . . . . 0.0 110.495 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.06 -26.34 10.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 109.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 58' ' ' LEU . 2.8 mm? -86.87 -45.19 11.08 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -49.48 -42.42 43.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -50.26 -51.99 40.06 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.084 0.945 . . . . 0.0 109.013 178.067 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -59.37 -47.33 85.84 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.92 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 41.8 mt -64.33 -32.74 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 111.332 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.588 ' HB2' ' N ' ' A' ' 82' ' ' SER . 14.4 ptmt -91.22 -42.2 10.55 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.033 -1.042 . . . . 0.0 111.379 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 9.6 mt-10 -94.95 -64.92 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.923 -1.111 . . . . 0.0 110.009 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.1 m-20 -56.53 -23.44 39.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.71 -1.244 . . . . 0.0 108.003 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.666 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -122.45 177.54 1.57 Allowed Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.9 Cg_endo -66.27 175.47 4.9 Favored 'Trans proline' 0 C--N 1.283 -2.896 0 O-C-N 124.037 1.546 . . . . 0.0 114.429 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.597 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pp -52.54 -13.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.607 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p -45.92 -30.39 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.604 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.77 -37.2 6.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.597 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -85.17 36.87 0.65 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.647 -0.914 . . . . 0.0 110.32 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.92 -110.62 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.019 -1.05 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 86' ' ' PHE . 4.4 m -166.11 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.877 -1.139 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' SER . 57.4 t-20 -39.86 -27.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.289 -0.882 . . . . 0.0 110.663 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.92 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.6 t80 -54.35 -42.07 69.83 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.953 -1.092 . . . . 0.0 108.847 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.549 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 3.9 p-10 -47.79 -28.02 2.33 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.175 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tp -78.6 -32.48 47.58 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.96 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.666 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 29.1 m-85 -74.28 -41.13 61.73 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.715 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 73' ' ' ILE . 67.0 t80 -63.36 -48.11 79.3 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.383 -0.823 . . . . 0.0 108.791 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 14.6 m-80 -52.12 -57.26 10.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.166 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.9 m-20 -54.05 -39.01 65.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.059 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.46 -37.99 80.69 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.351 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.794 HD11 ' CE2' ' A' ' 90' ' ' PHE . 12.9 mm -62.84 -61.11 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 25.1 mttt -57.35 -39.88 76.89 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -59.73 -43.11 94.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.462 -0.774 . . . . 0.0 109.746 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -70.9 -51.97 16.68 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.886 HG21 ' HG3' ' A' ' 105' ' ' GLN . 48.4 t -64.83 -42.07 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -1.124 . . . . 0.0 110.325 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 17.2 tp10 -60.18 -38.09 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.172 -0.955 . . . . 0.0 109.72 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.39 8.37 6.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.455 -0.778 . . . . 0.0 110.292 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.73 22.02 75.65 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -82.89 -66.94 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -1.148 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.21 177.0 4.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.739 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 16.7 mm-40 -111.01 126.14 54.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.45 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.886 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.5 98.32 9.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 110.985 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 O-C-N 123.684 1.36 . . . . 0.0 109.909 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.47 161.65 16.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.174 . . . . 0.0 109.741 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.582 ' O ' HD21 ' A' ' 55' ' ' LEU . 2.1 p -126.64 100.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.016 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 28.8 mttp -99.81 126.52 45.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 55' ' ' LEU . 25.0 tp . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.222 0.534 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 130.63 43.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -0.913 . . . . 0.0 110.304 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER -160.96 40.56 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 111.005 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.292 22.9 t 52.11 105.64 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.668 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -72.29 149.66 44.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.072 -1.018 . . . . 0.0 110.178 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 9.8 p -131.82 162.54 30.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 110.352 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' A' ' 50' ' ' LEU . 34.0 m-85 -59.44 -39.09 82.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.591 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -52.72 -46.35 67.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.1 mm-40 -56.95 -46.2 82.27 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.175 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.741 HD22 HG23 ' A' ' 73' ' ' ILE . 96.6 mt -52.33 -32.07 36.33 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.932 -1.105 . . . . 0.0 108.987 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.8 mt -82.2 -55.94 6.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.553 0.692 . . . . 0.0 109.362 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.606 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.8 mt -59.12 -51.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 6.0 mt-10 -62.95 -39.92 96.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.618 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.57 -45.1 96.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.996 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.9 mt -64.45 -36.61 84.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -1.046 . . . . 0.0 109.175 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m -72.88 -30.07 63.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.0 108.909 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.73 -19.75 23.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.556 -0.715 . . . . 0.0 110.041 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.4 mt -57.51 -40.76 79.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.093 -1.004 . . . . 0.0 109.581 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 2.0 mtpp 63.13 29.31 16.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.61 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -116.73 141.47 48.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.43 -24.8 13.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.39 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -75.35 -18.59 59.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.64 165.07 12.89 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD22 ' A' ' 58' ' ' LEU . 33.7 m -130.95 175.46 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.949 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.539 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 9.5 p -125.09 172.61 9.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.628 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.9 ttp180 -44.82 -48.56 29.02 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.78 -0.575 . . . . 0.0 111.151 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.4 Cg_endo -67.48 -42.37 7.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.234 1.123 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.32 -28.13 51.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -86.72 -51.19 6.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.803 . . . . 0.0 109.519 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 mttp -54.61 -42.04 70.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -52.39 -49.74 63.82 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.111 0.958 . . . . 0.0 108.646 177.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.618 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -59.76 -45.33 92.58 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.934 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 28.8 mt -65.18 -32.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.467 -0.771 . . . . 0.0 111.159 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.69 -41.48 10.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.85 -1.156 . . . . 0.0 111.178 -179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 11.9 mt-10 -95.88 -65.25 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 33.2 m-20 -56.43 -19.88 17.1 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.653 -1.279 . . . . 0.0 108.102 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.637 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.06 177.33 1.99 Allowed Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 177.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.55 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 50.0 Cg_endo -68.46 176.77 5.33 Favored 'Trans proline' 0 C--N 1.281 -3.006 0 O-C-N 123.997 1.525 . . . . 0.0 114.261 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.3 tt -50.72 -15.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.846 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.6 p -45.42 -29.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.94 -35.94 6.21 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -82.43 45.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -1.012 . . . . 0.0 109.972 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.78 -127.01 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 43.5 t -150.68 -78.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.86 -1.15 . . . . 0.0 110.844 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' PHE . 55.8 t-20 -52.4 -34.55 48.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.128 -0.982 . . . . 0.0 110.868 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.2 t80 -48.51 -38.76 21.07 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.731 -1.23 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -46.8 -32.93 4.01 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.678 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 tp -75.93 -32.86 59.77 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 47' ' ' TYR . 5.7 m-85 -69.73 -46.72 65.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 32.8 t80 -58.09 -41.02 82.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.132 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.9 m-20 -56.82 -55.11 38.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.966 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -54.37 -38.88 66.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.285 -0.885 . . . . 0.0 108.889 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.02 -41.32 99.51 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.4 mm -63.42 -58.8 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 36.2 mttp -56.06 -41.44 75.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -49.23 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -69.45 -48.13 46.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 105' ' ' GLN . 40.2 t -63.9 -43.44 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -1.031 . . . . 0.0 110.57 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.3 tp10 -61.92 -34.56 76.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.66 11.77 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 74.78 21.39 78.65 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 7.1 t0 -85.54 -68.42 0.73 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -1.155 . . . . 0.0 109.969 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.22 169.73 8.28 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.541 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -110.9 126.85 55.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.811 ' HB2' HG11 ' A' ' 98' ' ' VAL . 1.3 mm100 -138.51 109.72 8.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.763 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.3 Cg_endo -80.53 -157.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.021 1.537 . . . . 0.0 109.891 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 2.4 mptp? -136.96 -82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 110.22 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.66 -146.65 30.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.86 4.86 5.73 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.261 1.663 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.85 -103.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 O-C-N 121.872 -0.518 . . . . 0.0 109.935 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.52 128.85 1.0 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.06 121.66 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -1.165 . . . . 0.0 109.926 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.6 p -81.27 126.19 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -125.23 128.76 48.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.83 . . . . 0.0 109.781 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.728 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.6 tp -74.59 117.37 16.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.103 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . 169.98 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' GLY . 0.3 OUTLIER -62.05 150.6 37.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.16 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' OXT' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.298 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.233 0.54 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.99 86.44 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.13 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 44' ' ' SER . 1.5 t 56.75 -156.93 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.857 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.3 31.2 t -174.39 179.35 1.82 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.922 -175.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -77.37 117.26 18.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 42.7 p -131.54 177.5 7.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.637 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 96.5 m-85 -62.9 -33.05 74.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.393 -0.817 . . . . 0.0 110.195 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.775 ' CD ' HD11 ' A' ' 52' ' ' ILE 0.25 2.7 tmm_? -49.14 -44.61 42.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 13.7 mt-10 -57.74 -45.58 85.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.091 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.777 HD22 HG23 ' A' ' 73' ' ' ILE . 98.7 mt -52.99 -32.56 47.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.062 -1.023 . . . . 0.0 108.883 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.3 mt -78.93 -56.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.563 0.697 . . . . 0.0 109.314 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.775 HD11 ' CD ' ' A' ' 48' ' ' ARG . 23.5 mt -59.0 -53.08 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 1.9 mm-40 -61.07 -39.66 90.71 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.99 -46.83 93.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.958 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.1 mt -63.89 -38.78 92.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -1.055 . . . . 0.0 109.077 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -69.75 -28.2 65.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.64 -22.47 21.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.0 109.724 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.977 HD11 HD21 ' A' ' 69' ' ' LEU . 12.8 mt -55.66 -36.43 67.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.326 -0.859 . . . . 0.0 109.219 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 7.2 mtpp 62.52 30.53 17.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.355 0.598 . . . . 0.0 110.177 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 59' ' ' LYS . 29.6 mt-10 -141.0 119.76 12.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 109.883 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -87.48 -19.09 28.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.375 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -60.79 -27.68 68.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 130.94 165.07 11.42 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.552 ' OG ' HD22 ' A' ' 58' ' ' LEU . 20.9 m -144.84 -179.83 6.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.546 -0.973 . . . . 0.0 109.787 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -128.59 174.06 9.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 111.549 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.647 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -47.57 -47.51 60.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.792 -0.568 . . . . 0.0 111.318 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -66.96 -42.21 8.69 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.286 1.15 . . . . 0.0 110.47 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.52 -27.24 56.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.669 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.977 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -92.08 -47.42 7.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 109.597 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.786 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.1 mttp -55.88 -40.21 72.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 108.517 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 5.3 ttpt -54.54 -52.7 61.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t80 -58.52 -43.54 89.22 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.938 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 54.8 mt -63.35 -33.1 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 0.0 111.104 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 6.5 pttt -91.62 -41.55 10.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.007 -1.058 . . . . 0.0 111.418 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.55 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.5 mt-10 -95.42 -65.44 0.98 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.042 . . . . 0.0 109.897 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.9 m-20 -56.82 -21.1 26.45 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.077 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -125.25 176.54 2.35 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.6 Cg_endo -66.05 175.44 4.73 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 O-C-N 123.976 1.514 . . . . 0.0 114.119 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.916 HG23 ' HB3' ' A' ' 82' ' ' SER . 17.8 mm -52.42 -12.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.937 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.3 p -45.97 -31.14 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.31 -38.25 7.29 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.916 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -82.32 42.29 0.74 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.621 -0.929 . . . . 0.0 110.078 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.04 -133.76 0.29 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' PHE . 20.7 m -143.9 -92.18 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.912 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.2 t30 -40.18 -28.14 0.05 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.142 -0.974 . . . . 0.0 110.965 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -48.32 -42.11 30.26 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.537 179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.4 t0 -47.42 -30.66 3.48 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.767 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.5 tp -76.81 -28.15 55.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.464 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 49.1 m-85 -77.05 -46.98 21.85 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.207 -0.933 . . . . 0.0 108.892 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.828 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 70.7 t80 -56.9 -43.03 80.93 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-20 -55.5 -57.0 13.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.185 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 6.9 m-20 -54.87 -40.17 69.43 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.028 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -62.0 -45.57 93.04 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.485 -0.76 . . . . 0.0 109.016 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.828 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 16.7 mm -60.01 -58.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -0.807 . . . . 0.0 109.015 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.76 -38.2 74.99 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.758 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 5.2 tptt -66.03 -50.97 62.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.848 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -63.63 -51.48 53.73 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 105' ' ' GLN . 93.1 t -60.81 -39.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.978 . . . . 0.0 110.054 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 34.4 tp10 -63.19 -33.48 75.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.186 -0.947 . . . . 0.0 109.863 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.93 17.39 3.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.384 -0.822 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.6 73.4 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -87.57 -69.2 0.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.329 -1.101 . . . . 0.0 110.103 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -107.66 169.32 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -108.59 125.54 51.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.588 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.74 97.87 8.92 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.987 . . . . 0.0 110.63 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.5 Cg_endo -78.33 -163.97 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.905 1.476 . . . . 0.0 109.896 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -118.56 -67.69 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.949 . . . . 0.0 110.101 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.47 -150.56 16.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.92 4.75 5.85 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.146 1.603 . . . . 0.0 111.268 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.57 -91.0 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.848 -0.533 . . . . 0.0 110.153 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.86 112.35 0.32 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -102.37 160.16 14.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.972 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.487 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.9 p -121.19 117.58 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.862 -1.149 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 1.2 mttp -114.25 128.63 56.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.715 ' HB2' HD22 ' A' ' 55' ' ' LEU . 56.8 tp -82.99 128.19 34.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.86 88.57 2.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 110.086 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -110.34 118.04 35.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.224 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.284 0.564 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.29 59.99 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.1 OUTLIER -94.93 43.99 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.299 23.3 t 50.77 178.07 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.908 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -104.5 114.5 28.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.116 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.488 ' OG ' ' CG ' ' A' ' 49' ' ' GLU . 13.8 p -98.98 137.25 37.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 61.9 m-85 -48.07 -25.86 1.6 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.23 -0.919 . . . . 0.0 109.082 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -69.7 -45.62 67.85 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' GLU . 39.4 mt-10 -58.47 -42.25 87.06 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.294 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 47' ' ' TYR . 77.8 mt -54.26 -34.17 60.16 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.869 -1.145 . . . . 0.0 108.701 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 94' ' ' ILE . 57.7 mt -79.35 -55.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.636 -0.665 . . . . 0.0 109.27 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.8 mt -59.24 -54.49 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.5 mt-10 -62.2 -41.58 98.5 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.9 -43.71 96.54 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -62.35 -36.54 82.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -1.021 . . . . 0.0 109.041 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -72.2 -28.42 63.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.355 -0.84 . . . . 0.0 109.051 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.26 -18.13 26.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.59 -0.694 . . . . 0.0 109.632 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.019 HD12 ' HA ' ' A' ' 55' ' ' LEU . 14.4 mt -61.67 -42.05 98.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.239 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 57.52 31.78 20.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.599 -0.688 . . . . 0.0 110.395 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -93.87 -43.05 8.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 109.881 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER 73.26 -4.0 2.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 111.144 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -117.53 -26.26 6.69 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.031 -1.043 . . . . 0.0 109.951 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 140.08 168.65 11.41 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.618 ' OG ' HD22 ' A' ' 58' ' ' LEU . 13.8 m -149.94 177.03 10.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.588 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.8 p -127.81 176.58 7.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.4 tpp85 -46.28 -47.6 45.62 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.5 Cg_endo -67.99 -42.51 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.274 1.144 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.588 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -58.06 -36.52 72.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -78.36 -49.52 13.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.815 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 73' ' ' ILE . 1.7 mtpt -52.09 -39.63 60.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 7.6 ttpt -50.94 -51.7 49.71 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.53 -48.41 81.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.988 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 11.8 mt -61.62 -33.49 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.596 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.552 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -91.28 -41.65 10.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.151 -0.968 . . . . 0.0 111.575 -179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.552 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 38.5 mt-10 -92.3 -65.81 0.97 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.963 -1.086 . . . . 0.0 110.106 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 18.0 m-20 -59.09 -22.02 60.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.865 -1.147 . . . . 0.0 108.214 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.621 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -123.8 176.87 1.97 Allowed Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.574 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -65.07 172.74 6.9 Favored 'Trans proline' 0 C--N 1.282 -2.941 0 O-C-N 124.071 1.564 . . . . 0.0 113.527 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -52.9 -12.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.495 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG13 HG22 ' A' ' 73' ' ' ILE . 8.5 p -45.64 -29.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.543 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.13 -36.72 7.49 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 16.1 t -65.57 -8.63 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.543 -0.975 . . . . 0.0 110.432 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.79 -160.69 0.5 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 111.108 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.5 t -127.21 -67.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.264 -0.897 . . . . 0.0 110.682 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 16.0 t-20 -40.73 -41.27 1.5 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.215 -0.928 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.988 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.12 -40.91 25.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.6 t70 -46.72 -32.18 3.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -71.99 -33.82 68.41 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.636 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 21.6 m-85 -75.09 -43.01 55.46 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.402 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.614 ' CE2' HG12 ' A' ' 51' ' ' ILE . 43.7 t80 -57.46 -39.02 75.43 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -62.88 -54.88 31.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.508 -0.745 . . . . 0.0 109.487 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.9 m-20 -50.69 -38.86 49.39 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.844 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.651 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.16 -47.61 73.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 51' ' ' ILE . 14.5 mm -56.26 -61.03 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.076 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -56.68 -40.31 75.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.635 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -61.6 -47.33 85.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.47 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.44 -52.22 10.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.752 HG21 ' HG3' ' A' ' 105' ' ' GLN . 57.9 t -59.17 -36.72 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.355 -1.085 . . . . 0.0 110.419 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 4.0 tp10 -61.66 -37.33 83.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.199 -0.938 . . . . 0.0 110.06 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.494 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.54 17.36 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 109.931 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.52 25.31 74.96 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.1 m-20 -82.78 -67.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.136 -1.214 . . . . 0.0 109.893 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -102.91 168.23 9.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.977 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 34.3 mm-40 -105.9 125.71 51.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -0.845 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.752 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -141.09 102.37 6.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.118 -0.989 . . . . 0.0 111.103 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -80.85 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.632 1.333 . . . . 0.0 109.648 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -123.02 -61.56 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.086 . . . . 0.0 110.246 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.81 -145.56 3.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.85 4.89 5.7 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.329 1.699 . . . . 0.0 111.407 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.86 -97.86 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.814 -0.554 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.19 116.35 0.37 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -103.57 160.65 14.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -1.109 . . . . 0.0 109.672 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.8 p -122.61 117.33 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.87 -1.144 . . . . 0.0 110.718 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 14.1 mtpt -115.43 129.27 56.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 109.762 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.2 tp -74.87 96.28 3.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.199 -0.938 . . . . 0.0 110.906 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . 31.91 57.48 0.34 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.809 -0.557 . . . . 0.0 111.236 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 61' ' ' ARG . 22.8 mmtm -85.51 115.83 23.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.6 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.231 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' CD ' ' N ' ' A' ' 41' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.271 0.558 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.88 179.11 4.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.361 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER 42.5 40.03 1.77 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.26 -0.9 . . . . 0.0 110.794 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.302 23.3 t 50.15 -175.95 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.381 -1.328 . . . . 0.0 110.946 175.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -73.69 128.36 35.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.758 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 66.1 p -78.72 164.22 24.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.667 ' CB ' ' HB2' ' A' ' 93' ' ' ALA . 42.9 m-85 -53.69 -27.3 27.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.92 -45.7 91.26 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.33 -46.17 83.54 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.246 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.507 HD13 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 mt -50.41 -33.35 20.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.884 -1.135 . . . . 0.0 108.451 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.9 mt -80.77 -56.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.449 0.642 . . . . 0.0 109.384 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.62 HG12 ' CE1' ' A' ' 103' ' ' PHE . 74.2 mt -57.65 -53.41 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.7 mt-10 -59.24 -40.29 85.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.3 -46.49 86.43 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.791 HD22 ' CB ' ' A' ' 115' ' ' LEU . 9.1 mt -67.56 -39.89 84.93 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.54 -0.976 . . . . 0.0 108.657 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.4 m -66.19 -28.35 68.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -87.43 -29.21 21.62 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 64' ' ' SER . 10.4 mt -55.79 -21.16 17.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.843 . . . . 0.0 108.997 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.1 mtpt 61.4 57.17 2.43 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.336 0.589 . . . . 0.0 110.389 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 35.9 mm-40 56.19 157.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 167.96 166.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -61.83 -21.59 64.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.02 169.22 31.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.708 ' HB3' HD11 ' A' ' 58' ' ' LEU . 1.1 m -136.34 160.81 37.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 110.23 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.722 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -134.64 175.99 9.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.164 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.27 -47.03 68.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.589 -0.694 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 41.0 Cg_endo -69.34 -42.81 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.231 1.122 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -57.99 -30.44 66.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.975 . . . . 0.0 109.791 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 65' ' ' SER . 4.5 mm? -86.7 -49.91 7.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.588 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.925 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.5 mtpt -56.33 -39.64 73.14 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.452 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.67 -49.97 45.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 3.1 t80 -63.0 -47.52 82.79 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.974 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 14.9 mt -61.04 -31.85 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.446 -0.783 . . . . 0.0 111.114 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.25 -43.04 10.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.0 -1.062 . . . . 0.0 111.643 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 26.7 mt-10 -94.0 -65.36 0.99 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.968 -1.082 . . . . 0.0 109.911 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 9.7 m-20 -59.08 -17.42 25.87 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 108.383 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.2 m-85 -129.29 176.47 2.78 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 43.3 Cg_endo -65.27 173.35 6.34 Favored 'Trans proline' 0 C--N 1.28 -3.031 0 O-C-N 123.942 1.496 . . . . 0.0 114.082 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 82' ' ' SER . 33.6 mt -50.48 -16.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.452 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.663 HG13 HG22 ' A' ' 73' ' ' ILE . 7.2 p -44.51 -29.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.31 -33.07 8.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB3' HG23 ' A' ' 79' ' ' ILE . 12.4 t -51.17 -55.7 16.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.621 -0.929 . . . . 0.0 110.743 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.67 -171.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.523 -0.736 . . . . 0.0 111.241 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -119.99 -54.63 2.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 110.429 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 51.8 t30 -42.07 -41.35 2.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -49.03 -41.39 34.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.979 -1.075 . . . . 0.0 108.209 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.513 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 33.3 t0 -45.69 -31.41 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -70.33 -40.62 74.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.436 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 71.5 m-85 -68.32 -42.75 78.91 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.618 ' CE2' HG12 ' A' ' 51' ' ' ILE . 32.3 t80 -59.42 -32.6 70.33 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.3 m-80 -66.95 -53.59 30.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.53 -0.731 . . . . 0.0 109.427 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.4 m-20 -53.62 -40.19 65.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.113 -0.992 . . . . 0.0 108.797 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.46 -36.17 82.11 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.694 HG21 ' NE2' ' A' ' 105' ' ' GLN . 6.5 mm -65.19 -60.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.37 -38.12 73.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 8.4 tptm -63.08 -50.02 72.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.362 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.93 -52.72 31.21 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.831 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.8 t -59.37 -33.77 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.492 -1.005 . . . . 0.0 109.902 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 1.2 tp10 -60.73 -40.33 92.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.287 -0.883 . . . . 0.0 109.616 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.56 15.77 3.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 109.891 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.16 24.99 76.47 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 3.4 m-20 -81.15 -67.41 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.213 -1.169 . . . . 0.0 109.86 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.712 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -106.78 162.23 13.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.251 -0.906 . . . . 0.0 109.725 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 11.9 mm-40 -101.19 125.57 47.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.672 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.831 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -133.99 98.17 14.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 111.283 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.1 Cg_endo -78.9 172.69 14.61 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.933 1.491 . . . . 0.0 109.342 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 108' ' ' GLY . 11.2 mmtt -104.02 -55.39 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 109.89 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.07 -151.29 0.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.89 4.74 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.281 1.674 . . . . 0.0 111.371 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.66 -107.25 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.186 0 O-C-N 121.751 -0.593 . . . . 0.0 110.063 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.93 117.51 0.48 Allowed Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -112.52 160.05 18.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -1.051 . . . . 0.0 109.856 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 64' ' ' SER . 1.4 p -121.57 113.23 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.082 . . . . 0.0 109.752 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -109.85 129.85 55.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.979 . . . . 0.0 110.133 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.791 ' CB ' HD22 ' A' ' 55' ' ' LEU . 19.8 tp -76.61 116.77 17.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.03 108.07 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -73.14 144.97 46.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.274 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.294 0.569 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.78 135.4 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 44' ' ' SER . 54.4 p -125.47 31.98 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.771 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.305 15.9 t 50.14 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 118.184 -1.406 . . . . 0.0 110.777 175.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.94 156.35 20.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 4.8 p -116.13 135.69 53.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 0.0 110.061 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 60.8 m-85 -47.85 -30.71 4.3 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.042 -1.036 . . . . 0.0 108.812 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 52' ' ' ILE . 17.2 ttm180 -59.24 -45.76 90.31 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' GLU . 59.1 mt-10 -59.08 -43.77 91.82 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 73' ' ' ILE . 96.2 mt -53.42 -32.53 50.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.654 -1.279 . . . . 0.0 108.713 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 93' ' ' ALA . 22.7 mt -81.23 -56.42 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.679 0.752 . . . . 0.0 109.107 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 103' ' ' PHE . 57.4 mt -59.11 -53.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.991 0.901 . . . . 0.0 108.68 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -61.6 -39.33 90.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.59 -49.14 79.76 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -58.52 -36.35 73.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.444 -1.033 . . . . 0.0 109.61 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -74.29 -30.13 61.95 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.771 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.94 -10.62 41.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.666 -0.646 . . . . 0.0 110.069 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 69' ' ' LEU . 12.5 mt -64.58 -53.49 46.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 109.773 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 56.67 16.83 2.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.88 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.47 -152.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.848 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -150.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.068 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -75.05 -0.74 19.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.475 -0.766 . . . . 0.0 110.754 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . -162.8 168.94 37.86 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.071 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.791 ' OG ' HD13 ' A' ' 58' ' ' LEU . 27.3 m -137.81 -172.88 3.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -1.061 . . . . 0.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HD23 ' A' ' 69' ' ' LEU . 53.7 p -130.63 173.5 10.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 111.145 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.668 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 12.0 ttp180 -52.42 -45.68 95.13 Favored Pre-proline 0 C--N 1.296 -1.725 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.7 -42.97 4.16 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.299 1.157 . . . . 0.0 110.788 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.18 -22.57 17.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.075 -1.016 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -91.05 -48.4 6.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.356 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 73' ' ' ILE . 27.9 mttt -56.34 -42.07 77.11 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 1.7 ttpt -51.24 -49.81 60.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.879 0.847 . . . . 0.0 108.815 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.05 -47.4 86.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.921 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.5 mt -63.41 -31.29 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.969 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 45.1 pttt -91.6 -41.04 10.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.877 -1.139 . . . . 0.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.6 mt-10 -96.03 -65.7 0.95 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.055 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 50.7 m-20 -56.62 -19.92 18.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.622 -1.299 . . . . 0.0 107.992 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.44 177.97 1.74 Allowed Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.143 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 77' ' ' TYR . 47.4 Cg_endo -67.77 176.19 5.45 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.949 1.5 . . . . 0.0 114.108 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -51.99 -15.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.857 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.605 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -44.28 -30.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.27 -36.45 6.6 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.2 m -73.06 -1.21 16.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -1.075 . . . . 0.0 110.323 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -81.27 -151.35 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 110.619 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.78 -74.59 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.855 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 35.4 t-20 -41.12 -35.64 0.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.322 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.5 -42.05 61.4 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.078 -1.049 . . . . 0.0 108.553 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 26.1 m-20 -45.61 -27.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -80.83 -34.49 33.84 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.031 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 20.8 m-85 -71.94 -41.1 68.2 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.05 -1.032 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.0 t80 -59.84 -43.27 94.69 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.484 -0.76 . . . . 0.0 108.956 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 59.5 m-20 -56.98 -56.83 16.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.51 -0.744 . . . . 0.0 109.462 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.2 m-20 -51.99 -39.84 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.075 -1.016 . . . . 0.0 108.985 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.44 -45.5 87.21 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.465 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 12.8 mm -60.15 -60.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.42 -38.16 73.91 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.893 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -66.61 -48.68 68.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 0.0 110.155 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -65.11 -52.52 40.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.604 HG21 ' HG3' ' A' ' 105' ' ' GLN . 37.8 t -61.56 -41.29 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.549 -0.971 . . . . 0.0 110.457 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 6.6 tp10 -61.25 -35.34 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.224 -0.923 . . . . 0.0 110.016 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.7 14.04 4.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.972 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.09 24.23 76.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.4 m-20 -85.84 -69.28 0.67 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -1.23 . . . . 0.0 109.754 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -115.5 125.73 53.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.673 ' NE2' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -134.91 98.18 13.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.664 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo -78.46 170.18 18.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.873 1.459 . . . . 0.0 110.076 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -98.17 -91.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.87 -150.64 43.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.02 4.73 5.91 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.18 1.621 . . . . 0.0 111.341 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -164.97 -105.18 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.202 0 O-C-N 121.79 -0.569 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.31 109.71 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -99.92 160.17 14.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -1.069 . . . . 0.0 109.933 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.2 p -122.22 127.1 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 110.352 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.533 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 11.9 mtpt -126.45 129.56 48.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.804 ' HB2' HD13 ' A' ' 55' ' ' LEU . 8.7 tp -82.27 102.36 11.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . 14.83 60.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.078 0.466 . . . . 0.0 112.114 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' LEU . 43.3 mttt -112.06 143.28 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.144 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.206 0.527 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.95 120.13 13.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.9 OUTLIER -98.42 26.37 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.771 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.299 13.8 t 51.71 174.28 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.304 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.33 114.95 29.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 49' ' ' GLU . 85.8 p -101.72 143.74 31.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 110.296 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.963 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.0 m-85 -48.74 -26.69 2.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.02 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.95 -45.53 82.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 53.2 mm-40 -57.85 -19.32 28.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.877 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 47' ' ' TYR . 29.6 mt -86.34 -31.75 21.37 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.7 -1.25 . . . . 0.0 108.961 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.14 -56.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.595 -0.691 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.605 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 24.9 mt -52.74 -49.99 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 78.0 mt-10 -64.95 -41.5 95.43 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.912 0.863 . . . . 0.0 108.786 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -55.95 -44.83 87.71 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.985 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.9 mt -67.77 -44.15 78.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -1.047 . . . . 0.0 109.355 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -67.64 -26.29 66.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.208 -0.932 . . . . 0.0 108.848 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.57 -25.85 20.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.663 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.022 HD22 ' OG ' ' A' ' 64' ' ' SER . 8.3 mt -54.19 -35.92 62.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.23 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 41.31 37.43 0.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.855 -0.528 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.67 -159.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.922 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -46.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -72.08 -24.73 61.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.26 170.98 12.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 1.022 ' OG ' HD22 ' A' ' 58' ' ' LEU . 65.4 m -134.93 166.53 22.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 0.0 110.15 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.519 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 5.1 p -120.97 173.04 7.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.091 -1.006 . . . . 0.0 110.97 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.627 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -43.73 -48.71 20.29 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.878 -0.513 . . . . 0.0 111.38 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.6 Cg_endo -67.55 -42.87 6.4 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.263 1.138 . . . . 0.0 110.436 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.95 -28.93 59.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -83.3 -51.68 7.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 109.504 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.842 ' HA ' HD12 ' A' ' 73' ' ' ILE . 2.3 mtpt -50.06 -38.54 38.63 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.643 -1.223 . . . . 0.0 107.747 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.81 -55.96 12.17 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.629 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.74 -45.5 89.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 22.2 mt -62.39 -34.19 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.477 -0.765 . . . . 0.0 111.022 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.27 -41.81 10.74 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.037 -1.04 . . . . 0.0 111.595 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 20.8 mt-10 -94.61 -65.02 1.01 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.57 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.2 m-20 -57.94 -20.56 38.59 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.645 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.6 m-85 -126.15 177.11 2.09 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.562 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.3 Cg_endo -65.09 174.86 4.38 Favored 'Trans proline' 0 C--N 1.283 -2.869 0 O-C-N 123.838 1.441 . . . . 0.0 114.03 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.613 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pt -52.97 -12.46 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.031 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.4 p -46.34 -28.95 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -36.93 7.88 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 107.179 -2.368 . . . . 0.0 107.179 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.613 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 48.3 t -57.22 -38.68 74.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.883 . . . . 0.0 110.289 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -52.08 -169.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.526 -0.733 . . . . 0.0 111.033 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 85' ' ' ASN . 4.8 p -124.62 -65.8 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 110.339 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 61.4 t30 -42.65 -36.0 1.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -0.911 . . . . 0.0 109.988 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.889 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -50.92 -42.03 59.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.202 -0.999 . . . . 0.0 108.388 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 46.9 t0 -45.52 -27.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -80.46 -34.45 35.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 m-85 -70.76 -43.61 68.44 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.727 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.5 t80 -55.13 -40.54 70.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-80 -59.22 -55.77 30.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.554 -0.717 . . . . 0.0 109.717 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.7 m-20 -51.52 -38.35 53.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.718 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.806 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.49 -40.63 76.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.9 mm -63.42 -60.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 2.8 mttp -57.13 -37.81 72.57 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 12.5 tptm -63.96 -49.09 73.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.84 . . . . 0.0 109.468 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.93 -53.96 20.42 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 103' ' ' PHE . 61.9 t -56.49 -34.02 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -1.067 . . . . 0.0 109.826 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 24.5 tp10 -68.66 -35.03 76.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.53 11.29 5.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 110.043 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.18 21.57 78.85 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.702 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -88.98 -65.44 1.02 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 110.468 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.7 ' HB2' HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -99.05 166.94 11.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.765 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 114' ' ' LYS . 52.7 mm-40 -114.12 124.0 51.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.672 ' HG3' HG21 ' A' ' 98' ' ' VAL . 1.2 mt-30 -135.41 114.48 11.43 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 111.222 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.54 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 50.9 Cg_endo -89.94 -155.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.883 1.465 . . . . 0.0 109.141 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.54 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -135.9 -85.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.955 -1.091 . . . . 0.0 110.568 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.51 -151.61 1.44 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 49.3 Cg_endo -77.94 5.24 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.107 1.583 . . . . 0.0 111.389 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -179.3 101.45 0.03 OUTLIER 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.367 0.603 . . . . 0.0 109.695 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.33 113.17 5.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -89.36 159.49 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.654 HG22 HD21 ' A' ' 55' ' ' LEU . 1.4 p -114.4 101.6 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -101.86 129.39 48.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 178.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 55' ' ' LEU . 13.3 tp -67.78 148.75 50.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.235 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 102' ' ' ASP . . . -67.71 66.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 117' ' ' LYS . 16.6 pttt -72.81 127.21 31.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 4.0 mttp . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.198 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.174 0.511 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.18 99.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.016 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 44' ' ' SER . 1.1 p 63.52 -160.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.561 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.295 30.4 t -174.29 95.06 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.073 -175.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 123.71 26.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 109.979 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p -121.42 178.82 4.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.159 -0.963 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 55.1 m-85 -66.85 -39.05 87.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 110.037 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HA ' ' HB1' ' A' ' 93' ' ' ALA 0.25 3.2 ttp180 -49.74 -44.6 48.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 53.3 mm-40 -57.67 -45.37 85.68 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.823 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD12 ' HD1' ' A' ' 47' ' ' TYR . 35.6 mt -52.21 -31.22 30.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.816 -1.177 . . . . 0.0 108.596 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.4 mt -80.09 -56.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.566 0.698 . . . . 0.0 109.308 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.634 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.5 mt -61.41 -54.48 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.1 mt-10 -58.77 -38.63 78.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.68 -49.62 75.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -59.97 -39.15 84.66 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.585 -0.95 . . . . 0.0 108.58 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 56' ' ' THR . 0.7 OUTLIER -70.31 -24.44 63.02 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -86.04 -31.21 22.1 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 64' ' ' SER . 25.5 mt -51.47 -36.23 43.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.9 mtpm? 59.3 32.45 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.317 0.579 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 45.4 mt-10 -123.62 -44.97 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER 65.88 7.42 4.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -0.841 . . . . 0.0 110.306 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -96.02 -39.2 9.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 172.88 161.78 23.86 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.829 ' HB2' HG13 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -151.83 165.2 35.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.492 -1.005 . . . . 0.0 110.263 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.737 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.7 p -134.63 170.67 15.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 18.5 ttp180 -49.24 -49.25 71.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.1 Cg_endo -67.45 -42.4 7.34 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.301 1.158 . . . . 0.0 110.627 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -54.12 -31.1 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 109.464 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.0 mm? -82.84 -51.19 7.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.443 -0.785 . . . . 0.0 109.537 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' HD12 ' A' ' 73' ' ' ILE . 4.6 mttt -50.36 -41.23 51.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 5.3 tmmm? -49.14 -55.85 11.03 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.97 -46.14 88.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.929 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 17.5 mt -65.53 -31.72 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.924 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 46.0 pttt -91.81 -40.77 11.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.966 -1.084 . . . . 0.0 111.624 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 14.9 mt-10 -95.97 -65.31 0.98 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.905 -1.122 . . . . 0.0 109.89 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 18.6 m-20 -56.31 -21.6 25.19 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.666 -1.272 . . . . 0.0 107.845 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.616 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.57 175.7 2.49 Favored Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 80' ' ' VAL . 49.5 Cg_endo -69.84 178.31 4.75 Favored 'Trans proline' 0 C--N 1.28 -3.033 0 O-C-N 123.903 1.475 . . . . 0.0 113.885 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.6 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -51.0 -15.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.034 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.633 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.06 -30.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.77 -34.64 6.79 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -83.1 23.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -1.064 . . . . 0.0 110.362 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -104.83 -139.07 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.473 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -140.55 -77.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.893 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' SER . 50.4 t30 -42.05 -36.29 1.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.929 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -49.22 -40.53 34.08 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.361 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.1 m-20 -46.62 -29.66 1.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.15 -33.79 50.13 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.01 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.67 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 12.7 m-85 -72.21 -44.83 62.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.152 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 83.8 t80 -56.55 -39.9 74.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.486 -0.759 . . . . 0.0 109.184 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -60.63 -55.39 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.464 -0.773 . . . . 0.0 109.279 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 9.3 m-20 -50.87 -36.63 38.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 108.852 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.639 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -71.29 -39.43 71.51 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.212 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.7 mm -64.16 -59.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 108.976 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.53 -41.02 80.08 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -61.87 -42.89 99.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.964 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -74.43 -52.01 7.89 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 105' ' ' GLN . 48.0 t -61.71 -40.11 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.123 . . . . 0.0 110.346 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 9.2 tp10 -59.87 -36.85 77.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.72 13.44 4.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.49 78.04 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.5 m-20 -82.66 -68.28 0.72 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.732 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.72 157.69 17.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.542 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 117' ' ' LYS . 6.1 mm-40 -96.73 123.89 40.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.692 ' HB2' HG11 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -134.98 106.09 10.47 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 110.701 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.531 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 49.4 Cg_endo -79.51 -160.19 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 109.978 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -134.04 -86.84 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.073 -1.017 . . . . 0.0 110.418 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.73 -162.05 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.23 5.22 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.102 1.58 . . . . 0.0 111.285 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.04 96.05 0.5 Allowed 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.255 0.55 . . . . 0.0 110.063 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.45 135.68 22.52 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.13 126.53 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -1.064 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 64' ' ' SER . 2.1 p -83.49 104.52 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.5 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 5.4 mttp -101.29 125.86 47.97 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.039 -1.038 . . . . 0.0 109.301 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 0.4 OUTLIER -67.64 151.17 47.73 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.414 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 72.25 164.81 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.543 ' HA ' ' CG ' ' A' ' 104' ' ' GLU . 14.1 ttpt -115.22 137.78 51.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 30.3 mttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.377 0.608 . . . . 0.0 110.634 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 41' ' ' GLU . . . 59.97 63.36 1.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.505 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' SER . 74.9 m -138.3 -172.45 3.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 0.0 110.589 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.302 41.1 t -174.63 162.65 3.4 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.97 -175.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.57 115.66 27.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.439 ' OG ' ' HG2' ' A' ' 49' ' ' GLU . 78.5 p -80.29 -178.93 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.382 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.63 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 73.5 m-85 -58.84 -40.55 84.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 109.928 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 51' ' ' ILE . 5.0 ttp85 -54.93 -47.58 74.24 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE1' HD12 ' A' ' 52' ' ' ILE . 3.0 mm-40 -57.16 -43.67 82.74 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.227 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 21.1 mt -53.21 -33.21 51.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.84 -1.162 . . . . 0.0 108.635 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.1 mt -79.84 -56.31 7.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.57 0.7 . . . . 0.0 109.169 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 ' OE1' ' A' ' 49' ' ' GLU . 65.3 mt -57.42 -52.13 60.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.3 mt-10 -64.57 -40.72 96.05 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -56.87 -44.04 92.34 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.2 mt -65.71 -38.76 90.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -1.072 . . . . 0.0 109.428 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -67.7 -31.19 70.98 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.286 -0.884 . . . . 0.0 108.906 178.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -90.94 -24.43 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.631 -0.668 . . . . 0.0 110.029 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.032 HD11 HD21 ' A' ' 69' ' ' LEU . 10.2 mt -52.49 -30.38 29.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 37.88 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.365 0.602 . . . . 0.0 110.717 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -94.77 -35.65 12.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 110.075 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 1.2 tpt180 71.32 -54.16 0.67 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.839 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 63' ' ' GLY . 3.0 ptpt -63.62 -18.26 63.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.071 -1.018 . . . . 0.0 110.703 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' N ' ' HG3' ' A' ' 62' ' ' LYS . . . 125.5 172.04 13.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 1.004 ' OG ' HD22 ' A' ' 58' ' ' LEU . 19.5 m -147.62 -172.2 3.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 109.951 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.708 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.9 p -134.75 174.4 10.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.0 111.009 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.619 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -51.11 -47.23 88.06 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.661 -0.649 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.6 Cg_endo -69.97 -41.91 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.263 1.139 . . . . 0.0 110.396 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.33 -36.13 65.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' LEU . 4.4 mm? -75.98 -47.11 26.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.9 ' HA ' HD12 ' A' ' 73' ' ' ILE . 93.6 mttt -54.59 -46.61 73.8 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 70' ' ' LYS . 9.4 ttpt -42.01 -56.76 2.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 2.2 t80 -57.59 -42.89 84.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.998 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 32.5 mt -66.02 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 111.476 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.48 -42.51 10.24 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.747 -1.22 . . . . 0.0 111.087 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -95.4 -65.04 1.0 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.061 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.4 m-20 -56.93 -19.64 19.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.877 -1.14 . . . . 0.0 107.969 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.692 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 2.3 m-85 -126.89 175.04 3.59 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.577 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.62 176.55 4.9 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 O-C-N 123.941 1.495 . . . . 0.0 113.841 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 82' ' ' SER . 8.2 mt -52.55 -12.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.96 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.5 p -46.55 -29.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.14 -37.35 7.2 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.875 ' HB3' HG23 ' A' ' 79' ' ' ILE . 4.1 t -72.0 -2.89 19.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.563 -0.963 . . . . 0.0 110.263 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -78.27 -153.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.429 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 86' ' ' PHE . 28.2 m -133.19 -78.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.763 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 43.5 t-20 -40.72 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -0.922 . . . . 0.0 110.331 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.998 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -56.32 -44.98 80.46 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.086 -1.009 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 6.3 p-10 -45.42 -26.89 0.61 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.8 tp -82.28 -30.11 30.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.585 -0.697 . . . . 0.0 109.964 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.5 m-85 -76.45 -42.11 45.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 47.3 t80 -58.29 -42.47 86.68 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -59.04 -57.67 12.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.305 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.9 m-20 -52.21 -38.54 58.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.683 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.23 -41.4 90.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.696 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -62.39 -60.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.752 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -57.29 -37.62 72.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -65.09 -49.84 68.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.44 -0.787 . . . . 0.0 109.775 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -64.51 -51.41 52.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 103' ' ' PHE . 74.4 t -61.56 -40.97 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -1.023 . . . . 0.0 109.813 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 11.9 tp10 -58.52 -34.28 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 109.691 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -86.11 15.58 5.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.745 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 23.96 76.95 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.548 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.6 m-20 -85.1 -68.05 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -1.22 . . . . 0.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -110.28 159.51 17.35 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.905 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 117' ' ' LYS . 24.9 mm-40 -100.13 143.45 30.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.681 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -149.82 98.08 3.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.968 . . . . 0.0 111.014 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 45.1 Cg_endo -74.97 -167.18 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.726 1.382 . . . . 0.0 109.439 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 70.4 mmtt -130.92 -110.36 0.26 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.996 -1.065 . . . . 0.0 110.227 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.31 -154.31 45.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.94 5.16 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.137 1.598 . . . . 0.0 111.388 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -173.23 97.89 0.12 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.284 0.564 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.53 119.51 12.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -100.95 160.62 14.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -1.003 . . . . 0.0 109.907 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.4 p -114.43 121.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.948 -1.095 . . . . 0.0 110.262 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -122.2 125.77 46.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.753 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 22.0 tp -70.61 132.8 46.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.363 -0.835 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 71.64 156.41 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -112.88 143.97 43.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.002 . . . . 0.0 110.321 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.204 0.526 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.68 55.02 1.65 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.429 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -154.36 172.35 17.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.833 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.316 48.4 t -175.56 176.91 1.85 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.804 -175.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 3.3 mtmp? -70.68 124.51 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.431 ' N ' ' OE2' ' A' ' 49' ' ' GLU . 49.1 p -123.96 170.75 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.776 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 97.1 m-85 -63.22 -23.64 67.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.706 . . . . 0.0 110.184 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 10.5 ttm180 -53.71 -46.12 70.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 16.3 mt-10 -57.06 -44.72 83.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.14 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 19.0 mt -51.6 -32.63 29.49 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.789 -1.194 . . . . 0.0 108.304 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 93' ' ' ALA . 11.0 mt -81.54 -55.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.602 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.2 mt -56.57 -52.27 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.1 mt-10 -62.48 -40.96 98.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.32 -45.64 95.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.966 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.5 mt -64.46 -41.25 96.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -1.002 . . . . 0.0 109.551 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -68.01 -28.79 67.72 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 108.832 178.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.55 -20.84 22.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.658 -0.651 . . . . 0.0 109.822 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.4 mt -57.44 -39.32 76.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.487 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.7 mtpt 61.79 22.33 12.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.607 -0.683 . . . . 0.0 110.194 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -120.43 112.31 18.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -77.97 -17.63 56.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -13.2 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.972 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 111.33 169.57 18.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.604 ' OG ' HD22 ' A' ' 58' ' ' LEU . 47.9 m -141.66 172.69 12.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -1.102 . . . . 0.0 109.944 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.5 p -125.69 176.25 7.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -46.53 -47.62 48.5 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 110.98 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -67.46 -42.26 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.634 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.93 -33.71 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -81.08 -51.33 8.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.448 -0.782 . . . . 0.0 109.61 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' NZ ' ' HB3' ' A' ' 87' ' ' ASP . 2.7 mtpt -53.8 -41.54 67.4 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 3.9 tmmm? -47.55 -53.74 13.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.998 0.904 . . . . 0.0 108.733 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.6 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.0 t80 -59.88 -49.66 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.967 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 19.9 mt -63.88 -31.53 53.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.395 -0.815 . . . . 0.0 110.669 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.631 ' HG3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -92.4 -34.97 13.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.085 . . . . 0.0 111.897 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 39.6 mt-10 -98.35 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.701 -1.249 . . . . 0.0 109.461 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.4 m-20 -57.01 -18.97 15.81 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -127.57 174.1 4.68 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.1 Cg_endo -65.8 175.84 4.16 Favored 'Trans proline' 0 C--N 1.281 -2.978 0 O-C-N 124.096 1.577 . . . . 0.0 114.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 82' ' ' SER . 4.0 mt -51.97 -13.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.504 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.59 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.5 p -45.83 -29.84 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -86.54 -38.95 7.94 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.789 ' HB2' HG23 ' A' ' 79' ' ' ILE . 50.0 m -62.51 -29.05 70.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.695 -0.885 . . . . 0.0 110.435 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -59.2 -162.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.435 -0.79 . . . . 0.0 111.409 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -127.11 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.665 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.0 t-20 -39.53 -38.91 0.64 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 0.0 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.967 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -47.12 -39.06 12.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 3.7 p-10 -48.13 -35.03 10.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.5 tp -69.0 -30.9 69.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.21 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 20.2 m-30 -76.84 -45.45 28.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -61.25 -35.17 76.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 65.3 m-20 -63.75 -56.78 12.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.711 . . . . 0.0 109.364 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.2 m-20 -50.12 -37.19 33.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.668 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -67.3 -40.09 86.01 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.218 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.68 HD13 HD13 ' A' ' 51' ' ' ILE . 13.3 mm -63.15 -59.84 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 1.8 mtpt -57.67 -40.36 79.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tppt? -61.41 -47.27 86.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.547 -0.721 . . . . 0.0 109.766 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -68.89 -51.82 27.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 105' ' ' GLN . 48.2 t -61.23 -40.7 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -1.064 . . . . 0.0 110.188 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 10.3 tp10 -60.2 -35.49 75.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 110.033 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.58 16.18 4.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -0.818 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.39 25.5 74.72 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 14.7 m-20 -86.19 -68.37 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 110.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -105.73 179.4 4.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.06 131.08 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.537 ' OE1' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.32 101.66 6.16 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.061 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.1 Cg_endo -83.78 177.57 6.09 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.946 1.498 . . . . 0.0 109.764 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 33.4 mmtm -114.07 -110.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.051 -1.031 . . . . 0.0 110.073 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.17 -157.43 52.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 49.9 Cg_endo -77.58 4.94 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.006 1.53 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -176.4 99.24 0.06 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.315 0.579 . . . . 0.0 110.153 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.09 126.97 12.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -113.47 127.14 55.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -1.134 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.69 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.1 p -81.13 128.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -124.91 132.54 53.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 55' ' ' LEU . 18.5 tp -82.75 113.95 20.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.15 112.51 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.412 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 121.09 25.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.121 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.1 tttt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.202 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 1.3 mm-40 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.246 0.546 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 41' ' ' GLU . . . 62.97 144.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.025 . . . . 0.0 109.645 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -65.75 -168.44 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.626 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.304 37.9 t -174.65 60.4 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.704 -1.199 . . . . 0.0 110.748 -175.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 148.73 29.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 5.1 p -117.29 -179.58 3.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.867 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 -64.73 -32.69 74.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.93 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -50.57 -44.53 56.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' GLU . 4.6 mm-40 -57.53 -43.94 84.75 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.393 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' HD1' ' A' ' 47' ' ' TYR . 46.2 mt -53.03 -31.2 39.97 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.682 -1.261 . . . . 0.0 107.856 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.6 mt -81.95 -55.57 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.58 0.705 . . . . 0.0 109.178 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.597 HG12 ' CE1' ' A' ' 103' ' ' PHE . 59.8 mt -59.27 -55.31 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -58.65 -38.87 79.05 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.43 -48.62 84.01 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.835 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.0 mt -59.2 -36.43 75.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -1.083 . . . . 0.0 109.388 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -37.69 87.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.255 -0.903 . . . . 0.0 108.854 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -91.11 -18.75 24.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.562 -0.712 . . . . 0.0 109.82 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 55' ' ' LEU . 11.1 mt -49.58 -31.77 11.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 109.041 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.3 ptmt 24.22 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.292 0.568 . . . . 0.0 111.564 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 58' ' ' LEU . 2.1 mt-10 -100.54 -115.34 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 172.82 -49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.639 -1.288 . . . . 0.0 110.843 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.72 -22.19 37.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 110.805 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 62' ' ' LYS . . . 138.57 169.14 11.49 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.516 -1.326 . . . . 0.0 109.977 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.592 ' OG ' HD22 ' A' ' 58' ' ' LEU . 74.4 m -139.73 148.84 42.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -1.054 . . . . 0.0 109.5 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.5 p -107.19 178.89 4.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.042 . . . . 0.0 111.094 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -46.67 -47.14 50.73 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.716 -0.615 . . . . 0.0 110.799 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.71 -43.44 5.42 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.113 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.27 -35.15 59.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 108.862 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -79.3 -46.17 18.25 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.8 mtpt -54.59 -40.93 69.31 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.3 ttpt -46.84 -49.72 19.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -65.99 -49.57 67.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.886 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -62.08 -30.35 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.587 ' HB2' ' CA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.06 -42.61 10.4 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.072 -1.018 . . . . 0.0 112.153 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.545 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 10.9 mt-10 -95.82 -65.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 109.849 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.3 m-20 -57.82 -18.96 25.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.814 -1.179 . . . . 0.0 107.902 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 3.0 m-85 -127.82 175.39 3.45 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.563 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.1 Cg_endo -66.18 174.55 5.86 Favored 'Trans proline' 0 C--N 1.282 -2.93 0 O-C-N 123.894 1.47 . . . . 0.0 114.118 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.648 HD12 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.02 -16.18 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.781 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.4 p -44.18 -31.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.46 -35.24 6.64 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.329 -2.308 . . . . 0.0 107.329 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.648 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -84.73 26.32 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.549 -0.971 . . . . 0.0 110.525 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -107.49 -133.66 0.33 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' PHE . 14.7 t -143.53 -83.05 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 0.0 110.831 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 13.1 t-20 -40.91 -28.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.209 -0.932 . . . . 0.0 110.79 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.886 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.9 t80 -52.02 -42.2 62.84 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.461 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.1 t0 -45.55 -30.14 1.38 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.9 tp -76.17 -36.49 58.69 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.921 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 m-85 -71.07 -44.04 66.55 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.103 -0.998 . . . . 0.0 108.379 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 73' ' ' ILE . 73.6 t80 -57.84 -38.52 75.8 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 25.8 m-20 -60.86 -56.13 24.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.559 -0.713 . . . . 0.0 109.449 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.1 m-20 -53.36 -39.0 63.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 109.023 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.03 -38.74 82.88 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.024 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.669 HG21 ' NE2' ' A' ' 105' ' ' GLN . 8.1 mm -64.19 -59.74 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.372 -0.83 . . . . 0.0 109.021 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -59.03 -38.62 79.73 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.341 -0.849 . . . . 0.0 108.853 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.1 tptm -64.46 -47.84 77.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.08 -50.22 53.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.859 HG21 ' HG3' ' A' ' 105' ' ' GLN . 99.5 t -62.35 -45.52 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.367 -1.078 . . . . 0.0 109.737 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 35.9 tp10 -56.77 -33.69 66.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 1.018 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -83.82 12.88 5.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.856 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.0 23.65 77.9 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 1.018 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.2 m-20 -87.34 -67.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.139 -1.213 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.721 ' N ' ' CD1' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.17 159.98 16.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.932 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 21.0 mm-40 -97.27 134.62 40.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.859 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -142.51 98.3 5.94 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 111.415 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo -75.95 -157.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.948 1.499 . . . . 0.0 109.581 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -127.32 -53.45 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.973 -1.079 . . . . 0.0 110.133 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.52 -151.27 0.48 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.95 4.79 5.82 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.242 1.654 . . . . 0.0 111.289 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.31 -94.22 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.878 -0.514 . . . . 0.0 110.122 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 113.84 0.29 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -105.36 159.5 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.153 . . . . 0.0 110.047 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.2 p -121.7 115.02 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.981 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 4.6 mmtt -108.9 143.97 37.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.087 -1.008 . . . . 0.0 109.765 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.835 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.5 tp -89.28 134.04 34.22 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.507 -0.745 . . . . 0.0 110.362 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . -42.34 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -84.96 132.02 34.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 110.211 -179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' C ' ' HE3' ' A' ' 117' ' ' LYS . 1.6 mttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.212 0.53 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' SER . . . -42.05 130.33 3.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 44' ' ' SER . 4.8 p -56.32 -165.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.3 34.5 t -174.69 68.09 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.925 -175.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HE2' ' OH ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -72.5 134.27 45.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.357 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 78.3 p -115.43 174.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 110.223 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 65.4 m-85 -62.17 -39.52 92.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 109.845 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 13.5 ttp180 -52.1 -47.16 65.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' GLU . 24.6 mm-40 -57.16 -44.29 83.32 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 47' ' ' TYR . 74.4 mt -52.21 -32.25 35.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.633 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.764 HD11 ' HB3' ' A' ' 93' ' ' ALA . 12.7 mt -81.7 -56.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.614 HG12 ' CE1' ' A' ' 103' ' ' PHE . 68.7 mt -58.11 -52.29 60.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.9 mt-10 -62.38 -41.22 98.47 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -55.79 -40.7 81.26 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.01 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.5 mt -67.41 -37.04 82.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.457 -1.025 . . . . 0.0 109.559 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -29.5 62.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 108.922 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.8 -22.93 20.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.586 -0.696 . . . . 0.0 110.058 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.01 HD12 ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt -53.12 -40.48 64.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 36.9 43.57 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.622 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -85.11 -83.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.69 -62.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 111.043 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -122.03 -40.94 2.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 111.408 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.18 172.9 32.79 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.232 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.816 ' OG ' HD22 ' A' ' 58' ' ' LEU . 30.9 m -138.25 -179.08 5.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.971 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.571 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 16.7 p -133.37 178.32 7.0 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.131 -0.98 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.629 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -46.81 -46.42 51.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.716 -0.615 . . . . 0.0 111.235 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.14 -42.64 5.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.268 1.141 . . . . 0.0 110.665 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' CD2' ' A' ' 58' ' ' LEU . . . -57.32 -24.75 57.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.949 HD21 HD11 ' A' ' 58' ' ' LEU . 4.0 mm? -92.97 -48.59 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.1 mtpt -58.41 -41.29 84.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -47.97 -51.84 22.12 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.985 0.898 . . . . 0.0 108.806 178.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 t80 -62.22 -48.98 77.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.943 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 46.3 mt -65.17 -29.91 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 8.5 ptpt -92.02 -42.43 9.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.766 -1.209 . . . . 0.0 111.52 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 8.6 mt-10 -95.57 -64.8 1.02 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.477 ' CG ' ' HA ' ' A' ' 72' ' ' PHE . 6.0 m-20 -55.75 -22.01 21.83 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.828 -1.17 . . . . 0.0 107.953 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.79 178.02 1.6 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 177.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.584 ' HG2' HG12 ' A' ' 80' ' ' VAL . 46.1 Cg_endo -68.79 175.62 7.05 Favored 'Trans proline' 0 C--N 1.281 -3.011 0 O-C-N 123.88 1.463 . . . . 0.0 114.231 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.605 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.2 mp -49.71 -15.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.864 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.5 -31.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.35 -37.78 6.51 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -85.21 46.6 1.3 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.79 -0.83 . . . . 0.0 109.455 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.84 178.76 6.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 0.0 110.943 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 85' ' ' ASN . 65.8 m -104.75 156.3 18.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.455 -0.778 . . . . 0.0 109.786 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' SER . 5.7 t-20 76.79 -40.54 0.37 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.427 -0.796 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -48.65 -42.08 33.31 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.657 -1.277 . . . . 0.0 108.192 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.2 p30 -47.23 -36.41 8.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.8 tp -63.46 -34.35 77.58 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.253 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 79.8 m-85 -76.13 -47.88 22.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 51' ' ' ILE . 37.9 t80 -61.2 -36.03 78.77 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 75.0 m-20 -62.51 -56.71 15.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 8.1 m-20 -50.13 -39.18 42.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.165 -0.96 . . . . 0.0 108.499 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.764 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.34 -40.85 98.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 51' ' ' ILE . 13.2 mm -64.19 -59.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 20.6 mtpt -55.41 -37.99 68.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.8 tppt? -65.4 -51.32 61.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -67.94 -47.35 60.73 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 105' ' ' GLN . 98.8 t -63.08 -42.17 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -1.021 . . . . 0.0 110.459 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 5.8 tp10 -61.62 -34.54 75.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.29 15.67 3.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 25.51 74.46 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 3.8 t0 -84.93 -67.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -1.153 . . . . 0.0 110.097 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.18 159.82 16.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.173 -0.954 . . . . 0.0 109.727 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 39.9 mm-40 -97.35 128.46 44.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.168 -0.958 . . . . 0.0 109.206 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.741 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -141.41 109.67 6.26 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.119 -0.988 . . . . 0.0 111.137 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 50.5 Cg_endo -86.87 -158.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.004 1.528 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 1.3 mptp? -135.77 -83.87 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.996 -1.065 . . . . 0.0 110.238 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 44.01 -151.53 0.56 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 48.9 Cg_endo -77.83 4.86 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.279 1.673 . . . . 0.0 111.409 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -179.86 97.36 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.235 0.541 . . . . 0.0 110.137 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.68 120.14 16.02 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -96.51 137.62 35.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.128 . . . . 0.0 109.998 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.3 p -94.31 106.03 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.042 -1.036 . . . . 0.0 110.755 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 0.7 OUTLIER -99.29 128.94 45.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.745 179.095 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.803 ' CB ' HD22 ' A' ' 55' ' ' LEU . 26.2 tp -76.46 116.73 17.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.957 . . . . 0.0 109.705 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . -13.57 78.34 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.308 0.575 . . . . 0.0 112.405 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -115.89 127.43 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.402 -0.812 . . . . 0.0 110.074 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.217 0.532 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.3 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 110.493 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 44' ' ' SER . 5.0 p -134.78 178.85 6.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.307 43.5 t -174.86 132.29 0.33 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.356 -175.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -69.75 161.05 30.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 109.526 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 49' ' ' GLU . 21.3 p -121.65 139.86 53.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.001 -1.062 . . . . 0.0 110.187 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.712 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 71.3 m-85 -50.47 -22.8 2.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.231 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 1.9 ttm180 -57.42 -46.17 83.83 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.3 mt-10 -55.95 -45.27 78.91 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 73' ' ' ILE . 75.7 mt -51.77 -35.3 43.22 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.74 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 103' ' ' PHE . 17.3 mt -79.35 -56.25 7.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.516 0.674 . . . . 0.0 109.374 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.7 mt -56.81 -51.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.8 mm-40 -60.83 -43.46 98.22 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -52.82 -41.85 58.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.3 mt -72.12 -40.34 68.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.649 -0.912 . . . . 0.0 108.678 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 m -67.08 -23.2 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.13 -23.95 21.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 64' ' ' SER . 12.0 mt -57.56 -30.14 64.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.681 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER 68.95 70.86 0.27 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.323 0.582 . . . . 0.0 111.078 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.78 76.59 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.721 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -113.54 154.28 27.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -5.78 21.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.04 167.1 16.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 58' ' ' LEU . 63.0 m -158.79 135.12 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.523 -0.987 . . . . 0.0 109.365 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 17.8 p -88.67 -179.06 5.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.091 -1.006 . . . . 0.0 111.257 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.664 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -51.03 -44.75 87.65 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.701 -0.624 . . . . 0.0 110.774 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.5 Cg_endo -68.68 -43.07 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.314 1.165 . . . . 0.0 109.818 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.98 -30.48 10.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.464 -0.895 . . . . 0.0 108.735 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.545 ' HG ' HG11 ' A' ' 113' ' ' VAL . 3.9 mm? -87.17 -50.85 6.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.775 ' HA ' HD12 ' A' ' 73' ' ' ILE . 88.9 mttt -53.92 -39.23 65.67 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.9 ttpp -51.56 -50.38 60.19 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.571 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.08 -47.95 82.4 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.896 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 17.0 mt -61.42 -33.27 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 110.663 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 43.6 pttt -91.52 -40.26 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 37.8 mt-10 -93.99 -66.11 0.94 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.897 -1.127 . . . . 0.0 110.218 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 25.4 m-20 -58.74 -21.49 55.41 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.68 -1.262 . . . . 0.0 108.077 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.644 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.46 175.0 2.86 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.2 Cg_endo -65.24 174.09 5.44 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 O-C-N 124.179 1.62 . . . . 0.0 113.839 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 6.3 mt -52.46 -12.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.812 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -45.96 -29.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.27 -36.45 7.06 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.339 -2.305 . . . . 0.0 107.339 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.645 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.8 t -73.44 -0.25 14.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.604 -0.939 . . . . 0.0 110.295 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -79.21 -149.34 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.209 -0.932 . . . . 0.0 110.827 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 85' ' ' ASN . 2.7 p -133.72 -79.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 16.3 t-20 -41.64 -35.09 0.69 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.279 -0.888 . . . . 0.0 110.572 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.896 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.3 t80 -48.8 -40.95 31.01 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.902 -1.123 . . . . 0.0 108.339 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 92.5 m-20 -47.11 -26.23 1.05 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 5.7 tp -82.74 -33.75 27.39 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.883 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 30.1 m-85 -71.15 -45.69 63.01 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.301 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 73' ' ' ILE . 81.0 t80 -52.92 -31.95 42.81 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 19.5 m-20 -67.59 -52.29 40.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.538 -0.726 . . . . 0.0 109.433 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -54.23 -40.38 67.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 108.992 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -65.81 -37.28 85.84 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.948 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.701 HG23 ' HG3' ' A' ' 105' ' ' GLN . 9.6 mm -64.08 -59.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 108.865 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.43 -40.95 79.51 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -61.44 -45.33 94.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.781 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.63 -51.26 12.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 103' ' ' PHE . 92.5 t -61.86 -38.61 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.6 tp10 -58.49 -39.19 79.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.15 13.26 4.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.529 -0.732 . . . . 0.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.15 23.5 77.51 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 2.3 m-20 -83.11 -67.96 0.75 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -109.0 166.16 11.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 56.8 mm-40 -109.55 136.65 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 94' ' ' ILE . 6.0 mm-40 -146.28 107.16 4.16 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.034 -1.041 . . . . 0.0 111.435 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.532 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 51.6 Cg_endo -77.97 -166.37 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.89 1.469 . . . . 0.0 109.0 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 1.9 mptp? -133.45 -86.32 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.021 -1.049 . . . . 0.0 110.8 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 45.64 -155.96 0.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 47.9 Cg_endo -77.55 4.39 6.02 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.958 1.504 . . . . 0.0 111.139 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -179.52 99.6 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.289 0.566 . . . . 0.0 110.053 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.71 149.14 23.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.97 138.25 54.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.159 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.545 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -82.17 117.57 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 111.041 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -111.12 132.9 53.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 55' ' ' LEU . 17.7 tp -73.56 141.51 46.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 102' ' ' ASP . . . -55.63 84.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.398 -0.814 . . . . 0.0 110.087 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -99.62 145.14 27.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 110.371 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.25 152.94 38.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.254 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 44' ' ' SER . 35.3 t -104.66 48.94 0.82 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.345 -0.847 . . . . 0.0 110.827 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.296 28.8 t 50.83 -176.0 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.101 175.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -85.01 155.33 21.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 p -131.82 152.4 51.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.242 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.822 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 92.1 m-85 -53.76 -22.26 8.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.323 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 52' ' ' ILE 0.25 7.0 ttp180 -51.43 -44.15 62.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 5.0 mt-10 -56.76 -46.77 81.22 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.2 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.672 HD22 HG23 ' A' ' 73' ' ' ILE . 14.9 mt -52.07 -34.78 45.22 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.482 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 94' ' ' ILE . 3.3 mt -75.85 -56.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 109.393 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' CE1' ' A' ' 103' ' ' PHE . 25.3 mt -59.65 -54.07 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.907 0.86 . . . . 0.0 108.738 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 8.0 mt-10 -60.33 -35.68 76.2 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.775 0.798 . . . . 0.0 108.905 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -64.49 -49.71 63.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -59.65 -42.0 91.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -1.085 . . . . 0.0 109.303 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -66.1 -31.48 72.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.268 -0.895 . . . . 0.0 109.085 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.653 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.92 -15.35 29.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 HD21 ' A' ' 69' ' ' LEU . 12.3 mt -59.73 -42.47 93.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 70.99 14.57 6.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.846 -0.533 . . . . 0.0 110.392 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.67 159.47 15.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.17 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.12 -8.86 8.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -100.92 -25.58 14.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 135.47 168.66 11.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' HD13 ' A' ' 58' ' ' LEU . 16.4 m -142.99 -177.28 5.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -1.076 . . . . 0.0 109.834 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.658 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 8.2 p -135.02 174.76 10.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.129 -0.982 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 ttp180 -45.34 -47.74 34.55 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.692 -0.63 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.2 Cg_endo -66.45 -42.81 9.08 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.14 1.074 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -59.89 -34.33 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.651 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.959 HD21 HD11 ' A' ' 58' ' ' LEU . 4.2 mm? -80.92 -51.59 8.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -49.38 -38.23 27.81 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.303 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.81 -53.86 35.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 1.8 t80 -60.78 -46.17 91.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.722 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 8.3 mt -64.15 -31.44 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.235 -0.915 . . . . 0.0 110.635 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' N ' ' A' ' 82' ' ' SER . 1.1 ptpt -92.1 -38.78 11.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.932 -1.105 . . . . 0.0 110.888 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.558 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 16.5 mt-10 -95.36 -64.88 1.02 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.807 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 11.4 m120 -58.64 -17.94 26.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -128.0 176.7 2.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.0 Cg_endo -67.16 175.68 5.46 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 O-C-N 124.021 1.537 . . . . 0.0 113.764 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 82' ' ' SER . 11.6 mt -52.39 -12.7 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.004 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.9 p -46.34 -30.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.05 -36.77 8.13 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 107.184 -2.366 . . . . 0.0 107.184 176.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB3' HG23 ' A' ' 79' ' ' ILE . 3.1 t -74.44 1.82 10.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.653 -0.91 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -84.79 -150.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.165 -0.959 . . . . 0.0 110.914 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' ASN . 31.0 t -134.18 -80.8 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.246 -0.909 . . . . 0.0 110.759 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' SER . 45.5 t-20 -39.19 -34.48 0.18 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.23 -0.919 . . . . 0.0 110.417 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -48.69 -40.29 27.64 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.437 178.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 50.5 t0 -48.11 -30.68 4.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.862 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.32 -28.69 59.76 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.193 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.609 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 12.4 m-85 -76.18 -46.14 29.9 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.618 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.9 t80 -57.72 -38.31 75.05 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 26.0 m-20 -60.04 -55.29 35.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.514 -0.741 . . . . 0.0 109.331 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.5 m-20 -56.13 -41.39 75.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.345 -0.847 . . . . 0.0 109.201 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.822 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -64.32 -40.12 95.26 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.09 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 51' ' ' ILE . 6.7 mm -60.93 -59.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 108.677 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -57.32 -41.41 79.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.3 tppp? -59.43 -47.8 84.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.614 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -69.5 -52.94 18.88 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.911 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.1 t -60.64 -39.6 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.524 -0.986 . . . . 0.0 110.376 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.1 tp10 -64.44 -34.13 77.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.787 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . . . -82.44 11.79 5.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.912 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 22.73 78.75 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.704 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -85.9 -67.65 0.79 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.231 -1.158 . . . . 0.0 110.14 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -100.87 178.67 4.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 109.663 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -120.2 126.5 50.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.911 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -136.01 128.0 17.41 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.993 . . . . 0.0 110.514 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 51.8 Cg_endo -86.2 -156.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.776 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 106' ' ' PRO . 9.9 mmtm -161.26 110.23 1.58 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.273 -0.892 . . . . 0.0 109.147 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.15 -149.52 6.55 Favored Glycine 0 C--N 1.286 -2.233 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.27 4.78 5.58 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.256 1.661 . . . . 0.0 111.325 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.0 78.5 0.59 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.316 0.579 . . . . 0.0 109.966 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.05 128.48 47.74 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' O ' ' CD ' ' A' ' 106' ' ' PRO . . . -121.39 153.1 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -1.074 . . . . 0.0 109.913 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.458 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.1 p -120.07 115.02 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.679 -1.263 . . . . 0.0 110.458 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 4.0 mtmp? -108.27 124.81 50.88 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.959 HD13 ' N ' ' A' ' 116' ' ' ALA . 2.6 tm? -73.62 137.6 44.32 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.378 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.959 ' N ' HD13 ' A' ' 115' ' ' LEU . . . -176.3 98.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 110.299 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -95.0 109.47 21.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.13 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 pttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.261 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 31.8 tt0 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 124.29 21.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 0.0 110.178 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.84 49.73 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.298 28.0 t 50.8 -174.66 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.007 175.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -64.32 130.55 44.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.475 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 58.7 p -131.53 -179.27 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.414 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 -66.76 -36.56 82.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.758 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -50.96 -45.64 60.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.07 -45.05 83.59 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.177 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.724 HD12 ' HD1' ' A' ' 47' ' ' TYR . 94.8 mt -52.29 -31.97 35.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.82 -1.175 . . . . 0.0 108.448 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.7 mt -82.16 -54.69 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.758 HD11 ' HD3' ' A' ' 48' ' ' ARG . 64.0 mt -58.42 -52.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 11.4 mt-10 -62.36 -38.62 90.25 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.768 0.794 . . . . 0.0 109.052 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -62.66 -45.94 94.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.068 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.8 mt -59.74 -37.2 78.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -1.101 . . . . 0.0 109.629 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -74.27 -28.31 61.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.028 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.83 -11.12 40.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.607 -0.683 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.068 HD12 ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt -68.14 -53.37 25.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 110.111 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 66.87 39.17 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.025 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -92.78 -167.39 1.73 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.459 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -127.18 -58.97 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.682 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -81.2 -40.38 23.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.18 168.38 31.11 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.746 ' OG ' HD13 ' A' ' 58' ' ' LEU . 72.2 m -114.96 -177.72 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -1.048 . . . . 0.0 109.562 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.677 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 37.1 p -134.84 173.53 11.6 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.447 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.632 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -49.83 -45.8 80.26 Favored Pre-proline 0 C--N 1.299 -1.597 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.956 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.3 Cg_endo -70.41 -42.77 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.354 1.186 . . . . 0.0 110.281 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.42 -24.44 30.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.751 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 58' ' ' LEU . 4.1 mm? -90.89 -51.1 5.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.75 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 73' ' ' ILE . 89.8 mttt -59.31 -36.96 76.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.55 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 3.4 ttpt -55.88 -51.08 68.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.83 -46.7 87.06 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.904 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 18.6 mt -63.05 -33.97 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.587 -0.696 . . . . 0.0 111.169 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 82' ' ' SER . 17.1 ptmt -91.43 -42.14 10.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.85 -1.157 . . . . 0.0 111.435 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 15.6 mt-10 -94.43 -65.06 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 109.875 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 24.2 m-20 -56.7 -23.82 44.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.807 -1.183 . . . . 0.0 108.094 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -122.76 178.19 1.38 Allowed Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.581 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.3 Cg_endo -65.67 176.66 3.36 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 O-C-N 123.996 1.524 . . . . 0.0 114.414 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.21 -12.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.72 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.5 p -45.81 -29.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.94 -35.78 7.53 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HG23 ' A' ' 79' ' ' ILE . 40.7 t -57.23 -40.46 77.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.571 -0.958 . . . . 0.0 110.317 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.33 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.738 . . . . 0.0 110.838 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 12.4 t -122.75 -64.38 1.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 110.472 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 7.1 m120 -43.98 -37.2 2.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.904 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.1 t80 -48.38 -42.27 31.32 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.155 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -44.75 -29.69 0.82 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.9 tp -78.33 -35.08 48.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.231 0.539 . . . . 0.0 109.667 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.694 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 6.2 m-85 -69.15 -46.3 67.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.13 -0.981 . . . . 0.0 108.666 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.822 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 54.1 t80 -57.58 -36.19 71.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 16.7 m-20 -60.23 -55.13 37.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.075 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.7 m-20 -55.43 -39.78 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 108.875 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.666 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.62 -40.63 95.82 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -63.07 -57.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 3.3 mtmm -60.12 -35.54 75.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -67.87 -53.4 26.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.48 -0.763 . . . . 0.0 109.651 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -61.65 -46.7 93.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' A' ' 105' ' ' GLN . 79.2 t -65.42 -46.2 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 7.9 tp10 -58.92 -33.47 70.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 109.874 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.28 13.49 4.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.32 24.19 76.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 4.2 t0 -87.06 -67.25 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.224 -1.162 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.46 159.97 16.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.024 . . . . 0.0 110.1 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 117' ' ' LYS . 6.9 mm-40 -97.54 128.76 44.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 109.754 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.758 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -144.05 98.82 5.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.962 . . . . 0.0 111.234 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.3 Cg_endo -76.26 -148.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.186 1.624 . . . . 0.0 108.965 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -149.07 105.79 3.56 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.627 -1.296 . . . . 0.0 109.348 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.09 -146.52 6.15 Favored Glycine 0 C--N 1.283 -2.382 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.26 4.88 6.2 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.348 1.709 . . . . 0.0 111.345 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 111' ' ' GLY . . . -170.86 21.92 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.822 -0.549 . . . . 0.0 111.118 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 110' ' ' ALA . . . 36.87 91.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -81.65 125.72 30.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -1.202 . . . . 0.0 109.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.3 p -92.18 133.76 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.862 -1.149 . . . . 0.0 110.962 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -126.82 124.18 39.06 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.352 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.796 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 tp -67.43 151.03 48.12 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 74.07 157.06 0.18 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.057 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HA ' ' CG ' ' A' ' 104' ' ' GLU . 5.5 ptpp? -115.01 143.96 44.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.348 0.594 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.94 70.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 44' ' ' SER . 4.1 t -119.84 41.1 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.958 . . . . 0.0 110.772 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.3 23.1 t 50.59 -178.96 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.057 175.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -89.67 159.96 16.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 6.0 p -130.58 178.23 6.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.105 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 71.2 m-85 -62.46 -30.06 70.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 3.2 ttm180 -55.64 -44.15 76.88 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 mm-40 -58.57 -43.24 89.35 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.199 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.59 HD22 HG23 ' A' ' 73' ' ' ILE . 36.4 mt -51.74 -32.22 29.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.588 -1.32 . . . . 0.0 107.636 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 93' ' ' ALA . 10.1 mt -82.34 -53.95 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.8 mt -58.72 -54.55 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.3 mt-10 -59.33 -38.89 81.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -57.83 -48.02 84.9 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.753 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.9 mt -66.86 -49.03 66.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.65 -0.912 . . . . 0.0 108.756 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -60.35 -24.86 65.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.49 -22.63 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.703 HD11 HD21 ' A' ' 69' ' ' LEU . 11.7 mt -60.5 -26.64 66.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 109.259 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 3.1 mtpt 70.37 70.16 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.253 0.549 . . . . 0.0 110.751 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 1.1 tp10 61.69 -118.6 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 72.23 149.2 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.969 -1.082 . . . . 0.0 110.329 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -13.67 50.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 110.585 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.25 169.48 18.4 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 10.3 m -141.98 155.13 45.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -1.045 . . . . 0.0 109.686 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.2 p -99.71 172.05 7.51 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.041 -1.037 . . . . 0.0 111.202 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.63 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -45.96 -48.07 41.52 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.823 -0.548 . . . . 0.0 110.801 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.8 Cg_endo -67.32 -42.7 7.1 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.214 1.113 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.62 -28.36 20.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.279 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.703 HD21 HD11 ' A' ' 58' ' ' LEU . 4.6 mm? -86.7 -48.84 7.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.573 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.902 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -52.02 -43.32 63.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 6.2 ttpt -47.19 -53.52 12.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.61 -46.92 85.99 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.96 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 13.9 mt -63.54 -33.91 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.823 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.65 -40.29 11.38 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.977 -1.077 . . . . 0.0 111.458 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 11.4 mt-10 -95.59 -65.42 0.98 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.055 -1.028 . . . . 0.0 109.729 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.3 m-20 -56.5 -21.52 26.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.076 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.7 177.74 1.78 Allowed Pre-proline 0 C--N 1.309 -1.158 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.559 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.2 Cg_endo -67.99 177.14 4.57 Favored 'Trans proline' 0 C--N 1.282 -2.939 0 O-C-N 123.925 1.487 . . . . 0.0 113.755 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.614 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 13.0 mt -52.72 -12.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.812 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.602 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.2 p -45.97 -30.38 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.46 -37.15 6.66 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 106.591 -2.603 . . . . 0.0 106.591 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -83.33 37.01 0.54 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.752 -0.852 . . . . 0.0 110.078 178.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.88 -137.27 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.988 . . . . 0.0 110.493 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' PHE . 16.5 p -139.13 -88.73 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.005 . . . . 0.0 111.106 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' OD1' ' CZ ' ' A' ' 89' ' ' TYR . 6.0 t-20 -35.62 -30.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.695 . . . . 0.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.96 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 2.1 t80 -54.19 -44.07 71.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.939 -1.1 . . . . 0.0 108.684 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.4 m-20 -46.96 -26.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.781 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.1 tp -80.94 -29.13 35.52 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.786 -0.765 . . . . 0.0 109.724 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.636 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 22.5 m-85 -77.33 -44.51 29.28 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.153 -0.967 . . . . 0.0 108.732 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.602 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.1 t80 -60.25 -46.37 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.359 -0.838 . . . . 0.0 108.822 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 3.5 m-80 -55.04 -57.5 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.27 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 m-20 -54.58 -42.27 70.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.09 -40.49 97.8 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 51' ' ' ILE . 8.5 mm -61.06 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.477 -0.765 . . . . 0.0 108.993 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -56.53 -37.95 71.17 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.588 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 23.9 tptp -65.51 -51.37 60.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.541 -0.724 . . . . 0.0 109.491 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.82 -49.93 64.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 54.1 t -50.71 -23.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -1.037 . . . . 0.0 109.372 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -93.33 -49.2 6.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.56 5.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 0.0 109.926 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -69.15 -9.21 60.0 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 m-20 66.79 37.14 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.861 -0.788 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' A' ' 97' ' ' GLY . 3.9 m-30 -87.08 146.63 26.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 109.821 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 23.8 mm-40 -97.44 124.73 41.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 108.892 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -144.63 98.48 4.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 110.897 -179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.4 Cg_endo -78.12 178.58 7.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.653 1.344 . . . . 0.0 109.7 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 5.0 mptp? -118.19 -92.51 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 110.282 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.67 -156.59 7.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.73 5.3 5.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.142 1.601 . . . . 0.0 111.572 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -170.75 100.5 0.23 Allowed 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.389 0.614 . . . . 0.0 110.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 133.26 12.11 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -117.71 160.36 21.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 109.603 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.3 p -110.66 124.23 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.629 -1.294 . . . . 0.0 110.32 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.69 132.63 53.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.918 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 55' ' ' LEU . 12.2 tp -76.06 98.3 4.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.654 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 63.71 160.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 109.728 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -109.4 111.13 22.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.096 -1.003 . . . . 0.0 110.299 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.272 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.21 0.529 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.93 57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.12 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' SER . 6.3 t 56.3 -165.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.31 -0.869 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.302 33.1 t -174.3 86.69 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.941 -175.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 48.0 mttm -90.7 126.86 36.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 17.9 p -118.2 149.82 40.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.036 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 29.8 m-85 -54.9 -33.51 62.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 0.0 109.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' A' ' 52' ' ' ILE . 4.1 ttt180 -61.14 -45.47 94.53 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 53' ' ' GLU . 55.1 mt-10 -58.38 -43.97 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 50' ' ' LEU . 46.6 mt -51.38 -34.09 32.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.688 -1.257 . . . . 0.0 108.311 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.66 HG21 ' CD2' ' A' ' 103' ' ' PHE . 30.2 mt -79.83 -55.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' A' ' 48' ' ' ARG . 60.2 mt -58.63 -53.98 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -61.17 -40.28 93.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.89 -47.74 84.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 8.2 mt -67.05 -49.87 63.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.937 . . . . 0.0 108.521 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 2.6 m -55.45 -24.39 30.56 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.78 -27.27 19.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 13.2 mt -52.39 -22.75 4.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -0.94 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 63.71 30.99 14.63 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.131 0.491 . . . . 0.0 110.913 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 61' ' ' ARG . 2.8 mt-10 57.33 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.516 -0.74 . . . . 0.0 110.972 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 176.26 -121.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 0.0 109.457 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 62' ' ' LYS . 1.7 ttmm -116.7 12.1 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 109.738 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.3 165.73 14.76 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.606 ' OG ' HD13 ' A' ' 58' ' ' LEU . 68.1 m -138.27 176.98 8.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -1.06 . . . . 0.0 109.649 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.692 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 20.5 p -131.26 174.51 9.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 111.237 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.635 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 tpp180 -48.07 -46.31 65.01 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.872 -0.517 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.7 Cg_endo -70.4 -43.15 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.229 1.12 . . . . 0.0 110.59 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.19 -31.9 61.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 65' ' ' SER . 3.6 mm? -78.45 -53.86 6.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.119 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.829 ' HA ' HD12 ' A' ' 73' ' ' ILE . 77.0 mttt -50.01 -36.41 28.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.65 -50.94 59.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.582 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.7 t80 -63.46 -45.93 88.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.87 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -63.77 -32.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.418 -0.801 . . . . 0.0 110.757 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 35.2 pttt -91.2 -41.38 11.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.095 -1.003 . . . . 0.0 111.494 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.572 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 34.2 mt-10 -93.83 -65.14 1.01 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.945 -1.097 . . . . 0.0 109.668 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.9 m-20 -59.94 -15.68 23.92 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.857 -1.152 . . . . 0.0 108.632 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.641 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -130.88 176.93 2.5 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.19 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.2 Cg_endo -65.74 173.63 6.57 Favored 'Trans proline' 0 C--N 1.283 -2.904 0 O-C-N 123.968 1.509 . . . . 0.0 113.594 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.621 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 3.1 mt -52.75 -12.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.882 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p -45.63 -30.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.28 -37.32 6.7 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -80.95 45.5 0.83 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.66 -0.906 . . . . 0.0 110.367 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.06 -138.18 0.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 1.9 t -141.46 -77.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.986 -1.071 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 20.1 t-20 -41.95 -36.93 1.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -1.0 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.87 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.35 -42.01 61.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.838 -1.163 . . . . 0.0 108.62 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.2 t0 -46.17 -27.31 0.95 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.18 -33.28 33.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.841 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.3 m-85 -71.92 -43.34 65.46 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.205 -0.934 . . . . 0.0 108.949 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' A' ' 51' ' ' ILE . 68.6 t80 -58.46 -38.82 78.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 13.2 m-80 -61.53 -55.4 31.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.666 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.4 m-20 -50.14 -39.2 42.54 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.396 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.11 -38.61 79.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 98' ' ' VAL . 10.1 mm -62.58 -60.55 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -39.17 73.81 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.291 -0.881 . . . . 0.0 108.644 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 16.8 tptt -66.78 -51.23 58.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.58 -49.56 68.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 94' ' ' ILE . 62.0 t -51.17 -25.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.472 -1.017 . . . . 0.0 109.369 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -90.5 -49.45 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.592 -0.693 . . . . 0.0 110.543 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.83 -32.58 5.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -67.56 -9.93 56.57 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.6 t0 69.3 37.37 2.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.642 -0.916 . . . . 0.0 110.992 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -89.18 144.75 25.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.137 . . . . 0.0 109.398 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 117' ' ' LYS . 23.9 mm-40 -97.43 126.66 42.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.14 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.613 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -143.55 124.33 7.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.842 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.3 Cg_endo -85.23 -164.84 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.805 1.424 . . . . 0.0 109.552 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -137.56 -3.7 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 111.516 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 107' ' ' LYS . . . -52.52 -167.09 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.46 4.94 4.54 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.887 1.467 . . . . 0.0 111.617 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' GLY . . . -131.97 64.68 1.59 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.408 0.623 . . . . 0.0 109.675 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 110' ' ' ALA . . . -43.61 113.61 0.75 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.613 ' O ' ' NE2' ' A' ' 105' ' ' GLN . . . -120.21 146.99 45.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -1.096 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.463 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -116.88 117.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.77 -1.207 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 23.5 mtpt -112.95 128.0 56.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 55' ' ' LEU . 16.6 tp -68.35 101.81 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.278 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 115' ' ' LEU . . . 39.74 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 110.602 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -68.35 95.75 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.96 . . . . 0.0 110.078 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 tttt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.222 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.214 0.531 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 43' ' ' SER . . . -163.4 170.08 18.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 110.197 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -58.14 -157.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.808 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.295 30.2 t -173.71 54.29 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.941 -175.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -103.2 149.15 24.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.833 . . . . 0.0 109.963 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -120.84 171.73 8.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 110.492 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 75.0 m-85 -57.84 -24.42 57.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.06 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -52.76 -45.57 67.13 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -57.86 -45.48 86.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.347 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.512 HD12 ' HD1' ' A' ' 47' ' ' TYR . 74.7 mt -51.44 -32.38 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.799 -1.188 . . . . 0.0 108.392 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 94' ' ' ILE . 50.8 mt -82.72 -55.12 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 ' CE1' ' A' ' 103' ' ' PHE . 56.1 mt -57.49 -53.59 42.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.5 mt-10 -60.14 -39.95 88.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.599 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.03 -44.17 96.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.991 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -64.35 -39.13 93.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.5 -1.0 . . . . 0.0 109.553 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -71.65 -27.82 63.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 108.64 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.78 -19.72 23.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.619 -0.676 . . . . 0.0 109.77 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.991 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.9 mt -57.92 -40.78 81.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.326 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.4 mtpp 63.57 67.25 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.733 -0.605 . . . . 0.0 110.398 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 11.6 mt-10 -148.84 -44.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.953 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER 68.77 2.31 3.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 111.137 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.49 -19.76 12.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.997 -1.064 . . . . 0.0 109.977 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 114' ' ' LYS . . . 133.22 163.91 10.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.601 ' OG ' HD22 ' A' ' 58' ' ' LEU . 9.0 m -148.99 -170.13 3.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.698 -0.884 . . . . 0.0 109.687 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.612 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p -133.69 171.06 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.923 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.3 ttp85 -46.14 -47.77 43.82 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.74 -43.23 5.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.258 1.136 . . . . 0.0 110.861 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.52 -20.63 13.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.941 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -93.17 -45.22 7.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.16 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.44 -44.15 84.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 2.4 ttpt -47.2 -49.7 22.33 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.5 t80 -64.71 -49.04 72.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.56 -0.712 . . . . 0.0 109.283 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 15.9 mt -60.82 -31.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 111.013 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.26 -41.83 10.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.079 -1.013 . . . . 0.0 111.732 -178.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 22.3 mt-10 -95.73 -65.55 0.97 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.926 -1.109 . . . . 0.0 110.055 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 97.5 m-20 -56.87 -22.01 33.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.827 -1.171 . . . . 0.0 107.916 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.3 m-85 -123.84 175.85 2.59 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.58 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.9 Cg_endo -66.69 175.56 5.17 Favored 'Trans proline' 0 C--N 1.28 -3.041 0 O-C-N 124.016 1.535 . . . . 0.0 114.069 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.57 -14.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.021 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.619 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 4.0 p -45.58 -30.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.16 -35.27 7.14 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -84.19 21.69 1.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.741 -0.858 . . . . 0.0 110.244 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -101.86 -140.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 0.0 110.571 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 1.3 p -135.86 -87.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.937 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.4 m120 -39.86 -26.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 0.0 111.092 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.906 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.46 -42.83 61.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.829 -1.169 . . . . 0.0 108.55 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 70' ' ' LYS . 2.0 m-20 -46.52 -29.79 1.94 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.86 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -77.19 -32.25 55.93 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.93 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 17.4 m-85 -75.53 -43.29 49.59 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.952 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.642 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 67.0 t80 -60.97 -43.95 98.05 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.671 -0.811 . . . . 0.0 108.963 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.8 m-20 -56.48 -58.39 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.778 . . . . 0.0 109.23 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.6 m-20 -53.56 -38.36 63.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 108.928 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.88 -35.04 74.35 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.298 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.651 ' HA ' HD13 ' A' ' 51' ' ' ILE . 7.1 mm -67.53 -59.68 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.96 -38.22 75.6 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.5 tppt? -60.91 -47.67 85.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.99 -51.4 34.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 105' ' ' GLN . 70.4 t -63.01 -42.43 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.456 -1.026 . . . . 0.0 110.262 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 21.9 tp10 -61.4 -35.35 77.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.153 -0.967 . . . . 0.0 109.815 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.46 11.44 4.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.82 23.59 77.78 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.518 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 1.1 t0 -85.35 -65.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -1.136 . . . . 0.0 110.167 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -99.81 -169.87 1.81 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.208 -0.932 . . . . 0.0 109.742 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' LYS . 34.9 mm-40 -129.66 125.09 35.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.7 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 98' ' ' VAL . 5.8 mt-30 -138.26 130.6 16.12 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 110.379 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -82.96 -160.8 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.89 1.468 . . . . 0.0 109.507 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 1.2 mmtt -158.41 109.92 2.2 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.217 -0.927 . . . . 0.0 109.199 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.17 7.45 Favored Glycine 0 C--N 1.284 -2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.52 5.04 5.46 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.326 1.698 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.09 87.05 1.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 121.321 0.581 . . . . 0.0 110.189 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.44 121.38 8.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.538 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -119.18 160.36 22.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -1.136 . . . . 0.0 109.79 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -128.24 122.14 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.785 -1.197 . . . . 0.0 111.052 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.528 ' CG ' ' HA2' ' A' ' 63' ' ' GLY . 33.1 mtpt -116.35 124.38 49.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.838 . . . . 0.0 109.486 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 55' ' ' LEU . 3.1 tm? -76.19 110.09 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . 166.82 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 110.504 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -115.1 123.52 49.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.404 -0.81 . . . . 0.0 109.805 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.289 -179.825 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 32.0 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 41' ' ' GLU . . . 56.63 172.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.3 p -131.38 36.91 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.742 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.287 22.3 t 53.33 167.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.198 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.61 99.46 6.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 110.122 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 33.2 p -132.9 148.06 52.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.134 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 76.8 m-85 -52.84 -26.61 15.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 109.193 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 52' ' ' ILE . 18.6 ttp180 -51.89 -44.11 63.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' GLU . 9.2 mt-10 -57.95 -43.92 86.68 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.508 HD22 HG23 ' A' ' 73' ' ' ILE . 31.1 mt -52.82 -31.95 41.57 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.551 -1.343 . . . . 0.0 107.859 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 93' ' ' ALA . 2.9 mt -82.77 -55.27 7.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 ' CE1' ' A' ' 103' ' ' PHE . 69.9 mt -58.03 -53.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.5 mt-10 -61.39 -40.09 93.09 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -57.21 -47.55 86.87 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.8 mt -65.61 -39.58 91.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.691 -0.888 . . . . 0.0 109.157 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 m -68.67 -29.27 67.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.196 -0.94 . . . . 0.0 108.609 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.64 -19.71 23.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.611 -0.681 . . . . 0.0 109.868 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.983 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.2 mt -58.71 -35.44 72.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.412 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 66.72 44.16 2.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.799 -0.563 . . . . 0.0 110.305 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HG3' ' C ' ' A' ' 59' ' ' LYS . 33.8 mt-10 -154.36 153.21 31.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -114.58 -19.49 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.148 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 1.2 ptpp? -63.94 -18.42 64.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.534 ' CA ' ' HG2' ' A' ' 114' ' ' LYS . . . 117.52 167.23 14.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.574 ' OG ' HD22 ' A' ' 58' ' ' LEU . 5.6 m -139.09 -169.3 2.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.718 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 12.0 p -135.6 172.78 12.52 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.192 -0.943 . . . . 0.0 111.243 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -48.71 -48.43 69.7 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.737 -0.602 . . . . 0.0 110.972 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -67.64 -42.47 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.301 1.158 . . . . 0.0 110.358 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.37 -25.75 50.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -91.17 -48.71 6.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.991 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -55.19 -47.67 74.91 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 9.0 ttpt -42.51 -53.68 4.23 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.57 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.72 -42.26 99.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.871 -0.518 . . . . 0.0 109.668 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 24.4 mt -64.38 -33.26 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.164 -0.96 . . . . 0.0 111.526 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.547 ' HG2' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -88.14 -44.6 10.79 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.836 -1.165 . . . . 0.0 111.252 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -96.8 -64.98 1.0 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 110.333 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 30.0 m-20 -53.81 -22.44 9.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.716 -1.24 . . . . 0.0 107.704 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.64 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -125.32 174.99 3.37 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HG2' HG12 ' A' ' 80' ' ' VAL . 51.5 Cg_endo -70.88 179.43 4.31 Favored 'Trans proline' 0 C--N 1.279 -3.085 0 O-C-N 123.923 1.486 . . . . 0.0 114.38 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.599 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -50.68 -15.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.073 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.601 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 2.6 p -44.89 -31.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.73 -42.15 5.48 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -85.98 44.68 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.683 -0.892 . . . . 0.0 109.618 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -116.56 -103.46 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -170.16 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.846 -1.158 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -45.63 -22.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.734 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 1.012 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.36 -44.49 62.11 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.878 -1.139 . . . . 0.0 108.607 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -45.98 -27.23 0.86 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.55 -30.65 33.03 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.829 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.618 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 18.5 m-85 -76.03 -43.56 43.43 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.66 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.65 ' CE1' HD11 ' A' ' 73' ' ' ILE . 76.4 t80 -56.47 -41.53 76.72 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.9 m-20 -57.35 -58.95 6.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 6.2 m-20 -54.75 -40.42 69.33 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.511 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.6 -44.8 92.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.563 -0.711 . . . . 0.0 109.159 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 98' ' ' VAL . 8.1 mm -62.21 -58.19 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.4 -37.18 72.31 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -66.0 -52.43 49.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.64 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -61.99 -48.04 86.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' ILE . 43.7 t -64.27 -44.55 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.464 -1.021 . . . . 0.0 109.989 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.9 tp10 -61.29 -36.13 79.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.34 4.81 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.122 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.45 19.57 77.97 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 6.5 m-20 -85.06 -66.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -1.204 . . . . 0.0 110.138 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.9 174.35 5.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 23.2 mm-40 -117.69 133.83 55.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.28 -0.887 . . . . 0.0 109.757 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.62 ' NE2' HG21 ' A' ' 94' ' ' ILE . 1.3 mm100 -140.67 100.13 6.78 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.98 . . . . 0.0 111.174 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.5 Cg_endo -84.05 -158.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.968 1.509 . . . . 0.0 109.398 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 47.9 mmtm -144.42 -94.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.48 -149.96 31.29 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.75 5.11 5.49 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.234 1.65 . . . . 0.0 111.498 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -176.73 100.47 0.06 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.3 0.571 . . . . 0.0 110.028 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.78 132.37 19.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.96 124.81 42.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 110.731 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 2.4 p -80.11 119.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 8.7 mtpt -113.29 125.65 54.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.826 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -81.51 141.22 34.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' N ' ' HG ' ' A' ' 115' ' ' LEU . . . -138.09 -160.36 1.05 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.356 -0.84 . . . . 0.0 109.806 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 123.35 12.33 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.18 -179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.228 0.537 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 156.27 29.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.942 . . . . 0.0 110.25 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.5 OUTLIER -83.0 -166.89 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.217 -0.927 . . . . 0.0 110.583 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.299 33.6 t -174.13 103.15 0.11 Allowed 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.068 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 9.2 ttpt -83.43 126.02 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.904 . . . . 0.0 110.031 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 87.7 p -118.07 162.8 17.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.722 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.7 m-85 -57.19 -27.96 62.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HD2' ' CA ' ' A' ' 97' ' ' GLY 0.25 0.0 OUTLIER -53.04 -44.7 67.58 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.553 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 15.6 mt-10 -56.91 -46.73 81.76 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.202 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 47' ' ' TYR . 51.6 mt -49.72 -32.81 14.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.865 -1.147 . . . . 0.0 107.992 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.88 -56.14 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.387 0.613 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 mt -58.0 -51.0 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.47 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -63.43 -38.55 91.58 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.625 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.16 -44.68 96.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 115' ' ' LEU . 5.2 mt -65.03 -36.82 85.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.6 -0.941 . . . . 0.0 108.999 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.418 ' HG1' ' H ' ' A' ' 56' ' ' THR . 1.1 m -65.45 -30.66 71.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -91.38 -19.05 23.32 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.313 0.578 . . . . 0.0 109.769 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.836 HD11 HD21 ' A' ' 69' ' ' LEU . 10.1 mt -57.11 -18.3 14.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.159 -0.963 . . . . 0.0 109.219 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 1.6 mmmt 81.71 15.87 0.49 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.191 0.519 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 60.15 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.041 -1.037 . . . . 0.0 110.463 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 1.0 OUTLIER 179.89 -153.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.929 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 114' ' ' LYS . 2.8 ttpm? -79.14 4.82 13.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.952 . . . . 0.0 109.859 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 61' ' ' ARG . . . 121.73 168.88 13.48 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.708 ' OG ' HD13 ' A' ' 58' ' ' LEU . 8.5 m -131.84 -168.82 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -1.047 . . . . 0.0 109.903 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 75.8 p -129.25 176.79 7.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.177 -0.952 . . . . 0.0 111.206 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -59.56 -43.83 96.53 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.824 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.449 1.236 . . . . 0.0 110.137 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.01 -30.3 59.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.369 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -78.03 -53.44 7.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 109.161 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.901 ' HA ' HD12 ' A' ' 73' ' ' ILE . 56.1 mttt -48.34 -34.42 10.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.977 -1.077 . . . . 0.0 108.308 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.6 ttpt -56.37 -51.9 66.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.625 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -60.39 -45.09 94.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.979 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.9 mt -61.67 -32.09 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -0.779 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.556 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 5.7 ptmm? -91.23 -41.48 10.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.065 -1.022 . . . . 0.0 111.571 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 30.5 mt-10 -92.12 -66.3 0.94 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.924 -1.11 . . . . 0.0 109.76 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.619 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 1.2 m120 -56.28 -27.04 53.97 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.985 -1.072 . . . . 0.0 108.278 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -120.48 177.87 1.32 Allowed Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.56 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.4 Cg_endo -64.62 173.37 5.6 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.097 1.577 . . . . 0.0 113.783 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.571 ' CA ' ' HB2' ' A' ' 82' ' ' SER . 5.8 pt -52.88 -12.93 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.914 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 73' ' ' ILE . 9.0 p -46.63 -28.55 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -35.46 8.77 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.571 ' HB2' ' CA ' ' A' ' 79' ' ' ILE . 14.3 m -51.16 -52.46 43.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.676 -0.896 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -49.95 -173.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.575 0.703 . . . . 0.0 111.222 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ASP . 46.8 t -117.2 -63.62 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 110.546 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 39.9 t30 -38.64 -38.8 0.43 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.348 -0.845 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -51.15 -41.37 60.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.894 -1.129 . . . . 0.0 108.428 178.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -45.69 -31.16 1.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -71.62 -39.5 70.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.727 -0.608 . . . . 0.0 109.733 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.616 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 19.8 m-85 -67.37 -42.47 83.38 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.653 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 51' ' ' ILE . 11.1 t80 -64.67 -41.5 96.04 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.871 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.1 m-20 -55.3 -52.03 64.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.836 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 7.7 m-20 -56.26 -41.87 76.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.139 -0.976 . . . . 0.0 108.914 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.793 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -58.88 -39.07 80.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.4 -0.813 . . . . 0.0 109.144 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HD13 ' A' ' 51' ' ' ILE . 18.1 mm -59.66 -56.45 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 108.977 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -39.69 93.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 29.1 tptt -63.03 -49.44 74.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.374 -0.829 . . . . 0.0 109.46 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -65.75 -50.36 54.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 19.6 t -49.6 -23.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.067 -1.255 . . . . 0.0 108.904 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 3.2 tp10 -87.17 -49.78 7.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.715 . . . . 0.0 110.178 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.78 -33.74 4.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -68.25 -11.33 61.38 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 97' ' ' GLY . 9.2 m-20 65.1 32.13 10.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.796 -0.826 . . . . 0.0 111.215 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 3.6 m-30 -77.5 146.57 36.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 109.22 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 58.1 mm-40 -97.38 123.39 41.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 108.609 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -140.89 99.04 6.8 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 111.076 -178.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 44.1 Cg_endo -73.58 -158.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.593 1.312 . . . . 0.0 109.508 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.9 mmtm -140.83 -110.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 -157.21 51.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.01 6.05 4.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.159 1.61 . . . . 0.0 111.56 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.64 97.52 0.67 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.413 0.625 . . . . 0.0 109.621 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.62 125.88 17.6 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -115.12 159.74 20.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.1 p -111.34 142.34 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.946 -1.096 . . . . 0.0 110.781 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 6.3 mttm -136.93 130.03 31.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.479 -0.763 . . . . 0.0 109.684 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' LEU . 24.5 tp -80.97 93.81 6.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.077 -1.014 . . . . 0.0 110.352 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 115' ' ' LEU . . . 56.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.407 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -54.68 138.95 40.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tttp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.106 -179.762 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.335 0.588 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.66 103.76 3.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.205 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 44' ' ' SER . 17.9 m -79.28 -158.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.727 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.301 30.4 t -174.52 80.9 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.841 -175.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -66.95 155.67 37.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 30.4 p -125.93 153.78 43.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 57.0 m-85 -54.93 -24.49 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -57.14 -43.75 82.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.112 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.9 mt-10 -59.7 -45.36 92.36 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.385 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 47' ' ' TYR . 52.4 mt -50.68 -31.51 16.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.78 -1.2 . . . . 0.0 108.089 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 93' ' ' ALA . 41.7 mt -84.0 -55.09 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 63.5 mt -56.14 -50.55 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -54.42 -45.06 76.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 115' ' ' LEU . 7.5 mt -63.21 -39.5 94.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.662 -0.905 . . . . 0.0 109.013 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -67.21 -30.92 70.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -90.98 -13.37 33.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.717 -0.614 . . . . 0.0 109.704 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 55' ' ' LEU . 9.3 mt -56.03 -46.14 78.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.156 -0.965 . . . . 0.0 109.011 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 53.13 21.79 2.3 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.371 0.605 . . . . 0.0 110.304 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.11 -161.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.848 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -143.48 3.61 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 0.0 111.076 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 -8.91 20.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.873 -1.142 . . . . 0.0 110.553 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 64' ' ' SER . . . 107.81 -29.64 10.08 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.218 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 58' ' ' LEU . 67.1 m 65.37 159.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.015 -0.697 . . . . 0.0 109.425 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 4.8 p -113.44 171.49 7.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.099 -1.001 . . . . 0.0 111.064 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -41.17 -50.26 8.25 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.87 -0.519 . . . . 0.0 111.059 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -66.86 -44.02 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.365 1.192 . . . . 0.0 110.495 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.06 -26.34 10.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 109.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 58' ' ' LEU . 2.8 mm? -86.87 -45.19 11.08 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -49.48 -42.42 43.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -50.26 -51.99 40.06 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.084 0.945 . . . . 0.0 109.013 178.067 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -59.37 -47.33 85.84 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.92 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 41.8 mt -64.33 -32.74 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 111.332 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.588 ' HB2' ' N ' ' A' ' 82' ' ' SER . 14.4 ptmt -91.22 -42.2 10.55 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.033 -1.042 . . . . 0.0 111.379 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 9.6 mt-10 -94.95 -64.92 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.923 -1.111 . . . . 0.0 110.009 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.1 m-20 -56.53 -23.44 39.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.71 -1.244 . . . . 0.0 108.003 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.666 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -122.45 177.54 1.57 Allowed Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.9 Cg_endo -66.27 175.47 4.9 Favored 'Trans proline' 0 C--N 1.283 -2.896 0 O-C-N 124.037 1.546 . . . . 0.0 114.429 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.597 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pp -52.54 -13.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.607 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p -45.92 -30.39 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.604 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.77 -37.2 6.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.597 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -85.17 36.87 0.65 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.647 -0.914 . . . . 0.0 110.32 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.92 -110.62 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.019 -1.05 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 86' ' ' PHE . 4.4 m -166.11 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.877 -1.139 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' SER . 57.4 t-20 -39.86 -27.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.289 -0.882 . . . . 0.0 110.663 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.92 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.6 t80 -54.35 -42.07 69.83 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.953 -1.092 . . . . 0.0 108.847 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.549 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 3.9 p-10 -47.79 -28.02 2.33 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.175 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tp -78.6 -32.48 47.58 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.96 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.666 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 29.1 m-85 -74.28 -41.13 61.73 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.715 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 73' ' ' ILE . 67.0 t80 -63.36 -48.11 79.3 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.383 -0.823 . . . . 0.0 108.791 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 14.6 m-80 -52.12 -57.26 10.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.166 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 7.9 m-20 -54.05 -39.01 65.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.059 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.46 -37.99 80.69 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.351 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.794 HD11 ' CE2' ' A' ' 90' ' ' PHE . 12.9 mm -62.84 -61.11 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 25.1 mttt -57.35 -39.88 76.89 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -59.73 -43.11 94.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.462 -0.774 . . . . 0.0 109.746 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -70.9 -51.97 16.68 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.886 HG21 ' HG3' ' A' ' 105' ' ' GLN . 48.4 t -64.83 -42.07 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -1.124 . . . . 0.0 110.325 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 17.2 tp10 -60.18 -38.09 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.172 -0.955 . . . . 0.0 109.72 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.39 8.37 6.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.455 -0.778 . . . . 0.0 110.292 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.73 22.02 75.65 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -82.89 -66.94 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -1.148 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.21 177.0 4.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.739 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 16.7 mm-40 -111.01 126.14 54.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.45 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.886 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.5 98.32 9.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 110.985 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -78.01 -174.9 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.684 1.36 . . . . 0.0 109.909 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -113.17 -81.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.081 -1.012 . . . . 0.0 110.071 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.45 -145.89 46.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.04 4.8 5.85 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.302 1.685 . . . . 0.0 111.265 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -168.53 -103.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.097 0 O-C-N 121.866 -0.522 . . . . 0.0 110.293 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.48 107.1 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.47 161.65 16.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.174 . . . . 0.0 109.741 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.582 ' O ' HD21 ' A' ' 55' ' ' LEU . 2.1 p -126.64 100.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.016 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 28.8 mttp -99.81 126.52 45.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 55' ' ' LEU . 25.0 tp -78.44 103.63 8.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . 165.53 177.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.289 -0.882 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.1 139.05 50.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 110.3 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.118 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' A' ' 50' ' ' LEU . 34.0 m-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.24 0.543 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -52.72 -46.35 67.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.1 mm-40 -56.95 -46.2 82.27 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.175 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.741 HD22 HG23 ' A' ' 73' ' ' ILE . 96.6 mt -52.33 -32.07 36.33 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.932 -1.105 . . . . 0.0 108.987 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.8 mt -82.2 -55.94 6.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.553 0.692 . . . . 0.0 109.362 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.606 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.8 mt -59.12 -51.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 6.0 mt-10 -62.95 -39.92 96.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.618 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.57 -45.1 96.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.996 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.9 mt -64.45 -36.61 84.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -1.046 . . . . 0.0 109.175 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m -72.88 -30.07 63.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.0 108.909 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.426 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.73 -19.75 23.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.556 -0.715 . . . . 0.0 110.041 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.4 mt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.093 -1.004 . . . . 0.0 109.581 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD22 ' A' ' 58' ' ' LEU . 33.7 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.539 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 9.5 p -125.09 172.61 9.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.628 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.9 ttp180 -44.82 -48.56 29.02 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.78 -0.575 . . . . 0.0 111.151 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.4 Cg_endo -67.48 -42.37 7.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.234 1.123 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.32 -28.13 51.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -86.72 -51.19 6.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.803 . . . . 0.0 109.519 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 mttp -54.61 -42.04 70.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -52.39 -49.74 63.82 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.111 0.958 . . . . 0.0 108.646 177.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.618 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -59.76 -45.33 92.58 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.934 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 28.8 mt -65.18 -32.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.467 -0.771 . . . . 0.0 111.159 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.69 -41.48 10.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.85 -1.156 . . . . 0.0 111.178 -179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 11.9 mt-10 -95.88 -65.25 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 33.2 m-20 -56.43 -19.88 17.1 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.653 -1.279 . . . . 0.0 108.102 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.637 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.06 177.33 1.99 Allowed Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 177.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.55 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 50.0 Cg_endo -68.46 176.77 5.33 Favored 'Trans proline' 0 C--N 1.281 -3.006 0 O-C-N 123.997 1.525 . . . . 0.0 114.261 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.3 tt -50.72 -15.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.846 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.6 p -45.42 -29.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.94 -35.94 6.21 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -82.43 45.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -1.012 . . . . 0.0 109.972 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.78 -127.01 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 43.5 t -150.68 -78.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.86 -1.15 . . . . 0.0 110.844 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' PHE . 55.8 t-20 -52.4 -34.55 48.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.128 -0.982 . . . . 0.0 110.868 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.2 t80 -48.51 -38.76 21.07 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.731 -1.23 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -46.8 -32.93 4.01 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.678 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 tp -75.93 -32.86 59.77 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 47' ' ' TYR . 5.7 m-85 -69.73 -46.72 65.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 32.8 t80 -58.09 -41.02 82.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.132 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.9 m-20 -56.82 -55.11 38.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.966 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -38.88 66.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.285 -0.885 . . . . 0.0 108.889 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.02 -41.32 99.51 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.4 mm -63.42 -58.8 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 36.2 mttp -56.06 -41.44 75.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -49.23 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -69.45 -48.13 46.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 105' ' ' GLN . 40.2 t -63.9 -43.44 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -1.031 . . . . 0.0 110.57 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.3 tp10 -61.92 -34.56 76.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.66 11.77 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.39 78.65 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 7.1 t0 -85.54 -68.42 0.73 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -1.155 . . . . 0.0 109.969 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.22 169.73 8.28 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.541 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -110.9 126.85 55.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.811 ' HB2' HG11 ' A' ' 98' ' ' VAL . 1.3 mm100 -138.51 109.72 8.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.763 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.3 Cg_endo . . . . . 0 C--N 1.305 -1.723 0 O-C-N 124.021 1.537 . . . . 0.0 109.891 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.06 121.66 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -1.165 . . . . 0.0 109.926 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.6 p -81.27 126.19 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -125.23 128.76 48.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.83 . . . . 0.0 109.781 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.728 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.6 tp . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.103 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 96.5 m-85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.26 0.553 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.775 ' CD ' HD11 ' A' ' 52' ' ' ILE 0.25 2.7 tmm_? -49.14 -44.61 42.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 13.7 mt-10 -57.74 -45.58 85.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.091 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.777 HD22 HG23 ' A' ' 73' ' ' ILE . 98.7 mt -52.99 -32.56 47.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.062 -1.023 . . . . 0.0 108.883 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.3 mt -78.93 -56.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.563 0.697 . . . . 0.0 109.314 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.775 HD11 ' CD ' ' A' ' 48' ' ' ARG . 23.5 mt -59.0 -53.08 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 1.9 mm-40 -61.07 -39.66 90.71 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.99 -46.83 93.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.958 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.1 mt -63.89 -38.78 92.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -1.055 . . . . 0.0 109.077 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -69.75 -28.2 65.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.477 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.64 -22.47 21.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.0 109.724 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.977 HD11 HD21 ' A' ' 69' ' ' LEU . 12.8 mt . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.326 -0.859 . . . . 0.0 109.219 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.552 ' OG ' HD22 ' A' ' 58' ' ' LEU . 20.9 m . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -128.59 174.06 9.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 111.549 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.647 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -47.57 -47.51 60.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.792 -0.568 . . . . 0.0 111.318 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -66.96 -42.21 8.69 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.286 1.15 . . . . 0.0 110.47 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.52 -27.24 56.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.669 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.977 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -92.08 -47.42 7.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 109.597 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.786 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.1 mttp -55.88 -40.21 72.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 108.517 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 5.3 ttpt -54.54 -52.7 61.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t80 -58.52 -43.54 89.22 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.938 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 54.8 mt -63.35 -33.1 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 0.0 111.104 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 6.5 pttt -91.62 -41.55 10.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.007 -1.058 . . . . 0.0 111.418 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.55 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.5 mt-10 -95.42 -65.44 0.98 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.042 . . . . 0.0 109.897 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.9 m-20 -56.82 -21.1 26.45 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.077 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -125.25 176.54 2.35 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.6 Cg_endo -66.05 175.44 4.73 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 O-C-N 123.976 1.514 . . . . 0.0 114.119 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.916 HG23 ' HB3' ' A' ' 82' ' ' SER . 17.8 mm -52.42 -12.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.937 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.3 p -45.97 -31.14 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.31 -38.25 7.29 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.916 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -82.32 42.29 0.74 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.621 -0.929 . . . . 0.0 110.078 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.04 -133.76 0.29 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' PHE . 20.7 m -143.9 -92.18 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.912 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.2 t30 -40.18 -28.14 0.05 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.142 -0.974 . . . . 0.0 110.965 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -48.32 -42.11 30.26 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.537 179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.4 t0 -47.42 -30.66 3.48 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.767 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.5 tp -76.81 -28.15 55.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.464 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 49.1 m-85 -77.05 -46.98 21.85 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.207 -0.933 . . . . 0.0 108.892 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.828 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 70.7 t80 -56.9 -43.03 80.93 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-20 -55.5 -57.0 13.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.185 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.87 -40.17 69.43 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.028 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -62.0 -45.57 93.04 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.485 -0.76 . . . . 0.0 109.016 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.828 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 16.7 mm -60.01 -58.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -0.807 . . . . 0.0 109.015 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.76 -38.2 74.99 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.758 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 5.2 tptt -66.03 -50.97 62.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.848 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -63.63 -51.48 53.73 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 105' ' ' GLN . 93.1 t -60.81 -39.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.978 . . . . 0.0 110.054 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 34.4 tp10 -63.19 -33.48 75.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.186 -0.947 . . . . 0.0 109.863 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.93 17.39 3.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.384 -0.822 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.6 73.4 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -87.57 -69.2 0.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.329 -1.101 . . . . 0.0 110.103 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -107.66 169.32 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -108.59 125.54 51.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.588 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.74 97.87 8.92 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.987 . . . . 0.0 110.63 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.5 Cg_endo . . . . . 0 C--N 1.305 -1.762 0 O-C-N 123.905 1.476 . . . . 0.0 109.896 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -102.37 160.16 14.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.972 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.487 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.9 p -121.19 117.58 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.862 -1.149 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -114.25 128.63 56.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.715 ' HB2' HD22 ' A' ' 55' ' ' LEU . 56.8 tp . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 61.9 m-85 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -69.7 -45.62 67.85 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' GLU . 39.4 mt-10 -58.47 -42.25 87.06 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.294 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 47' ' ' TYR . 77.8 mt -54.26 -34.17 60.16 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.869 -1.145 . . . . 0.0 108.701 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 94' ' ' ILE . 57.7 mt -79.35 -55.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.636 -0.665 . . . . 0.0 109.27 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.8 mt -59.24 -54.49 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.5 mt-10 -62.2 -41.58 98.5 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.9 -43.71 96.54 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -62.35 -36.54 82.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -1.021 . . . . 0.0 109.041 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -72.2 -28.42 63.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.355 -0.84 . . . . 0.0 109.051 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.13 26.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.59 -0.694 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.019 HD12 ' HA ' ' A' ' 55' ' ' LEU . 14.4 mt . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.239 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.618 ' OG ' HD22 ' A' ' 58' ' ' LEU . 13.8 m . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.588 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.8 p -127.81 176.58 7.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.4 tpp85 -46.28 -47.6 45.62 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.5 Cg_endo -67.99 -42.51 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.274 1.144 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.588 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -58.06 -36.52 72.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -78.36 -49.52 13.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.815 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 73' ' ' ILE . 1.7 mtpt -52.09 -39.63 60.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 7.6 ttpt -50.94 -51.7 49.71 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.53 -48.41 81.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.988 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 11.8 mt -61.62 -33.49 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.596 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.552 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -91.28 -41.65 10.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.151 -0.968 . . . . 0.0 111.575 -179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.552 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 38.5 mt-10 -92.3 -65.81 0.97 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.963 -1.086 . . . . 0.0 110.106 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 18.0 m-20 -59.09 -22.02 60.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.865 -1.147 . . . . 0.0 108.214 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.621 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -123.8 176.87 1.97 Allowed Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.574 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -65.07 172.74 6.9 Favored 'Trans proline' 0 C--N 1.282 -2.941 0 O-C-N 124.071 1.564 . . . . 0.0 113.527 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -52.9 -12.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.495 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG13 HG22 ' A' ' 73' ' ' ILE . 8.5 p -45.64 -29.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.543 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.13 -36.72 7.49 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 16.1 t -65.57 -8.63 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.543 -0.975 . . . . 0.0 110.432 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.79 -160.69 0.5 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 111.108 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.5 t -127.21 -67.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.264 -0.897 . . . . 0.0 110.682 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 16.0 t-20 -40.73 -41.27 1.5 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.215 -0.928 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.988 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.12 -40.91 25.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.6 t70 -46.72 -32.18 3.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -71.99 -33.82 68.41 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.636 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 21.6 m-85 -75.09 -43.01 55.46 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.402 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.614 ' CE2' HG12 ' A' ' 51' ' ' ILE . 43.7 t80 -57.46 -39.02 75.43 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -62.88 -54.88 31.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.508 -0.745 . . . . 0.0 109.487 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.69 -38.86 49.39 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.844 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.651 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.16 -47.61 73.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 51' ' ' ILE . 14.5 mm -56.26 -61.03 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.076 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -56.68 -40.31 75.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.635 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -61.6 -47.33 85.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.47 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.44 -52.22 10.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.752 HG21 ' HG3' ' A' ' 105' ' ' GLN . 57.9 t -59.17 -36.72 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.355 -1.085 . . . . 0.0 110.419 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 4.0 tp10 -61.66 -37.33 83.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.199 -0.938 . . . . 0.0 110.06 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.54 17.36 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 109.931 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.52 25.31 74.96 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.1 m-20 -82.78 -67.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.136 -1.214 . . . . 0.0 109.893 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -102.91 168.23 9.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.977 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 34.3 mm-40 -105.9 125.71 51.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -0.845 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.752 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -141.09 102.37 6.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.118 -0.989 . . . . 0.0 111.103 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.304 -1.766 0 O-C-N 123.632 1.333 . . . . 0.0 109.648 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -103.57 160.65 14.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -1.109 . . . . 0.0 109.672 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.8 p -122.61 117.33 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.87 -1.144 . . . . 0.0 110.718 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 14.1 mtpt -115.43 129.27 56.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 109.762 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.2 tp . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.199 -0.938 . . . . 0.0 110.906 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.667 ' CB ' ' HB2' ' A' ' 93' ' ' ALA . 42.9 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.305 0.574 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.521 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.92 -45.7 91.26 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.33 -46.17 83.54 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.246 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.507 HD13 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 mt -50.41 -33.35 20.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.884 -1.135 . . . . 0.0 108.451 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.9 mt -80.77 -56.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.449 0.642 . . . . 0.0 109.384 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.62 HG12 ' CE1' ' A' ' 103' ' ' PHE . 74.2 mt -57.65 -53.41 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.7 mt-10 -59.24 -40.29 85.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.3 -46.49 86.43 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.791 HD22 ' CB ' ' A' ' 115' ' ' LEU . 9.1 mt -67.56 -39.89 84.93 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.54 -0.976 . . . . 0.0 108.657 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.4 m -66.19 -28.35 68.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -87.43 -29.21 21.62 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 64' ' ' SER . 10.4 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.843 . . . . 0.0 108.997 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.708 ' HB3' HD11 ' A' ' 58' ' ' LEU . 1.1 m . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.199 0.523 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.722 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -134.64 175.99 9.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.164 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.27 -47.03 68.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.589 -0.694 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 41.0 Cg_endo -69.34 -42.81 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.231 1.122 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -57.99 -30.44 66.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.975 . . . . 0.0 109.791 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 65' ' ' SER . 4.5 mm? -86.7 -49.91 7.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.588 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.925 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.5 mtpt -56.33 -39.64 73.14 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.452 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.67 -49.97 45.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 3.1 t80 -63.0 -47.52 82.79 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.974 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 14.9 mt -61.04 -31.85 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.446 -0.783 . . . . 0.0 111.114 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.25 -43.04 10.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.0 -1.062 . . . . 0.0 111.643 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 26.7 mt-10 -94.0 -65.36 0.99 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.968 -1.082 . . . . 0.0 109.911 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 9.7 m-20 -59.08 -17.42 25.87 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 108.383 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.2 m-85 -129.29 176.47 2.78 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 43.3 Cg_endo -65.27 173.35 6.34 Favored 'Trans proline' 0 C--N 1.28 -3.031 0 O-C-N 123.942 1.496 . . . . 0.0 114.082 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 82' ' ' SER . 33.6 mt -50.48 -16.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.452 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.663 HG13 HG22 ' A' ' 73' ' ' ILE . 7.2 p -44.51 -29.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.31 -33.07 8.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB3' HG23 ' A' ' 79' ' ' ILE . 12.4 t -51.17 -55.7 16.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.621 -0.929 . . . . 0.0 110.743 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.67 -171.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.523 -0.736 . . . . 0.0 111.241 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -119.99 -54.63 2.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 110.429 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.4 t-20 -42.07 -41.35 2.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -49.03 -41.39 34.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.979 -1.075 . . . . 0.0 108.209 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.513 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 33.3 t0 -45.69 -31.41 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -70.33 -40.62 74.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.436 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 71.5 m-85 -68.32 -42.75 78.91 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.618 ' CE2' HG12 ' A' ' 51' ' ' ILE . 32.3 t80 -59.42 -32.6 70.33 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.3 m-80 -66.95 -53.59 30.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.53 -0.731 . . . . 0.0 109.427 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.62 -40.19 65.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.113 -0.992 . . . . 0.0 108.797 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.46 -36.17 82.11 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.638 HD13 HG21 ' A' ' 51' ' ' ILE . 6.5 mm -65.19 -60.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.37 -38.12 73.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 8.4 tptm -63.08 -50.02 72.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.362 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.93 -52.72 31.21 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.831 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.8 t -59.37 -33.77 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.492 -1.005 . . . . 0.0 109.902 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 1.2 tp10 -60.73 -40.33 92.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.287 -0.883 . . . . 0.0 109.616 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.56 15.77 3.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 109.891 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.16 24.99 76.47 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 3.4 m-20 -81.15 -67.41 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.213 -1.169 . . . . 0.0 109.86 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.712 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -106.78 162.23 13.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.251 -0.906 . . . . 0.0 109.725 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 11.9 mm-40 -101.19 125.57 47.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.672 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.831 ' HG3' HG21 ' A' ' 98' ' ' VAL . 1.1 mm-40 -133.99 98.17 14.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 111.283 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.1 Cg_endo . . . . . 0 C--N 1.304 -1.78 0 O-C-N 123.933 1.491 . . . . 0.0 109.342 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -112.52 160.05 18.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -1.051 . . . . 0.0 109.856 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 64' ' ' SER . 1.4 p -121.57 113.23 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.082 . . . . 0.0 109.752 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -109.85 129.85 55.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.979 . . . . 0.0 110.133 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.791 ' CB ' HD22 ' A' ' 55' ' ' LEU . 19.8 tp . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 60.8 m-85 . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 52' ' ' ILE . 17.2 ttm180 -59.24 -45.76 90.31 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' GLU . 59.1 mt-10 -59.08 -43.77 91.82 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 73' ' ' ILE . 96.2 mt -53.42 -32.53 50.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.654 -1.279 . . . . 0.0 108.713 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 93' ' ' ALA . 22.7 mt -81.23 -56.42 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.679 0.752 . . . . 0.0 109.107 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 103' ' ' PHE . 57.4 mt -59.11 -53.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.991 0.901 . . . . 0.0 108.68 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -61.6 -39.33 90.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.59 -49.14 79.76 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -58.52 -36.35 73.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.444 -1.033 . . . . 0.0 109.61 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -74.29 -30.13 61.95 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.771 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.94 -10.62 41.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.666 -0.646 . . . . 0.0 110.069 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 69' ' ' LEU . 12.5 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 109.773 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.791 ' OG ' HD13 ' A' ' 58' ' ' LEU . 27.3 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.15 0.5 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HD23 ' A' ' 69' ' ' LEU . 53.7 p -130.63 173.5 10.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 111.145 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.668 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 12.0 ttp180 -52.42 -45.68 95.13 Favored Pre-proline 0 C--N 1.296 -1.725 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.7 -42.97 4.16 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.299 1.157 . . . . 0.0 110.788 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.18 -22.57 17.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.075 -1.016 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -91.05 -48.4 6.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.356 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 73' ' ' ILE . 27.9 mttt -56.34 -42.07 77.11 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 1.7 ttpt -51.24 -49.81 60.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.879 0.847 . . . . 0.0 108.815 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.05 -47.4 86.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.921 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.5 mt -63.41 -31.29 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.969 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 45.1 pttt -91.6 -41.04 10.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.877 -1.139 . . . . 0.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.6 mt-10 -96.03 -65.7 0.95 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.055 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 50.7 m-20 -56.62 -19.92 18.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.622 -1.299 . . . . 0.0 107.992 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.44 177.97 1.74 Allowed Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.143 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 77' ' ' TYR . 47.4 Cg_endo -67.77 176.19 5.45 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.949 1.5 . . . . 0.0 114.108 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -51.99 -15.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.857 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.605 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -44.28 -30.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.27 -36.45 6.6 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.2 m -73.06 -1.21 16.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -1.075 . . . . 0.0 110.323 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -81.27 -151.35 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 110.619 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.78 -74.59 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.855 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 35.4 t-20 -41.12 -35.64 0.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.322 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.5 -42.05 61.4 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.078 -1.049 . . . . 0.0 108.553 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 26.1 m-20 -45.61 -27.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -80.83 -34.49 33.84 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.031 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 20.8 m-85 -71.94 -41.1 68.2 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.05 -1.032 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.0 t80 -59.84 -43.27 94.69 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.484 -0.76 . . . . 0.0 108.956 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 59.5 m-20 -56.98 -56.83 16.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.51 -0.744 . . . . 0.0 109.462 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.99 -39.84 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.075 -1.016 . . . . 0.0 108.985 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.44 -45.5 87.21 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.465 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 12.8 mm -60.15 -60.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.42 -38.16 73.91 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.893 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -66.61 -48.68 68.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 0.0 110.155 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -65.11 -52.52 40.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.604 HG21 ' HG3' ' A' ' 105' ' ' GLN . 37.8 t -61.56 -41.29 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.549 -0.971 . . . . 0.0 110.457 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 6.6 tp10 -61.25 -35.34 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.224 -0.923 . . . . 0.0 110.016 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.7 14.04 4.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.972 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.09 24.23 76.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.4 m-20 -85.84 -69.28 0.67 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -1.23 . . . . 0.0 109.754 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -115.5 125.73 53.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.673 ' NE2' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -134.91 98.18 13.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.664 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 123.873 1.459 . . . . 0.0 110.076 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -99.92 160.17 14.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -1.069 . . . . 0.0 109.933 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.2 p -122.22 127.1 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 110.352 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -126.45 129.56 48.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.804 ' HB2' HD13 ' A' ' 55' ' ' LEU . 8.7 tp . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.963 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.0 m-85 . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.95 -45.53 82.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 53.2 mm-40 -57.85 -19.32 28.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.877 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 47' ' ' TYR . 29.6 mt -86.34 -31.75 21.37 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.7 -1.25 . . . . 0.0 108.961 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.14 -56.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.595 -0.691 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.605 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 24.9 mt -52.74 -49.99 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 78.0 mt-10 -64.95 -41.5 95.43 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.912 0.863 . . . . 0.0 108.786 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -55.95 -44.83 87.71 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.985 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.9 mt -67.77 -44.15 78.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -1.047 . . . . 0.0 109.355 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -67.64 -26.29 66.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.208 -0.932 . . . . 0.0 108.848 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.57 -25.85 20.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.663 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.022 HD22 ' OG ' ' A' ' 64' ' ' SER . 8.3 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.23 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 1.022 ' OG ' HD22 ' A' ' 58' ' ' LEU . 65.4 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.135 0.493 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.519 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 5.1 p -120.97 173.04 7.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.091 -1.006 . . . . 0.0 110.97 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.627 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -43.73 -48.71 20.29 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.878 -0.513 . . . . 0.0 111.38 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.6 Cg_endo -67.55 -42.87 6.4 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.263 1.138 . . . . 0.0 110.436 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.95 -28.93 59.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -83.3 -51.68 7.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 109.504 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.842 ' HA ' HD12 ' A' ' 73' ' ' ILE . 2.3 mtpt -50.06 -38.54 38.63 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.643 -1.223 . . . . 0.0 107.747 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.81 -55.96 12.17 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.629 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.74 -45.5 89.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 22.2 mt -62.39 -34.19 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.477 -0.765 . . . . 0.0 111.022 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.27 -41.81 10.74 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.037 -1.04 . . . . 0.0 111.595 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 20.8 mt-10 -94.61 -65.02 1.01 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.57 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.2 m-20 -57.94 -20.56 38.59 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.645 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.6 m-85 -126.15 177.11 2.09 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.562 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.3 Cg_endo -65.09 174.86 4.38 Favored 'Trans proline' 0 C--N 1.283 -2.869 0 O-C-N 123.838 1.441 . . . . 0.0 114.03 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.613 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pt -52.97 -12.46 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.031 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.4 p -46.34 -28.95 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -36.93 7.88 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 107.179 -2.368 . . . . 0.0 107.179 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.613 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 48.3 t -57.22 -38.68 74.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.883 . . . . 0.0 110.289 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -52.08 -169.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.526 -0.733 . . . . 0.0 111.033 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 85' ' ' ASN . 4.8 p -124.62 -65.8 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 110.339 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 61.4 t30 -42.65 -36.0 1.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -0.911 . . . . 0.0 109.988 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.889 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -50.92 -42.03 59.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.202 -0.999 . . . . 0.0 108.388 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 46.9 t0 -45.52 -27.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -80.46 -34.45 35.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 m-85 -70.76 -43.61 68.44 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.727 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.5 t80 -55.13 -40.54 70.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-80 -59.22 -55.77 30.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.554 -0.717 . . . . 0.0 109.717 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.52 -38.35 53.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.718 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.806 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.49 -40.63 76.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.9 mm -63.42 -60.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 2.8 mttp -57.13 -37.81 72.57 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 12.5 tptm -63.96 -49.09 73.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.84 . . . . 0.0 109.468 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.93 -53.96 20.42 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 103' ' ' PHE . 61.9 t -56.49 -34.02 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -1.067 . . . . 0.0 109.826 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 24.5 tp10 -68.66 -35.03 76.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.53 11.29 5.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 110.043 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.18 21.57 78.85 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.606 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -88.98 -65.44 1.02 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 110.468 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.7 ' HB2' HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -99.05 166.94 11.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.765 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 114' ' ' LYS . 52.7 mm-40 -114.12 124.0 51.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.672 ' HG3' HG21 ' A' ' 98' ' ' VAL . 1.2 mt-30 -135.41 114.48 11.43 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 111.222 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.9 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 O-C-N 123.883 1.465 . . . . 0.0 109.141 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.127 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -89.36 159.49 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.654 HG22 HD21 ' A' ' 55' ' ' LEU . 1.4 p -114.4 101.6 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -101.86 129.39 48.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 178.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 55' ' ' LEU . 13.3 tp . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.235 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 55.1 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.033 0.444 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HA ' ' HB1' ' A' ' 93' ' ' ALA 0.25 3.2 ttp180 -49.74 -44.6 48.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 53.3 mm-40 -57.67 -45.37 85.68 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.823 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD12 ' HD1' ' A' ' 47' ' ' TYR . 35.6 mt -52.21 -31.22 30.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.816 -1.177 . . . . 0.0 108.596 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.4 mt -80.09 -56.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.566 0.698 . . . . 0.0 109.308 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.634 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.5 mt -61.41 -54.48 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.1 mt-10 -58.77 -38.63 78.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.68 -49.62 75.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -59.97 -39.15 84.66 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.585 -0.95 . . . . 0.0 108.58 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 56' ' ' THR . 0.7 OUTLIER -70.31 -24.44 63.02 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -86.04 -31.21 22.1 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 64' ' ' SER . 25.5 mt . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.829 ' HB2' HG13 ' A' ' 113' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.345 0.593 . . . . 0.0 110.263 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.737 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.7 p -134.63 170.67 15.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 18.5 ttp180 -49.24 -49.25 71.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.1 Cg_endo -67.45 -42.4 7.34 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.301 1.158 . . . . 0.0 110.627 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -54.12 -31.1 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 109.464 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.0 mm? -82.84 -51.19 7.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.443 -0.785 . . . . 0.0 109.537 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' HD12 ' A' ' 73' ' ' ILE . 4.6 mttt -50.36 -41.23 51.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 5.3 tmmm? -49.14 -55.85 11.03 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.97 -46.14 88.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.929 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 17.5 mt -65.53 -31.72 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.924 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 46.0 pttt -91.81 -40.77 11.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.966 -1.084 . . . . 0.0 111.624 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 14.9 mt-10 -95.97 -65.31 0.98 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.905 -1.122 . . . . 0.0 109.89 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 18.6 m-20 -56.31 -21.6 25.19 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.666 -1.272 . . . . 0.0 107.845 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.616 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.57 175.7 2.49 Favored Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 80' ' ' VAL . 49.5 Cg_endo -69.84 178.31 4.75 Favored 'Trans proline' 0 C--N 1.28 -3.033 0 O-C-N 123.903 1.475 . . . . 0.0 113.885 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.6 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -51.0 -15.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.034 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.633 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.06 -30.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.77 -34.64 6.79 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -83.1 23.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -1.064 . . . . 0.0 110.362 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -104.83 -139.07 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.473 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -140.55 -77.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.893 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' SER . 50.4 t30 -42.05 -36.29 1.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.929 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -49.22 -40.53 34.08 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.361 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.1 m-20 -46.62 -29.66 1.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.15 -33.79 50.13 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.01 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.67 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 12.7 m-85 -72.21 -44.83 62.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.152 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 83.8 t80 -56.55 -39.9 74.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.486 -0.759 . . . . 0.0 109.184 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -60.63 -55.39 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.464 -0.773 . . . . 0.0 109.279 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -50.87 -36.63 38.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 108.852 178.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.639 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -71.29 -39.43 71.51 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.212 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.7 mm -64.16 -59.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 108.976 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.53 -41.02 80.08 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -61.87 -42.89 99.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.964 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -74.43 -52.01 7.89 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 105' ' ' GLN . 48.0 t -61.71 -40.11 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.123 . . . . 0.0 110.346 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 9.2 tp10 -59.87 -36.85 77.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.72 13.44 4.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.49 78.04 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.5 m-20 -82.66 -68.28 0.72 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.732 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.72 157.69 17.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.542 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -96.73 123.89 40.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.692 ' HB2' HG11 ' A' ' 98' ' ' VAL . 6.0 mm-40 -134.98 106.09 10.47 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 110.701 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.4 Cg_endo . . . . . 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 109.978 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.13 126.53 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -1.064 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 64' ' ' SER . 2.1 p -83.49 104.52 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -101.29 125.86 47.97 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.039 -1.038 . . . . 0.0 109.301 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.665 ' HB2' HD13 ' A' ' 55' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.414 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.63 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 73.5 m-85 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.365 0.602 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 51' ' ' ILE . 5.0 ttp85 -54.93 -47.58 74.24 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE1' HD12 ' A' ' 52' ' ' ILE . 3.0 mm-40 -57.16 -43.67 82.74 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.227 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 21.1 mt -53.21 -33.21 51.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.84 -1.162 . . . . 0.0 108.635 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.1 mt -79.84 -56.31 7.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.57 0.7 . . . . 0.0 109.169 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 ' OE1' ' A' ' 49' ' ' GLU . 65.3 mt -57.42 -52.13 60.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.3 mt-10 -64.57 -40.72 96.05 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -56.87 -44.04 92.34 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.2 mt -65.71 -38.76 90.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -1.072 . . . . 0.0 109.428 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -67.7 -31.19 70.98 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.286 -0.884 . . . . 0.0 108.906 178.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.94 -24.43 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.631 -0.668 . . . . 0.0 110.029 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.032 HD11 HD21 ' A' ' 69' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 1.004 ' OG ' HD22 ' A' ' 58' ' ' LEU . 19.5 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.111 0.482 . . . . 0.0 109.951 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.708 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.9 p -134.75 174.4 10.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.0 111.009 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.619 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -51.11 -47.23 88.06 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.661 -0.649 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.6 Cg_endo -69.97 -41.91 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.263 1.139 . . . . 0.0 110.396 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.33 -36.13 65.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' LEU . 4.4 mm? -75.98 -47.11 26.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.9 ' HA ' HD12 ' A' ' 73' ' ' ILE . 93.6 mttt -54.59 -46.61 73.8 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 70' ' ' LYS . 9.4 ttpt -42.01 -56.76 2.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 2.2 t80 -57.59 -42.89 84.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.998 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 32.5 mt -66.02 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 111.476 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.48 -42.51 10.24 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.747 -1.22 . . . . 0.0 111.087 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -95.4 -65.04 1.0 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.061 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.4 m-20 -56.93 -19.64 19.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.877 -1.14 . . . . 0.0 107.969 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.692 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 2.3 m-85 -126.89 175.04 3.59 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.577 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.62 176.55 4.9 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 O-C-N 123.941 1.495 . . . . 0.0 113.841 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 82' ' ' SER . 8.2 mt -52.55 -12.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.96 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.5 p -46.55 -29.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.14 -37.35 7.2 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.875 ' HB3' HG23 ' A' ' 79' ' ' ILE . 4.1 t -72.0 -2.89 19.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.563 -0.963 . . . . 0.0 110.263 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -78.27 -153.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.429 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 86' ' ' PHE . 28.2 m -133.19 -78.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.763 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 43.5 t-20 -40.72 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -0.922 . . . . 0.0 110.331 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.998 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -56.32 -44.98 80.46 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.086 -1.009 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 6.3 p-10 -45.42 -26.89 0.61 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.8 tp -82.28 -30.11 30.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.585 -0.697 . . . . 0.0 109.964 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.5 m-85 -76.45 -42.11 45.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 47.3 t80 -58.29 -42.47 86.68 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -59.04 -57.67 12.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.305 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -52.21 -38.54 58.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.683 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.23 -41.4 90.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.696 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -62.39 -60.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.752 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -57.29 -37.62 72.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -65.09 -49.84 68.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.44 -0.787 . . . . 0.0 109.775 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -64.51 -51.41 52.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 103' ' ' PHE . 74.4 t -61.56 -40.97 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -1.023 . . . . 0.0 109.813 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 11.9 tp10 -58.52 -34.28 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 109.691 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -86.11 15.58 5.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.745 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 23.96 76.95 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.548 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.6 m-20 -85.1 -68.05 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -1.22 . . . . 0.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -110.28 159.51 17.35 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.905 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -100.13 143.45 30.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.681 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -149.82 98.08 3.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.968 . . . . 0.0 111.014 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 45.1 Cg_endo . . . . . 0 C--N 1.305 -1.725 0 O-C-N 123.726 1.382 . . . . 0.0 109.439 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.097 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -100.95 160.62 14.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -1.003 . . . . 0.0 109.907 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.4 p -114.43 121.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.948 -1.095 . . . . 0.0 110.262 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -122.2 125.77 46.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.743 ' HB2' HD13 ' A' ' 55' ' ' LEU . 22.0 tp . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.363 -0.835 . . . . 0.0 110.032 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 97.1 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.178 0.513 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 10.5 ttm180 -53.71 -46.12 70.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 16.3 mt-10 -57.06 -44.72 83.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.14 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 19.0 mt -51.6 -32.63 29.49 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.789 -1.194 . . . . 0.0 108.304 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 93' ' ' ALA . 11.0 mt -81.54 -55.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.602 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.2 mt -56.57 -52.27 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.1 mt-10 -62.48 -40.96 98.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.32 -45.64 95.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.966 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.5 mt -64.46 -41.25 96.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -1.002 . . . . 0.0 109.551 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -68.01 -28.79 67.72 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 108.832 178.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.55 -20.84 22.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.658 -0.651 . . . . 0.0 109.822 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.4 mt . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.487 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.604 ' OG ' HD22 ' A' ' 58' ' ' LEU . 47.9 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.5 p -125.69 176.25 7.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -46.53 -47.62 48.5 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 110.98 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -67.46 -42.26 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.634 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.93 -33.71 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -81.08 -51.33 8.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.448 -0.782 . . . . 0.0 109.61 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' NZ ' ' HB3' ' A' ' 87' ' ' ASP . 2.7 mtpt -53.8 -41.54 67.4 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 3.9 tmmm? -47.55 -53.74 13.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.998 0.904 . . . . 0.0 108.733 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.6 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.0 t80 -59.88 -49.66 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.967 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 19.9 mt -63.88 -31.53 53.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.395 -0.815 . . . . 0.0 110.669 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.631 ' HG3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -92.4 -34.97 13.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.085 . . . . 0.0 111.897 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 39.6 mt-10 -98.35 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.701 -1.249 . . . . 0.0 109.461 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.4 m-20 -57.01 -18.97 15.81 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -127.57 174.1 4.68 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.1 Cg_endo -65.8 175.84 4.16 Favored 'Trans proline' 0 C--N 1.281 -2.978 0 O-C-N 124.096 1.577 . . . . 0.0 114.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 82' ' ' SER . 4.0 mt -51.97 -13.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.504 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.59 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.5 p -45.83 -29.84 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -86.54 -38.95 7.94 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.789 ' HB2' HG23 ' A' ' 79' ' ' ILE . 50.0 m -62.51 -29.05 70.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.695 -0.885 . . . . 0.0 110.435 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -59.2 -162.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.435 -0.79 . . . . 0.0 111.409 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -127.11 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.665 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -39.53 -38.91 0.64 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 0.0 110.406 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.967 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -47.12 -39.06 12.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 3.7 p-10 -48.13 -35.03 10.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.5 tp -69.0 -30.9 69.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.21 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 20.2 m-30 -76.84 -45.45 28.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -61.25 -35.17 76.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 65.3 m-20 -63.75 -56.78 12.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.711 . . . . 0.0 109.364 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.12 -37.19 33.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.668 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -67.3 -40.09 86.01 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.218 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.68 HD13 HD13 ' A' ' 51' ' ' ILE . 13.3 mm -63.15 -59.84 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 1.8 mtpt -57.67 -40.36 79.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tppt? -61.41 -47.27 86.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.547 -0.721 . . . . 0.0 109.766 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -68.89 -51.82 27.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 105' ' ' GLN . 48.2 t -61.23 -40.7 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -1.064 . . . . 0.0 110.188 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 10.3 tp10 -60.2 -35.49 75.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 110.033 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.58 16.18 4.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -0.818 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.39 25.5 74.72 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 14.7 m-20 -86.19 -68.37 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 110.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -105.73 179.4 4.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.06 131.08 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.537 ' OE1' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.32 101.66 6.16 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.061 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.1 Cg_endo . . . . . 0 C--N 1.306 -1.676 0 O-C-N 123.946 1.498 . . . . 0.0 109.764 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -113.47 127.14 55.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -1.134 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.69 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.1 p -81.13 128.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.91 132.54 53.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 55' ' ' LEU . 18.5 tp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.14 0.495 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -50.57 -44.53 56.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' GLU . 4.6 mm-40 -57.53 -43.94 84.75 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.393 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' HD1' ' A' ' 47' ' ' TYR . 46.2 mt -53.03 -31.2 39.97 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.682 -1.261 . . . . 0.0 107.856 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.6 mt -81.95 -55.57 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.58 0.705 . . . . 0.0 109.178 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.597 HG12 ' CE1' ' A' ' 103' ' ' PHE . 59.8 mt -59.27 -55.31 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -58.65 -38.87 79.05 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.43 -48.62 84.01 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.835 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.0 mt -59.2 -36.43 75.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -1.083 . . . . 0.0 109.388 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -37.69 87.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.255 -0.903 . . . . 0.0 108.854 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.11 -18.75 24.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.562 -0.712 . . . . 0.0 109.82 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 55' ' ' LEU . 11.1 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 109.041 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.592 ' OG ' HD22 ' A' ' 58' ' ' LEU . 74.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.5 p -107.19 178.89 4.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.042 . . . . 0.0 111.094 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -46.67 -47.14 50.73 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.716 -0.615 . . . . 0.0 110.799 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.71 -43.44 5.42 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.113 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.27 -35.15 59.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 108.862 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -79.3 -46.17 18.25 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.8 mtpt -54.59 -40.93 69.31 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.3 ttpt -46.84 -49.72 19.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -65.99 -49.57 67.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.886 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -62.08 -30.35 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.587 ' HB2' ' CA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.06 -42.61 10.4 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.072 -1.018 . . . . 0.0 112.153 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.545 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 10.9 mt-10 -95.82 -65.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 109.849 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.3 m-20 -57.82 -18.96 25.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.814 -1.179 . . . . 0.0 107.902 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 3.0 m-85 -127.82 175.39 3.45 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.563 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.1 Cg_endo -66.18 174.55 5.86 Favored 'Trans proline' 0 C--N 1.282 -2.93 0 O-C-N 123.894 1.47 . . . . 0.0 114.118 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.648 HD12 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.02 -16.18 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.781 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.4 p -44.18 -31.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.46 -35.24 6.64 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.329 -2.308 . . . . 0.0 107.329 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.648 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -84.73 26.32 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.549 -0.971 . . . . 0.0 110.525 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -107.49 -133.66 0.33 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' PHE . 14.7 t -143.53 -83.05 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 0.0 110.831 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 13.1 t-20 -40.91 -28.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.209 -0.932 . . . . 0.0 110.79 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.886 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.9 t80 -52.02 -42.2 62.84 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.461 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.1 t0 -45.55 -30.14 1.38 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.9 tp -76.17 -36.49 58.69 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.921 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 m-85 -71.07 -44.04 66.55 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.103 -0.998 . . . . 0.0 108.379 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 73' ' ' ILE . 73.6 t80 -57.84 -38.52 75.8 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 25.8 m-20 -60.86 -56.13 24.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.559 -0.713 . . . . 0.0 109.449 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.36 -39.0 63.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 109.023 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.03 -38.74 82.88 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.024 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.669 HG21 ' NE2' ' A' ' 105' ' ' GLN . 8.1 mm -64.19 -59.74 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.372 -0.83 . . . . 0.0 109.021 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -59.03 -38.62 79.73 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.341 -0.849 . . . . 0.0 108.853 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.1 tptm -64.46 -47.84 77.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.08 -50.22 53.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.859 HG21 ' HG3' ' A' ' 105' ' ' GLN . 99.5 t -62.35 -45.52 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.367 -1.078 . . . . 0.0 109.737 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 35.9 tp10 -56.77 -33.69 66.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 1.018 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -83.82 12.88 5.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.856 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.0 23.65 77.9 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 1.018 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.2 m-20 -87.34 -67.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.139 -1.213 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.721 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.17 159.98 16.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.932 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 21.0 mm-40 -97.27 134.62 40.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.859 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -142.51 98.3 5.94 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 111.415 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo . . . . . 0 C--N 1.303 -1.851 0 O-C-N 123.948 1.499 . . . . 0.0 109.581 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -105.36 159.5 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.153 . . . . 0.0 110.047 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.2 p -121.7 115.02 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.981 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 4.6 mmtt -108.9 143.97 37.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.087 -1.008 . . . . 0.0 109.765 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.835 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.5 tp . . . . . 0 C--N 1.296 -1.722 0 O-C-N 121.507 -0.745 . . . . 0.0 110.362 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 65.4 m-85 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.161 0.505 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 13.5 ttp180 -52.1 -47.16 65.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' GLU . 24.6 mm-40 -57.16 -44.29 83.32 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 47' ' ' TYR . 74.4 mt -52.21 -32.25 35.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.633 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.764 HD11 ' HB3' ' A' ' 93' ' ' ALA . 12.7 mt -81.7 -56.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.614 HG12 ' CE1' ' A' ' 103' ' ' PHE . 68.7 mt -58.11 -52.29 60.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.9 mt-10 -62.38 -41.22 98.47 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -55.79 -40.7 81.26 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.01 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.5 mt -67.41 -37.04 82.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.457 -1.025 . . . . 0.0 109.559 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -29.5 62.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 108.922 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.8 -22.93 20.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.586 -0.696 . . . . 0.0 110.058 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.01 HD12 ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.816 ' OG ' HD22 ' A' ' 58' ' ' LEU . 30.9 m . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.571 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 16.7 p -133.37 178.32 7.0 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.131 -0.98 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.629 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -46.81 -46.42 51.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.716 -0.615 . . . . 0.0 111.235 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.14 -42.64 5.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.268 1.141 . . . . 0.0 110.665 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' CD2' ' A' ' 58' ' ' LEU . . . -57.32 -24.75 57.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.949 HD21 HD11 ' A' ' 58' ' ' LEU . 4.0 mm? -92.97 -48.59 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.1 mtpt -58.41 -41.29 84.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -47.97 -51.84 22.12 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.985 0.898 . . . . 0.0 108.806 178.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 t80 -62.22 -48.98 77.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.943 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 46.3 mt -65.17 -29.91 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 8.5 ptpt -92.02 -42.43 9.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.766 -1.209 . . . . 0.0 111.52 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 8.6 mt-10 -95.57 -64.8 1.02 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.477 ' CG ' ' HA ' ' A' ' 72' ' ' PHE . 6.0 m-20 -55.75 -22.01 21.83 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.828 -1.17 . . . . 0.0 107.953 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.79 178.02 1.6 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 177.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.584 ' HG2' HG12 ' A' ' 80' ' ' VAL . 46.1 Cg_endo -68.79 175.62 7.05 Favored 'Trans proline' 0 C--N 1.281 -3.011 0 O-C-N 123.88 1.463 . . . . 0.0 114.231 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.605 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.2 mp -49.71 -15.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.864 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.5 -31.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.35 -37.78 6.51 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -85.21 46.6 1.3 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.79 -0.83 . . . . 0.0 109.455 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.84 178.76 6.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 0.0 110.943 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 85' ' ' ASN . 65.8 m -104.75 156.3 18.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.455 -0.778 . . . . 0.0 109.786 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' SER . 5.7 t-20 76.79 -40.54 0.37 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.427 -0.796 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -48.65 -42.08 33.31 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.657 -1.277 . . . . 0.0 108.192 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.2 p30 -47.23 -36.41 8.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.8 tp -63.46 -34.35 77.58 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.253 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 79.8 m-85 -76.13 -47.88 22.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 51' ' ' ILE . 37.9 t80 -61.2 -36.03 78.77 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 75.0 m-20 -62.51 -56.71 15.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.13 -39.18 42.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.165 -0.96 . . . . 0.0 108.499 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.764 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.34 -40.85 98.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 51' ' ' ILE . 13.2 mm -64.19 -59.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 20.6 mtpt -55.41 -37.99 68.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.8 tppt? -65.4 -51.32 61.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -67.94 -47.35 60.73 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 105' ' ' GLN . 98.8 t -63.08 -42.17 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -1.021 . . . . 0.0 110.459 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 5.8 tp10 -61.62 -34.54 75.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.29 15.67 3.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 25.51 74.46 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 3.8 t0 -84.93 -67.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -1.153 . . . . 0.0 110.097 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.18 159.82 16.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.173 -0.954 . . . . 0.0 109.727 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 39.9 mm-40 -97.35 128.46 44.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.168 -0.958 . . . . 0.0 109.206 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.741 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -141.41 109.67 6.26 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.119 -0.988 . . . . 0.0 111.137 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 50.5 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 124.004 1.528 . . . . 0.0 109.536 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -96.51 137.62 35.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.128 . . . . 0.0 109.998 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.3 p -94.31 106.03 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.042 -1.036 . . . . 0.0 110.755 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 0.7 OUTLIER -99.29 128.94 45.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.745 179.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.803 ' CB ' HD22 ' A' ' 55' ' ' LEU . 26.2 tp . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.957 . . . . 0.0 109.705 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.712 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 71.3 m-85 . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 1.9 ttm180 -57.42 -46.17 83.83 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.3 mt-10 -55.95 -45.27 78.91 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 73' ' ' ILE . 75.7 mt -51.77 -35.3 43.22 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.74 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 103' ' ' PHE . 17.3 mt -79.35 -56.25 7.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.516 0.674 . . . . 0.0 109.374 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.7 mt -56.81 -51.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.8 mm-40 -60.83 -43.46 98.22 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -52.82 -41.85 58.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.3 mt -72.12 -40.34 68.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.649 -0.912 . . . . 0.0 108.678 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 m -67.08 -23.2 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.13 -23.95 21.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 64' ' ' SER . 12.0 mt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.681 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 58' ' ' LEU . 63.0 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 17.8 p -88.67 -179.06 5.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.091 -1.006 . . . . 0.0 111.257 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.664 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -51.03 -44.75 87.65 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.701 -0.624 . . . . 0.0 110.774 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.5 Cg_endo -68.68 -43.07 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.314 1.165 . . . . 0.0 109.818 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.98 -30.48 10.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.464 -0.895 . . . . 0.0 108.735 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.545 ' HG ' HG11 ' A' ' 113' ' ' VAL . 3.9 mm? -87.17 -50.85 6.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.775 ' HA ' HD12 ' A' ' 73' ' ' ILE . 88.9 mttt -53.92 -39.23 65.67 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.9 ttpp -51.56 -50.38 60.19 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.571 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.08 -47.95 82.4 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.896 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 17.0 mt -61.42 -33.27 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 110.663 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 43.6 pttt -91.52 -40.26 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 37.8 mt-10 -93.99 -66.11 0.94 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.897 -1.127 . . . . 0.0 110.218 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 25.4 m-20 -58.74 -21.49 55.41 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.68 -1.262 . . . . 0.0 108.077 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.644 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.46 175.0 2.86 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.2 Cg_endo -65.24 174.09 5.44 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 O-C-N 124.179 1.62 . . . . 0.0 113.839 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 6.3 mt -52.46 -12.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.812 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -45.96 -29.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.27 -36.45 7.06 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.339 -2.305 . . . . 0.0 107.339 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.645 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.8 t -73.44 -0.25 14.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.604 -0.939 . . . . 0.0 110.295 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -79.21 -149.34 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.209 -0.932 . . . . 0.0 110.827 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 85' ' ' ASN . 2.7 p -133.72 -79.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -41.64 -35.09 0.69 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.279 -0.888 . . . . 0.0 110.572 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.896 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.3 t80 -48.8 -40.95 31.01 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.902 -1.123 . . . . 0.0 108.339 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 92.5 m-20 -47.11 -26.23 1.05 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 5.7 tp -82.74 -33.75 27.39 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.883 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 30.1 m-85 -71.15 -45.69 63.01 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.301 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 73' ' ' ILE . 81.0 t80 -52.92 -31.95 42.81 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 19.5 m-20 -67.59 -52.29 40.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.538 -0.726 . . . . 0.0 109.433 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.23 -40.38 67.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 108.992 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -65.81 -37.28 85.84 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.948 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.701 HG23 ' HG3' ' A' ' 105' ' ' GLN . 9.6 mm -64.08 -59.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 108.865 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.43 -40.95 79.51 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -61.44 -45.33 94.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.781 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.63 -51.26 12.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 103' ' ' PHE . 92.5 t -61.86 -38.61 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.6 tp10 -58.49 -39.19 79.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.15 13.26 4.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.529 -0.732 . . . . 0.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.15 23.5 77.51 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 -83.11 -67.96 0.75 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -109.0 166.16 11.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 56.8 mm-40 -109.55 136.65 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 94' ' ' ILE . 6.0 mm-40 -146.28 107.16 4.16 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.034 -1.041 . . . . 0.0 111.435 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.6 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 123.89 1.469 . . . . 0.0 109.0 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.97 138.25 54.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.159 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.545 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -82.17 117.57 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 111.041 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -111.12 132.9 53.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 55' ' ' LEU . 17.7 tp . . . . . 0 C--N 1.298 -1.658 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.822 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 92.1 m-85 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 52' ' ' ILE 0.25 7.0 ttp180 -51.43 -44.15 62.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 5.0 mt-10 -56.76 -46.77 81.22 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.2 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.672 HD22 HG23 ' A' ' 73' ' ' ILE . 14.9 mt -52.07 -34.78 45.22 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.482 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 94' ' ' ILE . 3.3 mt -75.85 -56.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 109.393 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' CE1' ' A' ' 103' ' ' PHE . 25.3 mt -59.65 -54.07 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.907 0.86 . . . . 0.0 108.738 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 8.0 mt-10 -60.33 -35.68 76.2 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.775 0.798 . . . . 0.0 108.905 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -64.49 -49.71 63.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -59.65 -42.0 91.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -1.085 . . . . 0.0 109.303 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -66.1 -31.48 72.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.268 -0.895 . . . . 0.0 109.085 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.653 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.92 -15.35 29.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 HD21 ' A' ' 69' ' ' LEU . 12.3 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' HD13 ' A' ' 58' ' ' LEU . 16.4 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.062 0.458 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.658 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 8.2 p -135.02 174.76 10.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.129 -0.982 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 ttp180 -45.34 -47.74 34.55 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.692 -0.63 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.2 Cg_endo -66.45 -42.81 9.08 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.14 1.074 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -59.89 -34.33 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.651 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.959 HD21 HD11 ' A' ' 58' ' ' LEU . 4.2 mm? -80.92 -51.59 8.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -49.38 -38.23 27.81 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.303 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.81 -53.86 35.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 1.8 t80 -60.78 -46.17 91.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.722 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 8.3 mt -64.15 -31.44 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.235 -0.915 . . . . 0.0 110.635 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' N ' ' A' ' 82' ' ' SER . 1.1 ptpt -92.1 -38.78 11.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.932 -1.105 . . . . 0.0 110.888 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.558 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 16.5 mt-10 -95.36 -64.88 1.02 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.807 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 89.1 m-20 -58.64 -17.94 26.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -128.0 176.7 2.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.0 Cg_endo -67.16 175.68 5.46 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 O-C-N 124.021 1.537 . . . . 0.0 113.764 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 82' ' ' SER . 11.6 mt -52.39 -12.7 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.004 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.9 p -46.34 -30.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.05 -36.77 8.13 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 107.184 -2.366 . . . . 0.0 107.184 176.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB3' HG23 ' A' ' 79' ' ' ILE . 3.1 t -74.44 1.82 10.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.653 -0.91 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -84.79 -150.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.165 -0.959 . . . . 0.0 110.914 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' ASN . 31.0 t -134.18 -80.8 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.246 -0.909 . . . . 0.0 110.759 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' SER . 45.5 t-20 -39.19 -34.48 0.18 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.23 -0.919 . . . . 0.0 110.417 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -48.69 -40.29 27.64 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.437 178.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 50.5 t0 -48.11 -30.68 4.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.862 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.32 -28.69 59.76 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.193 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.609 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 12.4 m-85 -76.18 -46.14 29.9 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.618 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.9 t80 -57.72 -38.31 75.05 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 26.0 m-20 -60.04 -55.29 35.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.514 -0.741 . . . . 0.0 109.331 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.13 -41.39 75.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.345 -0.847 . . . . 0.0 109.201 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.822 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -64.32 -40.12 95.26 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.09 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 51' ' ' ILE . 6.7 mm -60.93 -59.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 108.677 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -57.32 -41.41 79.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.3 tppp? -59.43 -47.8 84.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.614 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -69.5 -52.94 18.88 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.911 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.1 t -60.64 -39.6 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.524 -0.986 . . . . 0.0 110.376 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.1 tp10 -64.44 -34.13 77.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.787 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . . . -82.44 11.79 5.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.912 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 22.73 78.75 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.704 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -85.9 -67.65 0.79 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.231 -1.158 . . . . 0.0 110.14 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -100.87 178.67 4.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 109.663 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -120.2 126.5 50.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.911 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -136.01 128.0 17.41 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.993 . . . . 0.0 110.514 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 51.8 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.776 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.541 ' O ' ' CD ' ' A' ' 106' ' ' PRO . . . -121.39 153.1 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -1.074 . . . . 0.0 109.913 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.458 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.1 p -120.07 115.02 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.679 -1.263 . . . . 0.0 110.458 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -108.27 124.81 50.88 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.848 HD23 HD13 ' A' ' 55' ' ' LEU . 2.6 tm? . . . . . 0 C--N 1.3 -1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.378 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.038 0.447 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.758 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -50.96 -45.64 60.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.07 -45.05 83.59 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.177 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.724 HD12 ' HD1' ' A' ' 47' ' ' TYR . 94.8 mt -52.29 -31.97 35.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.82 -1.175 . . . . 0.0 108.448 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.7 mt -82.16 -54.69 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.758 HD11 ' HD3' ' A' ' 48' ' ' ARG . 64.0 mt -58.42 -52.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 11.4 mt-10 -62.36 -38.62 90.25 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.768 0.794 . . . . 0.0 109.052 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -62.66 -45.94 94.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.068 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.8 mt -59.74 -37.2 78.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -1.101 . . . . 0.0 109.629 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -74.27 -28.31 61.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.028 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.83 -11.12 40.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.607 -0.683 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.068 HD12 ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 110.111 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.746 ' OG ' HD13 ' A' ' 58' ' ' LEU . 72.2 m . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.677 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 37.1 p -134.84 173.53 11.6 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.447 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.632 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -49.83 -45.8 80.26 Favored Pre-proline 0 C--N 1.299 -1.597 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.956 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.3 Cg_endo -70.41 -42.77 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.354 1.186 . . . . 0.0 110.281 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.42 -24.44 30.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.751 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 58' ' ' LEU . 4.1 mm? -90.89 -51.1 5.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.75 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 73' ' ' ILE . 89.8 mttt -59.31 -36.96 76.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.55 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 3.4 ttpt -55.88 -51.08 68.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.83 -46.7 87.06 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.904 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 18.6 mt -63.05 -33.97 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.587 -0.696 . . . . 0.0 111.169 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 82' ' ' SER . 17.1 ptmt -91.43 -42.14 10.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.85 -1.157 . . . . 0.0 111.435 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 15.6 mt-10 -94.43 -65.06 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 109.875 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 24.2 m-20 -56.7 -23.82 44.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.807 -1.183 . . . . 0.0 108.094 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -122.76 178.19 1.38 Allowed Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.581 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.3 Cg_endo -65.67 176.66 3.36 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 O-C-N 123.996 1.524 . . . . 0.0 114.414 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.21 -12.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.72 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.5 p -45.81 -29.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.94 -35.78 7.53 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HG23 ' A' ' 79' ' ' ILE . 40.7 t -57.23 -40.46 77.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.571 -0.958 . . . . 0.0 110.317 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.33 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.738 . . . . 0.0 110.838 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 12.4 t -122.75 -64.38 1.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 110.472 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 7.1 m120 -43.98 -37.2 2.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.904 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.1 t80 -48.38 -42.27 31.32 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.155 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -44.75 -29.69 0.82 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.9 tp -78.33 -35.08 48.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.231 0.539 . . . . 0.0 109.667 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.694 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 6.2 m-85 -69.15 -46.3 67.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.13 -0.981 . . . . 0.0 108.666 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.822 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 54.1 t80 -57.58 -36.19 71.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 16.7 m-20 -60.23 -55.13 37.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.075 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -55.43 -39.78 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 108.875 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.666 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.62 -40.63 95.82 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -63.07 -57.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 3.3 mtmm -60.12 -35.54 75.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -67.87 -53.4 26.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.48 -0.763 . . . . 0.0 109.651 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -61.65 -46.7 93.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' A' ' 105' ' ' GLN . 79.2 t -65.42 -46.2 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 7.9 tp10 -58.92 -33.47 70.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 109.874 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.28 13.49 4.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.32 24.19 76.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 4.2 t0 -87.06 -67.25 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.224 -1.162 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.46 159.97 16.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.024 . . . . 0.0 110.1 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -97.54 128.76 44.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 109.754 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.758 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -144.05 98.82 5.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.962 . . . . 0.0 111.234 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.3 Cg_endo . . . . . 0 C--N 1.304 -1.782 0 O-C-N 124.186 1.624 . . . . 0.0 108.965 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.556 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -81.65 125.72 30.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -1.202 . . . . 0.0 109.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.3 p -92.18 133.76 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.862 -1.149 . . . . 0.0 110.962 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -126.82 124.18 39.06 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.352 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.796 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 tp . . . . . 0 C--N 1.298 -1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 71.2 m-85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.079 0.466 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 3.2 ttm180 -55.64 -44.15 76.88 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 mm-40 -58.57 -43.24 89.35 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.199 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.59 HD22 HG23 ' A' ' 73' ' ' ILE . 36.4 mt -51.74 -32.22 29.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.588 -1.32 . . . . 0.0 107.636 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 93' ' ' ALA . 10.1 mt -82.34 -53.95 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.8 mt -58.72 -54.55 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.3 mt-10 -59.33 -38.89 81.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -57.83 -48.02 84.9 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.753 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.9 mt -66.86 -49.03 66.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.65 -0.912 . . . . 0.0 108.756 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -60.35 -24.86 65.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.49 -22.63 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.703 HD11 HD21 ' A' ' 69' ' ' LEU . 11.7 mt . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 109.259 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 10.3 m . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.2 p -99.71 172.05 7.51 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.041 -1.037 . . . . 0.0 111.202 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.63 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -45.96 -48.07 41.52 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.823 -0.548 . . . . 0.0 110.801 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.8 Cg_endo -67.32 -42.7 7.1 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.214 1.113 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.62 -28.36 20.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.279 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.703 HD21 HD11 ' A' ' 58' ' ' LEU . 4.6 mm? -86.7 -48.84 7.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.573 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.902 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -52.02 -43.32 63.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 6.2 ttpt -47.19 -53.52 12.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.61 -46.92 85.99 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.96 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 13.9 mt -63.54 -33.91 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.823 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.65 -40.29 11.38 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.977 -1.077 . . . . 0.0 111.458 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 11.4 mt-10 -95.59 -65.42 0.98 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.055 -1.028 . . . . 0.0 109.729 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.3 m-20 -56.5 -21.52 26.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.076 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.7 177.74 1.78 Allowed Pre-proline 0 C--N 1.309 -1.158 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.559 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.2 Cg_endo -67.99 177.14 4.57 Favored 'Trans proline' 0 C--N 1.282 -2.939 0 O-C-N 123.925 1.487 . . . . 0.0 113.755 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.614 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 13.0 mt -52.72 -12.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.812 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.602 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.2 p -45.97 -30.38 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.46 -37.15 6.66 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 106.591 -2.603 . . . . 0.0 106.591 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -83.33 37.01 0.54 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.752 -0.852 . . . . 0.0 110.078 178.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.88 -137.27 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.988 . . . . 0.0 110.493 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' PHE . 16.5 p -139.13 -88.73 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.005 . . . . 0.0 111.106 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' OD1' ' CZ ' ' A' ' 89' ' ' TYR . 6.0 t-20 -35.62 -30.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.695 . . . . 0.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.96 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 2.1 t80 -54.19 -44.07 71.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.939 -1.1 . . . . 0.0 108.684 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.4 m-20 -46.96 -26.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.781 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.1 tp -80.94 -29.13 35.52 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.786 -0.765 . . . . 0.0 109.724 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.636 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 22.5 m-85 -77.33 -44.51 29.28 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.153 -0.967 . . . . 0.0 108.732 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.602 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.1 t80 -60.25 -46.37 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.359 -0.838 . . . . 0.0 108.822 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 3.5 m-80 -55.04 -57.5 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.27 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.58 -42.27 70.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.09 -40.49 97.8 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 51' ' ' ILE . 8.5 mm -61.06 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.477 -0.765 . . . . 0.0 108.993 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -56.53 -37.95 71.17 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.588 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 23.9 tptp -65.51 -51.37 60.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.541 -0.724 . . . . 0.0 109.491 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.82 -49.93 64.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 54.1 t -50.71 -23.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -1.037 . . . . 0.0 109.372 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -93.33 -49.2 6.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.56 5.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 0.0 109.926 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -69.15 -9.21 60.0 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 m-20 66.79 37.14 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.861 -0.788 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' A' ' 97' ' ' GLY . 3.9 m-30 -87.08 146.63 26.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 109.821 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 23.8 mm-40 -97.44 124.73 41.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 108.892 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -144.63 98.48 4.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 110.897 -179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.4 Cg_endo . . . . . 0 C--N 1.306 -1.669 0 O-C-N 123.653 1.344 . . . . 0.0 109.7 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -117.71 160.36 21.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 109.603 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.3 p -110.66 124.23 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.629 -1.294 . . . . 0.0 110.32 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.69 132.63 53.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.918 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 55' ' ' LEU . 12.2 tp . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.654 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 29.8 m-85 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' A' ' 52' ' ' ILE . 4.1 ttt180 -61.14 -45.47 94.53 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 53' ' ' GLU . 55.1 mt-10 -58.38 -43.97 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 50' ' ' LEU . 46.6 mt -51.38 -34.09 32.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.688 -1.257 . . . . 0.0 108.311 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.66 HG21 ' CD2' ' A' ' 103' ' ' PHE . 30.2 mt -79.83 -55.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' A' ' 48' ' ' ARG . 60.2 mt -58.63 -53.98 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -61.17 -40.28 93.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.89 -47.74 84.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 8.2 mt -67.05 -49.87 63.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.937 . . . . 0.0 108.521 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 2.6 m -55.45 -24.39 30.56 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . -90.78 -27.27 19.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 13.2 mt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.196 -0.94 . . . . 0.0 108.728 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.606 ' OG ' HD13 ' A' ' 58' ' ' LEU . 68.1 m . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.692 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 20.5 p -131.26 174.51 9.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 111.237 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.635 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 tpp180 -48.07 -46.31 65.01 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.872 -0.517 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.7 Cg_endo -70.4 -43.15 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.229 1.12 . . . . 0.0 110.59 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.19 -31.9 61.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 65' ' ' SER . 3.6 mm? -78.45 -53.86 6.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.119 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.829 ' HA ' HD12 ' A' ' 73' ' ' ILE . 77.0 mttt -50.01 -36.41 28.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.65 -50.94 59.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.582 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.7 t80 -63.46 -45.93 88.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.87 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -63.77 -32.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.418 -0.801 . . . . 0.0 110.757 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.572 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 35.2 pttt -91.2 -41.38 11.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.095 -1.003 . . . . 0.0 111.494 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.572 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 34.2 mt-10 -93.83 -65.14 1.01 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.945 -1.097 . . . . 0.0 109.668 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.9 m-20 -59.94 -15.68 23.92 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.857 -1.152 . . . . 0.0 108.632 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.641 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -130.88 176.93 2.5 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.2 Cg_endo -65.74 173.63 6.57 Favored 'Trans proline' 0 C--N 1.283 -2.904 0 O-C-N 123.968 1.509 . . . . 0.0 113.594 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.621 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 3.1 mt -52.75 -12.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.882 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p -45.63 -30.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.28 -37.32 6.7 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -80.95 45.5 0.83 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.66 -0.906 . . . . 0.0 110.367 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.06 -138.18 0.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 1.9 t -141.46 -77.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.986 -1.071 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 20.1 t-20 -41.95 -36.93 1.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -1.0 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.87 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.35 -42.01 61.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.838 -1.163 . . . . 0.0 108.62 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.2 t0 -46.17 -27.31 0.95 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.18 -33.28 33.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.841 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.3 m-85 -71.92 -43.34 65.46 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.205 -0.934 . . . . 0.0 108.949 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' A' ' 51' ' ' ILE . 68.6 t80 -58.46 -38.82 78.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 13.2 m-80 -61.53 -55.4 31.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.666 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.14 -39.2 42.54 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.396 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.11 -38.61 79.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 98' ' ' VAL . 10.1 mm -62.58 -60.55 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -39.17 73.81 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.291 -0.881 . . . . 0.0 108.644 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 16.8 tptt -66.78 -51.23 58.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.58 -49.56 68.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 94' ' ' ILE . 62.0 t -51.17 -25.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.472 -1.017 . . . . 0.0 109.369 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -90.5 -49.45 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.592 -0.693 . . . . 0.0 110.543 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.83 -32.58 5.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -67.56 -9.93 56.57 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.6 t0 69.3 37.37 2.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.642 -0.916 . . . . 0.0 110.992 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -89.18 144.75 25.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.137 . . . . 0.0 109.398 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 23.9 mm-40 -97.43 126.66 42.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.14 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.531 ' NE2' ' HB ' ' A' ' 113' ' ' VAL . 6.7 mm-40 -143.55 124.33 7.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.3 Cg_endo . . . . . 0 C--N 1.307 -1.652 0 O-C-N 123.805 1.424 . . . . 0.0 109.552 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -120.21 146.99 45.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -1.096 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.531 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 1.5 p -116.88 117.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.77 -1.207 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 23.5 mtpt -112.95 128.0 56.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 55' ' ' LEU . 16.6 tp . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.278 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 75.0 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.288 0.566 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -52.76 -45.57 67.13 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -57.86 -45.48 86.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.347 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.512 HD12 ' HD1' ' A' ' 47' ' ' TYR . 74.7 mt -51.44 -32.38 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.799 -1.188 . . . . 0.0 108.392 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 94' ' ' ILE . 50.8 mt -82.72 -55.12 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 ' CE1' ' A' ' 103' ' ' PHE . 56.1 mt -57.49 -53.59 42.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.5 mt-10 -60.14 -39.95 88.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.599 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.03 -44.17 96.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.991 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -64.35 -39.13 93.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.5 -1.0 . . . . 0.0 109.553 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -71.65 -27.82 63.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 108.64 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.78 -19.72 23.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.619 -0.676 . . . . 0.0 109.77 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.991 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.9 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.326 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.601 ' OG ' HD22 ' A' ' 58' ' ' LEU . 9.0 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.612 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p -133.69 171.06 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.923 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.3 ttp85 -46.14 -47.77 43.82 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.74 -43.23 5.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.258 1.136 . . . . 0.0 110.861 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.52 -20.63 13.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.941 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -93.17 -45.22 7.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.16 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.44 -44.15 84.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 2.4 ttpt -47.2 -49.7 22.33 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.5 t80 -64.71 -49.04 72.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.56 -0.712 . . . . 0.0 109.283 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 15.9 mt -60.82 -31.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 111.013 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.26 -41.83 10.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.079 -1.013 . . . . 0.0 111.732 -178.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 22.3 mt-10 -95.73 -65.55 0.97 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.926 -1.109 . . . . 0.0 110.055 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 97.5 m-20 -56.87 -22.01 33.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.827 -1.171 . . . . 0.0 107.916 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.3 m-85 -123.84 175.85 2.59 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.58 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.9 Cg_endo -66.69 175.56 5.17 Favored 'Trans proline' 0 C--N 1.28 -3.041 0 O-C-N 124.016 1.535 . . . . 0.0 114.069 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.57 -14.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.021 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.619 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 4.0 p -45.58 -30.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.16 -35.27 7.14 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -84.19 21.69 1.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.741 -0.858 . . . . 0.0 110.244 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -101.86 -140.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 0.0 110.571 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 1.3 p -135.86 -87.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.937 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.4 m120 -39.86 -26.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 0.0 111.092 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.906 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.46 -42.83 61.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.829 -1.169 . . . . 0.0 108.55 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 70' ' ' LYS . 2.0 m-20 -46.52 -29.79 1.94 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.86 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -77.19 -32.25 55.93 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.93 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 17.4 m-85 -75.53 -43.29 49.59 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.952 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.642 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 67.0 t80 -60.97 -43.95 98.05 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.671 -0.811 . . . . 0.0 108.963 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.8 m-20 -56.48 -58.39 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.778 . . . . 0.0 109.23 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.56 -38.36 63.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 108.928 178.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.88 -35.04 74.35 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.298 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.651 ' HA ' HD13 ' A' ' 51' ' ' ILE . 7.1 mm -67.53 -59.68 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.96 -38.22 75.6 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.5 tppt? -60.91 -47.67 85.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.99 -51.4 34.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 105' ' ' GLN . 70.4 t -63.01 -42.43 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.456 -1.026 . . . . 0.0 110.262 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 21.9 tp10 -61.4 -35.35 77.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.153 -0.967 . . . . 0.0 109.815 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.46 11.44 4.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.82 23.59 77.78 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.518 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 1.1 t0 -85.35 -65.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -1.136 . . . . 0.0 110.167 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -99.81 -169.87 1.81 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.208 -0.932 . . . . 0.0 109.742 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' LYS . 34.9 mm-40 -129.66 125.09 35.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.7 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 98' ' ' VAL . 5.8 mt-30 -138.26 130.6 16.12 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 110.379 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 123.89 1.468 . . . . 0.0 109.507 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.538 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -119.18 160.36 22.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -1.136 . . . . 0.0 109.79 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -128.24 122.14 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.785 -1.197 . . . . 0.0 111.052 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' GLU . 33.1 mtpt -116.35 124.38 49.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.838 . . . . 0.0 109.486 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 55' ' ' LEU . 3.1 tm? . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 76.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 52' ' ' ILE . 18.6 ttp180 -51.89 -44.11 63.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' GLU . 9.2 mt-10 -57.95 -43.92 86.68 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.508 HD22 HG23 ' A' ' 73' ' ' ILE . 31.1 mt -52.82 -31.95 41.57 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.551 -1.343 . . . . 0.0 107.859 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 93' ' ' ALA . 2.9 mt -82.77 -55.27 7.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 ' CE1' ' A' ' 103' ' ' PHE . 69.9 mt -58.03 -53.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.5 mt-10 -61.39 -40.09 93.09 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -57.21 -47.55 86.87 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.8 mt -65.61 -39.58 91.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.691 -0.888 . . . . 0.0 109.157 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 m -68.67 -29.27 67.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.196 -0.94 . . . . 0.0 108.609 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.64 -19.71 23.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.611 -0.681 . . . . 0.0 109.868 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.983 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.412 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.574 ' OG ' HD22 ' A' ' 58' ' ' LEU . 5.6 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 12.0 p -135.6 172.78 12.52 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.192 -0.943 . . . . 0.0 111.243 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -48.71 -48.43 69.7 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.737 -0.602 . . . . 0.0 110.972 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -67.64 -42.47 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.301 1.158 . . . . 0.0 110.358 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.37 -25.75 50.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -91.17 -48.71 6.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.991 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -55.19 -47.67 74.91 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 9.0 ttpt -42.51 -53.68 4.23 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.57 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.72 -42.26 99.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.871 -0.518 . . . . 0.0 109.668 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 24.4 mt -64.38 -33.26 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.164 -0.96 . . . . 0.0 111.526 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.547 ' HG2' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -88.14 -44.6 10.79 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.836 -1.165 . . . . 0.0 111.252 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -96.8 -64.98 1.0 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 110.333 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 30.0 m-20 -53.81 -22.44 9.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.716 -1.24 . . . . 0.0 107.704 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.64 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -125.32 174.99 3.37 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HG2' HG12 ' A' ' 80' ' ' VAL . 51.5 Cg_endo -70.88 179.43 4.31 Favored 'Trans proline' 0 C--N 1.279 -3.085 0 O-C-N 123.923 1.486 . . . . 0.0 114.38 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.599 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -50.68 -15.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.073 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.601 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 2.6 p -44.89 -31.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.73 -42.15 5.48 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -85.98 44.68 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.683 -0.892 . . . . 0.0 109.618 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -116.56 -103.46 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -170.16 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.846 -1.158 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -45.63 -22.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.734 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 1.012 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.36 -44.49 62.11 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.878 -1.139 . . . . 0.0 108.607 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -45.98 -27.23 0.86 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.55 -30.65 33.03 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.829 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.618 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 18.5 m-85 -76.03 -43.56 43.43 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.66 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.65 ' CE1' HD11 ' A' ' 73' ' ' ILE . 76.4 t80 -56.47 -41.53 76.72 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.9 m-20 -57.35 -58.95 6.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -54.75 -40.42 69.33 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.511 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.6 -44.8 92.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.563 -0.711 . . . . 0.0 109.159 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 98' ' ' VAL . 8.1 mm -62.21 -58.19 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.4 -37.18 72.31 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -66.0 -52.43 49.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.64 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -61.99 -48.04 86.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' ILE . 43.7 t -64.27 -44.55 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.464 -1.021 . . . . 0.0 109.989 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.9 tp10 -61.29 -36.13 79.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.34 4.81 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.122 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.45 19.57 77.97 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 6.5 m-20 -85.06 -66.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -1.204 . . . . 0.0 110.138 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.9 174.35 5.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 23.2 mm-40 -117.69 133.83 55.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.28 -0.887 . . . . 0.0 109.757 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.62 ' NE2' HG21 ' A' ' 94' ' ' ILE . 1.3 mm100 -140.67 100.13 6.78 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.98 . . . . 0.0 111.174 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.5 Cg_endo . . . . . 0 C--N 1.304 -1.773 0 O-C-N 123.968 1.509 . . . . 0.0 109.398 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.96 124.81 42.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 110.731 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 2.4 p -80.11 119.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 8.7 mtpt -113.29 125.65 54.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.826 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.722 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.7 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.306 0.574 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HD2' ' CA ' ' A' ' 97' ' ' GLY 0.25 0.0 OUTLIER -53.04 -44.7 67.58 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.553 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 15.6 mt-10 -56.91 -46.73 81.76 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.202 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 47' ' ' TYR . 51.6 mt -49.72 -32.81 14.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.865 -1.147 . . . . 0.0 107.992 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.88 -56.14 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.387 0.613 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 mt -58.0 -51.0 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.47 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -63.43 -38.55 91.58 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.625 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.16 -44.68 96.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 115' ' ' LEU . 5.2 mt -65.03 -36.82 85.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.6 -0.941 . . . . 0.0 108.999 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.418 ' HG1' ' H ' ' A' ' 56' ' ' THR . 1.1 m -65.45 -30.66 71.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -91.38 -19.05 23.32 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.313 0.578 . . . . 0.0 109.769 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.836 HD11 HD21 ' A' ' 69' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.159 -0.963 . . . . 0.0 109.219 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.708 ' OG ' HD13 ' A' ' 58' ' ' LEU . 8.5 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.207 0.527 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 75.8 p -129.25 176.79 7.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.177 -0.952 . . . . 0.0 111.206 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -59.56 -43.83 96.53 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.824 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.449 1.236 . . . . 0.0 110.137 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.01 -30.3 59.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.369 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -78.03 -53.44 7.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 109.161 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.901 ' HA ' HD12 ' A' ' 73' ' ' ILE . 56.1 mttt -48.34 -34.42 10.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.977 -1.077 . . . . 0.0 108.308 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.6 ttpt -56.37 -51.9 66.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.625 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -60.39 -45.09 94.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.979 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.9 mt -61.67 -32.09 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -0.779 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.556 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 5.7 ptmm? -91.23 -41.48 10.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.065 -1.022 . . . . 0.0 111.571 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 30.5 mt-10 -92.12 -66.3 0.94 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.924 -1.11 . . . . 0.0 109.76 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.619 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 1.2 m120 -56.28 -27.04 53.97 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.985 -1.072 . . . . 0.0 108.278 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -120.48 177.87 1.32 Allowed Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.56 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.4 Cg_endo -64.62 173.37 5.6 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.097 1.577 . . . . 0.0 113.783 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.571 ' CA ' ' HB2' ' A' ' 82' ' ' SER . 5.8 pt -52.88 -12.93 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.914 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 73' ' ' ILE . 9.0 p -46.63 -28.55 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -35.46 8.77 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.571 ' HB2' ' CA ' ' A' ' 79' ' ' ILE . 14.3 m -51.16 -52.46 43.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.676 -0.896 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -49.95 -173.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.575 0.703 . . . . 0.0 111.222 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ASP . 46.8 t -117.2 -63.62 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 110.546 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 39.9 t30 -38.64 -38.8 0.43 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.348 -0.845 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -51.15 -41.37 60.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.894 -1.129 . . . . 0.0 108.428 178.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -45.69 -31.16 1.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -71.62 -39.5 70.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.727 -0.608 . . . . 0.0 109.733 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.616 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 19.8 m-85 -67.37 -42.47 83.38 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.653 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 51' ' ' ILE . 11.1 t80 -64.67 -41.5 96.04 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.871 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.1 m-20 -55.3 -52.03 64.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.836 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.26 -41.87 76.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.139 -0.976 . . . . 0.0 108.914 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.793 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -58.88 -39.07 80.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.4 -0.813 . . . . 0.0 109.144 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HD13 ' A' ' 51' ' ' ILE . 18.1 mm -59.66 -56.45 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 108.977 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -39.69 93.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 29.1 tptt -63.03 -49.44 74.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.374 -0.829 . . . . 0.0 109.46 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -65.75 -50.36 54.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 19.6 t -49.6 -23.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.067 -1.255 . . . . 0.0 108.904 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 3.2 tp10 -87.17 -49.78 7.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.715 . . . . 0.0 110.178 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.78 -33.74 4.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -68.25 -11.33 61.38 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 97' ' ' GLY . 9.2 m-20 65.1 32.13 10.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.796 -0.826 . . . . 0.0 111.215 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 3.6 m-30 -77.5 146.57 36.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 109.22 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 58.1 mm-40 -97.38 123.39 41.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 108.609 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -140.89 99.04 6.8 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 111.076 -178.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 44.1 Cg_endo . . . . . 0 C--N 1.305 -1.731 0 O-C-N 123.593 1.312 . . . . 0.0 109.508 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.059 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -115.12 159.74 20.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.1 p -111.34 142.34 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.946 -1.096 . . . . 0.0 110.781 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 6.3 mttm -136.93 130.03 31.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.479 -0.763 . . . . 0.0 109.684 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' LEU . 24.5 tp . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.077 -1.014 . . . . 0.0 110.352 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 57.0 m-85 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.398 0.618 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -57.14 -43.75 82.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.9 mt-10 -59.7 -45.36 92.36 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.385 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 47' ' ' TYR . 52.4 mt -50.68 -31.51 16.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.78 -1.2 . . . . 0.0 108.089 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 93' ' ' ALA . 41.7 mt -84.0 -55.09 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 63.5 mt -56.14 -50.55 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -54.42 -45.06 76.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 115' ' ' LEU . 7.5 mt -63.21 -39.5 94.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.662 -0.905 . . . . 0.0 109.013 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -67.21 -30.92 70.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.98 -13.37 33.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.717 -0.614 . . . . 0.0 109.704 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 55' ' ' LEU . 9.3 mt . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.156 -0.965 . . . . 0.0 109.011 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 58' ' ' LEU . 67.1 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 4.8 p -113.44 171.49 7.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.099 -1.001 . . . . 0.0 111.064 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.625 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -41.17 -50.26 8.25 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.87 -0.519 . . . . 0.0 111.059 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -66.86 -44.02 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.365 1.192 . . . . 0.0 110.495 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.06 -26.34 10.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 109.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 58' ' ' LEU . 2.8 mm? -86.87 -45.19 11.08 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -49.48 -42.42 43.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -50.26 -51.99 40.06 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.084 0.945 . . . . 0.0 109.013 178.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -59.37 -47.33 85.84 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.92 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 41.8 mt -64.33 -32.74 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 111.332 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.588 ' HB2' ' N ' ' A' ' 82' ' ' SER . 14.4 ptmt -91.22 -42.2 10.55 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.033 -1.042 . . . . 0.0 111.379 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 9.6 mt-10 -94.95 -64.92 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.923 -1.111 . . . . 0.0 110.009 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.1 m-20 -56.53 -23.44 39.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.71 -1.244 . . . . 0.0 108.003 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.666 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -122.45 177.54 1.57 Allowed Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.9 Cg_endo -66.27 175.47 4.9 Favored 'Trans proline' 0 C--N 1.283 -2.896 0 O-C-N 124.037 1.546 . . . . 0.0 114.429 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.597 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pp -52.54 -13.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.607 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p -45.92 -30.39 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.604 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.77 -37.2 6.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.597 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -85.17 36.87 0.65 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.647 -0.914 . . . . 0.0 110.32 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.92 -110.62 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.019 -1.05 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 86' ' ' PHE . 4.4 m -166.11 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.877 -1.139 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' SER . 57.4 t-20 -39.86 -27.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.289 -0.882 . . . . 0.0 110.663 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.92 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.6 t80 -54.35 -42.07 69.83 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.953 -1.092 . . . . 0.0 108.847 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.549 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 3.9 p-10 -47.79 -28.02 2.33 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.175 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tp -78.6 -32.48 47.58 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.96 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.666 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 29.1 m-85 -74.28 -41.13 61.73 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.715 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 73' ' ' ILE . 67.0 t80 -63.36 -48.11 79.3 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.383 -0.823 . . . . 0.0 108.791 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 14.6 m-80 -52.12 -57.26 10.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.166 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.05 -39.01 65.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.059 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.46 -37.99 80.69 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.351 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.794 HD11 ' CE2' ' A' ' 90' ' ' PHE . 12.9 mm -62.84 -61.11 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 25.1 mttt -57.35 -39.88 76.89 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -59.73 -43.11 94.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.462 -0.774 . . . . 0.0 109.746 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -70.9 -51.97 16.68 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.886 HG21 ' HG3' ' A' ' 105' ' ' GLN . 48.4 t -64.83 -42.07 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -1.124 . . . . 0.0 110.325 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 17.2 tp10 -60.18 -38.09 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.172 -0.955 . . . . 0.0 109.72 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.39 8.37 6.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.455 -0.778 . . . . 0.0 110.292 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.73 22.02 75.65 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -82.89 -66.94 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -1.148 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.21 177.0 4.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.739 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 16.7 mm-40 -111.01 126.14 54.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.45 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.886 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.5 98.32 9.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 110.985 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo . . . . . 0 C--N 1.307 -1.641 0 O-C-N 123.684 1.36 . . . . 0.0 109.909 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.47 161.65 16.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.174 . . . . 0.0 109.741 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.582 ' O ' HD21 ' A' ' 55' ' ' LEU . 2.1 p -126.64 100.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.016 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 28.8 mttp -99.81 126.52 45.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 55' ' ' LEU . 25.0 tp . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.222 0.534 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.62 130.63 43.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -0.913 . . . . 0.0 110.304 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER -160.96 40.56 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 111.005 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.292 22.9 t 52.11 105.64 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.668 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -72.29 149.66 44.28 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.072 -1.018 . . . . 0.0 110.178 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 9.8 p -131.82 162.54 30.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 110.352 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' A' ' 50' ' ' LEU . 34.0 m-85 -59.44 -39.09 82.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.591 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -52.72 -46.35 67.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 11.1 mm-40 -56.95 -46.2 82.27 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.175 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.741 HD22 HG23 ' A' ' 73' ' ' ILE . 96.6 mt -52.33 -32.07 36.33 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.932 -1.105 . . . . 0.0 108.987 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.792 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.8 mt -82.2 -55.94 6.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.553 0.692 . . . . 0.0 109.362 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.606 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.8 mt -59.12 -51.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 6.0 mt-10 -62.95 -39.92 96.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.618 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.57 -45.1 96.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.996 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.9 mt -64.45 -36.61 84.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.422 -1.046 . . . . 0.0 109.175 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m -72.88 -30.07 63.67 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.383 -0.823 . . . . 0.0 108.909 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.73 -19.75 23.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.556 -0.715 . . . . 0.0 110.041 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.996 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.4 mt -57.51 -40.76 79.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.093 -1.004 . . . . 0.0 109.581 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 2.0 mtpp 63.13 29.31 16.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.61 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -116.73 141.47 48.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 110.276 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.43 -24.8 13.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 110.39 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -75.35 -18.59 59.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.64 165.07 12.89 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.79 ' OG ' HD22 ' A' ' 58' ' ' LEU . 33.7 m -130.95 175.46 9.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.587 -0.949 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.539 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 9.5 p -125.09 172.61 9.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.006 -1.059 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.628 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.9 ttp180 -44.82 -48.56 29.02 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.78 -0.575 . . . . 0.0 111.151 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.4 Cg_endo -67.48 -42.37 7.33 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.234 1.123 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.32 -28.13 51.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.611 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -86.72 -51.19 6.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.414 -0.803 . . . . 0.0 109.519 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 mttp -54.61 -42.04 70.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -52.39 -49.74 63.82 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.111 0.958 . . . . 0.0 108.646 177.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.618 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -59.76 -45.33 92.58 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.934 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 28.8 mt -65.18 -32.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.467 -0.771 . . . . 0.0 111.159 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.594 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.69 -41.48 10.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.85 -1.156 . . . . 0.0 111.178 -179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 11.9 mt-10 -95.88 -65.25 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.103 -0.998 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 33.2 m-20 -56.43 -19.88 17.1 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.653 -1.279 . . . . 0.0 108.102 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.637 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.06 177.33 1.99 Allowed Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 177.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.55 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 50.0 Cg_endo -68.46 176.77 5.33 Favored 'Trans proline' 0 C--N 1.281 -3.006 0 O-C-N 123.997 1.525 . . . . 0.0 114.261 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.3 tt -50.72 -15.8 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.846 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.596 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.6 p -45.42 -29.9 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.625 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.94 -35.94 6.21 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -82.43 45.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -1.012 . . . . 0.0 109.972 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.78 -127.01 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.165 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 43.5 t -150.68 -78.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.86 -1.15 . . . . 0.0 110.844 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' PHE . 55.8 t-20 -52.4 -34.55 48.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.128 -0.982 . . . . 0.0 110.868 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.2 t80 -48.51 -38.76 21.07 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.731 -1.23 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.587 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -46.8 -32.93 4.01 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.678 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.6 tp -75.93 -32.86 59.77 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.941 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 47' ' ' TYR . 5.7 m-85 -69.73 -46.72 65.28 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.251 -0.905 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 32.8 t80 -58.09 -41.02 82.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.415 -0.803 . . . . 0.0 109.132 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.9 m-20 -56.82 -55.11 38.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 108.966 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.37 -38.88 66.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.285 -0.885 . . . . 0.0 108.889 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.02 -41.32 99.51 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.306 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 98' ' ' VAL . 11.4 mm -63.42 -58.8 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 108.955 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 36.2 mttp -56.06 -41.44 75.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -49.23 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -69.45 -48.13 46.37 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 105' ' ' GLN . 40.2 t -63.9 -43.44 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -1.031 . . . . 0.0 110.57 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.3 tp10 -61.92 -34.56 76.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.66 11.77 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.296 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 74.78 21.39 78.65 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 7.1 t0 -85.54 -68.42 0.73 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.236 -1.155 . . . . 0.0 109.969 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.686 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -105.22 169.73 8.28 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.541 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -110.9 126.85 55.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.811 ' HB2' HG11 ' A' ' 98' ' ' VAL . 1.3 mm100 -138.51 109.72 8.07 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.763 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 51.3 Cg_endo -80.53 -157.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.021 1.537 . . . . 0.0 109.891 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 2.4 mptp? -136.96 -82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 110.22 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.66 -146.65 30.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -77.86 4.86 5.73 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.261 1.663 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.85 -103.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 O-C-N 121.872 -0.518 . . . . 0.0 109.935 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.52 128.85 1.0 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.06 121.66 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -1.165 . . . . 0.0 109.926 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.6 p -81.27 126.19 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.978 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -125.23 128.76 48.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.83 . . . . 0.0 109.781 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.728 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.6 tp -74.59 117.37 16.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.103 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . 169.98 139.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' GLY . 0.3 OUTLIER -62.05 150.6 37.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.16 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' OXT' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.298 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.233 0.54 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.99 86.44 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.13 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 44' ' ' SER . 1.5 t 56.75 -156.93 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.857 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.3 31.2 t -174.39 179.35 1.82 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.436 -1.306 . . . . 0.0 110.922 -175.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -77.37 117.26 18.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 42.7 p -131.54 177.5 7.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.637 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 96.5 m-85 -62.9 -33.05 74.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.393 -0.817 . . . . 0.0 110.195 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.775 ' CD ' HD11 ' A' ' 52' ' ' ILE 0.25 2.7 tmm_? -49.14 -44.61 42.71 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 13.7 mt-10 -57.74 -45.58 85.65 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.091 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.777 HD22 HG23 ' A' ' 73' ' ' ILE . 98.7 mt -52.99 -32.56 47.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.062 -1.023 . . . . 0.0 108.883 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.783 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.3 mt -78.93 -56.56 6.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.563 0.697 . . . . 0.0 109.314 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.775 HD11 ' CD ' ' A' ' 48' ' ' ARG . 23.5 mt -59.0 -53.08 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 1.9 mm-40 -61.07 -39.66 90.71 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.99 -46.83 93.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.958 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.1 mt -63.89 -38.78 92.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -1.055 . . . . 0.0 109.077 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -69.75 -28.2 65.58 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.64 -22.47 21.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.598 -0.689 . . . . 0.0 109.724 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.977 HD11 HD21 ' A' ' 69' ' ' LEU . 12.8 mt -55.66 -36.43 67.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.326 -0.859 . . . . 0.0 109.219 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 7.2 mtpp 62.52 30.53 17.14 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.355 0.598 . . . . 0.0 110.177 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG3' ' C ' ' A' ' 59' ' ' LYS . 29.6 mt-10 -141.0 119.76 12.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.406 -0.809 . . . . 0.0 109.883 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -87.48 -19.09 28.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.0 110.375 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -60.79 -27.68 68.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 130.94 165.07 11.42 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.552 ' OG ' HD22 ' A' ' 58' ' ' LEU . 20.9 m -144.84 -179.83 6.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.546 -0.973 . . . . 0.0 109.787 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.5 p -128.59 174.06 9.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.959 -1.088 . . . . 0.0 111.549 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.647 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -47.57 -47.51 60.0 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.792 -0.568 . . . . 0.0 111.318 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -66.96 -42.21 8.69 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.286 1.15 . . . . 0.0 110.47 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.52 -27.24 56.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.669 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.977 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -92.08 -47.42 7.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 109.597 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.786 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.1 mttp -55.88 -40.21 72.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.135 -0.978 . . . . 0.0 108.517 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 74' ' ' LYS . 5.3 ttpt -54.54 -52.7 61.23 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.1 t80 -58.52 -43.54 89.22 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.938 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 54.8 mt -63.35 -33.1 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 0.0 111.104 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 6.5 pttt -91.62 -41.55 10.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.007 -1.058 . . . . 0.0 111.418 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.55 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.5 mt-10 -95.42 -65.44 0.98 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.032 -1.042 . . . . 0.0 109.897 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.9 m-20 -56.82 -21.1 26.45 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.077 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -125.25 176.54 2.35 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.6 Cg_endo -66.05 175.44 4.73 Favored 'Trans proline' 0 C--N 1.281 -3.005 0 O-C-N 123.976 1.514 . . . . 0.0 114.119 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.916 HG23 ' HB3' ' A' ' 82' ' ' SER . 17.8 mm -52.42 -12.57 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.937 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.637 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.3 p -45.97 -31.14 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.614 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.31 -38.25 7.29 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.916 ' HB3' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -82.32 42.29 0.74 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.621 -0.929 . . . . 0.0 110.078 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.04 -133.76 0.29 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.136 -0.978 . . . . 0.0 110.434 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' PHE . 20.7 m -143.9 -92.18 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.912 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 84' ' ' SER . 15.2 t30 -40.18 -28.14 0.05 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.142 -0.974 . . . . 0.0 110.965 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.938 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -48.32 -42.11 30.26 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.537 179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.56 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.4 t0 -47.42 -30.66 3.48 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.767 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.5 tp -76.81 -28.15 55.46 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.464 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 49.1 m-85 -77.05 -46.98 21.85 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.207 -0.933 . . . . 0.0 108.892 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.828 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 70.7 t80 -56.9 -43.03 80.93 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-20 -55.5 -57.0 13.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.185 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.87 -40.17 69.43 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.028 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -62.0 -45.57 93.04 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.485 -0.76 . . . . 0.0 109.016 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.828 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 16.7 mm -60.01 -58.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -0.807 . . . . 0.0 109.015 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.76 -38.2 74.99 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.758 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 5.2 tptt -66.03 -50.97 62.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.848 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -63.63 -51.48 53.73 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.588 HG21 ' HB2' ' A' ' 105' ' ' GLN . 93.1 t -60.81 -39.53 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.537 -0.978 . . . . 0.0 110.054 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.553 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 34.4 tp10 -63.19 -33.48 75.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.186 -0.947 . . . . 0.0 109.863 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.93 17.39 3.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.384 -0.822 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.6 73.4 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -87.57 -69.2 0.7 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.329 -1.101 . . . . 0.0 110.103 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -107.66 169.32 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -108.59 125.54 51.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.588 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.74 97.87 8.92 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.987 . . . . 0.0 110.63 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.5 Cg_endo -78.33 -163.97 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.905 1.476 . . . . 0.0 109.896 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -118.56 -67.69 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.949 . . . . 0.0 110.101 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.47 -150.56 16.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.92 4.75 5.85 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.146 1.603 . . . . 0.0 111.268 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.57 -91.0 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.848 -0.533 . . . . 0.0 110.153 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.86 112.35 0.32 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -102.37 160.16 14.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.972 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.487 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.9 p -121.19 117.58 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.862 -1.149 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 1.2 mttp -114.25 128.63 56.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.715 ' HB2' HD22 ' A' ' 55' ' ' LEU . 56.8 tp -82.99 128.19 34.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.86 88.57 2.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 110.086 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -110.34 118.04 35.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.261 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.224 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.284 0.564 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.29 59.99 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.1 OUTLIER -94.93 43.99 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.299 23.3 t 50.77 178.07 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.908 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -104.5 114.5 28.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 110.116 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.488 ' OG ' ' CG ' ' A' ' 49' ' ' GLU . 13.8 p -98.98 137.25 37.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 61.9 m-85 -48.07 -25.86 1.6 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.23 -0.919 . . . . 0.0 109.082 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -69.7 -45.62 67.85 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' GLU . 39.4 mt-10 -58.47 -42.25 87.06 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.294 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 47' ' ' TYR . 77.8 mt -54.26 -34.17 60.16 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.869 -1.145 . . . . 0.0 108.701 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.704 HG21 HD13 ' A' ' 94' ' ' ILE . 57.7 mt -79.35 -55.9 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.636 -0.665 . . . . 0.0 109.27 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.645 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.8 mt -59.24 -54.49 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.5 mt-10 -62.2 -41.58 98.5 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.9 -43.71 96.54 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -62.35 -36.54 82.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.464 -1.021 . . . . 0.0 109.041 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 m -72.2 -28.42 63.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.355 -0.84 . . . . 0.0 109.051 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.26 -18.13 26.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.59 -0.694 . . . . 0.0 109.632 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.019 HD12 ' HA ' ' A' ' 55' ' ' LEU . 14.4 mt -61.67 -42.05 98.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.239 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 57.52 31.78 20.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.599 -0.688 . . . . 0.0 110.395 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -93.87 -43.05 8.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.0 109.881 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.532 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER 73.26 -4.0 2.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.384 -0.822 . . . . 0.0 111.144 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -117.53 -26.26 6.69 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.031 -1.043 . . . . 0.0 109.951 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 140.08 168.65 11.41 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.618 ' OG ' HD22 ' A' ' 58' ' ' LEU . 13.8 m -149.94 177.03 10.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.394 -1.062 . . . . 0.0 109.771 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.588 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.8 p -127.81 176.58 7.45 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.4 tpp85 -46.28 -47.6 45.62 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 111.145 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.5 Cg_endo -67.99 -42.51 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.274 1.144 . . . . 0.0 110.77 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.588 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -58.06 -36.52 72.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 109.671 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -78.36 -49.52 13.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.815 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 73' ' ' ILE . 1.7 mtpt -52.09 -39.63 60.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.942 -1.099 . . . . 0.0 108.234 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 7.6 ttpt -50.94 -51.7 49.71 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.632 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.53 -48.41 81.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.988 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 11.8 mt -61.62 -33.49 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.596 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.552 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -91.28 -41.65 10.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.151 -0.968 . . . . 0.0 111.575 -179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.552 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 38.5 mt-10 -92.3 -65.81 0.97 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.963 -1.086 . . . . 0.0 110.106 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 18.0 m-20 -59.09 -22.02 60.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.865 -1.147 . . . . 0.0 108.214 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.621 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -123.8 176.87 1.97 Allowed Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.574 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.6 Cg_endo -65.07 172.74 6.9 Favored 'Trans proline' 0 C--N 1.282 -2.941 0 O-C-N 124.071 1.564 . . . . 0.0 113.527 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.63 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -52.9 -12.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.495 179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG13 HG22 ' A' ' 73' ' ' ILE . 8.5 p -45.64 -29.81 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.543 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.13 -36.72 7.49 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.409 -2.276 . . . . 0.0 107.409 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 16.1 t -65.57 -8.63 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.543 -0.975 . . . . 0.0 110.432 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.79 -160.69 0.5 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.285 -0.884 . . . . 0.0 111.108 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ASP . 1.5 t -127.21 -67.48 0.84 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.264 -0.897 . . . . 0.0 110.682 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 16.0 t-20 -40.73 -41.27 1.5 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.215 -0.928 . . . . 0.0 110.317 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.988 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -48.12 -40.91 25.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.6 t70 -46.72 -32.18 3.42 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -71.99 -33.82 68.41 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.394 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.636 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 21.6 m-85 -75.09 -43.01 55.46 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.402 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.614 ' CE2' HG12 ' A' ' 51' ' ' ILE . 43.7 t80 -57.46 -39.02 75.43 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -62.88 -54.88 31.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.508 -0.745 . . . . 0.0 109.487 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.69 -38.86 49.39 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.844 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.651 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.16 -47.61 73.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 51' ' ' ILE . 14.5 mm -56.26 -61.03 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 109.076 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -56.68 -40.31 75.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.635 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -61.6 -47.33 85.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.47 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.44 -52.22 10.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.752 HG21 ' HG3' ' A' ' 105' ' ' GLN . 57.9 t -59.17 -36.72 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.355 -1.085 . . . . 0.0 110.419 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 4.0 tp10 -61.66 -37.33 83.64 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.199 -0.938 . . . . 0.0 110.06 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.494 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.54 17.36 3.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.85 . . . . 0.0 109.931 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.52 25.31 74.96 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.494 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.1 m-20 -82.78 -67.37 0.79 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.136 -1.214 . . . . 0.0 109.893 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -102.91 168.23 9.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.977 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 34.3 mm-40 -105.9 125.71 51.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.347 -0.845 . . . . 0.0 109.324 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.752 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -141.09 102.37 6.22 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.118 -0.989 . . . . 0.0 111.103 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -80.85 -166.46 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.632 1.333 . . . . 0.0 109.648 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -123.02 -61.56 1.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.086 . . . . 0.0 110.246 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.81 -145.56 3.01 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.85 4.89 5.7 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.329 1.699 . . . . 0.0 111.407 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.86 -97.86 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.814 -0.554 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.19 116.35 0.37 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -103.57 160.65 14.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -1.109 . . . . 0.0 109.672 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.8 p -122.61 117.33 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.87 -1.144 . . . . 0.0 110.718 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 14.1 mtpt -115.43 129.27 56.51 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.247 -0.908 . . . . 0.0 109.762 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 55' ' ' LEU . 10.2 tp -74.87 96.28 3.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.199 -0.938 . . . . 0.0 110.906 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . 31.91 57.48 0.34 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.809 -0.557 . . . . 0.0 111.236 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 61' ' ' ARG . 22.8 mmtm -85.51 115.83 23.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.6 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.231 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' CD ' ' N ' ' A' ' 41' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.271 0.558 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.88 179.11 4.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.361 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.7 OUTLIER 42.5 40.03 1.77 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.26 -0.9 . . . . 0.0 110.794 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.302 23.3 t 50.15 -175.95 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.381 -1.328 . . . . 0.0 110.946 175.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -73.69 128.36 35.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.758 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 66.1 p -78.72 164.22 24.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.667 ' CB ' ' HB2' ' A' ' 93' ' ' ALA . 42.9 m-85 -53.69 -27.3 27.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.101 -0.999 . . . . 0.0 109.527 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.521 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.92 -45.7 91.26 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.33 -46.17 83.54 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.246 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.507 HD13 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 mt -50.41 -33.35 20.47 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.884 -1.135 . . . . 0.0 108.451 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.9 mt -80.77 -56.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.449 0.642 . . . . 0.0 109.384 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.62 HG12 ' CE1' ' A' ' 103' ' ' PHE . 74.2 mt -57.65 -53.41 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.7 mt-10 -59.24 -40.29 85.44 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.3 -46.49 86.43 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.791 HD22 ' CB ' ' A' ' 115' ' ' LEU . 9.1 mt -67.56 -39.89 84.93 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.54 -0.976 . . . . 0.0 108.657 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.4 m -66.19 -28.35 68.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -87.43 -29.21 21.62 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 64' ' ' SER . 10.4 mt -55.79 -21.16 17.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.843 . . . . 0.0 108.997 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.1 mtpt 61.4 57.17 2.43 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.336 0.589 . . . . 0.0 110.389 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 35.9 mm-40 56.19 157.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 167.96 166.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -61.83 -21.59 64.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.02 169.22 31.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.708 ' HB3' HD11 ' A' ' 58' ' ' LEU . 1.1 m -136.34 160.81 37.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.088 . . . . 0.0 110.23 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.722 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 7.1 p -134.64 175.99 9.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.174 -0.954 . . . . 0.0 111.164 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.27 -47.03 68.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.589 -0.694 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 41.0 Cg_endo -69.34 -42.81 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.231 1.122 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -57.99 -30.44 66.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.975 . . . . 0.0 109.791 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 65' ' ' SER . 4.5 mm? -86.7 -49.91 7.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.588 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.925 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.5 mtpt -56.33 -39.64 73.14 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.452 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.67 -49.97 45.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 3.1 t80 -63.0 -47.52 82.79 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.974 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 14.9 mt -61.04 -31.85 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.446 -0.783 . . . . 0.0 111.114 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.25 -43.04 10.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.0 -1.062 . . . . 0.0 111.643 -179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' ' 74' ' ' LYS . 26.7 mt-10 -94.0 -65.36 0.99 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.968 -1.082 . . . . 0.0 109.911 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 9.7 m-20 -59.08 -17.42 25.87 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 108.383 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.2 m-85 -129.29 176.47 2.78 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 77' ' ' TYR . 43.3 Cg_endo -65.27 173.35 6.34 Favored 'Trans proline' 0 C--N 1.28 -3.031 0 O-C-N 123.942 1.496 . . . . 0.0 114.082 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.765 HG23 ' HB3' ' A' ' 82' ' ' SER . 33.6 mt -50.48 -16.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.452 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.663 HG13 HG22 ' A' ' 73' ' ' ILE . 7.2 p -44.51 -29.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.31 -33.07 8.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.024 -2.03 . . . . 0.0 108.024 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.765 ' HB3' HG23 ' A' ' 79' ' ' ILE . 12.4 t -51.17 -55.7 16.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.621 -0.929 . . . . 0.0 110.743 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.67 -171.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.523 -0.736 . . . . 0.0 111.241 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -119.99 -54.63 2.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 110.429 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.4 t-20 -42.07 -41.35 2.56 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -49.03 -41.39 34.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.979 -1.075 . . . . 0.0 108.209 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.513 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 33.3 t0 -45.69 -31.41 1.94 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -70.33 -40.62 74.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.436 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 71.5 m-85 -68.32 -42.75 78.91 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.618 ' CE2' HG12 ' A' ' 51' ' ' ILE . 32.3 t80 -59.42 -32.6 70.33 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 14.3 m-80 -66.95 -53.59 30.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.53 -0.731 . . . . 0.0 109.427 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.62 -40.19 65.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.113 -0.992 . . . . 0.0 108.797 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.46 -36.17 82.11 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.638 HD13 HG21 ' A' ' 51' ' ' ILE . 6.5 mm -65.19 -60.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.37 -38.12 73.7 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 8.4 tptm -63.08 -50.02 72.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.362 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.469 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.93 -52.72 31.21 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.831 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.8 t -59.37 -33.77 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.492 -1.005 . . . . 0.0 109.902 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 1.2 tp10 -60.73 -40.33 92.0 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.287 -0.883 . . . . 0.0 109.616 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.56 15.77 3.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.803 . . . . 0.0 109.891 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.16 24.99 76.47 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 3.4 m-20 -81.15 -67.41 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.213 -1.169 . . . . 0.0 109.86 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.712 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -106.78 162.23 13.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.251 -0.906 . . . . 0.0 109.725 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 11.9 mm-40 -101.19 125.57 47.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.672 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.831 ' HG3' HG21 ' A' ' 98' ' ' VAL . 1.1 mm-40 -133.99 98.17 14.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 111.283 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.1 Cg_endo -78.9 172.69 14.61 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.933 1.491 . . . . 0.0 109.342 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 108' ' ' GLY . 11.2 mmtt -104.02 -55.39 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 109.89 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.07 -151.29 0.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -77.89 4.74 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 124.281 1.674 . . . . 0.0 111.371 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.66 -107.25 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.186 0 O-C-N 121.751 -0.593 . . . . 0.0 110.063 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.93 117.51 0.48 Allowed Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -112.52 160.05 18.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -1.051 . . . . 0.0 109.856 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 64' ' ' SER . 1.4 p -121.57 113.23 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.968 -1.082 . . . . 0.0 109.752 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -109.85 129.85 55.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.979 . . . . 0.0 110.133 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.791 ' CB ' HD22 ' A' ' 55' ' ' LEU . 19.8 tp -76.61 116.77 17.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.03 108.07 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.33 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -73.14 144.97 46.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.109 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.274 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.294 0.569 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.78 135.4 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 110.115 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 44' ' ' SER . 54.4 p -125.47 31.98 5.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.771 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.305 15.9 t 50.14 -172.47 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 118.184 -1.406 . . . . 0.0 110.777 175.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.94 156.35 20.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 4.8 p -116.13 135.69 53.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -0.965 . . . . 0.0 110.061 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.623 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 60.8 m-85 -47.85 -30.71 4.3 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.042 -1.036 . . . . 0.0 108.812 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 52' ' ' ILE . 17.2 ttm180 -59.24 -45.76 90.31 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' GLU . 59.1 mt-10 -59.08 -43.77 91.82 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 120.016 -0.673 . . . . 0.0 109.48 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 73' ' ' ILE . 96.2 mt -53.42 -32.53 50.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.654 -1.279 . . . . 0.0 108.713 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 93' ' ' ALA . 22.7 mt -81.23 -56.42 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-O 121.679 0.752 . . . . 0.0 109.107 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 103' ' ' PHE . 57.4 mt -59.11 -53.13 52.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.991 0.901 . . . . 0.0 108.68 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -61.6 -39.33 90.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.622 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.59 -49.14 79.76 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -58.52 -36.35 73.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.444 -1.033 . . . . 0.0 109.61 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -74.29 -30.13 61.95 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.309 -0.87 . . . . 0.0 108.771 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.94 -10.62 41.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.666 -0.646 . . . . 0.0 110.069 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 69' ' ' LEU . 12.5 mt -64.58 -53.49 46.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 109.773 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 56.67 16.83 2.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.568 -0.708 . . . . 0.0 109.88 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.47 -152.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 110.848 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -150.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.068 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -75.05 -0.74 19.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.475 -0.766 . . . . 0.0 110.754 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . -162.8 168.94 37.86 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.071 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.791 ' OG ' HD13 ' A' ' 58' ' ' LEU . 27.3 m -137.81 -172.88 3.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.396 -1.061 . . . . 0.0 109.953 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HD23 ' A' ' 69' ' ' LEU . 53.7 p -130.63 173.5 10.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 111.145 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.668 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 12.0 ttp180 -52.42 -45.68 95.13 Favored Pre-proline 0 C--N 1.296 -1.725 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.7 -42.97 4.16 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.299 1.157 . . . . 0.0 110.788 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.18 -22.57 17.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.075 -1.016 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -91.05 -48.4 6.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 109.356 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 73' ' ' ILE . 27.9 mttt -56.34 -42.07 77.11 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HE3' ' N ' ' A' ' 72' ' ' PHE . 1.7 ttpt -51.24 -49.81 60.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.879 0.847 . . . . 0.0 108.815 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -60.05 -47.4 86.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.921 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.5 mt -63.41 -31.29 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.856 . . . . 0.0 110.969 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 45.1 pttt -91.6 -41.04 10.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.877 -1.139 . . . . 0.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 7.6 mt-10 -96.03 -65.7 0.95 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.055 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 50.7 m-20 -56.62 -19.92 18.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.622 -1.299 . . . . 0.0 107.992 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -126.44 177.97 1.74 Allowed Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.143 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 77' ' ' TYR . 47.4 Cg_endo -67.77 176.19 5.45 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.949 1.5 . . . . 0.0 114.108 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -51.99 -15.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.857 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.605 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -44.28 -30.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.27 -36.45 6.6 Favored Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.603 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.2 m -73.06 -1.21 16.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -1.075 . . . . 0.0 110.323 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -81.27 -151.35 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.262 -0.899 . . . . 0.0 110.619 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.7 OUTLIER -132.78 -74.59 0.5 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.855 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 35.4 t-20 -41.12 -35.64 0.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.322 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.5 -42.05 61.4 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.078 -1.049 . . . . 0.0 108.553 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.535 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 26.1 m-20 -45.61 -27.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -80.83 -34.49 33.84 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.031 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' CB ' ' CE1' ' A' ' 47' ' ' TYR . 20.8 m-85 -71.94 -41.1 68.2 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.05 -1.032 . . . . 0.0 108.914 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.0 t80 -59.84 -43.27 94.69 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.484 -0.76 . . . . 0.0 108.956 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 59.5 m-20 -56.98 -56.83 16.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.51 -0.744 . . . . 0.0 109.462 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.99 -39.84 60.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.075 -1.016 . . . . 0.0 108.985 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.44 -45.5 87.21 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.465 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.738 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 12.8 mm -60.15 -60.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.42 -38.16 73.91 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.893 179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -66.61 -48.68 68.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.391 -0.818 . . . . 0.0 110.155 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -65.11 -52.52 40.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.604 HG21 ' HG3' ' A' ' 105' ' ' GLN . 37.8 t -61.56 -41.29 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.549 -0.971 . . . . 0.0 110.457 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.556 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 6.6 tp10 -61.25 -35.34 77.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.224 -0.923 . . . . 0.0 110.016 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.7 14.04 4.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.274 -0.891 . . . . 0.0 109.972 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.09 24.23 76.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.4 m-20 -85.84 -69.28 0.67 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -1.23 . . . . 0.0 109.754 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.53 175.14 5.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.199 -0.938 . . . . 0.0 109.519 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -115.5 125.73 53.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.673 ' NE2' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -134.91 98.18 13.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.664 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo -78.46 170.18 18.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.873 1.459 . . . . 0.0 110.076 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -98.17 -91.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.171 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.87 -150.64 43.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.02 4.73 5.91 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.18 1.621 . . . . 0.0 111.341 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -164.97 -105.18 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.202 0 O-C-N 121.79 -0.569 . . . . 0.0 110.268 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.31 109.71 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -99.92 160.17 14.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -1.069 . . . . 0.0 109.933 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.2 p -122.22 127.1 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.985 -1.072 . . . . 0.0 110.352 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.533 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 11.9 mtpt -126.45 129.56 48.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.804 ' HB2' HD13 ' A' ' 55' ' ' LEU . 8.7 tp -82.27 102.36 11.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . 14.83 60.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.078 0.466 . . . . 0.0 112.114 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 115' ' ' LEU . 43.3 mttt -112.06 143.28 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.912 . . . . 0.0 110.309 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.144 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.206 0.527 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.95 120.13 13.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.157 -0.965 . . . . 0.0 110.159 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.9 OUTLIER -98.42 26.37 5.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.771 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.299 13.8 t 51.71 174.28 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.304 175.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.33 114.95 29.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 49' ' ' GLU . 85.8 p -101.72 143.74 31.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 110.296 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.963 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.0 m-85 -48.74 -26.69 2.48 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.02 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.95 -45.53 82.75 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' CG ' ' A' ' 53' ' ' GLU . 53.2 mm-40 -57.85 -19.32 28.23 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.877 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 47' ' ' TYR . 29.6 mt -86.34 -31.75 21.37 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.7 -1.25 . . . . 0.0 108.961 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.806 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.14 -56.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.595 -0.691 . . . . 0.0 109.994 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.605 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 24.9 mt -52.74 -49.99 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.548 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 78.0 mt-10 -64.95 -41.5 95.43 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.912 0.863 . . . . 0.0 108.786 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -55.95 -44.83 87.71 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.985 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.9 mt -67.77 -44.15 78.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -1.047 . . . . 0.0 109.355 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 1.1 m -67.64 -26.29 66.15 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.208 -0.932 . . . . 0.0 108.848 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.57 -25.85 20.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.643 -0.661 . . . . 0.0 109.663 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.022 HD22 ' OG ' ' A' ' 64' ' ' SER . 8.3 mt -54.19 -35.92 62.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.23 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.513 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 41.31 37.43 0.63 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.855 -0.528 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.67 -159.06 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.922 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.62 -46.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -72.08 -24.73 61.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.26 170.98 12.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 1.022 ' OG ' HD22 ' A' ' 58' ' ' LEU . 65.4 m -134.93 166.53 22.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 0.0 110.15 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.519 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 5.1 p -120.97 173.04 7.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.091 -1.006 . . . . 0.0 110.97 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.627 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -43.73 -48.71 20.29 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.878 -0.513 . . . . 0.0 111.38 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.6 Cg_endo -67.55 -42.87 6.4 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.263 1.138 . . . . 0.0 110.436 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.95 -28.93 59.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.473 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 58' ' ' LEU . 3.7 mm? -83.3 -51.68 7.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.367 -0.833 . . . . 0.0 109.504 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.842 ' HA ' HD12 ' A' ' 73' ' ' ILE . 2.3 mtpt -50.06 -38.54 38.63 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.643 -1.223 . . . . 0.0 107.747 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -49.81 -55.96 12.17 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.629 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.74 -45.5 89.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 22.2 mt -62.39 -34.19 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.477 -0.765 . . . . 0.0 111.022 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.27 -41.81 10.74 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.037 -1.04 . . . . 0.0 111.595 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 20.8 mt-10 -94.61 -65.02 1.01 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.006 -1.059 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.57 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.2 m-20 -57.94 -20.56 38.59 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.645 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.6 m-85 -126.15 177.11 2.09 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.562 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.3 Cg_endo -65.09 174.86 4.38 Favored 'Trans proline' 0 C--N 1.283 -2.869 0 O-C-N 123.838 1.441 . . . . 0.0 114.03 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.613 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pt -52.97 -12.46 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.031 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.4 p -46.34 -28.95 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.605 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -36.93 7.88 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 107.179 -2.368 . . . . 0.0 107.179 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.613 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 48.3 t -57.22 -38.68 74.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.698 -0.883 . . . . 0.0 110.289 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -52.08 -169.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.526 -0.733 . . . . 0.0 111.033 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 85' ' ' ASN . 4.8 p -124.62 -65.8 1.02 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 110.339 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 61.4 t30 -42.65 -36.0 1.28 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -0.911 . . . . 0.0 109.988 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.889 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -50.92 -42.03 59.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.202 -0.999 . . . . 0.0 108.388 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.504 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 46.9 t0 -45.52 -27.77 0.8 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.6 tp -80.46 -34.45 35.91 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.623 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 5.3 m-85 -70.76 -43.61 68.44 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.727 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 71.5 t80 -55.13 -40.54 70.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.2 m-80 -59.22 -55.77 30.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.554 -0.717 . . . . 0.0 109.717 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -51.52 -38.35 53.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.718 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.806 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.49 -40.63 76.92 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.9 mm -63.42 -60.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 2.8 mttp -57.13 -37.81 72.57 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 12.5 tptm -63.96 -49.09 73.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.84 . . . . 0.0 109.468 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.93 -53.96 20.42 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 103' ' ' PHE . 61.9 t -56.49 -34.02 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -1.067 . . . . 0.0 109.826 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 24.5 tp10 -68.66 -35.03 76.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.957 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.53 11.29 5.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.427 -0.795 . . . . 0.0 110.043 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.18 21.57 78.85 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.702 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -88.98 -65.44 1.02 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 110.468 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.7 ' HB2' HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -99.05 166.94 11.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.765 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 114' ' ' LYS . 52.7 mm-40 -114.12 124.0 51.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.0 109.517 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.672 ' HG3' HG21 ' A' ' 98' ' ' VAL . 1.2 mt-30 -135.41 114.48 11.43 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 111.222 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.54 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 50.9 Cg_endo -89.94 -155.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.883 1.465 . . . . 0.0 109.141 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.54 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -135.9 -85.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.955 -1.091 . . . . 0.0 110.568 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.51 -151.61 1.44 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 49.3 Cg_endo -77.94 5.24 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 124.107 1.583 . . . . 0.0 111.389 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -179.3 101.45 0.03 OUTLIER 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.367 0.603 . . . . 0.0 109.695 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.33 113.17 5.16 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -89.36 159.49 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.654 HG22 HD21 ' A' ' 55' ' ' LEU . 1.4 p -114.4 101.6 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -101.86 129.39 48.08 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 178.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 55' ' ' LEU . 13.3 tp -67.78 148.75 50.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.235 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 102' ' ' ASP . . . -67.71 66.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 117' ' ' LYS . 16.6 pttt -72.81 127.21 31.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.926 . . . . 0.0 110.107 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 4.0 mttp . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.198 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.174 0.511 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.18 99.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.016 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 44' ' ' SER . 1.1 p 63.52 -160.15 0.3 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.181 -0.949 . . . . 0.0 110.561 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.295 30.4 t -174.29 95.06 0.09 Allowed 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.073 -175.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 123.71 26.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 109.979 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 p -121.42 178.82 4.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.159 -0.963 . . . . 0.0 110.462 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 55.1 m-85 -66.85 -39.05 87.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 110.037 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HA ' ' HB1' ' A' ' 93' ' ' ALA 0.25 3.2 ttp180 -49.74 -44.6 48.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 53.3 mm-40 -57.67 -45.37 85.68 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.823 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD12 ' HD1' ' A' ' 47' ' ' TYR . 35.6 mt -52.21 -31.22 30.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.816 -1.177 . . . . 0.0 108.596 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.4 mt -80.09 -56.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.566 0.698 . . . . 0.0 109.308 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.634 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.5 mt -61.41 -54.48 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.1 mt-10 -58.77 -38.63 78.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -58.68 -49.62 75.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.1 mt -59.97 -39.15 84.66 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.585 -0.95 . . . . 0.0 108.58 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 56' ' ' THR . 0.7 OUTLIER -70.31 -24.44 63.02 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -86.04 -31.21 22.1 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 64' ' ' SER . 25.5 mt -51.47 -36.23 43.32 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.9 mtpm? 59.3 32.45 21.93 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.317 0.579 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 45.4 mt-10 -123.62 -44.97 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER 65.88 7.42 4.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.355 -0.841 . . . . 0.0 110.306 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -96.02 -39.2 9.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 172.88 161.78 23.86 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.829 ' HB2' HG13 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -151.83 165.2 35.24 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.492 -1.005 . . . . 0.0 110.263 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.737 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 4.7 p -134.63 170.67 15.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 110.13 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 18.5 ttp180 -49.24 -49.25 71.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.1 Cg_endo -67.45 -42.4 7.34 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.301 1.158 . . . . 0.0 110.627 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -54.12 -31.1 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 109.464 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 4.0 mm? -82.84 -51.19 7.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.443 -0.785 . . . . 0.0 109.537 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HA ' HD12 ' A' ' 73' ' ' ILE . 4.6 mttt -50.36 -41.23 51.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 5.3 tmmm? -49.14 -55.85 11.03 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.3 t80 -58.97 -46.14 88.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.929 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 17.5 mt -65.53 -31.72 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.924 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 82' ' ' SER . 46.0 pttt -91.81 -40.77 11.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.966 -1.084 . . . . 0.0 111.624 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 14.9 mt-10 -95.97 -65.31 0.98 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.905 -1.122 . . . . 0.0 109.89 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 18.6 m-20 -56.31 -21.6 25.19 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.666 -1.272 . . . . 0.0 107.845 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.616 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.57 175.7 2.49 Favored Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.598 ' HG2' HG12 ' A' ' 80' ' ' VAL . 49.5 Cg_endo -69.84 178.31 4.75 Favored 'Trans proline' 0 C--N 1.28 -3.033 0 O-C-N 123.903 1.475 . . . . 0.0 113.885 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.6 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -51.0 -15.61 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.034 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.633 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.06 -30.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.77 -34.64 6.79 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -83.1 23.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -1.064 . . . . 0.0 110.362 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -104.83 -139.07 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.473 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -140.55 -77.14 0.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.09 -1.006 . . . . 0.0 110.893 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' SER . 50.4 t30 -42.05 -36.29 1.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.137 -0.977 . . . . 0.0 110.387 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.929 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -49.22 -40.53 34.08 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.361 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.546 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.1 m-20 -46.62 -29.66 1.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.15 -33.79 50.13 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.01 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.67 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 12.7 m-85 -72.21 -44.83 62.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.164 -0.96 . . . . 0.0 109.152 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 83.8 t80 -56.55 -39.9 74.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.486 -0.759 . . . . 0.0 109.184 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -60.63 -55.39 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.464 -0.773 . . . . 0.0 109.279 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.519 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.9 OUTLIER -50.87 -36.63 38.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 108.852 178.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.639 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -71.29 -39.43 71.51 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.212 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.686 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 5.7 mm -64.16 -59.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 108.976 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -57.53 -41.02 80.08 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -61.87 -42.89 99.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.448 -0.783 . . . . 0.0 109.964 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -74.43 -52.01 7.89 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 105' ' ' GLN . 48.0 t -61.71 -40.11 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.29 -1.123 . . . . 0.0 110.346 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 9.2 tp10 -59.87 -36.85 77.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.72 13.44 4.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.072 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.49 78.04 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.5 m-20 -82.66 -68.28 0.72 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.732 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.72 157.69 17.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.542 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 117' ' ' LYS . 6.1 mm-40 -96.73 123.89 40.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.692 ' HB2' HG11 ' A' ' 98' ' ' VAL . 6.0 mm-40 -134.98 106.09 10.47 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 0.0 110.701 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.531 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 49.4 Cg_endo -79.51 -160.19 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.458 . . . . 0.0 109.978 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -134.04 -86.84 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.073 -1.017 . . . . 0.0 110.418 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.73 -162.05 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -78.23 5.22 5.59 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.102 1.58 . . . . 0.0 111.285 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.04 96.05 0.5 Allowed 'General case' 0 C--N 1.284 -2.245 0 CA-C-O 121.255 0.55 . . . . 0.0 110.063 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.45 135.68 22.52 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -116.13 126.53 53.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -1.064 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.829 HG13 ' HB2' ' A' ' 64' ' ' SER . 2.1 p -83.49 104.52 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.5 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 5.4 mttp -101.29 125.86 47.97 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.039 -1.038 . . . . 0.0 109.301 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.771 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 0.4 OUTLIER -67.64 151.17 47.73 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.414 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 72.25 164.81 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.818 . . . . 0.0 110.127 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.543 ' HA ' ' CG ' ' A' ' 104' ' ' GLU . 14.1 ttpt -115.22 137.78 51.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.353 -0.842 . . . . 0.0 110.294 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 30.3 mttm . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.235 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.377 0.608 . . . . 0.0 110.634 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 41' ' ' GLU . . . 59.97 63.36 1.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.505 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' SER . 74.9 m -138.3 -172.45 3.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 0.0 110.589 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.302 41.1 t -174.63 162.65 3.4 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.727 -1.189 . . . . 0.0 110.97 -175.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.57 115.66 27.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.253 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.439 ' OG ' ' HG2' ' A' ' 49' ' ' GLU . 78.5 p -80.29 -178.93 6.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.382 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.63 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 73.5 m-85 -58.84 -40.55 84.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 109.928 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' HD12 ' A' ' 51' ' ' ILE . 5.0 ttp85 -54.93 -47.58 74.24 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.706 ' OE1' HD12 ' A' ' 52' ' ' ILE . 3.0 mm-40 -57.16 -43.67 82.74 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.227 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 21.1 mt -53.21 -33.21 51.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.84 -1.162 . . . . 0.0 108.635 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 93' ' ' ALA . 48.1 mt -79.84 -56.31 7.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.57 0.7 . . . . 0.0 109.169 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.706 HD12 ' OE1' ' A' ' 49' ' ' GLU . 65.3 mt -57.42 -52.13 60.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.3 mt-10 -64.57 -40.72 96.05 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -56.87 -44.04 92.34 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.932 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.2 mt -65.71 -38.76 90.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -1.072 . . . . 0.0 109.428 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.7 OUTLIER -67.7 -31.19 70.98 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.286 -0.884 . . . . 0.0 108.906 178.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -90.94 -24.43 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.631 -0.668 . . . . 0.0 110.029 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.032 HD11 HD21 ' A' ' 69' ' ' LEU . 10.2 mt -52.49 -30.38 29.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 37.88 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.365 0.602 . . . . 0.0 110.717 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -94.77 -35.65 12.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.838 . . . . 0.0 110.075 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 1.2 tpt180 71.32 -54.16 0.67 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.357 -0.839 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 63' ' ' GLY . 3.0 ptpt -63.62 -18.26 63.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.071 -1.018 . . . . 0.0 110.703 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' N ' ' HG3' ' A' ' 62' ' ' LYS . . . 125.5 172.04 13.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 1.004 ' OG ' HD22 ' A' ' 58' ' ' LEU . 19.5 m -147.62 -172.2 3.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 109.951 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.708 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 11.9 p -134.75 174.4 10.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.0 111.009 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.619 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -51.11 -47.23 88.06 Favored Pre-proline 0 C--N 1.301 -1.511 0 O-C-N 121.661 -0.649 . . . . 0.0 111.09 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.6 Cg_endo -69.97 -41.91 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.263 1.139 . . . . 0.0 110.396 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.33 -36.13 65.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' LEU . 4.4 mm? -75.98 -47.11 26.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.9 ' HA ' HD12 ' A' ' 73' ' ' ILE . 93.6 mttt -54.59 -46.61 73.8 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 70' ' ' LYS . 9.4 ttpt -42.01 -56.76 2.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' CZ ' ' CE1' ' A' ' 77' ' ' TYR . 2.2 t80 -57.59 -42.89 84.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.998 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 32.5 mt -66.02 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 111.476 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HB3' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.48 -42.51 10.24 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.747 -1.22 . . . . 0.0 111.087 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -95.4 -65.04 1.0 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 110.061 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.4 m-20 -56.93 -19.64 19.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.877 -1.14 . . . . 0.0 107.969 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.692 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 2.3 m-85 -126.89 175.04 3.59 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.577 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.4 Cg_endo -67.62 176.55 4.9 Favored 'Trans proline' 0 C--N 1.28 -3.076 0 O-C-N 123.941 1.495 . . . . 0.0 113.841 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 82' ' ' SER . 8.2 mt -52.55 -12.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.96 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.5 p -46.55 -29.36 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.14 -37.35 7.2 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.875 ' HB3' HG23 ' A' ' 79' ' ' ILE . 4.1 t -72.0 -2.89 19.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.563 -0.963 . . . . 0.0 110.263 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -78.27 -153.0 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.334 -0.854 . . . . 0.0 110.429 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 86' ' ' PHE . 28.2 m -133.19 -78.38 0.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.763 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 43.5 t-20 -40.72 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.225 -0.922 . . . . 0.0 110.331 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.998 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.6 t80 -56.32 -44.98 80.46 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.086 -1.009 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 88' ' ' LEU . 6.3 p-10 -45.42 -26.89 0.61 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.8 tp -82.28 -30.11 30.79 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.585 -0.697 . . . . 0.0 109.964 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.5 m-85 -76.45 -42.11 45.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 108.666 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 47.3 t80 -58.29 -42.47 86.68 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -59.04 -57.67 12.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.305 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -52.21 -38.54 58.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 108.683 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -66.23 -41.4 90.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.696 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -62.39 -60.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -0.833 . . . . 0.0 108.752 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -57.29 -37.62 72.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -65.09 -49.84 68.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.44 -0.787 . . . . 0.0 109.775 179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -64.51 -51.41 52.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 103' ' ' PHE . 74.4 t -61.56 -40.97 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -1.023 . . . . 0.0 109.813 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 11.9 tp10 -58.52 -34.28 70.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 0.0 109.691 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -86.11 15.58 5.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.745 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.22 23.96 76.95 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.548 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 11.6 m-20 -85.1 -68.05 0.75 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -1.22 . . . . 0.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -110.28 159.51 17.35 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.905 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 117' ' ' LYS . 24.9 mm-40 -100.13 143.45 30.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.681 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -149.82 98.08 3.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.15 -0.968 . . . . 0.0 111.014 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 45.1 Cg_endo -74.97 -167.18 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.726 1.382 . . . . 0.0 109.439 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 70.4 mmtt -130.92 -110.36 0.26 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.996 -1.065 . . . . 0.0 110.227 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.31 -154.31 45.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.94 5.16 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.137 1.598 . . . . 0.0 111.388 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -173.23 97.89 0.12 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.284 0.564 . . . . 0.0 109.927 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.53 119.51 12.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -100.95 160.62 14.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -1.003 . . . . 0.0 109.907 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.4 p -114.43 121.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.948 -1.095 . . . . 0.0 110.262 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -122.2 125.77 46.8 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.753 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 22.0 tp -70.61 132.8 46.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.363 -0.835 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 71.64 156.41 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -112.88 143.97 43.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.096 -1.002 . . . . 0.0 110.321 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.204 0.526 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.68 55.02 1.65 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.429 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.4 OUTLIER -154.36 172.35 17.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.833 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.316 48.4 t -175.56 176.91 1.85 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.804 -175.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 3.3 mtmp? -70.68 124.51 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.431 ' N ' ' OE2' ' A' ' 49' ' ' GLU . 49.1 p -123.96 170.75 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.776 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 97.1 m-85 -63.22 -23.64 67.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.706 . . . . 0.0 110.184 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 10.5 ttm180 -53.71 -46.12 70.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' GLU . 16.3 mt-10 -57.06 -44.72 83.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.14 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' TYR . 19.0 mt -51.6 -32.63 29.49 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.789 -1.194 . . . . 0.0 108.304 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 93' ' ' ALA . 11.0 mt -81.54 -55.66 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.602 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 53.2 mt -56.57 -52.27 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.1 mt-10 -62.48 -40.96 98.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.32 -45.64 95.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.966 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.5 mt -64.46 -41.25 96.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -1.002 . . . . 0.0 109.551 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -68.01 -28.79 67.72 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 108.832 178.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.55 -20.84 22.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.658 -0.651 . . . . 0.0 109.822 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.966 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.4 mt -57.44 -39.32 76.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.487 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.7 mtpt 61.79 22.33 12.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.607 -0.683 . . . . 0.0 110.194 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -120.43 112.31 18.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.169 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -77.97 -17.63 56.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 110.338 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -13.2 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.972 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 111.33 169.57 18.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.604 ' OG ' HD22 ' A' ' 58' ' ' LEU . 47.9 m -141.66 172.69 12.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.326 -1.102 . . . . 0.0 109.944 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.5 p -125.69 176.25 7.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 110.93 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -46.53 -47.62 48.5 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.789 -0.569 . . . . 0.0 110.98 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.3 Cg_endo -67.46 -42.26 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.262 1.138 . . . . 0.0 110.634 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.93 -33.71 64.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.774 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -81.08 -51.33 8.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.448 -0.782 . . . . 0.0 109.61 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' NZ ' ' HB3' ' A' ' 87' ' ' ASP . 2.7 mtpt -53.8 -41.54 67.4 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 72' ' ' PHE . 3.9 tmmm? -47.55 -53.74 13.65 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.998 0.904 . . . . 0.0 108.733 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.6 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.0 t80 -59.88 -49.66 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.967 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 19.9 mt -63.88 -31.53 53.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.395 -0.815 . . . . 0.0 110.669 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.631 ' HG3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -92.4 -34.97 13.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.085 . . . . 0.0 111.897 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 39.6 mt-10 -98.35 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.701 -1.249 . . . . 0.0 109.461 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 13.4 m-20 -57.01 -18.97 15.81 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -127.57 174.1 4.68 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.1 Cg_endo -65.8 175.84 4.16 Favored 'Trans proline' 0 C--N 1.281 -2.978 0 O-C-N 124.096 1.577 . . . . 0.0 114.07 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 82' ' ' SER . 4.0 mt -51.97 -13.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.504 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.59 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.5 p -45.83 -29.84 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -86.54 -38.95 7.94 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 107.177 -2.369 . . . . 0.0 107.177 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.789 ' HB2' HG23 ' A' ' 79' ' ' ILE . 50.0 m -62.51 -29.05 70.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.695 -0.885 . . . . 0.0 110.435 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -59.2 -162.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.435 -0.79 . . . . 0.0 111.409 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 87' ' ' ASP . 0.4 OUTLIER -127.11 -72.11 0.65 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.665 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -39.53 -38.91 0.64 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.35 -0.844 . . . . 0.0 110.406 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.967 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -47.12 -39.06 12.57 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 3.7 p-10 -48.13 -35.03 10.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' N ' ' OD1' ' A' ' 87' ' ' ASP . 5.5 tp -69.0 -30.9 69.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.21 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 47' ' ' TYR . 20.2 m-30 -76.84 -45.45 28.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -61.25 -35.17 76.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 65.3 m-20 -63.75 -56.78 12.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.563 -0.711 . . . . 0.0 109.364 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.12 -37.19 33.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.231 -0.918 . . . . 0.0 108.668 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.767 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -67.3 -40.09 86.01 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.218 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.68 HD13 HD13 ' A' ' 51' ' ' ILE . 13.3 mm -63.15 -59.84 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 1.8 mtpt -57.67 -40.36 79.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 5.0 tppt? -61.41 -47.27 86.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.547 -0.721 . . . . 0.0 109.766 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.475 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -68.89 -51.82 27.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 105' ' ' GLN . 48.2 t -61.23 -40.7 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.391 -1.064 . . . . 0.0 110.188 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 10.3 tp10 -60.2 -35.49 75.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.311 -0.868 . . . . 0.0 110.033 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -85.58 16.18 4.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -0.818 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.39 25.5 74.72 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 14.7 m-20 -86.19 -68.37 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -1.159 . . . . 0.0 110.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -105.73 179.4 4.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.06 131.08 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.556 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.537 ' OE1' HG21 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.32 101.66 6.16 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.061 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.1 Cg_endo -83.78 177.57 6.09 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.946 1.498 . . . . 0.0 109.764 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 33.4 mmtm -114.07 -110.04 0.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.051 -1.031 . . . . 0.0 110.073 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.17 -157.43 52.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 49.9 Cg_endo -77.58 4.94 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.006 1.53 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -176.4 99.24 0.06 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.315 0.579 . . . . 0.0 110.153 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.09 126.97 12.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -113.47 127.14 55.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -1.134 . . . . 0.0 110.004 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.69 HG11 ' HG ' ' A' ' 69' ' ' LEU . 3.1 p -81.13 128.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.961 -1.087 . . . . 0.0 110.733 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.46 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -124.91 132.54 53.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 55' ' ' LEU . 18.5 tp -82.75 113.95 20.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -173.15 112.51 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.216 -0.927 . . . . 0.0 110.412 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 121.09 25.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 0.0 110.121 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.1 tttt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.202 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 1.3 mm-40 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.246 0.546 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 41' ' ' GLU . . . 62.97 144.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.025 . . . . 0.0 109.645 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.6 OUTLIER -65.75 -168.44 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.626 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.304 37.9 t -174.65 60.4 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.704 -1.199 . . . . 0.0 110.748 -175.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 148.73 29.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 110.38 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 5.1 p -117.29 -179.58 3.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.312 -0.867 . . . . 0.0 110.241 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 -64.73 -32.69 74.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 109.93 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -50.57 -44.53 56.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' GLU . 4.6 mm-40 -57.53 -43.94 84.75 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.393 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' HD1' ' A' ' 47' ' ' TYR . 46.2 mt -53.03 -31.2 39.97 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.682 -1.261 . . . . 0.0 107.856 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.6 mt -81.95 -55.57 7.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.58 0.705 . . . . 0.0 109.178 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.597 HG12 ' CE1' ' A' ' 103' ' ' PHE . 59.8 mt -59.27 -55.31 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -58.65 -38.87 79.05 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -61.43 -48.62 84.01 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.835 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.0 mt -59.2 -36.43 75.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.358 -1.083 . . . . 0.0 109.388 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.54 -37.69 87.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.255 -0.903 . . . . 0.0 108.854 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -91.11 -18.75 24.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.562 -0.712 . . . . 0.0 109.82 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 55' ' ' LEU . 11.1 mt -49.58 -31.77 11.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 109.041 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 58' ' ' LEU . 10.3 ptmt 24.22 45.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.292 0.568 . . . . 0.0 111.564 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 58' ' ' LEU . 2.1 mt-10 -100.54 -115.34 0.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.643 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 172.82 -49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.639 -1.288 . . . . 0.0 110.843 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.72 -22.19 37.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 110.805 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 62' ' ' LYS . . . 138.57 169.14 11.49 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.516 -1.326 . . . . 0.0 109.977 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.592 ' OG ' HD22 ' A' ' 58' ' ' LEU . 74.4 m -139.73 148.84 42.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -1.054 . . . . 0.0 109.5 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.5 p -107.19 178.89 4.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.032 -1.042 . . . . 0.0 111.094 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -46.67 -47.14 50.73 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.716 -0.615 . . . . 0.0 110.799 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.71 -43.44 5.42 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.113 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.27 -35.15 59.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 108.862 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.734 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -79.3 -46.17 18.25 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 73' ' ' ILE . 5.8 mtpt -54.59 -40.93 69.31 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.3 ttpt -46.84 -49.72 19.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.616 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -65.99 -49.57 67.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.886 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -62.08 -30.35 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 111.028 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.587 ' HB2' ' CA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.06 -42.61 10.4 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.072 -1.018 . . . . 0.0 112.153 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.545 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 10.9 mt-10 -95.82 -65.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 109.849 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.3 m-20 -57.82 -18.96 25.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.814 -1.179 . . . . 0.0 107.902 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 3.0 m-85 -127.82 175.39 3.45 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.563 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 43.1 Cg_endo -66.18 174.55 5.86 Favored 'Trans proline' 0 C--N 1.282 -2.93 0 O-C-N 123.894 1.47 . . . . 0.0 114.118 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.648 HD12 ' OG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.02 -16.18 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.781 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 6.4 p -44.18 -31.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -92.46 -35.24 6.64 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.329 -2.308 . . . . 0.0 107.329 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.648 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -84.73 26.32 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.549 -0.971 . . . . 0.0 110.525 179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -107.49 -133.66 0.33 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 86' ' ' PHE . 14.7 t -143.53 -83.05 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.946 -1.096 . . . . 0.0 110.831 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 13.1 t-20 -40.91 -28.36 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.209 -0.932 . . . . 0.0 110.79 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.886 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.9 t80 -52.02 -42.2 62.84 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.461 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.1 t0 -45.55 -30.14 1.38 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.9 tp -76.17 -36.49 58.69 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.921 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 7.7 m-85 -71.07 -44.04 66.55 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.103 -0.998 . . . . 0.0 108.379 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.637 ' CE1' HD11 ' A' ' 73' ' ' ILE . 73.6 t80 -57.84 -38.52 75.8 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 25.8 m-20 -60.86 -56.13 24.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.559 -0.713 . . . . 0.0 109.449 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.526 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.36 -39.0 63.84 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 109.023 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.03 -38.74 82.88 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.024 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.669 HG21 ' NE2' ' A' ' 105' ' ' GLN . 8.1 mm -64.19 -59.74 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.372 -0.83 . . . . 0.0 109.021 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.5 OUTLIER -59.03 -38.62 79.73 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.341 -0.849 . . . . 0.0 108.853 178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 14.1 tptm -64.46 -47.84 77.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -66.08 -50.22 53.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.859 HG21 ' HG3' ' A' ' 105' ' ' GLN . 99.5 t -62.35 -45.52 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.367 -1.078 . . . . 0.0 109.737 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 35.9 tp10 -56.77 -33.69 66.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 1.018 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . . . -83.82 12.88 5.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.856 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.0 23.65 77.9 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 1.018 ' OD2' ' HB3' ' A' ' 100' ' ' ALA . 25.2 m-20 -87.34 -67.22 0.84 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.139 -1.213 . . . . 0.0 110.396 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.721 ' N ' ' CD1' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -110.17 159.98 16.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.932 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 21.0 mm-40 -97.27 134.62 40.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.859 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -142.51 98.3 5.94 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 111.415 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.6 Cg_endo -75.95 -157.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.948 1.499 . . . . 0.0 109.581 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -127.32 -53.45 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.973 -1.079 . . . . 0.0 110.133 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 43.52 -151.27 0.48 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.95 4.79 5.82 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.242 1.654 . . . . 0.0 111.289 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.31 -94.22 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.878 -0.514 . . . . 0.0 110.122 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.32 113.84 0.29 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -105.36 159.5 15.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.153 . . . . 0.0 110.047 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.2 p -121.7 115.02 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.981 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 4.6 mmtt -108.9 143.97 37.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.087 -1.008 . . . . 0.0 109.765 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.835 ' HB2' HD22 ' A' ' 55' ' ' LEU . 14.5 tp -89.28 134.04 34.22 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.507 -0.745 . . . . 0.0 110.362 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . -42.34 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -84.96 132.02 34.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 110.211 -179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' C ' ' HE3' ' A' ' 117' ' ' LYS . 1.6 mttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.212 0.53 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' SER . . . -42.05 130.33 3.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.232 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 44' ' ' SER . 4.8 p -56.32 -165.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 110.814 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.3 34.5 t -174.69 68.09 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.925 -175.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HE2' ' OH ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -72.5 134.27 45.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.265 -0.897 . . . . 0.0 110.357 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 78.3 p -115.43 174.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 110.223 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 65.4 m-85 -62.17 -39.52 92.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.939 . . . . 0.0 109.845 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 13.5 ttp180 -52.1 -47.16 65.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 53' ' ' GLU . 24.6 mm-40 -57.16 -44.29 83.32 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 47' ' ' TYR . 74.4 mt -52.21 -32.25 35.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.633 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.764 HD11 ' HB3' ' A' ' 93' ' ' ALA . 12.7 mt -81.7 -56.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.53 0.681 . . . . 0.0 109.369 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.614 HG12 ' CE1' ' A' ' 103' ' ' PHE . 68.7 mt -58.11 -52.29 60.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.9 mt-10 -62.38 -41.22 98.47 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 58' ' ' LEU . . . -55.79 -40.7 81.26 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.01 ' HA ' HD12 ' A' ' 58' ' ' LEU . 8.5 mt -67.41 -37.04 82.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.457 -1.025 . . . . 0.0 109.559 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -29.5 62.96 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 108.922 178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.8 -22.93 20.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.586 -0.696 . . . . 0.0 110.058 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.01 HD12 ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt -53.12 -40.48 64.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 109.517 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 36.9 43.57 0.3 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.622 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -85.11 -83.66 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.69 -62.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 111.043 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -122.03 -40.94 2.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.045 -1.034 . . . . 0.0 111.408 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.18 172.9 32.79 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.232 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.816 ' OG ' HD22 ' A' ' 58' ' ' LEU . 30.9 m -138.25 -179.08 5.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.549 -0.971 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.571 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 16.7 p -133.37 178.32 7.0 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.131 -0.98 . . . . 0.0 110.995 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.629 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -46.81 -46.42 51.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.716 -0.615 . . . . 0.0 111.235 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.7 Cg_endo -68.14 -42.64 5.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.268 1.141 . . . . 0.0 110.665 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.66 ' HB1' ' CD2' ' A' ' 58' ' ' LEU . . . -57.32 -24.75 57.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.016 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.949 HD21 HD11 ' A' ' 58' ' ' LEU . 4.0 mm? -92.97 -48.59 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HE3' ' CB ' ' A' ' 87' ' ' ASP . 1.1 mtpt -58.41 -41.29 84.63 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -47.97 -51.84 22.12 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.985 0.898 . . . . 0.0 108.806 178.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 t80 -62.22 -48.98 77.61 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.943 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 46.3 mt -65.17 -29.91 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 111.041 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 82' ' ' SER . 8.5 ptpt -92.02 -42.43 9.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.766 -1.209 . . . . 0.0 111.52 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 8.6 mt-10 -95.57 -64.8 1.02 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.671 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.477 ' CG ' ' HA ' ' A' ' 72' ' ' PHE . 6.0 m-20 -55.75 -22.01 21.83 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.828 -1.17 . . . . 0.0 107.953 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.647 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.79 178.02 1.6 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 177.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.584 ' HG2' HG12 ' A' ' 80' ' ' VAL . 46.1 Cg_endo -68.79 175.62 7.05 Favored 'Trans proline' 0 C--N 1.281 -3.011 0 O-C-N 123.88 1.463 . . . . 0.0 114.231 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.605 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.2 mp -49.71 -15.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.864 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.627 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.4 p -45.5 -31.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.628 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.35 -37.78 6.51 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -85.21 46.6 1.3 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.79 -0.83 . . . . 0.0 109.455 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.84 178.76 6.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 0.0 110.943 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 85' ' ' ASN . 65.8 m -104.75 156.3 18.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.455 -0.778 . . . . 0.0 109.786 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' SER . 5.7 t-20 76.79 -40.54 0.37 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.427 -0.796 . . . . 0.0 110.898 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.943 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -48.65 -42.08 33.31 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 120.657 -1.277 . . . . 0.0 108.192 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 2.2 p30 -47.23 -36.41 8.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.8 tp -63.46 -34.35 77.58 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.809 -0.757 . . . . 0.0 109.253 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 79.8 m-85 -76.13 -47.88 22.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' CE2' HG12 ' A' ' 51' ' ' ILE . 37.9 t80 -61.2 -36.03 78.77 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 75.0 m-20 -62.51 -56.71 15.47 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.13 -39.18 42.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.165 -0.96 . . . . 0.0 108.499 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.764 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.34 -40.85 98.44 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 51' ' ' ILE . 13.2 mm -64.19 -59.88 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 20.6 mtpt -55.41 -37.99 68.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.8 tppt? -65.4 -51.32 61.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.586 -0.696 . . . . 0.0 109.648 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -67.94 -47.35 60.73 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 105' ' ' GLN . 98.8 t -63.08 -42.17 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -1.021 . . . . 0.0 110.459 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 5.8 tp10 -61.62 -34.54 75.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.214 -0.929 . . . . 0.0 110.088 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.29 15.67 3.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 109.924 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 25.51 74.46 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 3.8 t0 -84.93 -67.3 0.81 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.241 -1.153 . . . . 0.0 110.097 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.69 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -107.18 159.82 16.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.173 -0.954 . . . . 0.0 109.727 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 39.9 mm-40 -97.35 128.46 44.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.168 -0.958 . . . . 0.0 109.206 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.741 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -141.41 109.67 6.26 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.119 -0.988 . . . . 0.0 111.137 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 50.5 Cg_endo -86.87 -158.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.004 1.528 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.526 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 1.3 mptp? -135.77 -83.87 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.996 -1.065 . . . . 0.0 110.238 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 44.01 -151.53 0.56 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 48.9 Cg_endo -77.83 4.86 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.279 1.673 . . . . 0.0 111.409 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -179.86 97.36 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.235 0.541 . . . . 0.0 110.137 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.68 120.14 16.02 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -96.51 137.62 35.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -1.128 . . . . 0.0 109.998 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.663 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.3 p -94.31 106.03 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.042 -1.036 . . . . 0.0 110.755 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 0.7 OUTLIER -99.29 128.94 45.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.745 179.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.803 ' CB ' HD22 ' A' ' 55' ' ' LEU . 26.2 tp -76.46 116.73 17.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -0.957 . . . . 0.0 109.705 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' C ' ' O ' ' A' ' 115' ' ' LEU . . . -13.57 78.34 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 121.308 0.575 . . . . 0.0 112.405 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.559 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -115.89 127.43 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.402 -0.812 . . . . 0.0 110.074 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.35 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.217 0.532 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.3 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.933 . . . . 0.0 110.493 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 44' ' ' SER . 5.0 p -134.78 178.85 6.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.307 43.5 t -174.86 132.29 0.33 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.356 -175.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -69.75 161.05 30.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 109.526 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.479 ' OG ' ' HG3' ' A' ' 49' ' ' GLU . 21.3 p -121.65 139.86 53.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.001 -1.062 . . . . 0.0 110.187 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.712 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 71.3 m-85 -50.47 -22.8 2.08 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.231 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HA ' ' HB1' ' A' ' 93' ' ' ALA . 1.9 ttm180 -57.42 -46.17 83.83 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.3 mt-10 -55.95 -45.27 78.91 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.683 HD22 HG23 ' A' ' 73' ' ' ILE . 75.7 mt -51.77 -35.3 43.22 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.74 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 103' ' ' PHE . 17.3 mt -79.35 -56.25 7.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.516 0.674 . . . . 0.0 109.374 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 65.7 mt -56.81 -51.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 49' ' ' GLU . 1.8 mm-40 -60.83 -43.46 98.22 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -52.82 -41.85 58.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 115' ' ' LEU . 7.3 mt -72.12 -40.34 68.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.649 -0.912 . . . . 0.0 108.678 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 m -67.08 -23.2 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.13 -23.95 21.21 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 64' ' ' SER . 12.0 mt -57.56 -30.14 64.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.681 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER 68.95 70.86 0.27 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.323 0.582 . . . . 0.0 111.078 179.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.78 76.59 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.319 -0.863 . . . . 0.0 110.721 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -113.54 154.28 27.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 110.228 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -5.78 21.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.04 167.1 16.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 58' ' ' LEU . 63.0 m -158.79 135.12 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.523 -0.987 . . . . 0.0 109.365 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 17.8 p -88.67 -179.06 5.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.091 -1.006 . . . . 0.0 111.257 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.664 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -51.03 -44.75 87.65 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.701 -0.624 . . . . 0.0 110.774 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.5 Cg_endo -68.68 -43.07 4.12 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.314 1.165 . . . . 0.0 109.818 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.98 -30.48 10.56 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.464 -0.895 . . . . 0.0 108.735 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.545 ' HG ' HG11 ' A' ' 113' ' ' VAL . 3.9 mm? -87.17 -50.85 6.33 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.775 ' HA ' HD12 ' A' ' 73' ' ' ILE . 88.9 mttt -53.92 -39.23 65.67 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.9 ttpp -51.56 -50.38 60.19 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.571 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.08 -47.95 82.4 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.896 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 17.0 mt -61.42 -33.27 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 110.663 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 82' ' ' SER . 43.6 pttt -91.52 -40.26 11.47 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.555 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 37.8 mt-10 -93.99 -66.11 0.94 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.897 -1.127 . . . . 0.0 110.218 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 25.4 m-20 -58.74 -21.49 55.41 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.68 -1.262 . . . . 0.0 108.077 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.644 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -122.46 175.0 2.86 Favored Pre-proline 0 C--N 1.309 -1.196 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.2 Cg_endo -65.24 174.09 5.44 Favored 'Trans proline' 0 C--N 1.281 -2.999 0 O-C-N 124.179 1.62 . . . . 0.0 113.839 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.645 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 6.3 mt -52.46 -12.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.812 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.5 p -45.96 -29.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.27 -36.45 7.06 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.339 -2.305 . . . . 0.0 107.339 176.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.645 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 3.8 t -73.44 -0.25 14.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.604 -0.939 . . . . 0.0 110.295 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -79.21 -149.34 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.209 -0.932 . . . . 0.0 110.827 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 85' ' ' ASN . 2.7 p -133.72 -79.51 0.47 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -41.64 -35.09 0.69 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.279 -0.888 . . . . 0.0 110.572 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.896 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.3 t80 -48.8 -40.95 31.01 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.902 -1.123 . . . . 0.0 108.339 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 92.5 m-20 -47.11 -26.23 1.05 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 5.7 tp -82.74 -33.75 27.39 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.883 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.63 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 30.1 m-85 -71.15 -45.69 63.01 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.301 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE1' HD11 ' A' ' 73' ' ' ILE . 81.0 t80 -52.92 -31.95 42.81 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 19.5 m-20 -67.59 -52.29 40.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.538 -0.726 . . . . 0.0 109.433 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.23 -40.38 67.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 108.992 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -65.81 -37.28 85.84 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.948 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.701 HG23 ' HG3' ' A' ' 105' ' ' GLN . 9.6 mm -64.08 -59.45 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 108.865 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -57.43 -40.95 79.51 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -61.44 -45.33 94.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.397 -0.814 . . . . 0.0 109.781 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 102' ' ' ASP . . . -72.63 -51.26 12.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 103' ' ' PHE . 92.5 t -61.86 -38.61 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 110.303 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.6 tp10 -58.49 -39.19 79.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 0.0 109.7 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.15 13.26 4.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.529 -0.732 . . . . 0.0 110.183 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.15 23.5 77.51 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 2.3 m-20 -83.11 -67.96 0.75 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.261 -1.141 . . . . 0.0 109.959 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -109.0 166.16 11.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 56.8 mm-40 -109.55 136.65 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.701 ' HG3' HG23 ' A' ' 94' ' ' ILE . 6.0 mm-40 -146.28 107.16 4.16 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.034 -1.041 . . . . 0.0 111.435 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.532 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 51.6 Cg_endo -77.97 -166.37 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.89 1.469 . . . . 0.0 109.0 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.532 ' CD ' ' O ' ' A' ' 106' ' ' PRO . 1.9 mptp? -133.45 -86.32 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.021 -1.049 . . . . 0.0 110.8 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' LYS . . . 45.64 -155.96 0.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 47.9 Cg_endo -77.55 4.39 6.02 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.958 1.504 . . . . 0.0 111.139 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 109' ' ' PRO . . . -179.52 99.6 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.289 0.566 . . . . 0.0 110.053 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.71 149.14 23.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.97 138.25 54.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.332 -1.099 . . . . 0.0 110.159 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.545 HG11 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -82.17 117.57 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 111.041 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -111.12 132.9 53.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.387 -0.821 . . . . 0.0 109.057 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 55' ' ' LEU . 17.7 tp -73.56 141.51 46.67 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.163 -0.961 . . . . 0.0 110.094 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 102' ' ' ASP . . . -55.63 84.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.398 -0.814 . . . . 0.0 110.087 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -99.62 145.14 27.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.363 -0.836 . . . . 0.0 110.371 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.199 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.25 152.94 38.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.254 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 44' ' ' SER . 35.3 t -104.66 48.94 0.82 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.345 -0.847 . . . . 0.0 110.827 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.296 28.8 t 50.83 -176.0 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.101 175.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -85.01 155.33 21.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 p -131.82 152.4 51.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.242 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.822 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 92.1 m-85 -53.76 -22.26 8.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.323 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 52' ' ' ILE 0.25 7.0 ttp180 -51.43 -44.15 62.23 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 5.0 mt-10 -56.76 -46.77 81.22 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.2 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.672 HD22 HG23 ' A' ' 73' ' ' ILE . 14.9 mt -52.07 -34.78 45.22 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.482 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 94' ' ' ILE . 3.3 mt -75.85 -56.04 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 109.393 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' CE1' ' A' ' 103' ' ' PHE . 25.3 mt -59.65 -54.07 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.907 0.86 . . . . 0.0 108.738 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 8.0 mt-10 -60.33 -35.68 76.2 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.775 0.798 . . . . 0.0 108.905 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -64.49 -49.71 63.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.1 mt -59.65 -42.0 91.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -1.085 . . . . 0.0 109.303 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 m -66.1 -31.48 72.38 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.268 -0.895 . . . . 0.0 109.085 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.653 ' CB ' ' CE1' ' A' ' 72' ' ' PHE . . . -90.92 -15.35 29.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.532 -0.73 . . . . 0.0 110.158 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.959 HD11 HD21 ' A' ' 69' ' ' LEU . 12.3 mt -59.73 -42.47 93.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 70.99 14.57 6.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.846 -0.533 . . . . 0.0 110.392 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.67 159.47 15.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.17 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.12 -8.86 8.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -100.92 -25.58 14.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 114' ' ' LYS . . . 135.47 168.66 11.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.401 ' CB ' HD13 ' A' ' 58' ' ' LEU . 16.4 m -142.99 -177.28 5.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -1.076 . . . . 0.0 109.834 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.658 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 8.2 p -135.02 174.76 10.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.129 -0.982 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.631 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 ttp180 -45.34 -47.74 34.55 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.692 -0.63 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.2 Cg_endo -66.45 -42.81 9.08 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.14 1.074 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.658 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -59.89 -34.33 73.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 109.651 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.959 HD21 HD11 ' A' ' 58' ' ' LEU . 4.2 mm? -80.92 -51.59 8.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -49.38 -38.23 27.81 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.303 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.81 -53.86 35.31 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 1.8 t80 -60.78 -46.17 91.54 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.722 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 8.3 mt -64.15 -31.44 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.235 -0.915 . . . . 0.0 110.635 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB2' ' N ' ' A' ' 82' ' ' SER . 1.1 ptpt -92.1 -38.78 11.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.932 -1.105 . . . . 0.0 110.888 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.558 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 16.5 mt-10 -95.36 -64.88 1.02 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.218 -0.926 . . . . 0.0 109.807 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 89.1 m-20 -58.64 -17.94 26.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.651 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -128.0 176.7 2.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.0 Cg_endo -67.16 175.68 5.46 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 O-C-N 124.021 1.537 . . . . 0.0 113.764 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 82' ' ' SER . 11.6 mt -52.39 -12.7 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.004 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.617 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.9 p -46.34 -30.23 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.05 -36.77 8.13 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 107.184 -2.366 . . . . 0.0 107.184 176.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.744 ' HB3' HG23 ' A' ' 79' ' ' ILE . 3.1 t -74.44 1.82 10.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.653 -0.91 . . . . 0.0 110.585 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -84.79 -150.32 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.165 -0.959 . . . . 0.0 110.914 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.455 ' O ' ' C ' ' A' ' 85' ' ' ASN . 31.0 t -134.18 -80.8 0.46 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.246 -0.909 . . . . 0.0 110.759 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 84' ' ' SER . 45.5 t-20 -39.19 -34.48 0.18 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.23 -0.919 . . . . 0.0 110.417 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -48.69 -40.29 27.64 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.437 178.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.574 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 50.5 t0 -48.11 -30.68 4.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.672 -0.811 . . . . 0.0 108.862 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.32 -28.69 59.76 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.193 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.609 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 12.4 m-85 -76.18 -46.14 29.9 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.384 -0.927 . . . . 0.0 108.571 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.618 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.9 t80 -57.72 -38.31 75.05 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 26.0 m-20 -60.04 -55.29 35.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.514 -0.741 . . . . 0.0 109.331 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.13 -41.39 75.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.345 -0.847 . . . . 0.0 109.201 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.822 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -64.32 -40.12 95.26 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.09 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.62 HD13 HD13 ' A' ' 51' ' ' ILE . 6.7 mm -60.93 -59.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 108.677 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -57.32 -41.41 79.9 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.3 tppp? -59.43 -47.8 84.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.614 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -69.5 -52.94 18.88 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.911 HG21 ' HG3' ' A' ' 105' ' ' GLN . 59.1 t -60.64 -39.6 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.524 -0.986 . . . . 0.0 110.376 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 8.1 tp10 -64.44 -34.13 77.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.787 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.704 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . . . -82.44 11.79 5.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.912 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.22 22.73 78.75 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.704 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -85.9 -67.65 0.79 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.231 -1.158 . . . . 0.0 110.14 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -100.87 178.67 4.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 109.663 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -120.2 126.5 50.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.292 -0.88 . . . . 0.0 109.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.911 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -136.01 128.0 17.41 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.993 . . . . 0.0 110.514 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 112' ' ' ALA . 51.8 Cg_endo -86.2 -156.27 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.776 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 106' ' ' PRO . 9.9 mmtm -161.26 110.23 1.58 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.273 -0.892 . . . . 0.0 109.147 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -171.15 -149.52 6.55 Favored Glycine 0 C--N 1.286 -2.233 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.27 4.78 5.58 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.256 1.661 . . . . 0.0 111.325 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.0 78.5 0.59 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.316 0.579 . . . . 0.0 109.966 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.05 128.48 47.74 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' O ' ' CD ' ' A' ' 106' ' ' PRO . . . -121.39 153.1 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -1.074 . . . . 0.0 109.913 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.458 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 1.1 p -120.07 115.02 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.679 -1.263 . . . . 0.0 110.458 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HG2' ' HA2' ' A' ' 63' ' ' GLY . 4.0 mtmp? -108.27 124.81 50.88 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.959 HD13 ' N ' ' A' ' 116' ' ' ALA . 2.6 tm? -73.62 137.6 44.32 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 110.378 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.959 ' N ' HD13 ' A' ' 115' ' ' LEU . . . -176.3 98.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 110.299 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -95.0 109.47 21.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.303 -0.873 . . . . 0.0 110.13 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 pttt . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.261 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 31.8 tt0 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.84 124.29 21.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.138 -0.976 . . . . 0.0 110.178 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.84 49.73 11.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 0.0 110.708 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.298 28.0 t 50.8 -174.66 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.007 175.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -64.32 130.55 44.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.475 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 58.7 p -131.53 -179.27 5.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.414 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' HD1' HD12 ' A' ' 50' ' ' LEU . 42.6 m-85 -66.76 -36.56 82.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.758 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -50.96 -45.64 60.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -57.07 -45.05 83.59 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.177 179.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.724 HD12 ' HD1' ' A' ' 47' ' ' TYR . 94.8 mt -52.29 -31.97 35.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.82 -1.175 . . . . 0.0 108.448 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 93' ' ' ALA . 4.7 mt -82.16 -54.69 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.758 HD11 ' HD3' ' A' ' 48' ' ' ARG . 64.0 mt -58.42 -52.41 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 11.4 mt-10 -62.36 -38.62 90.25 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.768 0.794 . . . . 0.0 109.052 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -62.66 -45.94 94.75 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.068 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.8 mt -59.74 -37.2 78.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.328 -1.101 . . . . 0.0 109.629 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -74.27 -28.31 61.14 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 109.028 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.83 -11.12 40.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.607 -0.683 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.068 HD12 ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt -68.14 -53.37 25.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 0.0 110.111 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 66.87 39.17 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 110.025 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -92.78 -167.39 1.73 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.459 ' N ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -127.18 -58.97 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 0.0 110.682 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -81.2 -40.38 23.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 169.18 168.38 31.11 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.746 ' OG ' HD13 ' A' ' 58' ' ' LEU . 72.2 m -114.96 -177.72 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -1.048 . . . . 0.0 109.562 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.677 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 37.1 p -134.84 173.53 11.6 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.447 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.632 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -49.83 -45.8 80.26 Favored Pre-proline 0 C--N 1.299 -1.597 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.956 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.3 Cg_endo -70.41 -42.77 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.354 1.186 . . . . 0.0 110.281 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.677 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.42 -24.44 30.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.751 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 58' ' ' LEU . 4.1 mm? -90.89 -51.1 5.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.75 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 73' ' ' ILE . 89.8 mttt -59.31 -36.96 76.58 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.55 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HE2' ' N ' ' A' ' 72' ' ' PHE . 3.4 ttpt -55.88 -51.08 68.83 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.602 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.83 -46.7 87.06 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.904 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 18.6 mt -63.05 -33.97 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.587 -0.696 . . . . 0.0 111.169 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 82' ' ' SER . 17.1 ptmt -91.43 -42.14 10.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.85 -1.157 . . . . 0.0 111.435 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 15.6 mt-10 -94.43 -65.06 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.966 -1.084 . . . . 0.0 109.875 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 24.2 m-20 -56.7 -23.82 44.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.807 -1.183 . . . . 0.0 108.094 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -122.76 178.19 1.38 Allowed Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.581 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.3 Cg_endo -65.67 176.66 3.36 Favored 'Trans proline' 0 C--N 1.283 -2.881 0 O-C-N 123.996 1.524 . . . . 0.0 114.414 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.21 -12.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.72 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 3.5 p -45.81 -29.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.94 -35.78 7.53 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HG23 ' A' ' 79' ' ' ILE . 40.7 t -57.23 -40.46 77.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.571 -0.958 . . . . 0.0 110.317 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -51.33 -170.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.738 . . . . 0.0 110.838 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 12.4 t -122.75 -64.38 1.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 110.472 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 7.1 m120 -43.98 -37.2 2.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 109.758 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.904 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.1 t80 -48.38 -42.27 31.32 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.155 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.534 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -44.75 -29.69 0.82 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.9 tp -78.33 -35.08 48.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.231 0.539 . . . . 0.0 109.667 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.694 ' CG ' ' CE2' ' A' ' 47' ' ' TYR . 6.2 m-85 -69.15 -46.3 67.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.13 -0.981 . . . . 0.0 108.666 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.822 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 54.1 t80 -57.58 -36.19 71.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 16.7 m-20 -60.23 -55.13 37.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -0.832 . . . . 0.0 109.075 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -55.43 -39.78 70.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 108.875 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.666 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -64.62 -40.63 95.82 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.822 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 9.7 mm -63.07 -57.59 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 3.3 mtmm -60.12 -35.54 75.48 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -67.87 -53.4 26.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.48 -0.763 . . . . 0.0 109.651 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ASP . . . -61.65 -46.7 93.72 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' A' ' 105' ' ' GLN . 79.2 t -65.42 -46.2 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -1.118 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 7.9 tp10 -58.92 -33.47 70.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 109.874 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.28 13.49 4.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.997 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.32 24.19 76.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 4.2 t0 -87.06 -67.25 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.224 -1.162 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.46 159.97 16.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.024 . . . . 0.0 110.1 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 117' ' ' LYS . 6.9 mm-40 -97.54 128.76 44.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -0.932 . . . . 0.0 109.754 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.758 ' HB2' HG21 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -144.05 98.82 5.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.962 . . . . 0.0 111.234 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 50.3 Cg_endo -76.26 -148.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.186 1.624 . . . . 0.0 108.965 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -149.07 105.79 3.56 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.627 -1.296 . . . . 0.0 109.348 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.09 -146.52 6.15 Favored Glycine 0 C--N 1.283 -2.382 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.26 4.88 6.2 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 124.348 1.709 . . . . 0.0 111.345 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 111' ' ' GLY . . . -170.86 21.92 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.822 -0.549 . . . . 0.0 111.118 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 110' ' ' ALA . . . 36.87 91.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -81.65 125.72 30.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -1.202 . . . . 0.0 109.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CA ' ' OE1' ' A' ' 105' ' ' GLN . 2.3 p -92.18 133.76 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.862 -1.149 . . . . 0.0 110.962 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -126.82 124.18 39.06 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.352 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.796 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 tp -67.43 151.03 48.12 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 109.858 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 74.07 157.06 0.18 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.057 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HA ' ' CG ' ' A' ' 104' ' ' GLU . 5.5 ptpp? -115.01 143.96 44.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.188 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.348 0.594 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.94 70.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 0.0 110.086 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 44' ' ' SER . 4.1 t -119.84 41.1 3.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.958 . . . . 0.0 110.772 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.3 23.1 t 50.59 -178.96 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.057 175.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -89.67 159.96 16.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.328 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 6.0 p -130.58 178.23 6.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.105 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 71.2 m-85 -62.46 -30.06 70.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.105 -0.997 . . . . 0.0 109.924 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' ILE . 3.2 ttm180 -55.64 -44.15 76.88 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' GLU . 3.4 mm-40 -58.57 -43.24 89.35 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.199 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.59 HD22 HG23 ' A' ' 73' ' ' ILE . 36.4 mt -51.74 -32.22 29.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 120.588 -1.32 . . . . 0.0 107.636 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 93' ' ' ALA . 10.1 mt -82.34 -53.95 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.8 mt -58.72 -54.55 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' GLU . 4.3 mt-10 -59.33 -38.89 81.46 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' CE2' ' A' ' 72' ' ' PHE . . . -57.83 -48.02 84.9 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.753 HD13 ' HB2' ' A' ' 115' ' ' LEU . 8.9 mt -66.86 -49.03 66.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.65 -0.912 . . . . 0.0 108.756 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -60.35 -24.86 65.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.49 -22.63 21.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.703 HD11 HD21 ' A' ' 69' ' ' LEU . 11.7 mt -60.5 -26.64 66.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.253 -0.904 . . . . 0.0 109.259 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 3.1 mtpt 70.37 70.16 0.21 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.253 0.549 . . . . 0.0 110.751 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 1.1 tp10 61.69 -118.6 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 0.0 110.729 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 72.23 149.2 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.969 -1.082 . . . . 0.0 110.329 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -13.67 50.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 0.0 110.585 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 153.25 169.48 18.4 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . 10.3 m -141.98 155.13 45.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -1.045 . . . . 0.0 109.686 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.2 p -99.71 172.05 7.51 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.041 -1.037 . . . . 0.0 111.202 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.63 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -45.96 -48.07 41.52 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.823 -0.548 . . . . 0.0 110.801 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.8 Cg_endo -67.32 -42.7 7.1 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.214 1.113 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.62 -28.36 20.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.279 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.703 HD21 HD11 ' A' ' 58' ' ' LEU . 4.6 mm? -86.7 -48.84 7.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.573 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.902 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -52.02 -43.32 63.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 6.2 ttpt -47.19 -53.52 12.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CE2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -58.61 -46.92 85.99 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.96 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 13.9 mt -63.54 -33.91 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.342 -0.849 . . . . 0.0 110.823 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.65 -40.29 11.38 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.977 -1.077 . . . . 0.0 111.458 -178.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 74' ' ' LYS . 11.4 mt-10 -95.59 -65.42 0.98 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.055 -1.028 . . . . 0.0 109.729 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 14.3 m-20 -56.5 -21.52 26.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.076 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.7 177.74 1.78 Allowed Pre-proline 0 C--N 1.309 -1.158 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.559 ' HG2' HG12 ' A' ' 80' ' ' VAL . 45.2 Cg_endo -67.99 177.14 4.57 Favored 'Trans proline' 0 C--N 1.282 -2.939 0 O-C-N 123.925 1.487 . . . . 0.0 113.755 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.614 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 13.0 mt -52.72 -12.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.812 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.602 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.2 p -45.97 -30.38 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.46 -37.15 6.66 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 106.591 -2.603 . . . . 0.0 106.591 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -83.33 37.01 0.54 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.752 -0.852 . . . . 0.0 110.078 178.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.88 -137.27 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.12 -0.988 . . . . 0.0 110.493 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 86' ' ' PHE . 16.5 p -139.13 -88.73 0.21 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.093 -1.005 . . . . 0.0 111.106 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' OD1' ' CZ ' ' A' ' 89' ' ' TYR . 6.0 t-20 -35.62 -30.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.695 . . . . 0.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.96 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 2.1 t80 -54.19 -44.07 71.24 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.939 -1.1 . . . . 0.0 108.684 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.4 m-20 -46.96 -26.83 1.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.595 -0.842 . . . . 0.0 108.781 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 6.1 tp -80.94 -29.13 35.52 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.786 -0.765 . . . . 0.0 109.724 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.636 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 22.5 m-85 -77.33 -44.51 29.28 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.153 -0.967 . . . . 0.0 108.732 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.602 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 72.1 t80 -60.25 -46.37 90.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.359 -0.838 . . . . 0.0 108.822 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 3.5 m-80 -55.04 -57.5 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.471 -0.768 . . . . 0.0 109.27 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.58 -42.27 70.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.774 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.09 -40.49 97.8 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 51' ' ' ILE . 8.5 mm -61.06 -60.84 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.477 -0.765 . . . . 0.0 108.993 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -56.53 -37.95 71.17 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.588 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 23.9 tptp -65.51 -51.37 60.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.541 -0.724 . . . . 0.0 109.491 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.82 -49.93 64.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.569 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 54.1 t -50.71 -23.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -1.037 . . . . 0.0 109.372 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -93.33 -49.2 6.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 110.527 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.56 5.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 0.0 109.926 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -69.15 -9.21 60.0 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.602 -2.199 . . . . 0.0 107.602 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 97' ' ' GLY . 7.9 m-20 66.79 37.14 4.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.861 -0.788 . . . . 0.0 110.849 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' A' ' 97' ' ' GLY . 3.9 m-30 -87.08 146.63 26.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.962 -1.086 . . . . 0.0 109.821 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 23.8 mm-40 -97.44 124.73 41.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 108.892 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -144.63 98.48 4.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.2 -0.937 . . . . 0.0 110.897 -179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.4 Cg_endo -78.12 178.58 7.41 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.653 1.344 . . . . 0.0 109.7 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 5.0 mptp? -118.19 -92.51 0.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 110.282 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.67 -156.59 7.34 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.73 5.3 5.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.142 1.601 . . . . 0.0 111.572 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -170.75 100.5 0.23 Allowed 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.389 0.614 . . . . 0.0 110.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.04 133.26 12.11 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -117.71 160.36 21.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 109.603 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.514 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.3 p -110.66 124.23 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.629 -1.294 . . . . 0.0 110.32 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.69 132.63 53.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.406 -0.809 . . . . 0.0 109.918 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.753 ' HB2' HD13 ' A' ' 55' ' ' LEU . 12.2 tp -76.06 98.3 4.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.654 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 115' ' ' LEU . . . 63.71 160.76 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.407 -0.808 . . . . 0.0 109.728 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -109.4 111.13 22.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.096 -1.003 . . . . 0.0 110.299 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.272 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.21 0.529 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.93 57.7 3.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.12 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' SER . 6.3 t 56.3 -165.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.31 -0.869 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.302 33.1 t -174.3 86.69 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.941 -175.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 48.0 mttm -90.7 126.86 36.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 110.233 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 17.9 p -118.2 149.82 40.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.036 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 29.8 m-85 -54.9 -33.51 62.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.101 -0.999 . . . . 0.0 109.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HD3' HD11 ' A' ' 52' ' ' ILE . 4.1 ttt180 -61.14 -45.47 94.53 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 53' ' ' GLU . 55.1 mt-10 -58.38 -43.97 88.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 50' ' ' LEU . 46.6 mt -51.38 -34.09 32.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.688 -1.257 . . . . 0.0 108.311 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.66 HG21 ' CD2' ' A' ' 103' ' ' PHE . 30.2 mt -79.83 -55.1 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.482 HD11 ' HD3' ' A' ' 48' ' ' ARG . 60.2 mt -58.63 -53.98 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -61.17 -40.28 93.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -56.89 -47.74 84.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 8.2 mt -67.05 -49.87 63.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.937 . . . . 0.0 108.521 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 53' ' ' GLU . 2.6 m -55.45 -24.39 30.56 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.78 -27.27 19.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 13.2 mt -52.39 -22.75 4.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -0.94 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 63.71 30.99 14.63 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.131 0.491 . . . . 0.0 110.913 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 61' ' ' ARG . 2.8 mt-10 57.33 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.516 -0.74 . . . . 0.0 110.972 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 176.26 -121.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.472 -0.768 . . . . 0.0 109.457 179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 62' ' ' LYS . 1.7 ttmm -116.7 12.1 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.86 -1.15 . . . . 0.0 109.738 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.3 165.73 14.76 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.606 ' OG ' HD13 ' A' ' 58' ' ' LEU . 68.1 m -138.27 176.98 8.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -1.06 . . . . 0.0 109.649 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.692 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 20.5 p -131.26 174.51 9.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 111.237 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.635 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 5.9 tpp180 -48.07 -46.31 65.01 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.872 -0.517 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.7 Cg_endo -70.4 -43.15 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.229 1.12 . . . . 0.0 110.59 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.19 -31.9 61.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 109.491 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 65' ' ' SER . 3.6 mm? -78.45 -53.86 6.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.344 -0.848 . . . . 0.0 109.119 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.829 ' HA ' HD12 ' A' ' 73' ' ' ILE . 77.0 mttt -50.01 -36.41 28.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -51.65 -50.94 59.36 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.582 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.7 t80 -63.46 -45.93 88.59 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.87 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 14.0 mt -63.77 -32.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.418 -0.801 . . . . 0.0 110.757 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 35.2 pttt -91.2 -41.38 11.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.095 -1.003 . . . . 0.0 111.494 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.572 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 34.2 mt-10 -93.83 -65.14 1.01 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.945 -1.097 . . . . 0.0 109.668 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 3.9 m-20 -59.94 -15.68 23.92 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.857 -1.152 . . . . 0.0 108.632 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.641 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -130.88 176.93 2.5 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.554 ' HG2' HG12 ' A' ' 80' ' ' VAL . 43.2 Cg_endo -65.74 173.63 6.57 Favored 'Trans proline' 0 C--N 1.283 -2.904 0 O-C-N 123.968 1.509 . . . . 0.0 113.594 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.621 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 3.1 mt -52.75 -12.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.882 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.612 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p -45.63 -30.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.28 -37.32 6.7 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 176.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -80.95 45.5 0.83 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.66 -0.906 . . . . 0.0 110.367 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.06 -138.18 0.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 110.07 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 1.9 t -141.46 -77.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.986 -1.071 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 20.1 t-20 -41.95 -36.93 1.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -1.0 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.87 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.35 -42.01 61.01 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.838 -1.163 . . . . 0.0 108.62 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.2 t0 -46.17 -27.31 0.95 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.18 -33.28 33.12 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.841 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 16.3 m-85 -71.92 -43.34 65.46 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.205 -0.934 . . . . 0.0 108.949 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' A' ' 51' ' ' ILE . 68.6 t80 -58.46 -38.82 78.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 13.2 m-80 -61.53 -55.4 31.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.666 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -50.14 -39.2 42.54 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.396 178.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.653 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -69.11 -38.61 79.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 98' ' ' VAL . 10.1 mm -62.58 -60.55 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -39.17 73.81 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.291 -0.881 . . . . 0.0 108.644 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 16.8 tptt -66.78 -51.23 58.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.452 -0.78 . . . . 0.0 109.609 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -63.58 -49.56 68.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 94' ' ' ILE . 62.0 t -51.17 -25.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.472 -1.017 . . . . 0.0 109.369 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -90.5 -49.45 6.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.592 -0.693 . . . . 0.0 110.543 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.83 -32.58 5.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -67.56 -9.93 56.57 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 97' ' ' GLY . 6.6 t0 69.3 37.37 2.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.642 -0.916 . . . . 0.0 110.992 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.66 ' CD2' HG21 ' A' ' 51' ' ' ILE . 3.6 m-30 -89.18 144.75 25.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.137 . . . . 0.0 109.398 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 117' ' ' LYS . 23.9 mm-40 -97.43 126.66 42.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.14 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.531 ' NE2' ' HB ' ' A' ' 113' ' ' VAL . 6.7 mm-40 -143.55 124.33 7.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.842 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 49.3 Cg_endo -85.23 -164.84 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.805 1.424 . . . . 0.0 109.552 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -137.56 -3.7 1.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 111.516 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 107' ' ' LYS . . . -52.52 -167.09 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.46 4.94 4.54 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.887 1.467 . . . . 0.0 111.617 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' GLY . . . -131.97 64.68 1.59 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-O 121.408 0.623 . . . . 0.0 109.675 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 110' ' ' ALA . . . -43.61 113.61 0.75 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -120.21 146.99 45.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -1.096 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.531 ' HB ' ' NE2' ' A' ' 105' ' ' GLN . 1.5 p -116.88 117.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.77 -1.207 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 23.5 mtpt -112.95 128.0 56.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.941 . . . . 0.0 109.664 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 55' ' ' LEU . 16.6 tp -68.35 101.81 1.28 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 110.278 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 115' ' ' LEU . . . 39.74 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.63 -0.669 . . . . 0.0 110.602 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.489 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -68.35 95.75 0.62 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.96 . . . . 0.0 110.078 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.7 tttt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.222 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.214 0.531 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 43' ' ' SER . . . -163.4 170.08 18.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 110.197 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -58.14 -157.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.808 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.295 30.2 t -173.71 54.29 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.345 -1.342 . . . . 0.0 110.941 -175.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -103.2 149.15 24.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.833 . . . . 0.0 109.963 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 p -120.84 171.73 8.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 110.492 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.66 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . 75.0 m-85 -57.84 -24.42 57.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.407 -0.808 . . . . 0.0 110.06 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.548 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -52.76 -45.57 67.13 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.8 mm-40 -57.86 -45.48 86.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.347 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.512 HD12 ' HD1' ' A' ' 47' ' ' TYR . 74.7 mt -51.44 -32.38 26.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.799 -1.188 . . . . 0.0 108.392 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 94' ' ' ILE . 50.8 mt -82.72 -55.12 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 ' CE1' ' A' ' 103' ' ' PHE . 56.1 mt -57.49 -53.59 42.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 49' ' ' GLU . 6.5 mt-10 -60.14 -39.95 88.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.599 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.03 -44.17 96.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.991 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.2 mt -64.35 -39.13 93.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.5 -1.0 . . . . 0.0 109.553 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -71.65 -27.82 63.33 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.259 -0.901 . . . . 0.0 108.64 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.78 -19.72 23.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.619 -0.676 . . . . 0.0 109.77 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.991 HD12 ' HA ' ' A' ' 55' ' ' LEU . 9.9 mt -57.92 -40.78 81.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.326 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 1.4 mtpp 63.57 67.25 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.733 -0.605 . . . . 0.0 110.398 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 61' ' ' ARG . 11.6 mt-10 -148.84 -44.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 109.953 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' CB ' ' O ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER 68.77 2.31 3.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.285 -0.884 . . . . 0.0 111.137 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.49 -19.76 12.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.997 -1.064 . . . . 0.0 109.977 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' HA2' ' CG ' ' A' ' 114' ' ' LYS . . . 133.22 163.91 10.65 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.601 ' OG ' HD22 ' A' ' 58' ' ' LEU . 9.0 m -148.99 -170.13 3.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.698 -0.884 . . . . 0.0 109.687 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.612 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p -133.69 171.06 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.923 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 1.3 ttp85 -46.14 -47.77 43.82 Favored Pre-proline 0 C--N 1.298 -1.672 0 O-C-N 121.658 -0.651 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 38.7 Cg_endo -67.74 -43.23 5.6 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.258 1.136 . . . . 0.0 110.861 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.612 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.52 -20.63 13.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 0.0 109.601 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.941 HD21 HD11 ' A' ' 58' ' ' LEU . 3.8 mm? -93.17 -45.22 7.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.16 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -57.44 -44.15 84.49 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 2.4 ttpt -47.2 -49.7 22.33 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.599 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 3.5 t80 -64.71 -49.04 72.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.56 -0.712 . . . . 0.0 109.283 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 15.9 mt -60.82 -31.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 111.013 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.58 ' HB2' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -91.26 -41.83 10.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.079 -1.013 . . . . 0.0 111.732 -178.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' CG ' ' HG3' ' A' ' 74' ' ' LYS . 22.3 mt-10 -95.73 -65.55 0.97 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.926 -1.109 . . . . 0.0 110.055 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 97.5 m-20 -56.87 -22.01 33.77 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.827 -1.171 . . . . 0.0 107.916 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.667 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.3 m-85 -123.84 175.85 2.59 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.58 ' HG2' HG12 ' A' ' 80' ' ' VAL . 44.9 Cg_endo -66.69 175.56 5.17 Favored 'Trans proline' 0 C--N 1.28 -3.041 0 O-C-N 124.016 1.535 . . . . 0.0 114.069 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.616 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -51.57 -14.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.021 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.619 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 4.0 p -45.58 -30.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -91.16 -35.27 7.14 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -84.19 21.69 1.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.741 -0.858 . . . . 0.0 110.244 178.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -101.86 -140.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 0.0 110.571 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 1.3 p -135.86 -87.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.937 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.4 m120 -39.86 -26.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 0.0 111.092 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.906 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 2.0 t80 -51.46 -42.83 61.85 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.829 -1.169 . . . . 0.0 108.55 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.58 ' CG ' ' HZ1' ' A' ' 70' ' ' LYS . 2.0 m-20 -46.52 -29.79 1.94 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.533 -0.867 . . . . 0.0 108.86 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 tp -77.19 -32.25 55.93 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.93 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.611 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 17.4 m-85 -75.53 -43.29 49.59 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.952 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.642 ' CZ ' HD11 ' A' ' 94' ' ' ILE . 67.0 t80 -60.97 -43.95 98.05 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.671 -0.811 . . . . 0.0 108.963 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.8 m-20 -56.48 -58.39 8.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.778 . . . . 0.0 109.23 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -53.56 -38.36 63.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 108.928 178.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB2' ' HB2' ' A' ' 47' ' ' TYR . . . -69.88 -35.04 74.35 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.298 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.651 ' HA ' HD13 ' A' ' 51' ' ' ILE . 7.1 mm -67.53 -59.68 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.96 -38.22 75.6 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.5 tppt? -60.91 -47.67 85.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -67.99 -51.4 34.41 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.679 HG21 ' HG3' ' A' ' 105' ' ' GLN . 70.4 t -63.01 -42.43 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.456 -1.026 . . . . 0.0 110.262 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.542 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 21.9 tp10 -61.4 -35.35 77.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.153 -0.967 . . . . 0.0 109.815 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.46 11.44 4.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.82 23.59 77.78 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.518 ' HB3' ' CD1' ' A' ' 103' ' ' PHE . 1.1 t0 -85.35 -65.58 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -1.136 . . . . 0.0 110.167 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -99.81 -169.87 1.81 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.208 -0.932 . . . . 0.0 109.742 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' LYS . 34.9 mm-40 -129.66 125.09 35.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.7 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HG3' HG21 ' A' ' 98' ' ' VAL . 5.8 mt-30 -138.26 130.6 16.12 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.387 -0.821 . . . . 0.0 110.379 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -82.96 -160.8 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.89 1.468 . . . . 0.0 109.507 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.51 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 1.2 mmtt -158.41 109.92 2.2 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.217 -0.927 . . . . 0.0 109.199 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.7 -148.17 7.45 Favored Glycine 0 C--N 1.284 -2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.52 5.04 5.46 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.326 1.698 . . . . 0.0 111.407 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.09 87.05 1.18 Allowed 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 121.321 0.581 . . . . 0.0 110.189 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.44 121.38 8.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.538 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -119.18 160.36 22.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -1.136 . . . . 0.0 109.79 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 1.5 p -128.24 122.14 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.785 -1.197 . . . . 0.0 111.052 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.528 ' CG ' ' HA2' ' A' ' 63' ' ' GLY . 33.1 mtpt -116.35 124.38 49.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.36 -0.838 . . . . 0.0 109.486 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.753 HD23 HD13 ' A' ' 55' ' ' LEU . 3.1 tm? -76.19 110.09 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . 166.82 161.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 110.504 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -115.1 123.52 49.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.404 -0.81 . . . . 0.0 109.805 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.289 -179.825 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 32.0 tt0 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 41' ' ' GLU . . . 56.63 172.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.134 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.3 p -131.38 36.91 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.742 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 43' ' ' SER 0.287 22.3 t 53.33 167.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.198 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.61 99.46 6.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.094 -1.004 . . . . 0.0 110.122 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 33.2 p -132.9 148.06 52.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 110.134 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 89' ' ' TYR . 76.8 m-85 -52.84 -26.61 15.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 109.193 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 52' ' ' ILE . 18.6 ttp180 -51.89 -44.11 63.63 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' GLU . 9.2 mt-10 -57.95 -43.92 86.68 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.508 HD22 HG23 ' A' ' 73' ' ' ILE . 31.1 mt -52.82 -31.95 41.57 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.551 -1.343 . . . . 0.0 107.859 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 93' ' ' ALA . 2.9 mt -82.77 -55.27 7.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 ' CE1' ' A' ' 103' ' ' PHE . 69.9 mt -58.03 -53.03 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 49' ' ' GLU . 5.5 mt-10 -61.39 -40.09 93.09 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -57.21 -47.55 86.87 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HA ' HD12 ' A' ' 58' ' ' LEU . 7.8 mt -65.61 -39.58 91.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.691 -0.888 . . . . 0.0 109.157 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 m -68.67 -29.27 67.69 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.196 -0.94 . . . . 0.0 108.609 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -90.64 -19.71 23.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.611 -0.681 . . . . 0.0 109.868 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.983 HD12 ' HA ' ' A' ' 55' ' ' LEU . 10.2 mt -58.71 -35.44 72.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.412 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.559 ' CD ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 66.72 44.16 2.24 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.799 -0.563 . . . . 0.0 110.305 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HG3' ' C ' ' A' ' 59' ' ' LYS . 33.8 mt-10 -154.36 153.21 31.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -114.58 -19.49 11.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 110.148 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' O ' ' HE3' ' A' ' 114' ' ' LYS . 1.2 ptpp? -63.94 -18.42 64.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.534 ' CA ' ' HG2' ' A' ' 114' ' ' LYS . . . 117.52 167.23 14.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.574 ' OG ' HD22 ' A' ' 58' ' ' LEU . 5.6 m -139.09 -169.3 2.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.718 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 12.0 p -135.6 172.78 12.52 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.192 -0.943 . . . . 0.0 111.243 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -48.71 -48.43 69.7 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.737 -0.602 . . . . 0.0 110.972 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -67.64 -42.47 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.301 1.158 . . . . 0.0 110.358 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.684 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -56.37 -25.75 50.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 58' ' ' LEU . 4.5 mm? -91.17 -48.71 6.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.991 ' HA ' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -55.19 -47.67 74.91 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 9.0 ttpt -42.51 -53.68 4.23 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.57 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.7 t80 -62.72 -42.26 99.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.871 -0.518 . . . . 0.0 109.668 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 24.4 mt -64.38 -33.26 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.164 -0.96 . . . . 0.0 111.526 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.547 ' HG2' ' C ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -88.14 -44.6 10.79 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.836 -1.165 . . . . 0.0 111.252 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -96.8 -64.98 1.0 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 110.333 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 30.0 m-20 -53.81 -22.44 9.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.716 -1.24 . . . . 0.0 107.704 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.64 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.5 m-85 -125.32 174.99 3.37 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HG2' HG12 ' A' ' 80' ' ' VAL . 51.5 Cg_endo -70.88 179.43 4.31 Favored 'Trans proline' 0 C--N 1.279 -3.085 0 O-C-N 123.923 1.486 . . . . 0.0 114.38 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.599 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -50.68 -15.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.073 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.601 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 2.6 p -44.89 -31.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.627 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -89.73 -42.15 5.48 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -85.98 44.68 1.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.683 -0.892 . . . . 0.0 109.618 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . -116.56 -103.46 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.353 -0.842 . . . . 0.0 110.383 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -170.16 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.846 -1.158 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -45.63 -22.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.125 -0.985 . . . . 0.0 110.734 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 1.012 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 1.7 t80 -51.36 -44.49 62.11 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.878 -1.139 . . . . 0.0 108.607 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -45.98 -27.23 0.86 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -81.55 -30.65 33.03 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.829 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.618 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 18.5 m-85 -76.03 -43.56 43.43 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.66 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.65 ' CE1' HD11 ' A' ' 73' ' ' ILE . 76.4 t80 -56.47 -41.53 76.72 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 15.9 m-20 -57.35 -58.95 6.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -54.75 -40.42 69.33 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.511 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -63.6 -44.8 92.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.563 -0.711 . . . . 0.0 109.159 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 98' ' ' VAL . 8.1 mm -62.21 -58.19 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -57.4 -37.18 72.31 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.7 OUTLIER -66.0 -52.43 49.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.453 -0.78 . . . . 0.0 109.64 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -61.99 -48.04 86.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 94' ' ' ILE . 43.7 t -64.27 -44.55 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.464 -1.021 . . . . 0.0 109.989 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 31.9 tp10 -61.29 -36.13 79.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 109.653 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.34 4.81 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.122 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.45 19.57 77.97 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HB3' ' CE1' ' A' ' 103' ' ' PHE . 6.5 m-20 -85.06 -66.67 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.154 -1.204 . . . . 0.0 110.138 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -106.9 174.35 5.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 23.2 mm-40 -117.69 133.83 55.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.28 -0.887 . . . . 0.0 109.757 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.62 ' NE2' HG21 ' A' ' 94' ' ' ILE . 1.3 mm100 -140.67 100.13 6.78 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.98 . . . . 0.0 111.174 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 47.5 Cg_endo -84.05 -158.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.968 1.509 . . . . 0.0 109.398 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 47.9 mmtm -144.42 -94.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.007 -1.058 . . . . 0.0 110.183 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.48 -149.96 31.29 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.75 5.11 5.49 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 124.234 1.65 . . . . 0.0 111.498 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -176.73 100.47 0.06 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.3 0.571 . . . . 0.0 110.028 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.78 132.37 19.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -124.96 124.81 42.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 110.731 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 2.4 p -80.11 119.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HG2' ' CA ' ' A' ' 63' ' ' GLY . 8.7 mtpt -113.29 125.65 54.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.826 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -81.51 141.22 34.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.174 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' N ' ' HG ' ' A' ' 115' ' ' LEU . . . -138.09 -160.36 1.05 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.356 -0.84 . . . . 0.0 109.806 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 123.35 12.33 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.599 -0.688 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.18 -179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.228 0.537 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 156.27 29.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.942 . . . . 0.0 110.25 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.5 OUTLIER -83.0 -166.89 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.217 -0.927 . . . . 0.0 110.583 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.299 33.6 t -174.13 103.15 0.11 Allowed 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.068 -175.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 9.2 ttpt -83.43 126.02 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.904 . . . . 0.0 110.031 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 87.7 p -118.07 162.8 17.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.722 ' HA ' HD12 ' A' ' 50' ' ' LEU . 63.7 m-85 -57.19 -27.96 62.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.918 . . . . 0.0 110.019 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HD2' ' CA ' ' A' ' 97' ' ' GLY 0.25 0.0 OUTLIER -53.04 -44.7 67.58 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.553 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 15.6 mt-10 -56.91 -46.73 81.76 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.202 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 47' ' ' TYR . 51.6 mt -49.72 -32.81 14.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.865 -1.147 . . . . 0.0 107.992 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 93' ' ' ALA . 8.2 mt -78.88 -56.14 8.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.387 0.613 . . . . 0.0 109.42 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.621 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 6.3 mt -58.0 -51.0 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.47 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 49' ' ' GLU . 4.6 mt-10 -63.43 -38.55 91.58 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.625 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -59.16 -44.68 96.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.909 HD13 ' HB2' ' A' ' 115' ' ' LEU . 5.2 mt -65.03 -36.82 85.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.6 -0.941 . . . . 0.0 108.999 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.418 ' HG1' ' H ' ' A' ' 56' ' ' THR . 1.1 m -65.45 -30.66 71.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.539 ' O ' ' CD ' ' A' ' 59' ' ' LYS . . . -91.38 -19.05 23.32 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.313 0.578 . . . . 0.0 109.769 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.836 HD11 HD21 ' A' ' 69' ' ' LEU . 10.1 mt -57.11 -18.3 14.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.159 -0.963 . . . . 0.0 109.219 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 58' ' ' LEU . 1.6 mmmt 81.71 15.87 0.49 Allowed 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.191 0.519 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 60.15 135.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.041 -1.037 . . . . 0.0 110.463 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 60' ' ' GLU . 1.0 OUTLIER 179.89 -153.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.929 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 114' ' ' LYS . 2.8 ttpm? -79.14 4.82 13.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.952 . . . . 0.0 109.859 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 61' ' ' ARG . . . 121.73 168.88 13.48 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.708 ' OG ' HD13 ' A' ' 58' ' ' LEU . 8.5 m -131.84 -168.82 2.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.42 -1.047 . . . . 0.0 109.903 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 75.8 p -129.25 176.79 7.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.177 -0.952 . . . . 0.0 111.206 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -59.56 -43.83 96.53 Favored Pre-proline 0 C--N 1.297 -1.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.824 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 40.9 Cg_endo -73.62 -41.07 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.449 1.236 . . . . 0.0 110.137 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 65' ' ' SER . . . -55.01 -30.3 59.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.369 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 58' ' ' LEU . 3.6 mm? -78.03 -53.44 7.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 109.161 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.901 ' HA ' HD12 ' A' ' 73' ' ' ILE . 56.1 mttt -48.34 -34.42 10.59 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.977 -1.077 . . . . 0.0 108.308 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 4.6 ttpt -56.37 -51.9 66.59 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.625 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.5 t80 -60.39 -45.09 94.8 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.979 HG21 ' CZ ' ' A' ' 86' ' ' PHE . 15.9 mt -61.67 -32.09 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.454 -0.779 . . . . 0.0 110.709 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.556 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 5.7 ptmm? -91.23 -41.48 10.95 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.065 -1.022 . . . . 0.0 111.571 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' HG3' ' CG ' ' A' ' 74' ' ' LYS . 30.5 mt-10 -92.12 -66.3 0.94 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.924 -1.11 . . . . 0.0 109.76 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.619 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 1.2 m120 -56.28 -27.04 53.97 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.985 -1.072 . . . . 0.0 108.278 178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 1.2 m-85 -120.48 177.87 1.32 Allowed Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.56 ' HG2' ' CG1' ' A' ' 80' ' ' VAL . 44.4 Cg_endo -64.62 173.37 5.6 Favored 'Trans proline' 0 C--N 1.285 -2.801 0 O-C-N 124.097 1.577 . . . . 0.0 113.783 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.571 ' CA ' ' HB2' ' A' ' 82' ' ' SER . 5.8 pt -52.88 -12.93 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.914 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 73' ' ' ILE . 9.0 p -46.63 -28.55 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -88.29 -35.46 8.77 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.571 ' HB2' ' CA ' ' A' ' 79' ' ' ILE . 14.3 m -51.16 -52.46 43.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.676 -0.896 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 82' ' ' SER . . . -49.95 -173.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.575 0.703 . . . . 0.0 111.222 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ASP . 46.8 t -117.2 -63.62 1.42 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 110.546 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 39.9 t30 -38.64 -38.8 0.43 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.348 -0.845 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.979 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -51.15 -41.37 60.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.894 -1.129 . . . . 0.0 108.428 178.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -45.69 -31.16 1.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 85' ' ' ASN . 5.7 tp -71.62 -39.5 70.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.727 -0.608 . . . . 0.0 109.733 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.616 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 19.8 m-85 -67.37 -42.47 83.38 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.653 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 51' ' ' ILE . 11.1 t80 -64.67 -41.5 96.04 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.652 -0.819 . . . . 0.0 108.871 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 87' ' ' ASP . 93.1 m-20 -55.3 -52.03 64.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.836 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -56.26 -41.87 76.51 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.139 -0.976 . . . . 0.0 108.914 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.793 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -58.88 -39.07 80.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.4 -0.813 . . . . 0.0 109.144 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HD13 ' A' ' 51' ' ' ILE . 18.1 mm -59.66 -56.45 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 108.977 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -39.69 93.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 29.1 tptt -63.03 -49.44 74.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.374 -0.829 . . . . 0.0 109.46 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' A' ' 103' ' ' PHE . . . -65.75 -50.36 54.08 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 103' ' ' PHE . 19.6 t -49.6 -23.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.067 -1.255 . . . . 0.0 108.904 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 3.2 tp10 -87.17 -49.78 7.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.715 . . . . 0.0 110.178 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.78 -33.74 4.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -68.25 -11.33 61.38 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 97' ' ' GLY . 9.2 m-20 65.1 32.13 10.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.796 -0.826 . . . . 0.0 111.215 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.621 ' CZ ' HG12 ' A' ' 52' ' ' ILE . 3.6 m-30 -77.5 146.57 36.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.852 -1.155 . . . . 0.0 109.22 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 114' ' ' LYS . 58.1 mm-40 -97.38 123.39 41.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 108.609 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -140.89 99.04 6.8 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 111.076 -178.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 44.1 Cg_endo -73.58 -158.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.593 1.312 . . . . 0.0 109.508 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 14.9 mmtm -140.83 -110.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 0.0 110.361 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 -157.21 51.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.01 6.05 4.91 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.159 1.61 . . . . 0.0 111.56 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.64 97.52 0.67 Allowed 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.413 0.625 . . . . 0.0 109.621 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.62 125.88 17.6 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -115.12 159.74 20.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 2.1 p -111.34 142.34 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.946 -1.096 . . . . 0.0 110.781 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.561 ' CB ' ' HB2' ' A' ' 104' ' ' GLU . 6.3 mttm -136.93 130.03 31.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.479 -0.763 . . . . 0.0 109.684 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.909 ' HB2' HD13 ' A' ' 55' ' ' LEU . 24.5 tp -80.97 93.81 6.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.077 -1.014 . . . . 0.0 110.352 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 115' ' ' LEU . . . 56.62 115.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.471 -0.768 . . . . 0.0 110.407 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -54.68 138.95 40.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -0.979 . . . . 0.0 110.156 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.5 tttp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.106 -179.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.335 0.588 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.66 103.76 3.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.205 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 44' ' ' SER . 17.9 m -79.28 -158.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.727 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 43' ' ' SER 0.301 30.4 t -174.52 80.9 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.841 -175.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -66.95 155.67 37.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.158 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 30.4 p -125.93 153.78 43.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.136 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.666 ' CE2' ' CD1' ' A' ' 89' ' ' TYR . 57.0 m-85 -54.93 -24.49 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -57.14 -43.75 82.76 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.9 mt-10 -59.7 -45.36 92.36 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.385 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 47' ' ' TYR . 52.4 mt -50.68 -31.51 16.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.78 -1.2 . . . . 0.0 108.089 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 93' ' ' ALA . 41.7 mt -84.0 -55.09 7.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.627 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 63.5 mt -56.14 -50.55 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.62 ' HA2' ' CD2' ' A' ' 72' ' ' PHE . . . -54.42 -45.06 76.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 115' ' ' LEU . 7.5 mt -63.21 -39.5 94.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.662 -0.905 . . . . 0.0 109.013 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.5 m -67.21 -30.92 70.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' O ' ' HD2' ' A' ' 59' ' ' LYS . . . -90.98 -13.37 33.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.717 -0.614 . . . . 0.0 109.704 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 55' ' ' LEU . 9.3 mt -56.03 -46.14 78.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.156 -0.965 . . . . 0.0 109.011 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 53.13 21.79 2.3 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.371 0.605 . . . . 0.0 110.304 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.11 -161.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.848 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -143.48 3.61 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.065 -1.022 . . . . 0.0 111.076 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.2 -8.91 20.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.873 -1.142 . . . . 0.0 110.553 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 64' ' ' SER . . . 107.81 -29.64 10.08 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.218 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.642 ' OG ' HD22 ' A' ' 58' ' ' LEU . 67.1 m 65.37 159.35 0.11 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.015 -0.697 . . . . 0.0 109.425 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 4.8 p -113.44 171.49 7.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.099 -1.001 . . . . 0.0 111.064 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.2 ttp180 -41.17 -50.26 8.25 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.87 -0.519 . . . . 0.0 111.059 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 39.0 Cg_endo -66.86 -44.02 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.365 1.192 . . . . 0.0 110.495 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.06 -26.34 10.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 109.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 58' ' ' LEU . 2.8 mm? -86.87 -45.19 11.08 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' CE ' ' HA ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -49.48 -42.42 43.3 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -50.26 -51.99 40.06 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.084 0.945 . . . . 0.0 109.013 178.067 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.62 ' CD2' ' HA2' ' A' ' 54' ' ' GLY . 2.4 t80 -59.37 -47.33 85.84 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.92 HD13 ' HZ ' ' A' ' 86' ' ' PHE . 41.8 mt -64.33 -32.74 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.474 -0.766 . . . . 0.0 111.332 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.588 ' HB2' ' N ' ' A' ' 82' ' ' SER . 14.4 ptmt -91.22 -42.2 10.55 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.033 -1.042 . . . . 0.0 111.379 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 9.6 mt-10 -94.95 -64.92 1.02 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.923 -1.111 . . . . 0.0 110.009 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.489 ' HB2' ' CD1' ' A' ' 72' ' ' PHE . 7.1 m-20 -56.53 -23.44 39.91 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.71 -1.244 . . . . 0.0 108.003 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.666 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -122.45 177.54 1.57 Allowed Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 80' ' ' VAL . 47.9 Cg_endo -66.27 175.47 4.9 Favored 'Trans proline' 0 C--N 1.283 -2.896 0 O-C-N 124.037 1.546 . . . . 0.0 114.429 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.597 ' HA ' ' CB ' ' A' ' 82' ' ' SER . 1.5 pp -52.54 -13.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.607 ' O ' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p -45.92 -30.39 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.604 ' HA2' ' CE2' ' A' ' 86' ' ' PHE . . . -90.77 -37.2 6.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 106.965 -2.454 . . . . 0.0 106.965 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.597 ' CB ' ' HA ' ' A' ' 79' ' ' ILE . 0.7 OUTLIER -85.17 36.87 0.65 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.647 -0.914 . . . . 0.0 110.32 179.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.92 -110.62 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.019 -1.05 . . . . 0.0 110.308 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 86' ' ' PHE . 4.4 m -166.11 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.877 -1.139 . . . . 0.0 110.343 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' SER . 57.4 t-20 -39.86 -27.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.289 -0.882 . . . . 0.0 110.663 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.92 ' HZ ' HD13 ' A' ' 73' ' ' ILE . 1.6 t80 -54.35 -42.07 69.83 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.953 -1.092 . . . . 0.0 108.847 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.549 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 3.9 p-10 -47.79 -28.02 2.33 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.175 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tp -78.6 -32.48 47.58 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.96 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.666 ' CD1' ' CE2' ' A' ' 47' ' ' TYR . 29.1 m-85 -74.28 -41.13 61.73 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.715 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 73' ' ' ILE . 67.0 t80 -63.36 -48.11 79.3 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.383 -0.823 . . . . 0.0 108.791 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 14.6 m-80 -52.12 -57.26 10.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.166 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.8 OUTLIER -54.05 -39.01 65.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.059 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 51' ' ' ILE . . . -68.46 -37.99 80.69 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.351 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.794 HD11 ' CE2' ' A' ' 90' ' ' PHE . 12.9 mm -62.84 -61.11 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 99' ' ' GLU . 25.1 mttt -57.35 -39.88 76.89 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -59.73 -43.11 94.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.462 -0.774 . . . . 0.0 109.746 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 102' ' ' ASP . . . -70.9 -51.97 16.68 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.886 HG21 ' HG3' ' A' ' 105' ' ' GLN . 48.4 t -64.83 -42.07 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -1.124 . . . . 0.0 110.325 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 95' ' ' LYS . 17.2 tp10 -60.18 -38.09 82.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.172 -0.955 . . . . 0.0 109.72 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.39 8.37 6.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.455 -0.778 . . . . 0.0 110.292 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.73 22.02 75.65 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 5.3 t0 -82.89 -66.94 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -1.148 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -109.21 177.0 4.88 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.739 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 114' ' ' LYS . 16.7 mm-40 -111.01 126.14 54.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.45 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.886 ' HG3' HG21 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -138.5 98.32 9.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 110.985 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 48.2 Cg_endo -78.01 -174.9 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.684 1.36 . . . . 0.0 109.909 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -113.17 -81.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.081 -1.012 . . . . 0.0 110.071 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.45 -145.89 46.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.04 4.8 5.85 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.302 1.685 . . . . 0.0 111.265 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -168.53 -103.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.097 0 O-C-N 121.866 -0.522 . . . . 0.0 110.293 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.48 107.1 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -89.47 161.65 16.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.174 . . . . 0.0 109.741 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.582 ' O ' HD21 ' A' ' 55' ' ' LEU . 2.1 p -126.64 100.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.118 . . . . 0.0 111.016 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 104' ' ' GLU . 28.8 mttp -99.81 126.52 45.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 55' ' ' LEU . 25.0 tp -78.44 103.63 8.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . 165.53 177.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.289 -0.882 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.1 139.05 50.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.76 . . . . 0.0 110.3 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.118 179.594 . . . . . . . . 1 1 . 1 stop_ save_